##fileformat=VCFv4.2
##fileDate=20200808
##reference=ftp://ftp.ncbi.nih.gov/genbank/genomes/Eukaryotes/vertebrates_mammals/Homo_sapiens/GRCh37/special_requests/GRCh37-lite.fa.gz
##source=CIViCpy_v1.1.2
##aboutURL=https://civicdb.org/help/evidence/overview
##INFO=<ID=GN,Number=1,Type=String,Description="HGNC Gene Symbol">
##INFO=<ID=VT,Number=1,Type=String,Description="CIViC Variant Name">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from CIViC. Format: Allele|Consequence|SYMBOL|Entrez Gene ID|Feature_type|Feature|HGVSc|HGVSp|CIViC Variant Name|CIViC Variant ID|CIViC Variant Aliases|CIViC HGVS|Allele Registry ID|ClinVar IDs|CIViC Variant Evidence Score|CIViC Entity Type|CIViC Entity ID|CIViC Entity URL|CIViC Entity Source|CIViC Entity Variant Origin|CIViC Entity Status|CIViC Entity Clinical Significance|CIViC Entity Direction|CIViC Entity Disease|CIViC Entity Drugs|CIViC Entity Drug Interaction Type|CIViC Evidence Phenotypes|CIViC Evidence Level|CIViC Evidence Rating|CIViC Assertion ACMG Codes|CIViC Assertion AMP Category|CIViC Assertion NCCN Guideline|CIVIC Assertion Regulatory Approval|CIVIC Assertion FDA Companion Test ">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	8073509	691	C	A	.	.	GN=ERRFI1;VT=E384*;CSQ=A|loss_of_function_variant&stop_gained|ERRFI1|54206|transcript|ENST00000377482.5|||E384*|691|GLU384TER&E384X|NC\x5F000001\x2E10\x3Ag\x2E8073509C\x3EA|CA338219584|NONE_FOUND|5.0|evidence|1724|https://civicdb.org/links/evidence/1724|24550739_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Erlotinib_(NCIt_ID_C65530)|||C|2|||||
1	11177096	609	C	A	.	.	GN=MTOR;VT=M2327I;CSQ=A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6981G>T||M2327I|609|MET2327ILE|ENST00000361445\x2E4\x3Ac\x2E6981G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11177096C\x3EA|CA338383476|NONE_FOUND|7.0|evidence|1545|https://civicdb.org/links/evidence/1545|27279227_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)&RapaLink-1|Substitutes||D|3|||||,A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6981G>T||M2327I|609|MET2327ILE|ENST00000361445\x2E4\x3Ac\x2E6981G\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11177096C\x3EA|CA338383476|NONE_FOUND|7.0|evidence|1544|https://civicdb.org/links/evidence/1544|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|MTOR_Kinase_Inhibitor_AZD8055_(NCIt_ID_C78856)|||D|4|||||
1	11184573	542	G	T	.	.	GN=MTOR;VT=S2215Y;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6644C>A||S2215Y|542|SER2215TYR|NP\x5F004949\x2E1\x3Ap\x2ESer2215Tyr&NM\x5F004958\x2E3\x3Ac\x2E6644C\x3EA&ENST00000361445\x2E4\x3Ac\x2E6644C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11184573G\x3ET|CA16602587|376129|2.0|evidence|1319|https://civicdb.org/links/evidence/1319|24631838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Endometrial_Adenocarcinoma_(DOID_2870)|Sirolimus_(NCIt_ID_C1212)|||D|2|||||
1	11184580	284	G	A	.	.	GN=MTOR;VT=P2213S;CSQ=A|gain_of_function_variant&missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6637C>T||P2213S|284|PRO2213SER|NP\x5F004949\x2E1\x3Ap\x2EPro2213Ser&NM\x5F004958\x2E3\x3Ac\x2E6637C\x3ET&ENST00000361445\x2E4\x3Ac\x2E6637C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11184580G\x3EA|CA16602798|376358|3.0|evidence|722|https://civicdb.org/links/evidence/722|26490311_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|PI3K/BET_Inhibitor_LY294002_(NCIt_ID_C148229)&Capivasertib_(NCIt_ID_C102564)|Combination||D|3|||||
1	11187094	470	G	T	.	.	GN=MTOR;VT=F2108L;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|ENST00000361445\x2E4\x3Ac\x2E6324C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11187094G\x3ET|CA338391533|NONE_FOUND|16.5|evidence|1543|https://civicdb.org/links/evidence/1543|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)|||D|4|||||,T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|ENST00000361445\x2E4\x3Ac\x2E6324C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11187094G\x3ET|CA338391533|NONE_FOUND|16.5|evidence|1110|https://civicdb.org/links/evidence/1110|25295501_(PubMed)|Somatic|accepted|Resistance|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Everolimus_(NCIt_ID_C48387)|||C|5|||||
1	11187796	610	G	A	.	.	GN=MTOR;VT=A2034V;CSQ=A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6101C>T||A2034V|610|ALA2034VAL|ENST00000361445\x2E4\x3Ac\x2E6101C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11187796G\x3EA|CA338393920|NONE_FOUND|8.0|evidence|1548|https://civicdb.org/links/evidence/1548|27279227_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Breast_Cancer_(DOID_1612)|RapaLink-1&MTOR_Kinase_Inhibitor_AZD8055_(NCIt_ID_C78856)|Substitutes||D|4|||||,A|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6101C>T||A2034V|610|ALA2034VAL|ENST00000361445\x2E4\x3Ac\x2E6101C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11187796G\x3EA|CA338393920|NONE_FOUND|8.0|evidence|1547|https://civicdb.org/links/evidence/1547|27279227_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)|||D|4|||||
1	11188519	283	G	A	.	.	GN=MTOR;VT=H1968Y;CSQ=A|gain_of_function_variant&missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.5902C>T||H1968Y|283|HIS1968TYR|NP\x5F004949\x2E1\x3Ap\x2EHis1968Tyr&NM\x5F004958\x2E3\x3Ac\x2E5902C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E11188519G\x3EA&ENST00000361445\x2E4\x3Ac\x2E5902C\x3ET|CA16602797|376357|3.0|evidence|713|https://civicdb.org/links/evidence/713|26490311_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Capivasertib_(NCIt_ID_C102564)&PI3K/BET_Inhibitor_LY294002_(NCIt_ID_C148229)|Substitutes||D|3|||||
1	11190804	544	C	T	.	.	GN=MTOR;VT=E1799K;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.5395G>A||E1799K|544|RS863225264&GLU1799LYS|ENST00000361445\x2E4\x3Ac\x2E5395G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11190804C\x3ET&NP\x5F004949\x2E1\x3Ap\x2EGlu1799Lys&NM\x5F004958\x2E3\x3Ac\x2E5395G\x3EA|CA279594|217823|2.0|evidence|1321|https://civicdb.org/links/evidence/1321|24631838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Clear_Cell_Renal_Cell_Carcinoma_(DOID_4467)|Sirolimus_(NCIt_ID_C1212)|||D|2|||||
1	11217230	543	C	T	.	.	GN=MTOR;VT=C1483Y;CSQ=T|missense_variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.4448G>A||C1483Y|543|CYS1483TYR|NP\x5F004949\x2E1\x3Ap\x2ECys1483Tyr&NM\x5F004958\x2E3\x3Ac\x2E4448G\x3EA&ENST00000361445\x2E4\x3Ac\x2E4448G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E11217230C\x3ET|CA16602888|376453|2.0|evidence|1320|https://civicdb.org/links/evidence/1320|24631838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Sirolimus_(NCIt_ID_C1212)|||D|2|||||
1	11856378	258	G	A	.	.	GN=MTHFR;VT=A222V;CSQ=A|missense_variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|ALA222VAL&C677T&RS1801133|NC\x5F000001\x2E10\x3Ag\x2E11856378G\x3EA&ENST00000376592\x2E1\x3Ac\x2E665G\x3EA&NP\x5F005948\x2E3\x3Ap\x2EAla222Val&NM\x5F005957\x2E4\x3Ac\x2E665C\x3ET|CA170990|3520|55.0|evidence|1756|https://civicdb.org/links/evidence/1756|27819322_(PubMed)|Rare_Germline|accepted|Better_Outcome|Supports|Pancreatic_Cancer_(DOID_1793)||||B|4|||||,A|missense_variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|ALA222VAL&C677T&RS1801133|NC\x5F000001\x2E10\x3Ag\x2E11856378G\x3EA&ENST00000376592\x2E1\x3Ac\x2E665G\x3EA&NP\x5F005948\x2E3\x3Ap\x2EAla222Val&NM\x5F005957\x2E4\x3Ac\x2E665C\x3ET|CA170990|3520|55.0|evidence|1757|https://civicdb.org/links/evidence/1757|26693073_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Rectum_Cancer_(DOID_1993)|Fluorouracil_(NCIt_ID_C505)|||B|4|||||,A|missense_variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|ALA222VAL&C677T&RS1801133|NC\x5F000001\x2E10\x3Ag\x2E11856378G\x3EA&ENST00000376592\x2E1\x3Ac\x2E665G\x3EA&NP\x5F005948\x2E3\x3Ap\x2EAla222Val&NM\x5F005957\x2E4\x3Ac\x2E665C\x3ET|CA170990|3520|55.0|evidence|669|https://civicdb.org/links/evidence/669|18704422_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Stomach_Cancer_(DOID_10534)|Fluorouracil_(NCIt_ID_C505)|||B|3|||||
1	17350521	2411	G	GGCAGCTGGTGCT	.	.	GN=SDHB;VT=p.193_196dupSTSC_(c.577_588dupAGCACCAGCTGC);CSQ=GCAGCTGGTGCT|inframe_insertion|SDHB|6390|transcript|ENST00000375499.3|||p.193_196dupSTSC_(c.577_588dupAGCACCAGCTGC)|2411|C\x2E589\x5F600DUP|NC\x5F000001\x2E10\x3Ag\x2E17350522\x5F17350533dup&NP\x5F002991\x2E2\x3Ap\x2E193\x5F196dupSTSC&NM\x5F003000\x2E2\x3Ac\x2E577\x5F588dupAGCACCAGCTGC|CA658820851||5.0|evidence|6442|https://civicdb.org/links/evidence/6442|20193854_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Paraganglioma_(DOID_0050773)||||C|2|||||
1	27057658	1510	C	T	.	.	GN=ARID1A;VT=Q456*;CSQ=T|stop_gained|ARID1A|8289|transcript|ENST00000324856.7|ENST00000324856.7:c.1366C>T||Q456*|1510|Q73X|ENST00000324856\x2E7\x3Ac\x2E1366C\x3ET|CA339267901|NONE_FOUND|0.0|evidence|4487|https://civicdb.org/links/evidence/4487|27364904_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Clear_Cell_Carcinoma_(DOID_0050934)|Dasatinib_(NCIt_ID_C38713)|||D|None|||||
1	65311203	822	C	A	.	.	GN=JAK1;VT=S703I;CSQ=A|missense_variant|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.2108G>T||S703I|822|SER703ILE|NC\x5F000001\x2E10\x3Ag\x2E65311203C\x3EA&ENST00000342505\x2E4\x3Ac\x2E2108G\x3ET|CA340667333|NONE_FOUND|4.0|evidence|1900|https://civicdb.org/links/evidence/1900|26701727_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Hepatocellular_Carcinoma_(DOID_684)|Ruxolitinib_(NCIt_ID_C77888)|||D|4|||||
1	65321333	614	G	A	.	.	GN=JAK1;VT=Q503*;CSQ=A|stop_gained|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.1507C>T||Q503*|614|GLN503TER&Q503X|ENST00000342505\x2E4\x3Ac\x2E1507C\x3ET&NC\x5F000001\x2E10\x3Ag\x2E65321333G\x3EA|CA340669637|NONE_FOUND|10.0|evidence|1567|https://civicdb.org/links/evidence/1567|27433843_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Pembrolizumab_(NCIt_ID_C106432)|||C|4|||||
1	68152388	705	T	C	.	.	GN=GADD45A;VT=rs681673;CSQ=C|coding_transcript_intron_variant|GADD45A|1647|transcript|ENST00000370986.4|||rs681673|705|1506T\x3EC||CA10728634||15.0|evidence|1751|https://civicdb.org/links/evidence/1751|26422378_(PubMed)|Common_Germline|accepted|Positive|Supports|Ovarian_Cancer_(DOID_2394)||||B|3|||||
1	97915614	737	C	T	.	.	GN=DPYD;VT=DPYD*2A_HOMOZYGOSITY;CSQ=T|splice_donor_variant|DPYD|1806|transcript|ENST00000370192.3|ENST00000370192.3:c.1905+1G>A||DPYD*2A_HOMOZYGOSITY|737|C\x2E1905\x2B1G\x3EA&DPYD\x3AIVS14\x20\x2B\x201G\x3EA&DPYD\x2A2A&RS3918290|ENST00000370192\x2E3\x3Ac\x2E1905\x2B1G\x3EA&NM\x5F000110\x2E3\x3Ac\x2E1905\x2B1G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E97915614C\x3ET|CA114277|432|50.0|evidence|1800|https://civicdb.org/links/evidence/1800|23988873_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Tegafur_(NCIt_ID_C513)&Capecitabine_(NCIt_ID_C1794)&Fluorouracil_(NCIt_ID_C505)|Substitutes||A|5|||||
1	97981343	738	A	C	.	.	GN=DPYD;VT=DPYD*13_HOMOZYGOSITY;CSQ=C|missense_variant|DPYD|1806|transcript|ENST00000370192.3|ENST00000370192.3:c.1679T>G||DPYD*13_HOMOZYGOSITY|738|I560S&ILE560SER&RS55886062|NC\x5F000001\x2E10\x3Ag\x2E97981343A\x3EC&ENST00000370192\x2E3\x3Ac\x2E1679T\x3EG&NP\x5F000101\x2E2\x3Ap\x2EIle560Ser&NM\x5F000110\x2E3\x3Ac\x2E1679T\x3EG|CA228118|88975|50.0|evidence|1801|https://civicdb.org/links/evidence/1801|23988873_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Tegafur_(NCIt_ID_C513)&Capecitabine_(NCIt_ID_C1794)&Fluorouracil_(NCIt_ID_C505)|Substitutes||A|5|||||
1	115256529	95	T	A	.	.	GN=NRAS;VT=Q61L;CSQ=A|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|RS11554290&GLN61LEU|ENST00000369535\x2E4\x3Ac\x2E182A\x3ET&NM\x5F002524\x2E4\x3Ac\x2E182A\x3ET&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EA&NP\x5F002515\x2E1\x3Ap\x2EGln61Leu|CA16602361|375874|5.0|evidence|22|https://civicdb.org/links/evidence/22|21576590_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Temozolomide_(NCIt_ID_C1244)|||C|2|||||
1	115256529	96	T	C	.	.	GN=NRAS;VT=Q61R;CSQ=C|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|RS11554290&GLN61ARG|ENST00000369535\x2E4\x3Ac\x2E182A\x3EG&NC\x5F000001\x2E10\x3Ag\x2E115256529T\x3EC&NP\x5F002515\x2E1\x3Ap\x2EGln61Arg&NM\x5F002524\x2E4\x3Ac\x2E182A\x3EG|CA123618|13900|5.0|evidence|23|https://civicdb.org/links/evidence/23|21576590_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Temozolomide_(NCIt_ID_C1244)|||C|2|||||
1	115256530	427	G	T	.	.	GN=NRAS;VT=Q61K;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|ENST00000369535\x2E4\x3Ac\x2E181C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|12.0|evidence|1002|https://civicdb.org/links/evidence/1002|26821351_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Everolimus_(NCIt_ID_C48387)&Binimetinib_(NCIt_ID_C84865)|Combination||D|3|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|ENST00000369535\x2E4\x3Ac\x2E181C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|12.0|evidence|1474|https://civicdb.org/links/evidence/1474|22194965_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|ENST00000369535\x2E4\x3Ac\x2E181C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|12.0|evidence|2907|https://civicdb.org/links/evidence/2907|23515407_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Trametinib_(NCIt_ID_C77908)&Selumetinib_(NCIt_ID_C66939)|Substitutes||D|2|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|ENST00000369535\x2E4\x3Ac\x2E181C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|12.0|evidence|2192|https://civicdb.org/links/evidence/2192|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|3|||||,T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|RS121913254&GLN61LYS|ENST00000369535\x2E4\x3Ac\x2E181C\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115256530G\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGln61Lys&NM\x5F002524\x2E4\x3Ac\x2E181C\x3EA|CA151263|73058|12.0|evidence|1475|https://civicdb.org/links/evidence/1475|22194965_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Selumetinib_(NCIt_ID_C66939)|||D|2|||||
1	115258744	93	C	T	.	.	GN=NRAS;VT=G13D;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.38G>A||G13D|93|RS121434596&GLY13ASP|ENST00000369535\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115258744C\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGly13Asp&NM\x5F002524\x2E4\x3Ac\x2E38G\x3EA|CA123620|13901|5.0|evidence|21|https://civicdb.org/links/evidence/21|18375819_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Tanespimycin_(NCIt_ID_C37899)|||C|2|||||
1	115258747	878	C	T	.	.	GN=NRAS;VT=G12D;CSQ=T|missense_variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|GLY12ASP&RS121913237|ENST00000369535\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E115258747C\x3ET&NP\x5F002515\x2E1\x3Ap\x2EGly12Asp&NM\x5F002524\x2E4\x3Ac\x2E35G\x3EA|CA130425|39648|0.0|evidence|3693|https://civicdb.org/links/evidence/3693|25666295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|None|||||
1	161479745	456	A	G	.	.	GN=FCGR2A;VT=H167R;CSQ=G|missense_variant|FCGR2A|2212|transcript|ENST00000271450.6|ENST00000271450.6:c.500A>G||H167R|456|HIS167ARG&H166R&H131R&RS1801274|NC\x5F000001\x2E10\x3Ag\x2E161479745A\x3EG&ENST00000271450\x2E6\x3Ac\x2E500A\x3EG&NP\x5F001129691\x2E1\x3Ap\x2EHis167Arg&NM\x5F001136219\x2E1\x3Ac\x2E500A\x3EG|CA124361|14823|35.0|evidence|1088|https://civicdb.org/links/evidence/1088|24989892_(PubMed)|Common_Germline|accepted|N/A|Does_Not_Support|Breast_Cancer_(DOID_1612)||||B|4|||||,G|missense_variant|FCGR2A|2212|transcript|ENST00000271450.6|ENST00000271450.6:c.500A>G||H167R|456|HIS167ARG&H166R&H131R&RS1801274|NC\x5F000001\x2E10\x3Ag\x2E161479745A\x3EG&ENST00000271450\x2E6\x3Ac\x2E500A\x3EG&NP\x5F001129691\x2E1\x3Ap\x2EHis167Arg&NM\x5F001136219\x2E1\x3Ac\x2E500A\x3EG|CA124361|14823|35.0|evidence|1084|https://civicdb.org/links/evidence/1084|22906996_(PubMed)|Common_Germline|accepted|N/A|Does_Not_Support|Breast_Cancer_(DOID_1612)||||B|3|||||
1	161514542	457	A	C	.	.	GN=FCGR3A;VT=F212V;CSQ=C|missense_variant|FCGR3A|2214|transcript|ENST00000367969.3|||F212V|457|V158F&RS396991|NC\x5F000001\x2E10\x3Ag\x2E161514542A\x3EC|CA1211378||35.0|evidence|1087|https://civicdb.org/links/evidence/1087|24989892_(PubMed)|Common_Germline|accepted|N/A|Does_Not_Support|Breast_Cancer_(DOID_1612)|Trastuzumab_(NCIt_ID_C1647)|||B|4|||||,C|missense_variant|FCGR3A|2214|transcript|ENST00000367969.3|||F212V|457|V158F&RS396991|NC\x5F000001\x2E10\x3Ag\x2E161514542A\x3EC|CA1211378||35.0|evidence|1085|https://civicdb.org/links/evidence/1085|22906996_(PubMed)|Common_Germline|accepted|N/A|Does_Not_Support|Breast_Cancer_(DOID_1612)||||B|3|||||
1	161643798	458	T	C	.	.	GN=FCGR2B;VT=I232T;CSQ=C|missense_variant|FCGR2B|2213|transcript|ENST00000358671.5|ENST00000358671.5:c.695T>C||I232T|458|ILE232THR&RS1050501|NC\x5F000001\x2E10\x3Ag\x2E161643798T\x3EC&ENST00000358671\x2E5\x3Ac\x2E695T\x3EC&NP\x5F003992\x2E3\x3Ap\x2EIle232Thr&NM\x5F004001\x2E4\x3Ac\x2E695T\x3EC|CA117549|5467|20.0|evidence|1086|https://civicdb.org/links/evidence/1086|24989892_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|4|||||
1	162724415	139	C	G	.	.	GN=DDR2;VT=L63V;CSQ=G|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.187C>G||L63V|139|LEU63VAL|NC\x5F000001\x2E10\x3Ag\x2E162724415C\x3EG&ENST00000367922\x2E3\x3Ac\x2E187C\x3EG&NP\x5F006173\x2E2\x3Ap\x2ELeu63Val&NM\x5F006182\x2E2\x3Ac\x2E187C\x3EG|CA1217196||4.0|evidence|271|https://civicdb.org/links/evidence/271|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162729630	140	T	G	.	.	GN=DDR2;VT=L239R;CSQ=G|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.716T>G||L239R|140|LEU239ARG|NC\x5F000001\x2E10\x3Ag\x2E162729630T\x3EG&ENST00000367922\x2E3\x3Ac\x2E716T\x3EG|CA16602598|376141|4.0|evidence|270|https://civicdb.org/links/evidence/270|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162729671	141	G	T	.	.	GN=DDR2;VT=G253C;CSQ=T|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.757G>T||G253C|141|GLY253CYS|NC\x5F000001\x2E10\x3Ag\x2E162729671G\x3ET&ENST00000367922\x2E3\x3Ac\x2E757G\x3ET|CA16602599|376142|4.0|evidence|266|https://civicdb.org/links/evidence/266|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162741822	142	G	A	.	.	GN=DDR2;VT=G505S;CSQ=A|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.1513G>A||G505S|142|RS115169993&GLY505SER|NC\x5F000001\x2E10\x3Ag\x2E162741822G\x3EA&ENST00000367922\x2E3\x3Ac\x2E1513G\x3EA&NP\x5F006173\x2E2\x3Ap\x2EGly505Ser&NM\x5F006182\x2E2\x3Ac\x2E1513G\x3EA|CA1217584|282994|4.0|evidence|267|https://civicdb.org/links/evidence/267|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162745497	143	A	T	.	.	GN=DDR2;VT=I638F;CSQ=T|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.1912A>T||I638F|143|ILE638PHE|NC\x5F000001\x2E10\x3Ag\x2E162745497A\x3ET&ENST00000367922\x2E3\x3Ac\x2E1912A\x3ET|CA16602600|376143|4.0|evidence|269|https://civicdb.org/links/evidence/269|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	162748390	145	T	A	.	.	GN=DDR2;VT=S768R;CSQ=A|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.2304T>A||S768R|145|SER768ARG|NC\x5F000001\x2E10\x3Ag\x2E162748390T\x3EA&ENST00000367922\x2E3\x3Ac\x2E2304T\x3EA|CA16602365|375878|7.5|evidence|272|https://civicdb.org/links/evidence/272|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Dasatinib_(NCIt_ID_C38713)|Combination||C|3|||||
1	162748407	144	G	T	.	.	GN=DDR2;VT=G774V;CSQ=T|missense_variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.2321G>T||G774V|144|GLY774VAL|NC\x5F000001\x2E10\x3Ag\x2E162748407G\x3ET&ENST00000367922\x2E3\x3Ac\x2E2321G\x3ET|CA16602601|376144|4.0|evidence|268|https://civicdb.org/links/evidence/268|22328973_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
1	243859016	1227	C	T	.	.	GN=AKT3;VT=E17K;CSQ=T|missense_variant|AKT3|10000|transcript|ENST00000366539.1|ENST00000366539.1:c.49G>A||E17K|1227|GLU17LYS&RS397514606|ENST00000366539\x2E1\x3Ac\x2E49G\x3EA&NC\x5F000001\x2E10\x3Ag\x2E243859016C\x3ET&NP\x5F001193658\x2E1\x3Ap\x2EGlu17Lys&NM\x5F001206729\x2E1\x3Ac\x2E49G\x3EA|CA130584|39816|3.0|evidence|4521|https://civicdb.org/links/evidence/4521|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||
2	29432664	9	C	T	.	.	GN=ALK;VT=R1275Q;CSQ=T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|1331|https://civicdb.org/links/evidence/1331|26554404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Lorlatinib_(NCIt_ID_C113655)|||D|4|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|1269|https://civicdb.org/links/evidence/1269|23598171_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|1270|https://civicdb.org/links/evidence/1270|23598171_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|143|https://civicdb.org/links/evidence/143|22072639_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|39|https://civicdb.org/links/evidence/39|18923525_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|TAE684|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|RS113994087&ARG1275GLN|ENST00000389048\x2E3\x3Ac\x2E3824G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29432664C\x3ET&NP\x5F004295\x2E2\x3Ap\x2EArg1275Gln&NM\x5F004304\x2E4\x3Ac\x2E3824G\x3EA|CA341482|18083|23.0|evidence|48|https://civicdb.org/links/evidence/48|18923525_(PubMed)|Somatic|accepted|Resistance|Supports|Neuroblastoma_(DOID_769)|TAE684|||D|3|||||
2	29432682	552	C	G	.	.	GN=ALK;VT=ALK_FUSION_G1269A;CSQ=G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC|CA16602590|376132|10.0|evidence|1342|https://civicdb.org/links/evidence/1342|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC|CA16602590|376132|10.0|evidence|1355|https://civicdb.org/links/evidence/1355|25727400_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Ceritinib_(NCIt_ID_C115112)|||D|2|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC|CA16602590|376132|10.0|evidence|1354|https://civicdb.org/links/evidence/1354|25727400_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||ALK_FUSION_G1269A|552|RS1057519781&ALK\x20FUSION\x20GLY1269ALA|NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC|CA16602590|376132|10.0|evidence|1353|https://civicdb.org/links/evidence/1353|25727400_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Brigatinib_(NCIt_ID_C98831)|||D|2|||||
2	29432682	308	C	G	.	.	GN=ALK;VT=EML4-ALK_G1269A;CSQ=G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|RS1057519781&EML4\x2DALK\x20GLY1269ALA|NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC|CA16602590|376132|17.5|evidence|765|https://civicdb.org/links/evidence/765|23344087_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||EML4-ALK_G1269A|308|RS1057519781&EML4\x2DALK\x20GLY1269ALA|NP\x5F004295\x2E2\x3Ap\x2EGly1269Ala&NM\x5F004304\x2E4\x3Ac\x2E3806G\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29432682C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3806G\x3EC|CA16602590|376132|17.5|evidence|764|https://civicdb.org/links/evidence/764|22235099_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||
2	29436859	551	A	C	.	.	GN=ALK;VT=ALK_FUSION_F1245C;CSQ=C|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||ALK_FUSION_F1245C|551|ALK\x20FUSION\x20PHE1245CYS&RS863225283|ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG|CA279597|217856|14.5|evidence|1338|https://civicdb.org/links/evidence/1338|26775591_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||C|3|||||,C|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||ALK_FUSION_F1245C|551|ALK\x20FUSION\x20PHE1245CYS&RS863225283|ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG|CA279597|217856|14.5|evidence|1339|https://civicdb.org/links/evidence/1339|26775591_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,C|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||ALK_FUSION_F1245C|551|ALK\x20FUSION\x20PHE1245CYS&RS863225283|ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG|CA279597|217856|14.5|evidence|1337|https://civicdb.org/links/evidence/1337|22034911_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Crizotinib_(NCIt_ID_C74061)|||D|2|||||
2	29436859	549	A	C	.	.	GN=ALK;VT=F1245C;CSQ=C|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|RS863225283&PHE1245CYS|ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG|CA279597|217856|10.5|evidence|1333|https://civicdb.org/links/evidence/1333|23598171_(PubMed)|Somatic|accepted|Resistance|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||,C|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|RS863225283&PHE1245CYS|ENST00000389048\x2E3\x3Ac\x2E3734T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29436859A\x3EC&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Cys&NM\x5F004304\x2E4\x3Ac\x2E3734T\x3EG|CA279597|217856|10.5|evidence|1330|https://civicdb.org/links/evidence/1330|26554404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Lorlatinib_(NCIt_ID_C113655)|||D|3|||||
2	29436860	1295	A	C	.	.	GN=ALK;VT=F1245V;CSQ=C|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3733T>G||F1245V|1295|RS281864720&PHE1245VAL|ENST00000389048\x2E3\x3Ac\x2E3733T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29436860A\x3EC&NP\x5F004295\x2E2\x3Ap\x2EPhe1245Val&NM\x5F004304\x2E4\x3Ac\x2E3733T\x3EG|CA345003|65671|7.5|evidence|2987|https://civicdb.org/links/evidence/2987|28183697_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Entrectinib_(NCIt_ID_C114984)|||C|3|||||
2	29443600	172	G	T	.	.	GN=ALK;VT=EML4-ALK_S1206Y;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||EML4-ALK_S1206Y|172|RS1057519782&EML4\x2DALK\x20SER1206TYR|NP\x5F004295\x2E2\x3Ap\x2ESer1206Tyr&NM\x5F004304\x2E4\x3Ac\x2E3617C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443600G\x3ET&ENST00000389048\x2E3\x3Ac\x2E3617C\x3EA|CA16602591|376133|6.0|evidence|1343|https://civicdb.org/links/evidence/1343|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Ceritinib_(NCIt_ID_C115112)|||D|2|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||EML4-ALK_S1206Y|172|RS1057519782&EML4\x2DALK\x20SER1206TYR|NP\x5F004295\x2E2\x3Ap\x2ESer1206Tyr&NM\x5F004304\x2E4\x3Ac\x2E3617C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443600G\x3ET&ENST00000389048\x2E3\x3Ac\x2E3617C\x3EA|CA16602591|376133|6.0|evidence|443|https://civicdb.org/links/evidence/443|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||
2	29443613	171	C	T	.	.	GN=ALK;VT=ALK_FUSION_G1202R;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|RS1057519783&ALK\x20FUSION\x20GLY1202ARG|NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA|CA16602592|376134|23.5|evidence|1357|https://civicdb.org/links/evidence/1357|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|RS1057519783&ALK\x20FUSION\x20GLY1202ARG|NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA|CA16602592|376134|23.5|evidence|1350|https://civicdb.org/links/evidence/1350|25727400_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|RS1057519783&ALK\x20FUSION\x20GLY1202ARG|NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA|CA16602592|376134|23.5|evidence|1352|https://civicdb.org/links/evidence/1352|22277784_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Tanespimycin_(NCIt_ID_C37899)|||D|2|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|RS1057519783&ALK\x20FUSION\x20GLY1202ARG|NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA|CA16602592|376134|23.5|evidence|1351|https://civicdb.org/links/evidence/1351|25727400_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Brigatinib_(NCIt_ID_C98831)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|RS1057519783&ALK\x20FUSION\x20GLY1202ARG|NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA|CA16602592|376134|23.5|evidence|441|https://civicdb.org/links/evidence/441|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||ALK_FUSION_G1202R|171|RS1057519783&ALK\x20FUSION\x20GLY1202ARG|NP\x5F004295\x2E2\x3Ap\x2EGly1202Arg&NM\x5F004304\x2E4\x3Ac\x2E3604G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443613C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3604G\x3EA|CA16602592|376134|23.5|evidence|1345|https://civicdb.org/links/evidence/1345|24675041_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|4|||||
2	29443631	7	G	T	.	.	GN=ALK;VT=EML4-ALK_L1196M;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|RS1057519784&EML4\x2DALK\x20LEU1196MET|NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA|CA16602593|376135|31.0|evidence|442|https://civicdb.org/links/evidence/442|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|RS1057519784&EML4\x2DALK\x20LEU1196MET|NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA|CA16602593|376135|31.0|evidence|1341|https://civicdb.org/links/evidence/1341|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|RS1057519784&EML4\x2DALK\x20LEU1196MET|NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA|CA16602593|376135|31.0|evidence|141|https://civicdb.org/links/evidence/141|21575866_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3586C>A||EML4-ALK_L1196M|7|RS1057519784&EML4\x2DALK\x20LEU1196MET|NP\x5F004295\x2E2\x3Ap\x2ELeu1196Met&NM\x5F004304\x2E4\x3Ac\x2E3586C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443631G\x3ET&ENST00000389048\x2E3\x3Ac\x2E3586C\x3EA|CA16602593|376135|31.0|evidence|237|https://civicdb.org/links/evidence/237|20979473_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||B|4|||||
2	29443679	528	C	G	.	.	GN=ALK;VT=EML4-ALK__V1180L;CSQ=G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||EML4-ALK__V1180L|528|EML4\x2DALK\x20VAL1180LEU|NC\x5F000002\x2E11\x3Ag\x2E29443679C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3538G\x3EC|CA346473150|NONE_FOUND|13.0|evidence|1289|https://civicdb.org/links/evidence/1289|25228534_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||EML4-ALK__V1180L|528|EML4\x2DALK\x20VAL1180LEU|NC\x5F000002\x2E11\x3Ag\x2E29443679C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3538G\x3EC|CA346473150|NONE_FOUND|13.0|evidence|1290|https://civicdb.org/links/evidence/1290|25228534_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|TAE684|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||EML4-ALK__V1180L|528|EML4\x2DALK\x20VAL1180LEU|NC\x5F000002\x2E11\x3Ag\x2E29443679C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3538G\x3EC|CA346473150|NONE_FOUND|13.0|evidence|1291|https://civicdb.org/links/evidence/1291|25228534_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Brigatinib_(NCIt_ID_C98831)|||D|2|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||EML4-ALK__V1180L|528|EML4\x2DALK\x20VAL1180LEU|NC\x5F000002\x2E11\x3Ag\x2E29443679C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3538G\x3EC|CA346473150|NONE_FOUND|13.0|evidence|1288|https://civicdb.org/links/evidence/1288|25228534_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|2|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||EML4-ALK__V1180L|528|EML4\x2DALK\x20VAL1180LEU|NC\x5F000002\x2E11\x3Ag\x2E29443679C\x3EG&ENST00000389048\x2E3\x3Ac\x2E3538G\x3EC|CA346473150|NONE_FOUND|13.0|evidence|1286|https://civicdb.org/links/evidence/1286|25228534_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)|||D|3|||||
2	29443695	8	G	T	.	.	GN=ALK;VT=F1174L;CSQ=T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|142|https://civicdb.org/links/evidence/142|18923525_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|TAE684|||D|4|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|33|https://civicdb.org/links/evidence/33|21030459_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|125|https://civicdb.org/links/evidence/125|22072639_(PubMed)|Somatic|accepted|Resistance|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|37|https://civicdb.org/links/evidence/37|21575866_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|32|https://civicdb.org/links/evidence/32|21030459_(PubMed)|Somatic|accepted|Resistance|Supports|Inflammatory_Myofibroblastic_Tumor_(DOID_0050905)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|38|https://civicdb.org/links/evidence/38|21948233_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|1271|https://civicdb.org/links/evidence/1271|23598171_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Neuroblastoma_(DOID_769)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|1327|https://civicdb.org/links/evidence/1327|26786851_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|AZD3463|||D|3|||||,T|missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|RS863225281&PHE1174LEU|ENST00000389048\x2E3\x3Ac\x2E3522C\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29443695G\x3ET&NP\x5F004295\x2E2\x3Ap\x2EPhe1174Leu&NM\x5F004304\x2E4\x3Ac\x2E3522C\x3EA|CA279586|217851|33.5|evidence|1329|https://civicdb.org/links/evidence/1329|26554404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Neuroblastoma_(DOID_769)|Lorlatinib_(NCIt_ID_C113655)|||D|4|||||
2	29445213	527	A	G	.	.	GN=ALK;VT=ALK_FUSION_I1171;CSQ=G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1285|https://civicdb.org/links/evidence/1285|25228534_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|TAE684|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1368|https://civicdb.org/links/evidence/1368|25736571_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||C|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1287|https://civicdb.org/links/evidence/1287|25228534_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|3|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1367|https://civicdb.org/links/evidence/1367|25736571_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)|||C|2|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1344|https://civicdb.org/links/evidence/1344|24675041_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||D|4|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1284|https://civicdb.org/links/evidence/1284|25228534_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Ceritinib_(NCIt_ID_C115112)|||C|4|||||,G|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||ALK_FUSION_I1171|527|ALK\x20FUSION\x20ILE1171|NP\x5F004295\x2E2\x3Ap\x2EIle1171Thr&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EC&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EG&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EC|CA346462880|375888|42.5|evidence|1283|https://civicdb.org/links/evidence/1283|25228534_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)|||C|4|||||
2	29445213	588	A	T	.	.	GN=ALK;VT=HIP1-ALK_I1171N;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>A||HIP1-ALK_I1171N|588|RS1057519698&HIP1\x2DALK\x20ILE1171ASN|NP\x5F004295\x2E2\x3Ap\x2EIle1171Asn&NM\x5F004304\x2E4\x3Ac\x2E3512T\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3ET&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EA|CA16602371|375888|5.0|evidence|1483|https://civicdb.org/links/evidence/1483|25393796_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)&Crizotinib_(NCIt_ID_C74061)|Sequential||C|2|||||
2	29445213	589	A	C	.	.	GN=ALK;VT=EML4-ALK_I1171S;CSQ=C|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>G||EML4-ALK_I1171S|589|EML4\x2DALK\x20ILE1171SER|NC\x5F000002\x2E11\x3Ag\x2E29445213A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3512T\x3EG|CA346462883|N/A|5.0|evidence|1484|https://civicdb.org/links/evidence/1484|25393796_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)&Crizotinib_(NCIt_ID_C74061)|Sequential||C|2|||||
2	29445258	6	C	T	.	.	GN=ALK;VT=EML4-ALK_C1156Y;CSQ=T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|RS1057519859&EML4\x2DALK\x20CYS1156TYR|NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA|CA16602783|376340|19.0|evidence|1346|https://civicdb.org/links/evidence/1346|24675041_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|4|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|RS1057519859&EML4\x2DALK\x20CYS1156TYR|NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA|CA16602783|376340|19.0|evidence|842|https://civicdb.org/links/evidence/842|26698910_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Lorlatinib_(NCIt_ID_C113655)|||C|3|||||,T|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||EML4-ALK_C1156Y|6|RS1057519859&EML4\x2DALK\x20CYS1156TYR|NP\x5F004295\x2E2\x3Ap\x2ECys1156Tyr&NM\x5F004304\x2E4\x3Ac\x2E3467G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E29445258C\x3ET&ENST00000389048\x2E3\x3Ac\x2E3467G\x3EA|CA16602783|376340|19.0|evidence|841|https://civicdb.org/links/evidence/841|26698910_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Luminespib_(NCIt_ID_C71467)&Ceritinib_(NCIt_ID_C115112)&Crizotinib_(NCIt_ID_C74061)|Sequential||C|3|||||
2	29445270	307	A	C	.	.	GN=ALK;VT=EML4-ALK_L1152R;CSQ=C|transcript_fusion&missense_variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3455T>G||EML4-ALK_L1152R|307|RS1057519785&EML4\x2DALK\x20LEU1152ARG|NP\x5F004295\x2E2\x3Ap\x2ELeu1152Arg&NM\x5F004304\x2E4\x3Ac\x2E3455T\x3EG&NC\x5F000002\x2E11\x3Ag\x2E29445270A\x3EC&ENST00000389048\x2E3\x3Ac\x2E3455T\x3EG|CA16602594|376136|10.0|evidence|763|https://civicdb.org/links/evidence/763|21791641_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||
2	29445271	173	G	GCGT	.	.	GN=ALK;VT=EML4-ALK_T1151INST;CSQ=CGT|transcript_fusion&inframe_insertion|ALK|238|transcript|ENST00000389048.3|||EML4-ALK_T1151INST|173|T1151\x5FL1152INST|NC\x5F000002\x2E11\x3Ag\x2E29445271\x5F29445272insCGT|CA645528802||18.0|evidence|444|https://civicdb.org/links/evidence/444|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||,CGT|transcript_fusion&inframe_insertion|ALK|238|transcript|ENST00000389048.3|||EML4-ALK_T1151INST|173|T1151\x5FL1152INST|NC\x5F000002\x2E11\x3Ag\x2E29445271\x5F29445272insCGT|CA645528802||18.0|evidence|1347|https://civicdb.org/links/evidence/1347|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Alectinib_(NCIt_ID_C101790)|||D|3|||||,CGT|transcript_fusion&inframe_insertion|ALK|238|transcript|ENST00000389048.3|||EML4-ALK_T1151INST|173|T1151\x5FL1152INST|NC\x5F000002\x2E11\x3Ag\x2E29445271\x5F29445272insCGT|CA645528802||18.0|evidence|1349|https://civicdb.org/links/evidence/1349|22277784_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Tanespimycin_(NCIt_ID_C37899)|||D|2|||||,CGT|transcript_fusion&inframe_insertion|ALK|238|transcript|ENST00000389048.3|||EML4-ALK_T1151INST|173|T1151\x5FL1152INST|NC\x5F000002\x2E11\x3Ag\x2E29445271\x5F29445272insCGT|CA645528802||18.0|evidence|1348|https://civicdb.org/links/evidence/1348|22277784_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|TAE684|||D|3|||||
2	47630413	763	A	AG	.	.	GN=MSH2;VT=E28FS;CSQ=G|frameshift_elongation|MSH2|4436|transcript|ENST00000233146.2|||E28FS|763||NC\x5F000002\x2E11\x3Ag\x2E47630414dupG|CA913189237|NONE_FOUND|0.5|evidence|1827|https://civicdb.org/links/evidence/1827|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	47637380	770	A	T	.	.	GN=MSH2;VT=K172*;CSQ=T|stop_gained|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.514A>T||K172*|770|LYS172TER&K172X|NC\x5F000002\x2E11\x3Ag\x2E47637380A\x3ET&ENST00000233146\x2E2\x3Ac\x2E514A\x3ET|CA346730730|NONE_FOUND|0.5|evidence|1834|https://civicdb.org/links/evidence/1834|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	47641432	762	GT	G	.	.	GN=MSH2;VT=V273FS;CSQ=-|frameshift_variant|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.818delT||V273FS|762||NC\x5F000002\x2E11\x3Ag\x2E47641433del&ENST00000233146\x2E2\x3Ac\x2E818delT|CA913090558||0.5|evidence|1826|https://civicdb.org/links/evidence/1826|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	47656951	727	C	T	.	.	GN=MSH2;VT=R383*;CSQ=T|stop_gained|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.1147C>T||R383*|727|RS63749849&ARG383TER&R383X|NC\x5F000002\x2E11\x3Ag\x2E47656951C\x3ET&ENST00000233146\x2E2\x3Ac\x2E1147C\x3ET&NP\x5F000242\x2E1\x3Ap\x2EArg383Ter&NM\x5F000251\x2E2\x3Ac\x2E1147C\x3ET|CA017356|90554|0.5|evidence|1790|https://civicdb.org/links/evidence/1790|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	47690231	773	A	G	.	.	GN=MSH2;VT=E483G;CSQ=G|missense_variant|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.1448A>G||E483G|773|GLU483GLY|ENST00000233146\x2E2\x3Ac\x2E1448A\x3EG&NC\x5F000002\x2E11\x3Ag\x2E47690231A\x3EG|CA346726930|NONE_FOUND|0.5|evidence|1837|https://civicdb.org/links/evidence/1837|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	48018217	761	C	A	.	.	GN=MSH6;VT=P138T;CSQ=A|missense_variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.412C>A||P138T|761|PRO138THR|NC\x5F000002\x2E11\x3Ag\x2E48018217C\x3EA&ENST00000234420\x2E5\x3Ac\x2E412C\x3EA|CA346737117|NONE_FOUND|0.25|evidence|1825|https://civicdb.org/links/evidence/1825|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|1|||||
2	48026176	775	G	A	.	.	GN=MSH6;VT=V352I;CSQ=A|missense_variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.1054G>A||V352I|775|RS730881787&VAL352ILE|NC\x5F000002\x2E11\x3Ag\x2E48026176G\x3EA&ENST00000234420\x2E5\x3Ac\x2E1054G\x3EA&NP\x5F000170\x2E1\x3Ap\x2EVal352Ile&NM\x5F000179\x2E2\x3Ac\x2E1054G\x3EA|CA007915|182617|0.5|evidence|1839|https://civicdb.org/links/evidence/1839|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	48027793	765	ATC	A	.	.	GN=MSH6;VT=I891FS;CSQ=-|frameshift_truncation|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.2672_2673delTC||I891FS|765|ILE891FS|NC\x5F000002\x2E11\x3Ag\x2E48027794\x5F48027795del&ENST00000234420\x2E5\x3Ac\x2E2672\x5F2673delTC|CA913090565|NONE_FOUND|0.5|evidence|1829|https://civicdb.org/links/evidence/1829|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	48033420	776	C	T	.	.	GN=MSH6;VT=R1242C;CSQ=T|missense_variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.3724C>T||R1242C|776|RS587779285&ARG1242CYS|NC\x5F000002\x2E11\x3Ag\x2E48033420C\x3ET&ENST00000234420\x2E5\x3Ac\x2E3724C\x3ET&NP\x5F000170\x2E1\x3Ap\x2EArg1242Cys&NM\x5F000179\x2E2\x3Ac\x2E3724C\x3ET|CA10578156|232375|0.5|evidence|1840|https://civicdb.org/links/evidence/1840|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	48033421	767	G	A	.	.	GN=MSH6;VT=R1242H;CSQ=A|missense_variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.3725G>A||R1242H|767|RS63750119&ARG1242HIS|NC\x5F000002\x2E11\x3Ag\x2E48033421G\x3EA&ENST00000234420\x2E5\x3Ac\x2E3725G\x3EA&NP\x5F000170\x2E1\x3Ap\x2EArg1242His&NM\x5F000179\x2E2\x3Ac\x2E3725G\x3EA|CA014077|140866|0.5|evidence|1831|https://civicdb.org/links/evidence/1831|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
2	158622516	1686	C	A	.	.	GN=ACVR1;VT=G328V;CSQ=A|missense_variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1:c.983G>T||G328V|1686|RS387906589&GLY328VAL|ENST00000434821\x2E1\x3Ac\x2E983G\x3ET&NC\x5F000002\x2E11\x3Ag\x2E158622516C\x3EA&NP\x5F001096\x2E1\x3Ap\x2EGly328Val&NM\x5F001105\x2E4\x3Ac\x2E983G\x3ET|CA16602802|376363|30.0|evidence|6955|https://civicdb.org/links/evidence/6955|24705254_(PubMed)|Somatic|accepted|Positive|Supports|Diffuse_Intrinsic_Pontine_Glioma||||B|3|||||,A|missense_variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1:c.983G>T||G328V|1686|RS387906589&GLY328VAL|ENST00000434821\x2E1\x3Ac\x2E983G\x3ET&NC\x5F000002\x2E11\x3Ag\x2E158622516C\x3EA&NP\x5F001096\x2E1\x3Ap\x2EGly328Val&NM\x5F001105\x2E4\x3Ac\x2E983G\x3ET|CA16602802|376363|30.0|evidence|4846|https://civicdb.org/links/evidence/4846|24705250_(PubMed)|Somatic|accepted|Positive|Supports|Diffuse_Intrinsic_Pontine_Glioma||||B|3|||||,A|missense_variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1:c.983G>T||G328V|1686|RS387906589&GLY328VAL|ENST00000434821\x2E1\x3Ac\x2E983G\x3ET&NC\x5F000002\x2E11\x3Ag\x2E158622516C\x3EA&NP\x5F001096\x2E1\x3Ap\x2EGly328Val&NM\x5F001105\x2E4\x3Ac\x2E983G\x3ET|CA16602802|376363|30.0|assertion|9|https://civicdb.org/links/assertion/9||Somatic|accepted|Positive|Supports|Diffuse_Intrinsic_Pontine_Glioma|||||||Tier_II_-_Level_C|||
2	198266834	565	T	C	.	.	GN=SF3B1;VT=K700E;CSQ=C|missense_variant|SF3B1|23451|transcript|ENST00000335508.6|ENST00000335508.6:c.2098A>G||K700E|565|RS559063155&LYS700GLU|ENST00000335508\x2E6\x3Ac\x2E2098A\x3EG&NP\x5F036565\x2E2\x3Ap\x2ELys700Glu&NM\x5F012433\x2E3\x3Ac\x2E2098A\x3EG&NC\x5F000002\x2E11\x3Ag\x2E198266834T\x3EC|CA2042597|376004|2.0|evidence|1417|https://civicdb.org/links/evidence/1417|25424858_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Spliceostatin_A|||D|2|||||
2	198267359	114	C	A	.	.	GN=SF3B1;VT=K666N;CSQ=A|missense_variant|SF3B1|23451|transcript|ENST00000335508.6|ENST00000335508.6:c.1998G>T||K666N|114|RS377023736&LYS666ASN|NC\x5F000002\x2E11\x3Ag\x2E198267359C\x3EA&ENST00000335508\x2E6\x3Ac\x2E1998G\x3ET&NP\x5F036565\x2E2\x3Ap\x2ELys666Asn&NM\x5F012433\x2E3\x3Ac\x2E1998G\x3ET|CA280929|219098|2.0|evidence|1418|https://civicdb.org/links/evidence/1418|25424858_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Spliceostatin_A|||D|2|||||
2	202149589	650	G	C	.	.	GN=CASP8;VT=D302H;CSQ=C|polymorphic_sequence_variant&missense_variant|CASP8|841|transcript|ENST00000264275.5|ENST00000264275.5:c.904G>C||D302H|650|ASP302HIS&D285H&RS1045485|NC\x5F000002\x2E11\x3Ag\x2E202149589G\x3EC&ENST00000264275\x2E5\x3Ac\x2E904G\x3EC&NP\x5F001219\x2E2\x3Ap\x2EAsp302His&NM\x5F001228\x2E4\x3Ac\x2E904G\x3EC|CA119051|7762|15.0|evidence|1654|https://civicdb.org/links/evidence/1654|25502557_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Neuroblastoma_(DOID_769)||||B|3|||||
2	209113112	420	C	T	.	.	GN=IDH1;VT=R132H;CSQ=T|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.395G>A||R132H|420|RS121913500&ARG132HIS|ENST00000415913\x2E1\x3Ac\x2E395G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E209113112C\x3ET&NP\x5F005887\x2E2\x3Ap\x2EArg132His&NM\x5F001282386\x2E1\x3Ac\x2E395G\x3EA|CA170874|156444|9.0|evidence|5987|https://civicdb.org/links/evidence/5987|27466707_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Pancreatic_Ductal_Adenocarcinoma_(DOID_3498)|Ivosidenib_(NCIt_ID_C114383)|||C|2|||||,T|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.395G>A||R132H|420|RS121913500&ARG132HIS|ENST00000415913\x2E1\x3Ac\x2E395G\x3EA&NC\x5F000002\x2E11\x3Ag\x2E209113112C\x3ET&NP\x5F005887\x2E2\x3Ap\x2EArg132His&NM\x5F001282386\x2E1\x3Ac\x2E395G\x3EA|CA170874|156444|9.0|evidence|979|https://civicdb.org/links/evidence/979|23558169_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Anaplastic_Oligodendroglioma_(DOID_3181)|AGI-5198|||D|4|||||
2	209113113	59	G	A	.	.	GN=IDH1;VT=R132C;CSQ=A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|2329|https://civicdb.org/links/evidence/2329|23558169_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Malignant_Glioma_(DOID_3070)|AGI-5198|||D|2|||||,A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|2332|https://civicdb.org/links/evidence/2332|24333121_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|BPTES|||D|3|||||,A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|2327|https://civicdb.org/links/evidence/2327|20975057_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Brain_Glioma_(DOID_0060108)|Temozolomide_(NCIt_ID_C1244)|||B|2|||||,A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|2331|https://civicdb.org/links/evidence/2331|25583779_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Ivosidenib_(NCIt_ID_C114383)|||B|2|||||,A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|732|https://civicdb.org/links/evidence/732|26436839_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|GSK321|||D|3|||||,A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|324|https://civicdb.org/links/evidence/324|20538800_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|2|||||,A|missense_variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|ARG132CYS&RS121913499|ENST00000415913\x2E1\x3Ac\x2E394C\x3ET&NC\x5F000002\x2E11\x3Ag\x2E209113113G\x3EA&NP\x5F005887\x2E2\x3Ap\x2EArg132Cys&NM\x5F005896\x2E3\x3Ac\x2E394C\x3ET|CA16602374|375891|63.0|evidence|224|https://civicdb.org/links/evidence/224|20538800_(PubMed)|Somatic|accepted|Positive|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||
2	234668881	729	T	TTATATATATATATA	.	.	GN=UGT1A1;VT=UGT1A1*28;CSQ=TATATATATATATA|microsatellite|UGT1A1|54658|transcript|ENST00000305208.5|||UGT1A1*28|729|RS8175347|NC\x5F000002\x2E11\x3Ag\x2E234668881\x5F234668882TA\x5B7\x5D|unregistered|226028|50.0|evidence|1792|https://civicdb.org/links/evidence/1792|26313268_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Belinostat_(NCIt_ID_C48812)|||A|5|||||
3	10183530	847	GAATGCCCCGGAGGGCGGAGAA	G	.	.	GN=VHL;VT=M1?_(c.1-1_20del21);CSQ=-|start_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.1-1_20del21||M1?_(c.1-1_20del21)|847|C\x2E1\x2D1\x5F20DEL21&NO\x20INITIATION&START\x20LOSS&MET1\x20LOSS|NC\x5F000003\x2E11\x3Ag\x2E10183531\x5F10183551del&ENST00000256474\x2E2\x3Ac\x2E1\x2D1\x5F20del21&NM\x5F000551\x2E3\x3Ac\x2E1\x2D1\x5F20del21&NP\x5F000542\x2E1\x3Ap\x2EMet1\x3F&NP\x5F000542\x2E1\x3Ap\x2E0|CA645524624|NONE_FOUND|0.5|evidence|1946|https://civicdb.org/links/evidence/1946|15932632_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
3	10183531	846	AATGCCCCGGAGGGCGGA	A	.	.	GN=VHL;VT=M1FS_(c.1_17del17);CSQ=-|start_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.1_17del17||M1FS_(c.1_17del17)|846|MET1FS&C\x2E1\x5F17DEL17|NM\x5F000551\x2E3\x3Ac\x2E1\x5F17del&NC\x5F000003\x2E11\x3Ag\x2E10183532\x5F10183548del&ENST00000256474\x2E2\x3Ac\x2E1\x5F17del17|CA645524623|NONE_FOUND|0.5|evidence|1945|https://civicdb.org/links/evidence/1945|15932632_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
3	10183534	848	G	A	.	.	GN=VHL;VT=M1?_(c.3G>A);CSQ=A|start_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.3G>A||M1?_(c.3G>A)|848|RS578091032&C\x2E3G\x3EA&NO\x20INITIATION&START\x20LOSS&MET1\x20LOSS|NC\x5F000003\x2E11\x3Ag\x2E10183534G\x3EA&ENST00000256474\x2E2\x3Ac\x2E3G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E3G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EMet1\x3F&NP\x5F000542\x2E1\x3Ap\x2E0|CA020331|135406|0.5|evidence|1947|https://civicdb.org/links/evidence/1947|11505222_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
3	10183550	849	A	G	.	.	GN=VHL;VT=N7D_(c.19A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.19A>G||N7D_(c.19A>G)|849|RS1311403806&C\x2E19A\x3EG&ASN7ASP|NP\x5F000542\x2E1\x3Ac\x2EAsn7Asp&ENST00000256474\x2E2\x3Ac\x2E19A\x3EG&NM\x5F000551\x2E3\x3Ac\x2E19A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183550A\x3EG|CA351747044|NONE_FOUND|0.25|evidence|1948|https://civicdb.org/links/evidence/1948|11536052_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|1|||||
3	10183605	850	C	T	.	.	GN=VHL;VT=P25L_(c.74C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.74C>T||P25L_(c.74C>T)|850|RS35460768&C\x2E74C\x3ET&PRO25LEU|NC\x5F000003\x2E11\x3Ag\x2E10183605C\x3ET&ENST00000256474\x2E2\x3Ac\x2E74C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro25Leu&NM\x5F000551\x2E3\x3Ac\x2E74C\x3ET|CA020538|93330|7.5|evidence|1949|https://civicdb.org/links/evidence/1949|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183667	1733	G	T	.	.	GN=VHL;VT=E46*_(c.136G>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.136G>T||E46*_(c.136G>T)|1733|C\x2E136G\x3ET&E46X&GLU46TER|NP\x5F000542\x2E1\x3Ap\x2EGlu46Ter&NM\x5F000551\x2E3\x3Ac\x2E136G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183667G\x3ET&ENST00000256474\x2E2\x3Ac\x2E136G\x3ET|CA351748085|NONE_FOUND|10.0|evidence|4895|https://civicdb.org/links/evidence/4895|12202531_(PubMed)|Rare_Germline|accepted|Likely_Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10183685	1734	G	A	.	.	GN=VHL;VT=E52K_(c.154G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.154G>A||E52K_(c.154G>A)|1734|RS373068386&C\x2E154G\x3EA&GLU52LYS|ENST00000256474\x2E2\x3Ac\x2E154G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183685G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu52Lys&NM\x5F000551\x2E3\x3Ac\x2E154G\x3EA|CA020056|161402|5.0|evidence|5272|https://civicdb.org/links/evidence/5272|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183692	829	TGGAGG	T	.	.	GN=VHL;VT=M54IFS_(c.162_166delGGAGG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.162_166delGGAGG||M54IFS_(c.162_166delGGAGG)|829|MET54ILEFS&C\x2E162\x5F166DELGGAGG|ENST00000256474\x2E2\x3Ac\x2E162\x5F166delGGAGG&NC\x5F000003\x2E11\x3Ag\x2E10183693\x5F10183697del&NP\x5F000542\x2E1\x3Ap\x2EMet54IlefsTer76&NM\x5F000551\x2E2\x3Ac\x2E162\x5F166delGGAGG|CA645524639|NONE_FOUND|0.5|evidence|1914|https://civicdb.org/links/evidence/1914|8187067_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
3	10183693	766	GG	G	.	.	GN=VHL;VT=E55RfsTer11_(c.163delG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.163delG||E55RfsTer11_(c.163delG)|766|GLU55ARGFS&C\x2E163DELG|ENST00000256474\x2E2\x3Ac\x2E163delG&NC\x5F000003\x2E11\x3Ag\x2E10183694del&NM\x5F000551\x2E2\x3Ac\x2E163delG&NP\x5F000542\x2E1\x3Ap\x2EGlu55ArgfsTer11&NP\x5F000542\x2E1\x3Ap\x2EGlu55fs|CA432536363|428800|7.5|evidence|1830|https://civicdb.org/links/evidence/1830|8956040_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10183693	764	GGA	G	.	.	GN=VHL;VT=E55FS_(c.163_164delGA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.163_164delGA||E55FS_(c.163_164delGA)|764|GLU55FS&C\x2E163\x5F164DELGA|ENST00000256474\x2E2\x3Ac\x2E163\x5F164delGA&NC\x5F000003\x2E11\x3Ag\x2E10183694\x5F10183695del&NP\x5F000542\x2E1\x3Ap\x2EGlu55fs|CA645524641|NONE_FOUND|0.5|evidence|1828|https://civicdb.org/links/evidence/1828|10408776_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
3	10183695	771	A	AG	.	.	GN=VHL;VT=A56FS_(c.164_165insG);CSQ=G|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|||A56FS_(c.164_165insG)|771|377\x5F378INSG&C\x2E164\x5F165INSG&164INSG|NC\x5F000003\x2E11\x3Ag\x2E10183697dupG&NC\x5F000003\x2E11\x3Ag\x2E10183695\x5F10183696insG&NM\x5F000551\x2E2\x3Ac\x2E164\x5F165insG&NP\x5F000542\x2E1\x3Ap\x2EAla56GlyfsTer74&NP\x5F000542\x2E1\x3Ap\x2EAla56fs|CA645524645|NONE_FOUND|20.0|evidence|1835|https://civicdb.org/links/evidence/1835|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||B|4|||||
3	10183695	793	A	AA	.	.	GN=VHL;VT=A56fs_(c.164_165insA);CSQ=A|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|||A56fs_(c.164_165insA)|793|C\x2E164\x5F165INSA&165INSA|NC\x5F000003\x2E12\x3Ag\x2E10142011dup&NC\x5F000003\x2E11\x3Ag\x2E10183695dupA&NC\x5F000003\x2E11\x3Ag\x2E10183695\x5F10183696insA&NM\x5F000551\x2E2\x3Ac\x2E164\x5F165insA&NP\x5F000542\x2E1\x3Ap\x2EAla56GlyfsTer74&NP\x5F000542\x2E1\x3Ap\x2EAla56fs|CA658795187|NONE_FOUND|5.0|evidence|1857|https://civicdb.org/links/evidence/1857|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183696	794	G	A	.	.	GN=VHL;VT=E55E_(c.165G>A);CSQ=A|silent_mutation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.165G>A||E55E_(c.165G>A)|794|GLU55\x3D&RS1553619391&C\x2E165G\x3EA&GLU55GLU|NP\x5F000542\x2E1\x3Ap\x2EGlu55\x3D&ENST00000256474\x2E2\x3Ac\x2E165G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183696G\x3EA&NM\x5F000551\x2E2\x3Ac\x2E165G\x3EA|CA432536364|486721|5.0|evidence|1858|https://civicdb.org/links/evidence/1858|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183697	1785	G	GA	.	.	GN=VHL;VT=A56fs_(c.166_167insA);CSQ=A|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.166_167insA||A56fs_(c.166_167insA)|1785|380INSA&L15409\x2E1\x3A380INSA|ENST00000256474\x2E2\x3Ac\x2E166\x5F167insA&NP\x5F000542\x2E1\x3Ap\x2EAla56AspfsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E166\x5F167insA&NC\x5F000003\x2E12\x3Ag\x2E10142013\x5F10142014insA&NC\x5F000003\x2E11\x3Ag\x2E10183697\x5F10183698insA|CA432536366|NONE_FOUND|5.0|evidence|4956|https://civicdb.org/links/evidence/4956|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10183704	851	G	GC	.	.	GN=VHL;VT=P59fs_(c.173_174insC);CSQ=C|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.173_174insC||P59fs_(c.173_174insC)|851|C\x2E173\x5F174INSC&PRO59FS|NC\x5F000003\x2E11\x3Ag\x2E10183704\x5F10183705insC&NM\x5F000551\x2E3\x3Ac\x2E173\x5F174insC&NP\x5F000542\x2E1\x3Ap\x2EPro59AlafsTer73&ENST00000256474\x2E2\x3Ac\x2E173\x5F174insC|CA658795188|NONE_FOUND|7.5|evidence|1950|https://civicdb.org/links/evidence/1950|19270817_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cyst_(HPO_ID_HP:0000107)&Pancreatic_cysts_(HPO_ID_HP:0001737)&Hemangioblastoma_(HPO_ID_HP:0010797)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)&Neoplasm_of_the_central_nervous_system_(HPO_ID_HP:0100006)|C|3|||||
3	10183705	1786	GC	G	.	.	GN=VHL;VT=P59R_(c.175delC);CSQ=-|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.175delC||P59R_(c.175delC)|1786|PRO59ARG&C\x2E175DELC|ENST00000256474\x2E2\x3Ac\x2E175delC|CA432536374|NONE_FOUND|10.0|evidence|5155|https://civicdb.org/links/evidence/5155|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183709	1964	CG	C	.	.	GN=VHL;VT=R60FS_(c.179delG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.179delG||R60FS_(c.179delG)|1964|ARG60FS&C\x2E179DELG|ENST00000256474\x2E2\x3Ac\x2E179delG|CA020069|NONE_FOUND|7.5|evidence|5290|https://civicdb.org/links/evidence/5290|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183710	1750	GG	G	.	.	GN=VHL;VT=V62C_(c.180delG);CSQ=-|inframe_deletion|VHL|7428|transcript|ENST|ENST00000256474.2:c.180delG||V62C_(c.180delG)|1750|VAL62CYS&C\x2E180DELG|ENST00000256474\x2E2\x3Ac\x2E180delG&NC\x5F000003\x2E11\x3Ag\x2E10183711delG&NP\x5F000542\x2E1\x3Ap\x2EVal62Cysfs&NM\x5F000551\x2E3\x3Ac\x2E180delG|CA020069|182986|10.0|evidence|4916|https://civicdb.org/links/evidence/4916|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10183712	2145	CCCGT	C	.	.	GN=VHL;VT=P61FS_(c.182_185delCCGT);CSQ=-|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.182_185delCCGT||P61FS_(c.182_185delCCGT)|2145|PRO61FS&C\x2E182\x5F185DELCCGT|NP\x5F000542\x2E1\x3Ap\x2EPro61ArgfsTer5&NM\x5F000551\x2E3\x3Ac\x2E182\x5F185delCCGT&NC\x5F000003\x2E11\x3Ag\x2E10183713\x5F10183716del&ENST00000256474\x2E2\x3Ac\x2E182\x5F185delCCGT|CA658820712|NONE_FOUND|10.0|evidence|5743|https://civicdb.org/links/evidence/5743|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183722	1867	G	C	.	.	GN=VHL;VT=R64P_(c.191G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.191G>C||R64P_(c.191G>C)|1867|RS104893826&ARG64PRO&C\x2E191G\x3EC|ENST00000256474\x2E2\x3Ac\x2E191G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183722G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EArg64Pro&NM\x5F000551\x2E3\x3Ac\x2E191G\x3EC|CA020089|2226|7.5|evidence|5094|https://civicdb.org/links/evidence/5094|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Paraganglioma_(HPO_ID_HP:0002668)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|3|||||
3	10183724	2011	T	G	.	.	GN=VHL;VT=S65A_(c.193T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.193T>G||S65A_(c.193T>G)|2011|RS869025616&SER65ALA&C\x2E193T\x3EG|ENST00000256474\x2E2\x3Ac\x2E193T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183724T\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Ala&NM\x5F000551\x2E3\x3Ac\x2E193T\x3EG|CA357048|223160|7.5|evidence|5413|https://civicdb.org/links/evidence/5413|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10183724	1903	T	C	.	.	GN=VHL;VT=S65P_(c.193T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.193T>C||S65P_(c.193T>C)|1903|RS869025616&SER65PRO&C\x2E193T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ESer65Pro&NM\x5F000551\x2E3\x3Ac\x2E193T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183724T\x3EC&ENST00000256474\x2E2\x3Ac\x2E193T\x3EC|CA351748798|547829|10.0|evidence|5160|https://civicdb.org/links/evidence/5160|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183725	1787	C	G	.	.	GN=VHL;VT=S65W_(c.194C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|6352|https://civicdb.org/links/evidence/6352|28650583_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5161|https://civicdb.org/links/evidence/5161|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|6789|https://civicdb.org/links/evidence/6789|28388566_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5592|https://civicdb.org/links/evidence/5592|22156657_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5034|https://civicdb.org/links/evidence/5034|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|6468|https://civicdb.org/links/evidence/6468|26622630_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Epididymal_cyst_(HPO_ID_HP:0030424)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|4917|https://civicdb.org/links/evidence/4917|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5026|https://civicdb.org/links/evidence/5026|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Multiple_renal_cysts_(HPO_ID_HP:0005562)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5693|https://civicdb.org/links/evidence/5693|23384228_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cyst_(HPO_ID_HP:0000107)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5765|https://civicdb.org/links/evidence/5765|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|4998|https://civicdb.org/links/evidence/4998|8730290_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|6661|https://civicdb.org/links/evidence/6661|25834951_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5212|https://civicdb.org/links/evidence/5212|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Hemangioblastoma_(HPO_ID_HP:0010797)&Renal_cyst_(HPO_ID_HP:0000107)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|5328|https://civicdb.org/links/evidence/5328|20518900_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.194C>G||S65W_(c.194C>G)|1787|RS5030826&SER65TRP&C\x2E194C\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer65Trp&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EG&ENST00000256474\x2E2\x3Ac\x2E194C\x3EG|CA020099|43597|105.0|evidence|4958|https://civicdb.org/links/evidence/4958|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183725	1788	C	T	.	.	GN=VHL;VT=S65L_(c.194C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6131|https://civicdb.org/links/evidence/6131|11505222_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Clear_Cell_Renal_Cell_Carcinoma_(DOID_4467)|||Sporadic_(HPO_ID_HP:0003745)&Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)|E|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|5159|https://civicdb.org/links/evidence/5159|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|5104|https://civicdb.org/links/evidence/5104|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Epididymal_cyst_(HPO_ID_HP:0030424)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6644|https://civicdb.org/links/evidence/6644|28379443_(PubMed)|Unknown|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6710|https://civicdb.org/links/evidence/6710|26308528_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6728|https://civicdb.org/links/evidence/6728|23797736_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6791|https://civicdb.org/links/evidence/6791|28388566_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6890|https://civicdb.org/links/evidence/6890|7915601_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Renal_Carcinoma_(DOID_4451)|||Sporadic_(HPO_ID_HP:0003745)&Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|5582|https://civicdb.org/links/evidence/5582|14722919_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|5287|https://civicdb.org/links/evidence/5287|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|5499|https://civicdb.org/links/evidence/5499|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|4959|https://civicdb.org/links/evidence/4959|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L_(c.194C>T)|1788|RS5030826&SER65LEU&C\x2E194C\x3ET|ENST00000256474\x2E2\x3Ac\x2E194C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer65Leu&NM\x5F000551\x2E3\x3Ac\x2E194C\x3ET|CA020104|182975|75.5|evidence|6662|https://civicdb.org/links/evidence/6662|25834951_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183725	1811	C	A	.	.	GN=VHL;VT=S65*_(c.194C>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.194C>A||S65*_(c.194C>A)|1811|RS5030826&SER65TER&S65X&C\x2E194C\x3EA|ENST00000256474\x2E2\x3Ac\x2E194C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer65Ter&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EA|CA357085|223161|15.0|evidence|5422|https://civicdb.org/links/evidence/5422|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,A|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.194C>A||S65*_(c.194C>A)|1811|RS5030826&SER65TER&S65X&C\x2E194C\x3EA|ENST00000256474\x2E2\x3Ac\x2E194C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183725C\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer65Ter&NM\x5F000551\x2E3\x3Ac\x2E194C\x3EA|CA357085|223161|15.0|evidence|5033|https://civicdb.org/links/evidence/5033|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183724	2130	TC	T	.	.	GN=VHL;VT=S65FS_(c.194delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194delC||S65FS_(c.194delC)|2130|SER65FS&C\x2E194DELC|NP\x5F000542\x2E1\x3Ap\x2ESer65TrpfsTer2&NM\x5F000551\x2E3\x3Ac\x2E194delC&NC\x5F000003\x2E11\x3Ag\x2E10183725delC&ENST00000256474\x2E2\x3Ac\x2E194delC|CA432536395|NONE_FOUND|10.0|evidence|5727|https://civicdb.org/links/evidence/5727|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183733	1873	T	C	.	.	GN=VHL;VT=S68P_(c.202T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.202T>C||S68P_(c.202T>C)|1873|SER68PRO&C\x2E202T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ESer68Pro&NM\x5F000551\x2E3\x3Ac\x2E202T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183733T\x3EC&ENST00000256474\x2E2\x3Ac\x2E202T\x3EC|CA16621912|NONE_FOUND|7.5|evidence|5105|https://civicdb.org/links/evidence/5105|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||
3	10183739	1834	G	T	.	.	GN=VHL;VT=E70*_(c.208G>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70*_(c.208G>T)|1834|RS5030802&GLU70TER&E70X&C\x2E208G\x3ET|ENST00000256474\x2E2\x3Ac\x2E208G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu70Ter&NM\x5F000551\x2E3\x3Ac\x2E208G\x3ET|CA16602179|428806|27.5|evidence|6059|https://civicdb.org/links/evidence/6059|7728151_(PubMed)|N/A|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|4|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70*_(c.208G>T)|1834|RS5030802&GLU70TER&E70X&C\x2E208G\x3ET|ENST00000256474\x2E2\x3Ac\x2E208G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu70Ter&NM\x5F000551\x2E3\x3Ac\x2E208G\x3ET|CA16602179|428806|27.5|evidence|5035|https://civicdb.org/links/evidence/5035|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70*_(c.208G>T)|1834|RS5030802&GLU70TER&E70X&C\x2E208G\x3ET|ENST00000256474\x2E2\x3Ac\x2E208G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu70Ter&NM\x5F000551\x2E3\x3Ac\x2E208G\x3ET|CA16602179|428806|27.5|evidence|5445|https://civicdb.org/links/evidence/5445|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70*_(c.208G>T)|1834|RS5030802&GLU70TER&E70X&C\x2E208G\x3ET|ENST00000256474\x2E2\x3Ac\x2E208G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu70Ter&NM\x5F000551\x2E3\x3Ac\x2E208G\x3ET|CA16602179|428806|27.5|evidence|5361|https://civicdb.org/links/evidence/5361|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10183739	1956	G	A	.	.	GN=VHL;VT=E70K_(c.208G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|5780|https://civicdb.org/links/evidence/5780|25562111_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|5805|https://civicdb.org/links/evidence/5805|25715769_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Adenocarcinoma_of_the_colon_(HPO_ID_HP:0040276)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|6742|https://civicdb.org/links/evidence/6742|27439424_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|6288|https://civicdb.org/links/evidence/6288|25715769_(PubMed)|Rare_Germline|accepted|Positive|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|6503|https://civicdb.org/links/evidence/6503|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|6860|https://civicdb.org/links/evidence/6860|25078357_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|evidence|5273|https://civicdb.org/links/evidence/5273|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K_(c.208G>A)|1956|RS5030802&GLU70LYS&C\x2E208G\x3EA|ENST00000256474\x2E2\x3Ac\x2E208G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183739G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu70Lys&NM\x5F000551\x2E3\x3Ac\x2E208G\x3EA|CA020108|43598|45.0|assertion|14|https://civicdb.org/links/assertion/14||Rare_Germline|accepted|Likely_Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||||PP4&PP1&PM2&PM1||||
3	10183745	1904	T	C	.	.	GN=VHL;VT=S72P_(c.214T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.214T>C||S72P_(c.214T>C)|1904|RS869025618&SER72PRO&C\x2E214T\x3EC|ENST00000256474\x2E2\x3Ac\x2E214T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183745T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ESer72Pro&NM\x5F000551\x2E3\x3Ac\x2E214T\x3EC|CA357006|223163|10.0|evidence|5162|https://civicdb.org/links/evidence/5162|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183744	1816	CT	C	.	.	GN=VHL;VT=S72P_(c.214delT);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.214delT||S72P_(c.214delT)|1816|C\x2E214DELT&SER72PRO|ENST00000256474\x2E2\x3Ac\x2E214delT|CA658795180|NONE_FOUND|10.0|evidence|5163|https://civicdb.org/links/evidence/5163|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183747	2041	CC	C	.	.	GN=VHL;VT=Q73FS_(c.217delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.217delC||Q73FS_(c.217delC)|2041|GLN73FS&C\x2E217DELC|NP\x5F000542\x2E1\x3Ap\x2EGln73ArgfsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E217del&NC\x5F000003\x2E11\x3Ag\x2E10183748del&ENST00000256474\x2E2\x3Ac\x2E217delC|CA432536422|NONE_FOUND|5.0|evidence|5500|https://civicdb.org/links/evidence/5500|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183748	1752	C	T	.	.	GN=VHL;VT=Q73*_(c.217C>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.217C>T||Q73*_(c.217C>T)|1752|RS869025619&GLN73TER&C\x2E217C\x3ET&Q73X|ENST00000256474\x2E2\x3Ac\x2E217C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183748C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln73Ter&NM\x5F000551\x2E3\x3Ac\x2E217C\x3ET|CA357036|223164|27.5|evidence|4918|https://civicdb.org/links/evidence/4918|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,T|stop_gained|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.217C>T||Q73*_(c.217C>T)|1752|RS869025619&GLN73TER&C\x2E217C\x3ET&Q73X|ENST00000256474\x2E2\x3Ac\x2E217C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183748C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln73Ter&NM\x5F000551\x2E3\x3Ac\x2E217C\x3ET|CA357036|223164|27.5|evidence|5270|https://civicdb.org/links/evidence/5270|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.217C>T||Q73*_(c.217C>T)|1752|RS869025619&GLN73TER&C\x2E217C\x3ET&Q73X|ENST00000256474\x2E2\x3Ac\x2E217C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183748C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln73Ter&NM\x5F000551\x2E3\x3Ac\x2E217C\x3ET|CA357036|223164|27.5|evidence|5135|https://civicdb.org/links/evidence/5135|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183752	1999	T	G	.	.	GN=VHL;VT=V74G_(c.221T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.221T>G||V74G_(c.221T>G)|1999|RS5030803&VAL74GLY&C\x2E221T\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183752T\x3EG&NP\x5F000542\x2E1\x3Ap\x2EVal74Gly&NM\x5F000551\x2E3\x3Ac\x2E221T\x3EG&ENST00000256474\x2E2\x3Ac\x2E221T\x3EG|CA70042528|NONE_FOUND|15.0|evidence|5374|https://civicdb.org/links/evidence/5374|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.221T>G||V74G_(c.221T>G)|1999|RS5030803&VAL74GLY&C\x2E221T\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183752T\x3EG&NP\x5F000542\x2E1\x3Ap\x2EVal74Gly&NM\x5F000551\x2E3\x3Ac\x2E221T\x3EG&ENST00000256474\x2E2\x3Ac\x2E221T\x3EG|CA70042528|NONE_FOUND|15.0|evidence|5446|https://civicdb.org/links/evidence/5446|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.221T>G||V74G_(c.221T>G)|1999|RS5030803&VAL74GLY&C\x2E221T\x3EG|NC\x5F000003\x2E11\x3Ag\x2E10183752T\x3EG&NP\x5F000542\x2E1\x3Ap\x2EVal74Gly&NM\x5F000551\x2E3\x3Ac\x2E221T\x3EG&ENST00000256474\x2E2\x3Ac\x2E221T\x3EG|CA70042528|NONE_FOUND|15.0|evidence|5424|https://civicdb.org/links/evidence/5424|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183754	1912	A	AT	.	.	GN=VHL;VT=F76fs_(c.223_224insT);CSQ=T|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|||F76fs_(c.223_224insT)|1912|C\x2E223\x5F224INST&C\x2E224DUPT&ILE75FS|NP\x5F001341652\x2E1\x3Ap\x2EPhe76LeufsTer\x3F&NP\x5F937799\x2E1\x3Ap\x2EPhe76LeufsTer\x3F&NC\x5F000003\x2E12\x3Ag\x2E10142071dupT&NP\x5F000542\x2E1\x3Ap\x2EF76Lfs\x2A56&NM\x5F000551\x2E3\x3Ac\x2E224dupT&NC\x5F000003\x2E11\x3Ag\x2E10183755dupT|CA913189239||7.5|evidence|5174|https://civicdb.org/links/evidence/5174|19270817_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10183754	2088	ATCT	A	.	.	GN=VHL;VT=F76del_(c.224_226delTCT);CSQ=-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|4919|https://civicdb.org/links/evidence/4919|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5654|https://civicdb.org/links/evidence/5654|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5650|https://civicdb.org/links/evidence/5650|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|6547|https://civicdb.org/links/evidence/6547|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5750|https://civicdb.org/links/evidence/5750|20151405_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5386|https://civicdb.org/links/evidence/5386|10761708_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5744|https://civicdb.org/links/evidence/5744|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5203|https://civicdb.org/links/evidence/5203|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|6121|https://civicdb.org/links/evidence/6121|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Epididymal_cyst_(HPO_ID_HP:0030424)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5447|https://civicdb.org/links/evidence/5447|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5641|https://civicdb.org/links/evidence/5641|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5682|https://civicdb.org/links/evidence/5682|23143947_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|4|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5749|https://civicdb.org/links/evidence/5749|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5426|https://civicdb.org/links/evidence/5426|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5766|https://civicdb.org/links/evidence/5766|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|6862|https://civicdb.org/links/evidence/6862|25078357_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|6557|https://civicdb.org/links/evidence/6557|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|evidence|5340|https://civicdb.org/links/evidence/5340|8641976_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del_(c.224_226delTCT)|2088|DELPHE76&C\x2E227\x5F229DELTCT&C\x2E226\x5F228DELTTC&C\x2E224\x5F226DELTCT&PHE76DEL|ENSP00000256474\x2E2\x3Ap\x2EPhe76del&NM\x5F000551\x2E3\x3Ac\x2E227\x5F229del&NC\x5F000003\x2E12\x3Ag\x2E10142074\x5F10142076del&NC\x5F000003\x2E11\x3Ag\x2E10183758\x5F10183760del&NP\x5F000542\x2E1\x3Ap\x2EPhe76del&ENST00000256474\x2E2\x3Ac\x2E224\x5F226delTCT|CA357012|223166|120.0|assertion|17|https://civicdb.org/links/assertion/17||Rare_Germline|accepted|Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||||PP1&PM4&PM2&PS2||||
3	10183758	1835	T	C	.	.	GN=VHL;VT=F76S_(c.227T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.227T>C||F76S_(c.227T>C)|1835|RS730882033&C\x2E277T\x3EC&PHE76SER|NP\x5F000542\x2E1\x3Ap\x2EPhe76Ser&NM\x5F000551\x2E3\x3Ac\x2E227T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183758T\x3EC&ENST00000256474\x2E2\x3Ac\x2E227T\x3EC|CA020125|182976|7.5|evidence|5037|https://civicdb.org/links/evidence/5037|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183759	1790	C	CC	.	.	GN=VHL;VT=C77FS_(c.228_229insC);CSQ=C|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.228_229insC||C77FS_(c.228_229insC)|1790|CYS77FS&C\x2E228\x5F229INSC|ENST00000256474\x2E2\x3Ac\x2E228\x5F229insC|CA658795177|NONE_FOUND|7.5|evidence|4961|https://civicdb.org/links/evidence/4961|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10183763	1754	A	C	.	.	GN=VHL;VT=N78H_(c.232A>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.232A>C||N78H_(c.232A>C)|1754|ASN78HIS&C\x2E232A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EAsn78His&NM\x5F000551\x2E3\x3Ac\x2E232A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183763A\x3EC&ENST00000256474\x2E2\x3Ac\x2E232A\x3EC|CA351749283|NONE_FOUND|32.5|evidence|5341|https://civicdb.org/links/evidence/5341|8641976_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.232A>C||N78H_(c.232A>C)|1754|ASN78HIS&C\x2E232A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EAsn78His&NM\x5F000551\x2E3\x3Ac\x2E232A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183763A\x3EC&ENST00000256474\x2E2\x3Ac\x2E232A\x3EC|CA351749283|NONE_FOUND|32.5|evidence|5130|https://civicdb.org/links/evidence/5130|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.232A>C||N78H_(c.232A>C)|1754|ASN78HIS&C\x2E232A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EAsn78His&NM\x5F000551\x2E3\x3Ac\x2E232A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183763A\x3EC&ENST00000256474\x2E2\x3Ac\x2E232A\x3EC|CA351749283|NONE_FOUND|32.5|evidence|4962|https://civicdb.org/links/evidence/4962|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.232A>C||N78H_(c.232A>C)|1754|ASN78HIS&C\x2E232A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EAsn78His&NM\x5F000551\x2E3\x3Ac\x2E232A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183763A\x3EC&ENST00000256474\x2E2\x3Ac\x2E232A\x3EC|CA351749283|NONE_FOUND|32.5|evidence|4920|https://civicdb.org/links/evidence/4920|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10183764	2037	A	T	.	.	GN=VHL;VT=N78I_(c.233A>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>T||N78I_(c.233A>T)|2037|RS5030804&ASN78ILE&C\x2E233A\x3ET|ENST00000256474\x2E2\x3Ac\x2E233A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3ET&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ile&NM\x5F000551\x2E3\x3Ac\x2E233A\x3ET|CA357063|223169|5.0|evidence|5489|https://civicdb.org/links/evidence/5489|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183764	1756	A	C	.	.	GN=VHL;VT=N78T_(c.233A>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST000|ENST00000256474.2:c.233A>C||N78T_(c.233A>C)|1756|RS5030804&ASN78THR&C\x2E233A\x3EC|ENST00000256474\x2E2\x3Ac\x2E233A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EC&NP\x5F000542\x2E1\x3Ap\x2EAsn78Thr&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EC|CA357095|223168|10.0|evidence|4922|https://civicdb.org/links/evidence/4922|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183764	1755	A	G	.	.	GN=VHL;VT=N78S_(c.233A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|4921|https://civicdb.org/links/evidence/4921|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|4|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|7893|https://civicdb.org/links/evidence/7893|11850829_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|6548|https://civicdb.org/links/evidence/6548|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|6289|https://civicdb.org/links/evidence/6289|26984080_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)&Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|5376|https://civicdb.org/links/evidence/5376|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|5250|https://civicdb.org/links/evidence/5250|19464396_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|5491|https://civicdb.org/links/evidence/5491|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|5027|https://civicdb.org/links/evidence/5027|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Multiple_renal_cysts_(HPO_ID_HP:0005562)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.233A>G||N78S_(c.233A>G)|1755|RS5030804&ASN78SER&C\x2E233A\x3EG|ENST00000256474\x2E2\x3Ac\x2E233A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183764A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn78Ser&NM\x5F000551\x2E3\x3Ac\x2E233A\x3EG|CA020131|93326|62.5|evidence|5020|https://civicdb.org/links/evidence/5020|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183767	1791	G	C	.	.	GN=VHL;VT=R79P_(c.236G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.236G>C||R79P_(c.236G>C)|1791|ARG79PRO&C\x2E236G\x3EC|NP\x5F000542\x2E1\x3Ap\x2EArg79Pro&NM\x5F000551\x2E3\x3Ac\x2E236G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183767G\x3EC&ENST00000256474\x2E2\x3Ac\x2E236G\x3EC|CA351749311|NONE_FOUND|7.5|evidence|4963|https://civicdb.org/links/evidence/4963|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183769	1963	A	C	.	.	GN=VHL;VT=S80R_(c.238A>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R_(c.238A>C)|1963|RS786202787&C\x2E238A\x3EC&SER80ARG|NP\x5F000542\x2E1\x3Ap\x2ESer80Arg&NM\x5F000551\x2E3\x3Ac\x2E238A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183769A\x3EC&ENST00000256474\x2E2\x3Ac\x2E238A\x3EC|CA16621913|496052|22.5|evidence|5547|https://civicdb.org/links/evidence/5547|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R_(c.238A>C)|1963|RS786202787&C\x2E238A\x3EC&SER80ARG|NP\x5F000542\x2E1\x3Ap\x2ESer80Arg&NM\x5F000551\x2E3\x3Ac\x2E238A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183769A\x3EC&ENST00000256474\x2E2\x3Ac\x2E238A\x3EC|CA16621913|496052|22.5|evidence|5548|https://civicdb.org/links/evidence/5548|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R_(c.238A>C)|1963|RS786202787&C\x2E238A\x3EC&SER80ARG|NP\x5F000542\x2E1\x3Ap\x2ESer80Arg&NM\x5F000551\x2E3\x3Ac\x2E238A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183769A\x3EC&ENST00000256474\x2E2\x3Ac\x2E238A\x3EC|CA16621913|496052|22.5|evidence|5288|https://civicdb.org/links/evidence/5288|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183770	1874	G	A	.	.	GN=VHL;VT=S80N_(c.239G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N_(c.239G>A)|1874|RS5030805&SER80ASN&C\x2E239G\x3EA|NP\x5F000542\x2E1\x3Ap\x2ESer80Asn&NM\x5F000551\x2E3\x3Ac\x2E239G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183770G\x3EA&ENST00000256474\x2E2\x3Ac\x2E239G\x3EA|CA70046108|NONE_FOUND|25.0|evidence|5415|https://civicdb.org/links/evidence/5415|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N_(c.239G>A)|1874|RS5030805&SER80ASN&C\x2E239G\x3EA|NP\x5F000542\x2E1\x3Ap\x2ESer80Asn&NM\x5F000551\x2E3\x3Ac\x2E239G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183770G\x3EA&ENST00000256474\x2E2\x3Ac\x2E239G\x3EA|CA70046108|NONE_FOUND|25.0|evidence|5427|https://civicdb.org/links/evidence/5427|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N_(c.239G>A)|1874|RS5030805&SER80ASN&C\x2E239G\x3EA|NP\x5F000542\x2E1\x3Ap\x2ESer80Asn&NM\x5F000551\x2E3\x3Ac\x2E239G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183770G\x3EA&ENST00000256474\x2E2\x3Ac\x2E239G\x3EA|CA70046108|NONE_FOUND|25.0|evidence|5371|https://civicdb.org/links/evidence/5371|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N_(c.239G>A)|1874|RS5030805&SER80ASN&C\x2E239G\x3EA|NP\x5F000542\x2E1\x3Ap\x2ESer80Asn&NM\x5F000551\x2E3\x3Ac\x2E239G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183770G\x3EA&ENST00000256474\x2E2\x3Ac\x2E239G\x3EA|CA70046108|NONE_FOUND|25.0|evidence|5289|https://civicdb.org/links/evidence/5289|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183770	1757	G	T	.	.	GN=VHL;VT=S80I_(c.239G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.239G>T||S80I_(c.239G>T)|1757|RS5030805&SER80ILE&C\x2E239G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183770G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer80Ile&NM\x5F000551\x2E3\x3Ac\x2E239G\x3ET&ENST00000256474\x2E2\x3Ac\x2E239G\x3ET|CA16621914|NONE_FOUND|15.0|evidence|4923|https://civicdb.org/links/evidence/4923|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.239G>T||S80I_(c.239G>T)|1757|RS5030805&SER80ILE&C\x2E239G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183770G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ESer80Ile&NM\x5F000551\x2E3\x3Ac\x2E239G\x3ET&ENST00000256474\x2E2\x3Ac\x2E239G\x3ET|CA16621914|NONE_FOUND|15.0|evidence|5428|https://civicdb.org/links/evidence/5428|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183771	1792	T	G	.	.	GN=VHL;VT=S80R_(c.240T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.240T>G||S80R_(c.240T>G)|1792|SER80ARG&C\x2E240T\x3EG|ENST00000256474\x2E2\x3Ac\x2E240T\x3EG|CA351750515|NONE_FOUND|12.5|evidence|5448|https://civicdb.org/links/evidence/5448|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.240T>G||S80R_(c.240T>G)|1792|SER80ARG&C\x2E240T\x3EG|ENST00000256474\x2E2\x3Ac\x2E240T\x3EG|CA351750515|NONE_FOUND|12.5|evidence|4964|https://civicdb.org/links/evidence/4964|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183772	1837	C	T	.	.	GN=VHL;VT=P81S_(c.241C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.241C>T||P81S_(c.241C>T)|1837|RS104893829&PRO81SER&C\x2E241C\x3ET|ENST00000256474\x2E2\x3Ac\x2E241C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183772C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro81Ser&NM\x5F000551\x2E3\x3Ac\x2E241C\x3ET|CA020148|2233|12.5|evidence|6505|https://civicdb.org/links/evidence/6505|24132471_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.241C>T||P81S_(c.241C>T)|1837|RS104893829&PRO81SER&C\x2E241C\x3ET|ENST00000256474\x2E2\x3Ac\x2E241C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183772C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro81Ser&NM\x5F000551\x2E3\x3Ac\x2E241C\x3ET|CA020148|2233|12.5|evidence|5369|https://civicdb.org/links/evidence/5369|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10183774	2264	GCGCGTCGTG	G	.	.	GN=VHL;VT=R82_V84del_(c.244_252del);CSQ=-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|||R82_V84del_(c.244_252del)|2264|C\x2E245\x5F253DEL&C\x2E244\x5F252DEL||CA658820713|NONE_FOUND|10.0|evidence|6060|https://civicdb.org/links/evidence/6060|7728151_(PubMed)|N/A|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|4|||||
3	10183776	1980	G	C	.	.	GN=VHL;VT=R82P_(c.245G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.245G>C||R82P_(c.245G>C)|1980|RS794726890&ARG82PRO&C\x2E245G\x3EC|ENST00000256474\x2E2\x3Ac\x2E245G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183776G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EArg82Pro&NM\x5F000551\x2E3\x3Ac\x2E245G\x3EC|CA020159|193118|0.0|evidence|5864|https://civicdb.org/links/evidence/5864|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10183781	1815	G	T	.	.	GN=VHL;VT=V84L_(c.250G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.250G>T||V84L_(c.250G>T)|1815|RS5030827&VAL84LEU&C\x2E250G\x3ET|ENST00000256474\x2E2\x3Ac\x2E250G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183781G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EVal84Leu&NM\x5F000551\x2E3\x3Ac\x2E250G\x3ET|CA020170|2236|5.0|evidence|5430|https://civicdb.org/links/evidence/5430|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183785	2020	T	C	.	.	GN=VHL;VT=L85P_(c.254T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.254T>C||L85P_(c.254T>C)|2020|RS5030828&LEU85PRO&C\x2E254T\x3EC|ENST00000256474\x2E2\x3Ac\x2E254T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183785T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu85Pro&NM\x5F000551\x2E3\x3Ac\x2E254T\x3EC|CA16602675|376222|5.0|evidence|5431|https://civicdb.org/links/evidence/5431|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183787	1902	C	T	.	.	GN=VHL;VT=P86S_(c.256C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.256C>T||P86S_(c.256C>T)|1902|RS398123481&PRO86SER&C\x2E256C\x3ET|ENST00000256474\x2E2\x3Ac\x2E256C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183787C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro86Ser&NM\x5F000551\x2E3\x3Ac\x2E256C\x3ET|CA020180|178692|27.5|evidence|5775|https://civicdb.org/links/evidence/5775|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.256C>T||P86S_(c.256C>T)|1902|RS398123481&PRO86SER&C\x2E256C\x3ET|ENST00000256474\x2E2\x3Ac\x2E256C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183787C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro86Ser&NM\x5F000551\x2E3\x3Ac\x2E256C\x3ET|CA020180|178692|27.5|evidence|6551|https://civicdb.org/links/evidence/6551|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.256C>T||P86S_(c.256C>T)|1902|RS398123481&PRO86SER&C\x2E256C\x3ET|ENST00000256474\x2E2\x3Ac\x2E256C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183787C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro86Ser&NM\x5F000551\x2E3\x3Ac\x2E256C\x3ET|CA020180|178692|27.5|evidence|5286|https://civicdb.org/links/evidence/5286|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.256C>T||P86S_(c.256C>T)|1902|RS398123481&PRO86SER&C\x2E256C\x3ET|ENST00000256474\x2E2\x3Ac\x2E256C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183787C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro86Ser&NM\x5F000551\x2E3\x3Ac\x2E256C\x3ET|CA020180|178692|27.5|evidence|5158|https://civicdb.org/links/evidence/5158|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183787	1759	C	G	.	.	GN=VHL;VT=P86A_(c.256C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>G||P86A_(c.256C>G)|1759|RS398123481&PRO86ALA&C\x2E256C\x3EG|ENST00000256474\x2E2\x3Ac\x2E256C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183787C\x3EG&NP\x5F000542\x2E1\x3Ap\x2EPro86Ala&NM\x5F000551\x2E3\x3Ac\x2E256C\x3EG|CA020174|93327|5.0|evidence|6550|https://civicdb.org/links/evidence/6550|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||
3	10183788	1849	C	G	.	.	GN=VHL;VT=P86R_(c.257C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.257C>G||P86R_(c.257C>G)|1849|RS730882034&PRO86ARG&C\x2E257C\x3EG|ENST00000256474\x2E2\x3Ac\x2E257C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183788C\x3EG&NP\x5F000542\x2E1\x3Ap\x2EPro86Arg&NM\x5F000551\x2E3\x3Ac\x2E257C\x3EG|CA357142|223170|17.5|evidence|5156|https://civicdb.org/links/evidence/5156|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.257C>G||P86R_(c.257C>G)|1849|RS730882034&PRO86ARG&C\x2E257C\x3EG|ENST00000256474\x2E2\x3Ac\x2E257C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183788C\x3EG&NP\x5F000542\x2E1\x3Ap\x2EPro86Arg&NM\x5F000551\x2E3\x3Ac\x2E257C\x3EG|CA357142|223170|17.5|evidence|5059|https://civicdb.org/links/evidence/5059|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183788	1760	C	T	.	.	GN=VHL;VT=P86L_(c.257C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>T||P86L_(c.257C>T)|1760|RS730882034&PRO86LEU&C\x2E257C\x3ET|ENST00000256474\x2E2\x3Ac\x2E257C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183788C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro86Leu&NM\x5F000551\x2E3\x3Ac\x2E257C\x3ET|CA020186|182977|20.0|evidence|5157|https://civicdb.org/links/evidence/5157|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>T||P86L_(c.257C>T)|1760|RS730882034&PRO86LEU&C\x2E257C\x3ET|ENST00000256474\x2E2\x3Ac\x2E257C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183788C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EPro86Leu&NM\x5F000551\x2E3\x3Ac\x2E257C\x3ET|CA020186|182977|20.0|evidence|4926|https://civicdb.org/links/evidence/4926|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183790	2432	G	GA	.	.	GN=VHL;VT=V87fs_(c.259_260insA);CSQ=A|frameshift_elongation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.259_260insA||V87fs_(c.259_260insA)|2432|VAL87FS&C\x2E259\x5F260INSA|ENST00000256474\x2E2\x3Ac\x2E259\x5F260insA|CA913189242|NONE_FOUND|0.0|evidence|6506|https://civicdb.org/links/evidence/6506|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|3|||||
3	10183793	2056	T	C	.	.	GN=VHL;VT=W88R_(c.262T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.262T>C||W88R_(c.262T>C)|2056|C\x2E262T\x3EC&TRP88ARG|NP\x5F000542\x2E1\x3Ap\x2ETrp88Arg&NM\x5F000551\x2E3\x3Ac\x2E262T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183793T\x3EC&ENST00000256474\x2E2\x3Ac\x2E262T\x3EC|CA351750667|496053|7.5|evidence|5549|https://civicdb.org/links/evidence/5549|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183793	1761	T	A	.	.	GN=VHL;VT=W88R_(c.262T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.262T>A||W88R_(c.262T>A)|1761|TRP88ARG&C\x2E262T\x3EA|NM\x5F000551\x2E3\x3Ac\x2E262T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183793T\x3EA&NP\x5F000542\x2E1\x3Ap\x2ETrp88Arg&ENST00000256474\x2E2\x3Ac\x2E262T\x3EA|CA351750671|456577|15.0|evidence|4927|https://civicdb.org/links/evidence/4927|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.262T>A||W88R_(c.262T>A)|1761|TRP88ARG&C\x2E262T\x3EA|NM\x5F000551\x2E3\x3Ac\x2E262T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183793T\x3EA&NP\x5F000542\x2E1\x3Ap\x2ETrp88Arg&ENST00000256474\x2E2\x3Ac\x2E262T\x3EA|CA351750671|456577|15.0|evidence|5168|https://civicdb.org/links/evidence/5168|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183794	2151	G	A	.	.	GN=VHL;VT=W88*_(c.263G>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263G>A||W88*_(c.263G>A)|2151|RS119103277&C\x2E263G\x3EA&TRP88TER&W88X|ENST00000256474\x2E2\x3Ac\x2E263G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183794G\x3EA&NP\x5F000542\x2E1\x3Ap\x2ETrp88Ter&NM\x5F000551\x2E3\x3Ac\x2E263G\x3EA|CA020197|182978|5.0|evidence|5776|https://civicdb.org/links/evidence/5776|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)&Epididymal_cyst_(HPO_ID_HP:0030424)|C|2|||||
3	10183794	1966	G	C	.	.	GN=VHL;VT=W88S_(c.263G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263G>C||W88S_(c.263G>C)|1966|RS119103277&TRP88SER&C\x2E263G\x3EC|ENST00000256474\x2E2\x3Ac\x2E263G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183794G\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETrp88Ser&NM\x5F000551\x2E3\x3Ac\x2E263G\x3EC|CA020202|2220|5.0|evidence|5296|https://civicdb.org/links/evidence/5296|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183793	2039	TGGC	TTT	.	.	GN=VHL;VT=W88FS_(c.263_265delGGCinsTT);CSQ=-|delins&frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263_265delGGCinsTT||W88FS_(c.263_265delGGCinsTT)|2039|TRP88FS&C\x2E263\x5F265DELGGCINSTT|NP\x5F000542\x2E1\x3Ap\x2ETrp88PhefsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E263\x5F265delinsTT&NC\x5F000003\x2E11\x3Ag\x2E10183794\x5F10183796delinsTT&ENST00000256474\x2E2\x3Ac\x2E263\x5F265delGGCinsTT|CA658683075|NONE_FOUND|5.0|evidence|5495|https://civicdb.org/links/evidence/5495|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183795	1908	G	A	.	.	GN=VHL;VT=W88*_(c.264G>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.264G>A||W88*_(c.264G>A)|1908|TRP88TER&W88X&C\x2E264G\x3EA|NM\x5F000551\x2E3\x3Ac\x2E264G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183795G\x3EA&NP\x5F000542\x2E1\x3Ap\x2ETrp88Ter&ENST00000256474\x2E2\x3Ac\x2E264G\x3EA|CA351750677|182978|10.0|evidence|5169|https://civicdb.org/links/evidence/5169|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10183797	1793	T	C	.	.	GN=VHL;VT=L89P_(c.266T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.266T>C||L89P_(c.266T>C)|1793|RS5030807&LEU89PRO&C\x2E266T\x3EC|ENST00000256474\x2E2\x3Ac\x2E266T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183797T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu89Pro&NM\x5F000551\x2E3\x3Ac\x2E266T\x3EC|CA020207|182979|32.5|evidence|5449|https://civicdb.org/links/evidence/5449|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.266T>C||L89P_(c.266T>C)|1793|RS5030807&LEU89PRO&C\x2E266T\x3EC|ENST00000256474\x2E2\x3Ac\x2E266T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183797T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu89Pro&NM\x5F000551\x2E3\x3Ac\x2E266T\x3EC|CA020207|182979|32.5|evidence|6552|https://civicdb.org/links/evidence/6552|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.266T>C||L89P_(c.266T>C)|1793|RS5030807&LEU89PRO&C\x2E266T\x3EC|ENST00000256474\x2E2\x3Ac\x2E266T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183797T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu89Pro&NM\x5F000551\x2E3\x3Ac\x2E266T\x3EC|CA020207|182979|32.5|evidence|5368|https://civicdb.org/links/evidence/5368|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.266T>C||L89P_(c.266T>C)|1793|RS5030807&LEU89PRO&C\x2E266T\x3EC|ENST00000256474\x2E2\x3Ac\x2E266T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183797T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu89Pro&NM\x5F000551\x2E3\x3Ac\x2E266T\x3EC|CA020207|182979|32.5|evidence|5150|https://civicdb.org/links/evidence/5150|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,C|missense_variant|VHL|7428|transcript|ENST0000|ENST00000256474.2:c.266T>C||L89P_(c.266T>C)|1793|RS5030807&LEU89PRO&C\x2E266T\x3EC|ENST00000256474\x2E2\x3Ac\x2E266T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183797T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu89Pro&NM\x5F000551\x2E3\x3Ac\x2E266T\x3EC|CA020207|182979|32.5|evidence|4965|https://civicdb.org/links/evidence/4965|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183806	2449	A	G	.	.	GN=VHL;VT=D92G_(c.275A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.275A>G||D92G_(c.275A>G)|2449|ASP92GLY&C\x2E275A\x3EG|NP\x5F000542\x2E1\x3Ap\x2EAsp92Gly&NM\x5F000551\x2E3\x3Ac\x2E275A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183806A\x3EG&ENST00000256474\x2E2\x3Ac\x2E275A\x3EG|CA351750765|NONE_FOUND|5.0|evidence|6553|https://civicdb.org/links/evidence/6553|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||
3	10183808	1859	G	A	.	.	GN=VHL;VT=G93S_(c.277G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>A||G93S_(c.277G>A)|1859|RS5030808&GLY93SER&C\x2E277G\x3EA|ENST00000256474\x2E2\x3Ac\x2E277G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183808G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGly93Ser&NM\x5F000551\x2E3\x3Ac\x2E277G\x3EA|CA020230|2237|22.5|evidence|5100|https://civicdb.org/links/evidence/5100|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>A||G93S_(c.277G>A)|1859|RS5030808&GLY93SER&C\x2E277G\x3EA|ENST00000256474\x2E2\x3Ac\x2E277G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183808G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGly93Ser&NM\x5F000551\x2E3\x3Ac\x2E277G\x3EA|CA020230|2237|22.5|evidence|5407|https://civicdb.org/links/evidence/5407|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>A||G93S_(c.277G>A)|1859|RS5030808&GLY93SER&C\x2E277G\x3EA|ENST00000256474\x2E2\x3Ac\x2E277G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183808G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGly93Ser&NM\x5F000551\x2E3\x3Ac\x2E277G\x3EA|CA020230|2237|22.5|evidence|6507|https://civicdb.org/links/evidence/6507|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|3|||||
3	10183808	1920	G	C	.	.	GN=VHL;VT=G93R_(c.277G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>C||G93R_(c.277G>C)|1920|RS5030808&GLY93ARG&C\x2E277G\x3EC|ENST00000256474\x2E2\x3Ac\x2E277G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183808G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EGly93Arg&NM\x5F000551\x2E3\x3Ac\x2E277G\x3EC|CA357130|223174|10.0|evidence|5450|https://civicdb.org/links/evidence/5450|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>C||G93R_(c.277G>C)|1920|RS5030808&GLY93ARG&C\x2E277G\x3EC|ENST00000256474\x2E2\x3Ac\x2E277G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183808G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EGly93Arg&NM\x5F000551\x2E3\x3Ac\x2E277G\x3EC|CA357130|223174|10.0|evidence|5432|https://civicdb.org/links/evidence/5432|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10183808	2008	G	T	.	.	GN=VHL;VT=G93C_(c.277G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>T||G93C_(c.277G>T)|2008|RS5030808&GLY93CYS&C\x2E277G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183808G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGly93Cys&NM\x5F000551\x2E3\x3Ac\x2E277G\x3ET&ENST00000256474\x2E2\x3Ac\x2E277G\x3ET|CA357106|223175|7.5|evidence|5406|https://civicdb.org/links/evidence/5406|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10183809	2009	G	T	.	.	GN=VHL;VT=G93V_(c.278G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.278G>T||G93V_(c.278G>T)|2009|GLY93VAL&C\x2E278G\x3ET|NP\x5F000542\x2E1\x3Ap\x2EGly93Val&NM\x5F000551\x2E3\x3Ac\x2E278G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183809G\x3ET&ENST00000256474\x2E2\x3Ac\x2E278G\x3ET|CA351750779|NONE_FOUND|7.5|evidence|5408|https://civicdb.org/links/evidence/5408|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10183809	2127	GC	G	.	.	GN=VHL;VT=G93FS_(c.279delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.279delC||G93FS_(c.279delC)|2127|GLY93FS&C\x2E279DELC|NP\x5F000542\x2E1\x3Ap\x2EGlu94SerfsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E279del&NC\x5F000003\x2E11\x3Ag\x2E10183810del&ENST00000256474\x2E2\x3Ac\x2E279delC|CA658820711|NONE_FOUND|0.0|evidence|5722|https://civicdb.org/links/evidence/5722|10862095_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10183811	1794	G	T	.	.	GN=VHL;VT=E94*_(c.280G>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94*_(c.280G>T)|1794|RS5030829&GLU94TER&E94X&C\x2E280G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183811G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu94Ter&NM\x5F198156\x2E2\x3Ac\x2E280G\x3ET&ENST00000256474\x2E2\x3Ac\x2E280G\x3ET|CA70046202|584477|42.5|evidence|5771|https://civicdb.org/links/evidence/5771|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)&Epididymal_cyst_(HPO_ID_HP:0030424)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94*_(c.280G>T)|1794|RS5030829&GLU94TER&E94X&C\x2E280G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183811G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu94Ter&NM\x5F198156\x2E2\x3Ac\x2E280G\x3ET&ENST00000256474\x2E2\x3Ac\x2E280G\x3ET|CA70046202|584477|42.5|evidence|5405|https://civicdb.org/links/evidence/5405|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94*_(c.280G>T)|1794|RS5030829&GLU94TER&E94X&C\x2E280G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183811G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu94Ter&NM\x5F198156\x2E2\x3Ac\x2E280G\x3ET&ENST00000256474\x2E2\x3Ac\x2E280G\x3ET|CA70046202|584477|42.5|evidence|5561|https://civicdb.org/links/evidence/5561|22133049_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94*_(c.280G>T)|1794|RS5030829&GLU94TER&E94X&C\x2E280G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183811G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu94Ter&NM\x5F198156\x2E2\x3Ac\x2E280G\x3ET&ENST00000256474\x2E2\x3Ac\x2E280G\x3ET|CA70046202|584477|42.5|evidence|5550|https://civicdb.org/links/evidence/5550|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94*_(c.280G>T)|1794|RS5030829&GLU94TER&E94X&C\x2E280G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183811G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu94Ter&NM\x5F198156\x2E2\x3Ac\x2E280G\x3ET&ENST00000256474\x2E2\x3Ac\x2E280G\x3ET|CA70046202|584477|42.5|evidence|5433|https://civicdb.org/links/evidence/5433|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94*_(c.280G>T)|1794|RS5030829&GLU94TER&E94X&C\x2E280G\x3ET|NC\x5F000003\x2E11\x3Ag\x2E10183811G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu94Ter&NM\x5F198156\x2E2\x3Ac\x2E280G\x3ET&ENST00000256474\x2E2\x3Ac\x2E280G\x3ET|CA70046202|584477|42.5|evidence|5137|https://civicdb.org/links/evidence/5137|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10183817	1848	C	T	.	.	GN=VHL;VT=Q96*_(c.286C>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST0|ENST00000256474.2:c.286C>T||Q96*_(c.286C>T)|1848|RS1131690959&GLN96TER&Q96X&C\x2E286C\x3ET|ENST00000256474\x2E2\x3Ac\x2E286C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183817C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln96Ter&NM\x5F000551\x2E3\x3Ac\x2E286C\x3ET|CA351750811|428804|15.0|evidence|5271|https://civicdb.org/links/evidence/5271|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST0|ENST00000256474.2:c.286C>T||Q96*_(c.286C>T)|1848|RS1131690959&GLN96TER&Q96X&C\x2E286C\x3ET|ENST00000256474\x2E2\x3Ac\x2E286C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183817C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln96Ter&NM\x5F000551\x2E3\x3Ac\x2E286C\x3ET|CA351750811|428804|15.0|evidence|5058|https://civicdb.org/links/evidence/5058|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183821	2160	CC	C	.	.	GN=VHL;VT=Y98FS_(c.291delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.291delC||Y98FS_(c.291delC)|2160|C\x2E291DELC&TYR98FS|NP\x5F000542\x2E1\x3Ap\x2ETyr98ThrfsTer&NM\x5F000551\x2E3\x3Ac\x2E291delC&NC\x5F000003\x2E11\x3Ag\x2E10183822delC&ENST00000256474\x2E2\x3Ac\x2E291delC|CA432420512|NONE_FOUND|10.0|evidence|5794|https://civicdb.org/links/evidence/5794|24396697_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cyst_(HPO_ID_HP:0000107)&Pancreatic_cysts_(HPO_ID_HP:0001737)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|4|||||
3	10183821	852	CCTACCCAACGCTGCCGCCTG	C	.	.	GN=VHL;VT=Y98FS_(c.291_310del20);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.291_310del||Y98FS_(c.291_310del20)|852|TYR98FS&C\x2E291\x5F310DEL20|NP\x5F000542\x2E1\x3Ap\x2ETyr98HisfsTer27&NM\x5F000551\x2E3\x3Ac\x2E291\x5F310del&NC\x5F000003\x2E11\x3Ag\x2E10183822\x5F10183841del&ENST00000256474\x2E2\x3Ac\x2E291\x5F310del|CA645524819|NONE_FOUND|0.5|evidence|1951|https://civicdb.org/links/evidence/1951|15932632_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||E|2|||||
3	10183823	1741	T	C	.	.	GN=VHL;VT=Y98H_(c.292T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|5372|https://civicdb.org/links/evidence/5372|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|6554|https://civicdb.org/links/evidence/6554|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|5807|https://civicdb.org/links/evidence/5807|25883647_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|5451|https://civicdb.org/links/evidence/5451|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|5418|https://civicdb.org/links/evidence/5418|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|7645|https://civicdb.org/links/evidence/7645|7759077_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Pheochromocytoma_(HPO_ID_HP:0002666)|B|4|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|5474|https://civicdb.org/links/evidence/5474|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|4906|https://civicdb.org/links/evidence/4906|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H_(c.292T>C)|1741|RS5030809&TYR98HIS&C\x2E292T\x3EC|ENST00000256474\x2E2\x3Ac\x2E292T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183823T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr98His&NM\x5F000551\x2E3\x3Ac\x2E292T\x3EC|CA020246|2223|67.5|evidence|4967|https://civicdb.org/links/evidence/4967|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183824	1933	A	G	.	.	GN=VHL;VT=Y98C__(c.293A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.293A>G||Y98C__(c.293A>G)|1933|RS864321643&TYR98CYS&C\x2E293A\x3EG|ENST00000256474\x2E2\x3Ac\x2E293A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183824A\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr98Cys&NM\x5F000551\x2E3\x3Ac\x2E293A\x3EG|CA357072|223176|5.0|evidence|5217|https://civicdb.org/links/evidence/5217|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10183835	2058	CC	C	.	.	GN=VHL;VT=P102fs_(c.305delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.305delC||P102fs_(c.305delC)|2058|PRO102FS&C\x2E305DELC|NP\x5F000542\x2E1\x3Ap\x2EPro102ArgfsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E305del&NC\x5F000003\x2E11\x3Ag\x2E10183836del&ENST00000256474\x2E2\x3Ac\x2E305delC|CA658820710|NONE_FOUND|7.5|evidence|5554|https://civicdb.org/links/evidence/5554|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183839	1795	CTG	C	.	.	GN=VHL;VT=P103FS_(c.309_310delTG);CSQ=-|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.309_310delTG||P103FS_(c.309_310delTG)|1795|PRO103FS&C\x2E309\x5F310DELTG|NP\x5F000542\x2E1\x3Ap\x2EGly104HisfsTer27&NM\x5F000551\x2E3\x3Ac\x2E309\x5F310del&NC\x5F000003\x2E11\x3Ag\x2E10183840\x5F10183841del&ENST00000256474\x2E2\x3Ac\x2E309\x5F310delTG|CA658795178|NONE_FOUND|7.5|evidence|5138|https://civicdb.org/links/evidence/5138|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||
3	10183842	2043	G	C	.	.	GN=VHL;VT=G104A_(c.311G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.311G>C||G104A_(c.311G>C)|2043|RS869025630&GLY104ALA&C\x2E311G\x3EC|ENST00000256474\x2E2\x3Ac\x2E311G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183842G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EGly104Ala&NM\x5F000551\x2E3\x3Ac\x2E311G\x3EC|CA16611067|411966|0.0|evidence|6109|https://civicdb.org/links/evidence/6109|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183844	1839	A	C	.	.	GN=VHL;VT=T105P_(c.313A>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.313A>C||T105P_(c.313A>C)|1839|RS1553619461&THR105PRO&C\x2E313A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EThr105Pro&NM\x5F000551\x2E3\x3Ac\x2E313A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183844A\x3EC&ENST00000256474\x2E2\x3Ac\x2E313A\x3EC|CA351751116|496055|12.5|evidence|5041|https://civicdb.org/links/evidence/5041|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.313A>C||T105P_(c.313A>C)|1839|RS1553619461&THR105PRO&C\x2E313A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EThr105Pro&NM\x5F000551\x2E3\x3Ac\x2E313A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183844A\x3EC&ENST00000256474\x2E2\x3Ac\x2E313A\x3EC|CA351751116|496055|12.5|evidence|5293|https://civicdb.org/links/evidence/5293|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183850	2007	C	G	.	.	GN=VHL;VT=R107G__(c.319C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.319C>G||R107G__(c.319C>G)|2007|RS397516440&ARG107GLY&C\x2E319C\x3EG|ENST00000256474\x2E2\x3Ac\x2E319C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183850C\x3EG&NP\x5F000542\x2E1\x3Ap\x2EArg107Gly&NM\x5F000551\x2E3\x3Ac\x2E319C\x3EG|CA020257|43599|7.5|evidence|5399|https://civicdb.org/links/evidence/5399|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10183851	1840	G	C	.	.	GN=VHL;VT=R107P_(c.320G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.320G>C||R107P_(c.320G>C)|1840|RS193922609&ARG107PRO&C\x2E320G\x3EC|ENST00000256474\x2E2\x3Ac\x2E320G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183851G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EArg107Pro&NM\x5F000551\x2E3\x3Ac\x2E320G\x3EC|CA020262|36900|7.5|evidence|5042|https://civicdb.org/links/evidence/5042|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183862	2045	A	T	.	.	GN=VHL;VT=S111C_(c.331A>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|||S111C_(c.331A>T)|2045|C\x2E331A\x3ET&RS1559426203&SER111CYS|NP\x5F000542\x2E1\x3Ap\x2ESer111Cys&NM\x5F000551\x2E3\x3Ac\x2E331A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183862A\x3ET|CA351751322|565557|7.5|evidence|6600|https://civicdb.org/links/evidence/6600|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||
3	10183861	1762	CA	C	.	.	GN=VHL;VT=S111FS_(c.331delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.331del||S111FS_(c.331delA)|1762|SER111FS&C\x2E331DELA|ENST00000256474\x2E2\x3Ac\x2E331del&NP\x5F001341652\x2E1\x3Ap\x2ESer111AlafsTer6&NM\x5F001354723\x2E1\x3Ac\x2E331del&NP\x5F937799\x2E1\x3Ap\x2ESer111AlafsTer7&NM\x5F198156\x2E2\x3Ac\x2E331del&NM\x5F000551\x2E3\x3Ac\x2E331del&NC\x5F000003\x2E11\x3Ag\x2E10183862del&NC\x5F000003\x2E12\x3Ag\x2E10142178del|CA432420649|NONE_FOUND|10.0|evidence|4928|https://civicdb.org/links/evidence/4928|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183863	1763	G	A	.	.	GN=VHL;VT=S111N_(c.332G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.332G>A||S111N_(c.332G>A)|1763|RS869025631&SER111ASN&C\x2E332G\x3EA|ENST00000256474\x2E2\x3Ac\x2E332G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183863G\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer111Asn&NM\x5F000551\x2E3\x3Ac\x2E332G\x3EA|CA357091|223186|17.5|evidence|6601|https://civicdb.org/links/evidence/6601|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.332G>A||S111N_(c.332G>A)|1763|RS869025631&SER111ASN&C\x2E332G\x3EA|ENST00000256474\x2E2\x3Ac\x2E332G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183863G\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer111Asn&NM\x5F000551\x2E3\x3Ac\x2E332G\x3EA|CA357091|223186|17.5|evidence|4929|https://civicdb.org/links/evidence/4929|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10183864	1764	C	G	.	.	GN=VHL;VT=S111R_(c.333C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.333C>G||S111R_(c.333C>G)|1764|RS765978945&SER111ARG&C\x2E333C\x3EG|ENST00000256474\x2E2\x3Ac\x2E333C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183864C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer111Arg&NM\x5F000551\x2E3\x3Ac\x2E333C\x3EG|CA040305|223187|15.0|evidence|5498|https://civicdb.org/links/evidence/5498|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.333C>G||S111R_(c.333C>G)|1764|RS765978945&SER111ARG&C\x2E333C\x3EG|ENST00000256474\x2E2\x3Ac\x2E333C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10183864C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ESer111Arg&NM\x5F000551\x2E3\x3Ac\x2E333C\x3EG|CA040305|223187|15.0|evidence|4930|https://civicdb.org/links/evidence/4930|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|4|||||
3	10183865	1865	T	C	.	.	GN=VHL;VT=Y112H_(c.334T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.334T>C||Y112H_(c.334T>C)|1865|RS104893824&TYR112HIS&C\x2E334T\x3EC|ENST00000256474\x2E2\x3Ac\x2E334T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183865T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ETyr112His&NM\x5F000551\x2E3\x3Ac\x2E334T\x3EC|CA020277|2222|5.0|evidence|5475|https://civicdb.org/links/evidence/5475|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10183867	1766	C	A	.	.	GN=VHL;VT=Y112*_(c.336C>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.336C>A||Y112*_(c.336C>A)|1766|TYR112TER&Y112X&C\x2E336C\x3EA|NP\x5F000542\x2E1\x3Ap\x2ETyr112Ter&NM\x5F000551\x2E3\x3Ac\x2E336C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183867C\x3EA&ENST00000256474\x2E2\x3Ac\x2E336C\x3EA|CA16602183|NONE_FOUND|10.0|evidence|4932|https://civicdb.org/links/evidence/4932|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioma_(HPO_ID_HP:0001028)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|4|||||
3	10183867	2143	CC	C	.	.	GN=VHL;VT=R113FS_(c.337delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337delC||R113FS_(c.337delC)|2143|ARG113FS&C\x2E337DELC|NP\x5F000542\x2E1\x3Ap\x2EArg113GlufsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E337delC&NC\x5F000003\x2E11\x3Ag\x2E10183868delC&ENST00000256474\x2E2\x3Ac\x2E337delC|CA432420675|NONE_FOUND|10.0|evidence|5741|https://civicdb.org/links/evidence/5741|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10183868	1796	C	T	.	.	GN=VHL;VT=R113*_(c.337C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113*_(c.337C>T)|1796|RS5030810&ARG113TER&R113X&C\x2E337C\x3ET|ENST00000256474\x2E2\x3Ac\x2E337C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183868C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg113Ter&NM\x5F000551\x2E3\x3Ac\x2E337C\x3ET|CA348491|220414|37.5|evidence|5352|https://civicdb.org/links/evidence/5352|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113*_(c.337C>T)|1796|RS5030810&ARG113TER&R113X&C\x2E337C\x3ET|ENST00000256474\x2E2\x3Ac\x2E337C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183868C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg113Ter&NM\x5F000551\x2E3\x3Ac\x2E337C\x3ET|CA348491|220414|37.5|evidence|6602|https://civicdb.org/links/evidence/6602|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113*_(c.337C>T)|1796|RS5030810&ARG113TER&R113X&C\x2E337C\x3ET|ENST00000256474\x2E2\x3Ac\x2E337C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183868C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg113Ter&NM\x5F000551\x2E3\x3Ac\x2E337C\x3ET|CA348491|220414|37.5|evidence|5043|https://civicdb.org/links/evidence/5043|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113*_(c.337C>T)|1796|RS5030810&ARG113TER&R113X&C\x2E337C\x3ET|ENST00000256474\x2E2\x3Ac\x2E337C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183868C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg113Ter&NM\x5F000551\x2E3\x3Ac\x2E337C\x3ET|CA348491|220414|37.5|evidence|5260|https://civicdb.org/links/evidence/5260|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113*_(c.337C>T)|1796|RS5030810&ARG113TER&R113X&C\x2E337C\x3ET|ENST00000256474\x2E2\x3Ac\x2E337C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183868C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg113Ter&NM\x5F000551\x2E3\x3Ac\x2E337C\x3ET|CA348491|220414|37.5|evidence|5177|https://civicdb.org/links/evidence/5177|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10183871	1797	G	T	.	.	GN=VHL;VT=G114C_(c.340G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>T||G114C_(c.340G>T)|1797|GLY114CYS&C\x2E340G\x3ET|NP\x5F000542\x2E1\x3Ap\x2EGly114Cys&NM\x5F000551\x2E3\x3Ac\x2E340G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183871G\x3ET&ENST00000256474\x2E2\x3Ac\x2E340G\x3ET|CA351751376|NONE_FOUND|12.5|evidence|5139|https://civicdb.org/links/evidence/5139|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>T||G114C_(c.340G>T)|1797|GLY114CYS&C\x2E340G\x3ET|NP\x5F000542\x2E1\x3Ap\x2EGly114Cys&NM\x5F000551\x2E3\x3Ac\x2E340G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10183871G\x3ET&ENST00000256474\x2E2\x3Ac\x2E340G\x3ET|CA351751376|NONE_FOUND|12.5|evidence|4970|https://civicdb.org/links/evidence/4970|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10183871	2026	G	A	.	.	GN=VHL;VT=G114S_(c.340G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>A||G114S_(c.340G>A)|2026|GLY114SER&C\x2E340G\x3EA|NP\x5F000542\x2E1\x3Ap\x2EGly114Ser&NM\x5F000551\x2E3\x3Ac\x2E340G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183871G\x3EA&ENST00000256474\x2E2\x3Ac\x2E340G\x3EA|CA351751372|583094|5.0|evidence|5452|https://civicdb.org/links/evidence/5452|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10183871	1857	G	C	.	.	GN=VHL;VT=G114R_(c.340G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.340G>C||G114R_(c.340G>C)|1857|RS869025636&GLY114ARG&C\x2E340G\x3EC|ENST00000256474\x2E2\x3Ac\x2E340G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183871G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EGly114Arg&NM\x5F000551\x2E3\x3Ac\x2E340G\x3EC|CA357101|223193|12.5|evidence|5476|https://civicdb.org/links/evidence/5476|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.340G>C||G114R_(c.340G>C)|1857|RS869025636&GLY114ARG&C\x2E340G\x3EC|ENST00000256474\x2E2\x3Ac\x2E340G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10183871G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EGly114Arg&NM\x5F000551\x2E3\x3Ac\x2E340G\x3EC|CA357101|223193|12.5|evidence|5305|https://civicdb.org/links/evidence/5305|19464396_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10183872	2114	G	A	.	.	GN=VHL;VT=Splicing_alteration_(c.340+1G>A);CSQ=A|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splicing_alteration_(c.340+1G>A)|2114|C\x2E553\x2B1G\x3EA&C\x2E340\x2B1G\x3EA|ENST00000256474\x2E2\x3Ac\x2E340\x2B1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183872G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E340\x2B1G\x3EA|CA357042|223190|35.0|evidence|6509|https://civicdb.org/links/evidence/6509|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|3|||||,A|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splicing_alteration_(c.340+1G>A)|2114|C\x2E553\x2B1G\x3EA&C\x2E340\x2B1G\x3EA|ENST00000256474\x2E2\x3Ac\x2E340\x2B1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183872G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E340\x2B1G\x3EA|CA357042|223190|35.0|evidence|5689|https://civicdb.org/links/evidence/5689|23298237_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|4|||||,A|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splicing_alteration_(c.340+1G>A)|2114|C\x2E553\x2B1G\x3EA&C\x2E340\x2B1G\x3EA|ENST00000256474\x2E2\x3Ac\x2E340\x2B1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183872G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E340\x2B1G\x3EA|CA357042|223190|35.0|evidence|5845|https://civicdb.org/links/evidence/5845|25952756_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,A|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splicing_alteration_(c.340+1G>A)|2114|C\x2E553\x2B1G\x3EA&C\x2E340\x2B1G\x3EA|ENST00000256474\x2E2\x3Ac\x2E340\x2B1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183872G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E340\x2B1G\x3EA|CA357042|223190|35.0|evidence|5332|https://civicdb.org/links/evidence/5332|20518900_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,A|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splicing_alteration_(c.340+1G>A)|2114|C\x2E553\x2B1G\x3EA&C\x2E340\x2B1G\x3EA|ENST00000256474\x2E2\x3Ac\x2E340\x2B1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10183872G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E340\x2B1G\x3EA|CA357042|223190|35.0|evidence|5099|https://civicdb.org/links/evidence/5099|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|3|||||
3	10188196	2133	A	C	.	.	GN=VHL;VT=Splicing_alteration_(c.341-2A>C);CSQ=C|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.341-2A>C||Splicing_alteration_(c.341-2A>C)|2133|C\x2E341\x2D2A\x3EC|ENST00000256474\x2E2\x3Ac\x2E341\x2D2A\x3EC&NM\x5F000551\x2E3\x3Ac\x2E341\x2D2A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188196A\x3EC|CA351753579|NONE_FOUND|17.5|evidence|5748|https://civicdb.org/links/evidence/5748|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,C|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.341-2A>C||Splicing_alteration_(c.341-2A>C)|2133|C\x2E341\x2D2A\x3EC|ENST00000256474\x2E2\x3Ac\x2E341\x2D2A\x3EC&NM\x5F000551\x2E3\x3Ac\x2E341\x2D2A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188196A\x3EC|CA351753579|NONE_FOUND|17.5|evidence|5730|https://civicdb.org/links/evidence/5730|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)||||C|4|||||
3	10188200	1921	C	T	.	.	GN=VHL;VT=H115Y_(c.343C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.343C>T||H115Y_(c.343C>T)|1921|RS5030811&HIS115TYR&C\x2E343C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EHis115Tyr&NM\x5F000551\x2E3\x3Ac\x2E343C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188200C\x3ET&ENST00000256474\x2E2\x3Ac\x2E343C\x3ET|CA16621930|NONE_FOUND|10.0|evidence|5363|https://civicdb.org/links/evidence/5363|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.343C>T||H115Y_(c.343C>T)|1921|RS5030811&HIS115TYR&C\x2E343C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EHis115Tyr&NM\x5F000551\x2E3\x3Ac\x2E343C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188200C\x3ET&ENST00000256474\x2E2\x3Ac\x2E343C\x3ET|CA16621930|NONE_FOUND|10.0|evidence|5193|https://civicdb.org/links/evidence/5193|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188201	2000	A	G	.	.	GN=VHL;VT=H115R_(c.344A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344A>G||H115R_(c.344A>G)|2000|RS5030812&HIS115ARG&C\x2E344A\x3EG|NP\x5F000542\x2E1\x3Ap\x2EHis115Arg&NM\x5F000551\x2E3\x3Ac\x2E344A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188201A\x3EG&ENST00000256474\x2E2\x3Ac\x2E344A\x3EG|CA70049376|664415|10.0|evidence|5772|https://civicdb.org/links/evidence/5772|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344A>G||H115R_(c.344A>G)|2000|RS5030812&HIS115ARG&C\x2E344A\x3EG|NP\x5F000542\x2E1\x3Ap\x2EHis115Arg&NM\x5F000551\x2E3\x3Ac\x2E344A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188201A\x3EG&ENST00000256474\x2E2\x3Ac\x2E344A\x3EG|CA70049376|664415|10.0|evidence|5377|https://civicdb.org/links/evidence/5377|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188200	2057	CA	C	.	.	GN=VHL;VT=H115FS_(c.344delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344delA||H115FS_(c.344delA)|2057|HIS115FS&C\x2E344DELA|NP\x5F000542\x2E1\x3Ap\x2EHis115ProfsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E344delA&NC\x5F000003\x2E11\x3Ag\x2E10188201del&ENST00000256474\x2E2\x3Ac\x2E344delA|CA70049370|NONE_FOUND|7.5|evidence|5553|https://civicdb.org/links/evidence/5553|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188201	1885	A	C	.	.	GN=VHL;VT=H115P_(c.344A>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344A>C||H115P_(c.344A>C)|1885|RS5030812&HIS115PRO&C\x2E344A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EHis115Pro&NM\x5F000551\x2E3\x3Ac\x2E344A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188201A\x3EC&ENST00000256474\x2E2\x3Ac\x2E344A\x3EC|CA351753626|560744|10.0|evidence|5140|https://civicdb.org/links/evidence/5140|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10188202	1957	C	G	.	.	GN=VHL;VT=H115Q_(c.345C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>G||H115Q_(c.345C>G)|1957|C\x2E345C\x3EG&HIS115GLN|NP\x5F000542\x2E1\x3Ap\x2EHis115Gln&NM\x5F000551\x2E3\x3Ac\x2E345C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188202C\x3EG&ENST00000256474\x2E2\x3Ac\x2E345C\x3EG|CA351753634|496058|12.5|evidence|6604|https://civicdb.org/links/evidence/6604|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>G||H115Q_(c.345C>G)|1957|C\x2E345C\x3EG&HIS115GLN|NP\x5F000542\x2E1\x3Ap\x2EHis115Gln&NM\x5F000551\x2E3\x3Ac\x2E345C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188202C\x3EG&ENST00000256474\x2E2\x3Ac\x2E345C\x3EG|CA351753634|496058|12.5|evidence|5274|https://civicdb.org/links/evidence/5274|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10188202	1742	C	A	.	.	GN=VHL;VT=H115Q_(c.345C>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>A||H115Q_(c.345C>A)|1742|HIS115GLN&C\x2E345C\x3EA|NM\x5F000551\x2E3\x3Ac\x2E345C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188202C\x3EA&NP\x5F000542\x2E1\x3Ap\x2EHis115Gln&ENST00000256474\x2E2\x3Ac\x2E345C\x3EA|CA351753631|496057|5.0|evidence|4907|https://civicdb.org/links/evidence/4907|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10188203	1820	C	G	.	.	GN=VHL;VT=L116V_(c.346C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.346C>G||L116V_(c.346C>G)|1820|LEU116VAL&C\x2E346C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu116Val&NM\x5F000551\x2E3\x3Ac\x2E346C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188203C\x3EG&ENST00000256474\x2E2\x3Ac\x2E346C\x3EG|CA351753642|NONE_FOUND|10.0|evidence|5022|https://civicdb.org/links/evidence/5022|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10188206	2027	T	TT	.	.	GN=VHL;VT=W117FS_(c.349dupT);CSQ=T|inframe_insertion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.349dupT||W117FS_(c.349dupT)|2027|C\x2E349DUPT&TRP117LEUFS|NP\x5F000542\x2E1\x3Ap\x2EcTrp117LeufsTer15&NM\x5F000551\x2E3\x3Ac\x2E349dup&ENST00000256474\x2E2\x3Ac\x2E349dupT&NC\x5F000003\x2E11\x3Ag\x2E10188206dup|CA432421788|NONE_FOUND|5.0|evidence|5453|https://civicdb.org/links/evidence/5453|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10188208	1767	G	T	.	.	GN=VHL;VT=W117C_(c.351G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.351G>T||W117C_(c.351G>T)|1767|RS727504215&TRP117CYS&C\x2E351G\x3ET|ENST00000256474\x2E2\x3Ac\x2E351G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188208G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ETrp117Cys&NM\x5F000551\x2E3\x3Ac\x2E351G\x3ET|CA020294|167827|25.0|evidence|5295|https://civicdb.org/links/evidence/5295|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.351G>T||W117C_(c.351G>T)|1767|RS727504215&TRP117CYS&C\x2E351G\x3ET|ENST00000256474\x2E2\x3Ac\x2E351G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188208G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ETrp117Cys&NM\x5F000551\x2E3\x3Ac\x2E351G\x3ET|CA020294|167827|25.0|evidence|5044|https://civicdb.org/links/evidence/5044|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.351G>T||W117C_(c.351G>T)|1767|RS727504215&TRP117CYS&C\x2E351G\x3ET|ENST00000256474\x2E2\x3Ac\x2E351G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188208G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ETrp117Cys&NM\x5F000551\x2E3\x3Ac\x2E351G\x3ET|CA020294|167827|25.0|evidence|4933|https://civicdb.org/links/evidence/4933|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10188210	1798	T	C	.	.	GN=VHL;VT=L118P_(c.353T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.353T>C||L118P_(c.353T>C)|1798|RS5030830&LEU118PRO&C\x2E353T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10188210T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu118Pro&NM\x5F000551\x2E3\x3Ac\x2E353T\x3EC&ENST00000256474\x2E2\x3Ac\x2E353T\x3EC|CA70049399|NONE_FOUND|35.0|evidence|5477|https://civicdb.org/links/evidence/5477|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.353T>C||L118P_(c.353T>C)|1798|RS5030830&LEU118PRO&C\x2E353T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10188210T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu118Pro&NM\x5F000551\x2E3\x3Ac\x2E353T\x3EC&ENST00000256474\x2E2\x3Ac\x2E353T\x3EC|CA70049399|NONE_FOUND|35.0|evidence|5276|https://civicdb.org/links/evidence/5276|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.353T>C||L118P_(c.353T>C)|1798|RS5030830&LEU118PRO&C\x2E353T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10188210T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu118Pro&NM\x5F000551\x2E3\x3Ac\x2E353T\x3EC&ENST00000256474\x2E2\x3Ac\x2E353T\x3EC|CA70049399|NONE_FOUND|35.0|evidence|5143|https://civicdb.org/links/evidence/5143|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,C|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.353T>C||L118P_(c.353T>C)|1798|RS5030830&LEU118PRO&C\x2E353T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10188210T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu118Pro&NM\x5F000551\x2E3\x3Ac\x2E353T\x3EC&ENST00000256474\x2E2\x3Ac\x2E353T\x3EC|CA70049399|NONE_FOUND|35.0|evidence|5435|https://civicdb.org/links/evidence/5435|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.353T>C||L118P_(c.353T>C)|1798|RS5030830&LEU118PRO&C\x2E353T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10188210T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu118Pro&NM\x5F000551\x2E3\x3Ac\x2E353T\x3EC&ENST00000256474\x2E2\x3Ac\x2E353T\x3EC|CA70049399|NONE_FOUND|35.0|evidence|4971|https://civicdb.org/links/evidence/4971|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188214	1743	C	G	.	.	GN=VHL;VT=F119L_(c.357C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L_(c.357C>G)|1743|RS1559428077&PHE119LEU&C\x2E357C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EPhe119Leu&NM\x5F000551\x2E3\x3Ac\x2E357C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188214C\x3EG&ENST00000256474\x2E2\x3Ac\x2E357C\x3EG|CA351753726|625240|22.5|evidence|5411|https://civicdb.org/links/evidence/5411|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L_(c.357C>G)|1743|RS1559428077&PHE119LEU&C\x2E357C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EPhe119Leu&NM\x5F000551\x2E3\x3Ac\x2E357C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188214C\x3EG&ENST00000256474\x2E2\x3Ac\x2E357C\x3EG|CA351753726|625240|22.5|evidence|4908|https://civicdb.org/links/evidence/4908|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L_(c.357C>G)|1743|RS1559428077&PHE119LEU&C\x2E357C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EPhe119Leu&NM\x5F000551\x2E3\x3Ac\x2E357C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188214C\x3EG&ENST00000256474\x2E2\x3Ac\x2E357C\x3EG|CA351753726|625240|22.5|evidence|5454|https://civicdb.org/links/evidence/5454|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L_(c.357C>G)|1743|RS1559428077&PHE119LEU&C\x2E357C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EPhe119Leu&NM\x5F000551\x2E3\x3Ac\x2E357C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188214C\x3EG&ENST00000256474\x2E2\x3Ac\x2E357C\x3EG|CA351753726|625240|22.5|evidence|5436|https://civicdb.org/links/evidence/5436|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10188215	1914	A	G	.	.	GN=VHL;VT=R120G_(c.358A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.358A>G||R120G_(c.358A>G)|1914|RS869025642&ARG120GLY&C\x2E358A\x3EG|ENST00000256474\x2E2\x3Ac\x2E358A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188215A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EArg120Gly&NM\x5F000551\x2E3\x3Ac\x2E358A\x3EG|CA357028|223199|22.5|evidence|6511|https://civicdb.org/links/evidence/6511|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.358A>G||R120G_(c.358A>G)|1914|RS869025642&ARG120GLY&C\x2E358A\x3EG|ENST00000256474\x2E2\x3Ac\x2E358A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188215A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EArg120Gly&NM\x5F000551\x2E3\x3Ac\x2E358A\x3EG|CA357028|223199|22.5|evidence|5178|https://civicdb.org/links/evidence/5178|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.358A>G||R120G_(c.358A>G)|1914|RS869025642&ARG120GLY&C\x2E358A\x3EG|ENST00000256474\x2E2\x3Ac\x2E358A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188215A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EArg120Gly&NM\x5F000551\x2E3\x3Ac\x2E358A\x3EG|CA357028|223199|22.5|evidence|6605|https://civicdb.org/links/evidence/6605|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||
3	10188219	1813	A	G	.	.	GN=VHL;VT=D121G_(c.362A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.362A>G||D121G_(c.362A>G)|1813|RS5030832&ASP121GLY&C\x2E362A\x3EG|ENST00000256474\x2E2\x3Ac\x2E362A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188219A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsp121Gly&NM\x5F000551\x2E3\x3Ac\x2E362A\x3EG|CA357083|223200|10.0|evidence|5437|https://civicdb.org/links/evidence/5437|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.362A>G||D121G_(c.362A>G)|1813|RS5030832&ASP121GLY&C\x2E362A\x3EG|ENST00000256474\x2E2\x3Ac\x2E362A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188219A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsp121Gly&NM\x5F000551\x2E3\x3Ac\x2E362A\x3EG|CA357083|223200|10.0|evidence|5455|https://civicdb.org/links/evidence/5455|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10188221	2028	GC	AT	.	.	GN=VHL;VT=A122I_(c.364_365GC>AT);CSQ=AT|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.364_365delinsAT||A122I_(c.364_365GC>AT)|2028|ALA122ILE&C\x2E364\x5F365GC\x3EAT|NC\x5F000003\x2E12\x3Ag\x2E10146537\x5F10146538delinsAT&NC\x5F000003\x2E11\x3Ag\x2E10188221\x5F10188222delinsAT&ENST00000256474\x2E2\x3Ac\x2E364\x5F365delinsAT&NM\x5F000551\x2E3\x3Ac\x2E364\x5F365delinsAT|CA658820874|NONE_FOUND|12.5|evidence|6417|https://civicdb.org/links/evidence/6417|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,AT|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.364_365delinsAT||A122I_(c.364_365GC>AT)|2028|ALA122ILE&C\x2E364\x5F365GC\x3EAT|NC\x5F000003\x2E12\x3Ag\x2E10146537\x5F10146538delinsAT&NC\x5F000003\x2E11\x3Ag\x2E10188221\x5F10188222delinsAT&ENST00000256474\x2E2\x3Ac\x2E364\x5F365delinsAT&NM\x5F000551\x2E3\x3Ac\x2E364\x5F365delinsAT|CA658820874|NONE_FOUND|12.5|evidence|5456|https://civicdb.org/links/evidence/5456|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10188223	1905	AG	A	.	.	GN=VHL;VT=G123FS_(c.367delG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.367delG||G123FS_(c.367delG)|1905|GLY123FS&C\x2E367DELG|ENST00000256474\x2E2\x3Ac\x2E367delG|CA432421810|NONE_FOUND|10.0|evidence|5164|https://civicdb.org/links/evidence/5164|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10188232	1918	C	CC	.	.	GN=VHL;VT=D126FS_(c.375_376insC);CSQ=C|inframe_insertion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.375_376insC||D126FS_(c.375_376insC)|1918|ASP126FS&C\x2E375\x5F376INSC|ENST00000256474\x2E2\x3Ac\x2E375\x5F376insC|CA16621931|NONE_FOUND|5.0|evidence|5188|https://civicdb.org/links/evidence/5188|21463266_(PubMed)|Rare_Germline|accepted|Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188240	1886	T	G	.	.	GN=VHL;VT=L128R_(c.383T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.383T>G||L128R_(c.383T>G)|1886|LEU128ARG&C\x2E383T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu128Arg&NM\x5F000551\x2E3\x3Ac\x2E383T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188240T\x3EG&ENST00000256474\x2E2\x3Ac\x2E383T\x3EG|CA351753891|NONE_FOUND|10.0|evidence|5144|https://civicdb.org/links/evidence/5144|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10188240	1996	TT	T	.	.	GN=VHL;VT=L129fs_(c.384delT);CSQ=-|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.384delT||L129fs_(c.384delT)|1996|LEU129FS&C\x2E384DELT|ENST00000256474\x2E2\x3Ac\x2E384delT|CA70049452|NONE_FOUND|7.5|evidence|5365|https://civicdb.org/links/evidence/5365|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10188243	2034	T	C	.	.	GN=VHL;VT=L129P_(c.386T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.386T>C||L129P_(c.386T>C)|2034|LEU129PRO&C\x2E386T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ELeu129Pro&NM\x5F000551\x2E3\x3Ac\x2E386T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188243T\x3EC&ENST00000256474\x2E2\x3Ac\x2E386T\x3EC|CA351753904|NONE_FOUND|5.0|evidence|5479|https://civicdb.org/links/evidence/5479|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10188245	1970	G	C	.	.	GN=VHL;VT=V130L_(c.388G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.388G>C||V130L_(c.388G>C)|1970|RS104893830&VAL130LEU&C\x2E388G\x3EC|ENST00000256474\x2E2\x3Ac\x2E388G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188245G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EVal130Leu&NM\x5F000551\x2E3\x3Ac\x2E388G\x3EC|CA020325|2229|5.0|evidence|5301|https://civicdb.org/links/evidence/5301|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10188246	1800	TTA	T	.	.	GN=VHL;VT=N131P_(c.390_391delTA);CSQ=-|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.390_391delTA||N131P_(c.390_391delTA)|1800|ASN131PRO&C\x2E390\x5F391DELTA|ENST00000256474\x2E2\x3Ac\x2E390\x5F391delTA|CA658795179|NONE_FOUND|15.0|evidence|5128|https://civicdb.org/links/evidence/5128|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|3|||||,-|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.390_391delTA||N131P_(c.390_391delTA)|1800|ASN131PRO&C\x2E390\x5F391DELTA|ENST00000256474\x2E2\x3Ac\x2E390\x5F391delTA|CA658795179|NONE_FOUND|15.0|evidence|4973|https://civicdb.org/links/evidence/4973|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188249	2580	A	C	.	.	GN=VHL;VT=N131T_(c.392A>C);CSQ=C|non_conservative_missense_variant|VHL|7428|transcript|ENST00000256474.2|||N131T_(c.392A>C)|2580||CM000665\x2E1\x3Ag\x2E10188249A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188249A\x3EC|CA351753944|NONE_FOUND|7.5|evidence|6606|https://civicdb.org/links/evidence/6606|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,C|non_conservative_missense_variant|VHL|7428|transcript|ENST00000256474.2|||N131T_(c.392A>C)|2580||CM000665\x2E1\x3Ag\x2E10188249A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188249A\x3EC|CA351753944|NONE_FOUND|7.5|evidence|5046|https://civicdb.org/links/evidence/5046|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188250	1953	C	A	.	.	GN=VHL;VT=N131K_(c.393C>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.393C>A||N131K_(c.393C>A)|1953|RS1064794272&ASN131LYS&C\x2E393C\x3EA|ENST00000256474\x2E2\x3Ac\x2E393C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188250C\x3EA&NP\x5F000542\x2E1\x3Ap\x2EAsn131Lys&NM\x5F000551\x2E3\x3Ac\x2E393C\x3EA|CA16617789|420074|10.0|evidence|5266|https://civicdb.org/links/evidence/5266|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.393C>A||N131K_(c.393C>A)|1953|RS1064794272&ASN131LYS&C\x2E393C\x3EA|ENST00000256474\x2E2\x3Ac\x2E393C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188250C\x3EA&NP\x5F000542\x2E1\x3Ap\x2EAsn131Lys&NM\x5F000551\x2E3\x3Ac\x2E393C\x3EA|CA16617789|420074|10.0|evidence|5457|https://civicdb.org/links/evidence/5457|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10188251	1994	C	T	.	.	GN=VHL;VT=Q132*_(c.394C>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.394C>T||Q132*_(c.394C>T)|1994|RS5030813&GLN132TER&Q132X&C\x2E394C\x3ET|ENST00000256474\x2E2\x3Ac\x2E394C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188251C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln132Ter&NM\x5F000551\x2E3\x3Ac\x2E394C\x3ET|CA10606205|288749|10.0|evidence|5458|https://civicdb.org/links/evidence/5458|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.394C>T||Q132*_(c.394C>T)|1994|RS5030813&GLN132TER&Q132X&C\x2E394C\x3ET|ENST00000256474\x2E2\x3Ac\x2E394C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188251C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln132Ter&NM\x5F000551\x2E3\x3Ac\x2E394C\x3ET|CA10606205|288749|10.0|evidence|5358|https://civicdb.org/links/evidence/5358|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188252	2125	A	C	.	.	GN=VHL;VT=Q132P_(c.395A>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.395A>C||Q132P_(c.395A>C)|2125|GLN132PRO&C\x2E395A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EGln132Pro&NM\x5F000551\x2E3\x3Ac\x2E395A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188252A\x3EC&ENST00000256474\x2E2\x3Ac\x2E395A\x3EC|CA351753958|496063|10.0|evidence|5131|https://civicdb.org/links/evidence/5131|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10188253	2456	AA	A	.	.	GN=VHL;VT=T133Lfs*26_(c.397delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.397delA||T133Lfs*26_(c.397delA)|2456|THR133LEUFS\x2A26&C\x2E397DELA|ENST00000256474\x2E2\x3Ac\x2E397delA|CA432421843|NONE_FOUND|7.5|evidence|6607|https://civicdb.org/links/evidence/6607|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||
3	10188260	1906	TT	T	.	.	GN=VHL;VT=L135FS_(c.404delT);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.404delT||L135FS_(c.404delT)|1906|LEU135FS&C\x2E404DELT|NP\x5F000542\x2E1\x3Ap\x2ELeu135TyrfsTer24&NM\x5F000551\x2E3\x3Ac\x2E404delT&NC\x5F000003\x2E11\x3Ag\x2E10188261del&ENST00000256474\x2E2\x3Ac\x2E404delT|CA432421852|NONE_FOUND|10.0|evidence|5165|https://civicdb.org/links/evidence/5165|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10188261	1769	T	A	.	.	GN=VHL;VT=L135*_(c.404T>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.404T>A||L135*_(c.404T>A)|1769|LEU135TER&L135X&C\x2E404T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu135Ter&NM\x5F000551\x2E3\x3Ac\x2E404T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188261T\x3EA&ENST00000256474\x2E2\x3Ac\x2E404T\x3EA|CA351754021|NONE_FOUND|10.0|evidence|6608|https://civicdb.org/links/evidence/6608|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,A|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.404T>A||L135*_(c.404T>A)|1769|LEU135TER&L135X&C\x2E404T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu135Ter&NM\x5F000551\x2E3\x3Ac\x2E404T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188261T\x3EA&ENST00000256474\x2E2\x3Ac\x2E404T\x3EA|CA351754021|NONE_FOUND|10.0|evidence|4935|https://civicdb.org/links/evidence/4935|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioma_(HPO_ID_HP:0001028)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|4|||||
3	10188264	1814	T	G	.	.	GN=VHL;VT=F136C_(c.407T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>G||F136C_(c.407T>G)|1814|RS5030833&PHE136CYS&C\x2E407T\x3EG|NP\x5F000542\x2E1\x3Ap\x2EPhe136Cys&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EG&ENST00000256474\x2E2\x3Ac\x2E407T\x3EG|CA70049495|496065|12.5|evidence|5412|https://civicdb.org/links/evidence/5412|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>G||F136C_(c.407T>G)|1814|RS5030833&PHE136CYS&C\x2E407T\x3EG|NP\x5F000542\x2E1\x3Ap\x2EPhe136Cys&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EG&ENST00000256474\x2E2\x3Ac\x2E407T\x3EG|CA70049495|496065|12.5|evidence|5480|https://civicdb.org/links/evidence/5480|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10188264	1801	T	C	.	.	GN=VHL;VT=F136S_(c.407T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|5152|https://civicdb.org/links/evidence/5152|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|5202|https://civicdb.org/links/evidence/5202|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|6512|https://civicdb.org/links/evidence/6512|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Multiple_renal_cysts_(HPO_ID_HP:0005562)|C|3|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|5543|https://civicdb.org/links/evidence/5543|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|5284|https://civicdb.org/links/evidence/5284|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|4974|https://civicdb.org/links/evidence/4974|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.407T>C||F136S_(c.407T>C)|1801|RS5030833&PHE136SER&C\x2E407T\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPhe136Ser&NM\x5F000551\x2E3\x3Ac\x2E407T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188264T\x3EC&ENST00000256474\x2E2\x3Ac\x2E407T\x3EC|CA040847|496064|47.5|evidence|6573|https://civicdb.org/links/evidence/6573|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||
3	10188269	1928	C	A	.	.	GN=VHL;VT=P138T_(c.412C>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.412C>A||P138T_(c.412C>A)|1928|C\x2E412C\x3EA&PRO138THR|NP\x5F000542\x2E1\x3Ap\x2EPro138Thr&NM\x5F000551\x2E3\x3Ac\x2E412C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188269C\x3EA&ENST00000256474\x2E2\x3Ac\x2E412C\x3EA|CA16621932|NONE_FOUND|10.0|evidence|6574|https://civicdb.org/links/evidence/6574|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.412C>A||P138T_(c.412C>A)|1928|C\x2E412C\x3EA&PRO138THR|NP\x5F000542\x2E1\x3Ap\x2EPro138Thr&NM\x5F000551\x2E3\x3Ac\x2E412C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10188269C\x3EA&ENST00000256474\x2E2\x3Ac\x2E412C\x3EA|CA16621932|NONE_FOUND|10.0|evidence|5205|https://civicdb.org/links/evidence/5205|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10188287	1850	G	T	.	.	GN=VHL;VT=G144*_(c.430G>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.430G>T||G144*_(c.430G>T)|1850|RS869025650&GLY144TER&G144X&C\x2E430G\x3ET|ENST00000256474\x2E2\x3Ac\x2E430G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188287G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGly144Ter&NM\x5F000551\x2E3\x3Ac\x2E430G\x3ET|CA357109|223208|7.5|evidence|5064|https://civicdb.org/links/evidence/5064|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188290	1883	C	T	.	.	GN=VHL;VT=Q145*_(c.433C>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.433C>T||Q145*_(c.433C>T)|1883|GLN145TER&Q145X&C\x2E433C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EGln145Ter&NM\x5F000551\x2E3\x3Ac\x2E433C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188290C\x3ET&ENST00000256474\x2E2\x3Ac\x2E433C\x3ET|CA351754219|NONE_FOUND|10.0|evidence|5798|https://civicdb.org/links/evidence/5798|25586603_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Polycythemia_(HPO_ID_HP:0001901)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.433C>T||Q145*_(c.433C>T)|1883|GLN145TER&Q145X&C\x2E433C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EGln145Ter&NM\x5F000551\x2E3\x3Ac\x2E433C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188290C\x3ET&ENST00000256474\x2E2\x3Ac\x2E433C\x3ET|CA351754219|NONE_FOUND|10.0|evidence|5248|https://civicdb.org/links/evidence/5248|21972040_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188292	2055	GC	G	.	.	GN=VHL;VT=P146fs_(c.436delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.436delC||P146fs_(c.436delC)|2055|PRO146FS&C\x2E436DELC|ENST00000256474\x2E2\x3Ac\x2E436delC|CA432421892|NONE_FOUND|7.5|evidence|5544|https://civicdb.org/links/evidence/5544|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188302	1744	G	A	.	.	GN=VHL;VT=A149T_(c.445G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445G>A||A149T_(c.445G>A)|1744|RS587780077&ALA149THR&C\x2E445G\x3EA|NC\x5F000003\x2E11\x3Ag\x2E10188302G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EAla149Thr&NM\x5F000551\x2E3\x3Ac\x2E445G\x3EA&ENST00000256474\x2E2\x3Ac\x2E445G\x3EA|CA357066|223213|5.0|evidence|4909|https://civicdb.org/links/evidence/4909|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10188301	2042	TG	T	.	.	GN=VHL;VT=A149fs_(c.445delG);CSQ=-|inframe_deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445delG||A149fs_(c.445delG)|2042|ALA149FS&C\x2E445DELG|NP\x5F000542\x2E1\x3Ap\x2EAla149ProfsTer10&NM\x5F000551\x2E3\x3Ac\x2E445delG&NC\x5F000003\x2E11\x3Ag\x2E10188302delG&ENST00000256474\x2E2\x3Ac\x2E445delG|CA432421902|NONE_FOUND|5.0|evidence|5501|https://civicdb.org/links/evidence/5501|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10188302	820	G	T	.	.	GN=VHL;VT=A149S_(c.445G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445G>T||A149S_(c.445G>T)|820|RS587780077&C\x2E445G\x3ET&ALA149SER|NC\x5F000003\x2E11\x3Ag\x2E10188302G\x3ET&ENST00000256474\x2E2\x3Ac\x2E445G\x3ET&NM\x5F000551\x2E2\x3Ac\x2E445G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EAla149Ser|CA020355|127829|17.5|evidence|5679|https://civicdb.org/links/evidence/5679|23673869_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445G>T||A149S_(c.445G>T)|820|RS587780077&C\x2E445G\x3ET&ALA149SER|NC\x5F000003\x2E11\x3Ag\x2E10188302G\x3ET&ENST00000256474\x2E2\x3Ac\x2E445G\x3ET&NM\x5F000551\x2E2\x3Ac\x2E445G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EAla149Ser|CA020355|127829|17.5|evidence|1896|https://civicdb.org/links/evidence/1896|9435426_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10188301	2029	TGCCAATATCACACT	T	.	.	GN=VHL;VT=N150fs_(c.445_458del);CSQ=-|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445_458delGCCAATATCACACT||N150fs_(c.445_458del)|2029|ASN150FS&C\x2E445\x5F458DEL|ENST00000256474\x2E2\x3Ac\x2E445\x5F458delGCCAATATCACACT|CA658820719|NONE_FOUND|5.0|evidence|5459|https://civicdb.org/links/evidence/5459|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10188306	2162	A	G	.	.	GN=VHL;VT=N150S_(c.449A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.449A>G||N150S_(c.449A>G)|2162|RS760184234&ASN150SER&C\x2E449A\x3EG|ENST00000256474\x2E2\x3Ac\x2E449A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188306A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EAsn150Ser&NM\x5F000551\x2E3\x3Ac\x2E449A\x3EG|CA041030|371992|5.0|evidence|5799|https://civicdb.org/links/evidence/5799|25586603_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Polycythemia_(HPO_ID_HP:0001901)|C|2|||||
3	10188308	2150	A	T	.	.	GN=VHL;VT=I151F_(c.451A>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.451A>T||I151F_(c.451A>T)|2150|ILE151PHE&C\x2E451A\x3ET|ENST00000256474\x2E2\x3Ac\x2E451A\x3ET|CA351754353|NONE_FOUND|5.0|evidence|5773|https://civicdb.org/links/evidence/5773|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)&Epididymal_cyst_(HPO_ID_HP:0030424)|C|2|||||
3	10188309	1871	T	C	.	.	GN=VHL;VT=I151T_(c.452T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T_(c.452T>C)|1871|RS869025655&ILE151THR&C\x2E452T\x3EC|ENST00000256474\x2E2\x3Ac\x2E452T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188309T\x3EC&NP\x5F000542\x2E1\x3Ap\x2EIle151Thr&NM\x5F000551\x2E3\x3Ac\x2E452T\x3EC|CA351754359|428803|17.5|evidence|5720|https://civicdb.org/links/evidence/5720|10567493_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T_(c.452T>C)|1871|RS869025655&ILE151THR&C\x2E452T\x3EC|ENST00000256474\x2E2\x3Ac\x2E452T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188309T\x3EC&NP\x5F000542\x2E1\x3Ap\x2EIle151Thr&NM\x5F000551\x2E3\x3Ac\x2E452T\x3EC|CA351754359|428803|17.5|evidence|5141|https://civicdb.org/links/evidence/5141|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T_(c.452T>C)|1871|RS869025655&ILE151THR&C\x2E452T\x3EC|ENST00000256474\x2E2\x3Ac\x2E452T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188309T\x3EC&NP\x5F000542\x2E1\x3Ap\x2EIle151Thr&NM\x5F000551\x2E3\x3Ac\x2E452T\x3EC|CA351754359|428803|17.5|evidence|5101|https://civicdb.org/links/evidence/5101|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|3|||||
3	10188310	2030	C	G	.	.	GN=VHL;VT=I151M_(c.453C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.453C>G||I151M_(c.453C>G)|2030|ILE151MET&C\x2E453C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EIle151Met&NM\x5F000551\x2E3\x3Ac\x2E453C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10188310C\x3EG&ENST00000256474\x2E2\x3Ac\x2E453C\x3EG|CA351754364|NONE_FOUND|5.0|evidence|5460|https://civicdb.org/links/evidence/5460|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10188315	1923	T	C	.	.	GN=VHL;VT=L153P_(c.458T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.458T>C||L153P_(c.458T>C)|1923|LEU153PRO&C\x2E458T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ELeu153Pro&NM\x5F000551\x2E3\x3Ac\x2E458T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188315T\x3EC&ENST00000256474\x2E2\x3Ac\x2E458T\x3EC|CA16621942|NONE_FOUND|7.5|evidence|6576|https://civicdb.org/links/evidence/6576|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.458T>C||L153P_(c.458T>C)|1923|LEU153PRO&C\x2E458T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ELeu153Pro&NM\x5F000551\x2E3\x3Ac\x2E458T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188315T\x3EC&ENST00000256474\x2E2\x3Ac\x2E458T\x3EC|CA16621942|NONE_FOUND|7.5|evidence|5196|https://civicdb.org/links/evidence/5196|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cyst_(HPO_ID_HP:0000107)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188318	1782	C	T	.	.	GN=VHL;VT=P154L_(c.461C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.461C>T||P154L_(c.461C>T)|1782|PRO154LEU&C\x2E461C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EPro154Leu&NM\x5F000551\x2E3\x3Ac\x2E461C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188318C\x3ET&ENST00000256474\x2E2\x3Ac\x2E461C\x3ET|CA351754410|NONE_FOUND|30.0|evidence|6609|https://civicdb.org/links/evidence/6609|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.461C>T||P154L_(c.461C>T)|1782|PRO154LEU&C\x2E461C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EPro154Leu&NM\x5F000551\x2E3\x3Ac\x2E461C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188318C\x3ET&ENST00000256474\x2E2\x3Ac\x2E461C\x3ET|CA351754410|NONE_FOUND|30.0|evidence|5154|https://civicdb.org/links/evidence/5154|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.461C>T||P154L_(c.461C>T)|1782|PRO154LEU&C\x2E461C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EPro154Leu&NM\x5F000551\x2E3\x3Ac\x2E461C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188318C\x3ET&ENST00000256474\x2E2\x3Ac\x2E461C\x3ET|CA351754410|NONE_FOUND|30.0|evidence|5461|https://civicdb.org/links/evidence/5461|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.461C>T||P154L_(c.461C>T)|1782|PRO154LEU&C\x2E461C\x3ET|NP\x5F000542\x2E1\x3Ap\x2EPro154Leu&NM\x5F000551\x2E3\x3Ac\x2E461C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188318C\x3ET&ENST00000256474\x2E2\x3Ac\x2E461C\x3ET|CA351754410|NONE_FOUND|30.0|evidence|4976|https://civicdb.org/links/evidence/4976|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10188318	1771	CA	C	.	.	GN=VHL;VT=P154fs_(c.462delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462delA||P154fs_(c.462delA)|1771|PRO154FS&C\x2E462DELA|NP\x5F000542\x2E1\x3Ap\x2EVal155CysfsTer4&NM\x5F000551\x2E3\x3Ac\x2E462del&NC\x5F000003\x2E11\x3Ag\x2E10188319del&ENST00000256474\x2E2\x3Ac\x2E462delA|CA432421926|NONE_FOUND|7.5|evidence|4937|https://civicdb.org/links/evidence/4937|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||
3	10188319	1962	A	C	.	.	GN=VHL;VT=P154P_(c.462A>C);CSQ=C|synonymous_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462A>C||P154P_(c.462A>C)|1962|PRO154PRO&C\x2E462A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPro154\x3D&NM\x5F000551\x2E3\x3Ac\x2E462A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188319A\x3EC&ENST00000256474\x2E2\x3Ac\x2E462A\x3EC|CA16621934|NONE_FOUND|15.0|evidence|6513|https://civicdb.org/links/evidence/6513|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|3|||||,C|synonymous_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462A>C||P154P_(c.462A>C)|1962|PRO154PRO&C\x2E462A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPro154\x3D&NM\x5F000551\x2E3\x3Ac\x2E462A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188319A\x3EC&ENST00000256474\x2E2\x3Ac\x2E462A\x3EC|CA16621934|NONE_FOUND|15.0|evidence|6577|https://civicdb.org/links/evidence/6577|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,C|synonymous_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462A>C||P154P_(c.462A>C)|1962|PRO154PRO&C\x2E462A\x3EC|NP\x5F000542\x2E1\x3Ap\x2EPro154\x3D&NM\x5F000551\x2E3\x3Ac\x2E462A\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188319A\x3EC&ENST00000256474\x2E2\x3Ac\x2E462A\x3EC|CA16621934|NONE_FOUND|15.0|evidence|5285|https://civicdb.org/links/evidence/5285|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10188321	1998	G	C	.	.	GN=VHL;VT=Splicing_alteration_(c.463+1G>C);CSQ=C|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+1G>C||Splicing_alteration_(c.463+1G>C)|1998|RS869025657&C\x2E463\x2B1G\x3EC|ENST00000256474\x2E2\x3Ac\x2E463\x2B1G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188321G\x3EC&NM\x5F000551\x2E3\x3Ac\x2E463\x2B1G\x3EC|CA357023|223217|5.0|evidence|5373|https://civicdb.org/links/evidence/5373|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10188322	2075	T	C	.	.	GN=VHL;VT=Splicing_alteration_(c.463+2T>C);CSQ=C|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+2T>C||Splicing_alteration_(c.463+2T>C)|2075|RS5030814&C\x2E463\x2B2T\x3EC|ENST00000256474\x2E2\x3Ac\x2E463\x2B2T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188322T\x3EC&NM\x5F000551\x2E3\x3Ac\x2E463\x2B2T\x3EC|CA16621936|NONE_FOUND|0.0|evidence|6610|https://civicdb.org/links/evidence/6610|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,C|splice_donor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+2T>C||Splicing_alteration_(c.463+2T>C)|2075|RS5030814&C\x2E463\x2B2T\x3EC|ENST00000256474\x2E2\x3Ac\x2E463\x2B2T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10188322T\x3EC&NM\x5F000551\x2E3\x3Ac\x2E463\x2B2T\x3EC|CA16621936|NONE_FOUND|0.0|evidence|6514|https://civicdb.org/links/evidence/6514|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Multiple_renal_cysts_(HPO_ID_HP:0005562)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)|C|3|||||
3	10188328	2292	C	T	.	.	GN=VHL;VT=Splicing_alteration_(c.463+8C>T);CSQ=T|splicing_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+8C>T||Splicing_alteration_(c.463+8C>T)|2292||NM\x5F000551\x2E3\x3Ac\x2E463\x2B8C\x3ET&ENST00000256474\x2E2\x3Ac\x2E463\x2B8C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188328C\x3ET|CA020379|127830|5.0|evidence|5356|https://civicdb.org/links/evidence/5356|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,T|splicing_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+8C>T||Splicing_alteration_(c.463+8C>T)|2292||NM\x5F000551\x2E3\x3Ac\x2E463\x2B8C\x3ET&ENST00000256474\x2E2\x3Ac\x2E463\x2B8C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10188328C\x3ET|CA020379|127830|5.0|evidence|6108|https://civicdb.org/links/evidence/6108|9663592_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Adrenal_Gland_Pheochromocytoma_(DOID_0050892)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10191469	1992	A	T	.	.	GN=VHL;VT=Splicing_alteration_(c.464-2A>T);CSQ=T|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>T||Splicing_alteration_(c.464-2A>T)|1992|RS5030816&C\x2E464\x2D2A\x3ET|NP\x5F000542\x2E1\x3Ap\x2E\x3D&ENST00000256474\x2E2\x3Ac\x2E464\x2D2A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191469A\x3ET&NM\x5F000551\x2E3\x3Ac\x2E464\x2D2A\x3ET|CA70052157|NONE_FOUND|5.0|evidence|5351|https://civicdb.org/links/evidence/5351|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191469	2078	A	G	.	.	GN=VHL;VT=Splicing_alteration_(c.464-2A>G);CSQ=G|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>G||Splicing_alteration_(c.464-2A>G)|2078|RS5030816&C\x2E464\x2D2A\x3EG|ENST00000256474\x2E2\x3Ac\x2E464\x2D2A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191469A\x3EG&NM\x5F000551\x2E3\x3Ac\x2E464\x2D2A\x3EG|CA357046|223222|20.0|evidence|5724|https://civicdb.org/links/evidence/5724|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,G|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>G||Splicing_alteration_(c.464-2A>G)|2078|RS5030816&C\x2E464\x2D2A\x3EG|ENST00000256474\x2E2\x3Ac\x2E464\x2D2A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191469A\x3EG&NM\x5F000551\x2E3\x3Ac\x2E464\x2D2A\x3EG|CA357046|223222|20.0|evidence|5462|https://civicdb.org/links/evidence/5462|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,G|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>G||Splicing_alteration_(c.464-2A>G)|2078|RS5030816&C\x2E464\x2D2A\x3EG|ENST00000256474\x2E2\x3Ac\x2E464\x2D2A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191469A\x3EG&NM\x5F000551\x2E3\x3Ac\x2E464\x2D2A\x3EG|CA357046|223222|20.0|evidence|5851|https://civicdb.org/links/evidence/5851|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10191470	2077	G	C	.	.	GN=VHL;VT=Splicing_alteration_(c.464-1G>C);CSQ=C|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>C||Splicing_alteration_(c.464-1G>C)|2077|IVS2\x2D1G\x3EC&RS5030817&C\x2E464\x2D1G\x3EC|NC\x5F000003\x2E12\x3Ag\x2E10149786G\x3EC&NP\x5F000542\x2E1\x3Ap\x2E\x3D&ENST00000256474\x2E2\x3Ac\x2E464\x2D1G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191470G\x3EC&NM\x5F000551\x2E3\x3Ac\x2E464\x2D1G\x3EC|CA357081|223220|10.0|evidence|5745|https://civicdb.org/links/evidence/5745|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191470	1974	G	A	.	.	GN=VHL;VT=Splicing_alteration_(c.464-1G>A);CSQ=A|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>A||Splicing_alteration_(c.464-1G>A)|1974|RS5030817&C\x2E464\x2D1G\x3EA|ENST00000256474\x2E2\x3Ac\x2E464\x2D1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191470G\x3EA&NM\x5F000551\x2E3\x3Ac\x2E464\x2D1G\x3EA|CA020389|43603|5.0|evidence|5357|https://civicdb.org/links/evidence/5357|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191470	1990	G	T	.	.	GN=VHL;VT=Splicing_alteration_(c.464-1G>T);CSQ=T|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>T||Splicing_alteration_(c.464-1G>T)|1990|RS5030817&C\x2E464\x2D1G\x3ET|ENST00000256474\x2E2\x3Ac\x2E464\x2D1G\x3ET&NM\x5F000551\x2E3\x3Ac\x2E464\x2D1G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191470G\x3ET|CA357144|223221|12.5|evidence|5642|https://civicdb.org/links/evidence/5642|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|splice_acceptor_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>T||Splicing_alteration_(c.464-1G>T)|1990|RS5030817&C\x2E464\x2D1G\x3ET|ENST00000256474\x2E2\x3Ac\x2E464\x2D1G\x3ET&NM\x5F000551\x2E3\x3Ac\x2E464\x2D1G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191470G\x3ET|CA357144|223221|12.5|evidence|5343|https://civicdb.org/links/evidence/5343|8641976_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10191471	1934	T	G	.	.	GN=VHL;VT=V155G_(c.464T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464T>G||V155G_(c.464T>G)|1934|VAL155GLY&C\x2E464T\x3EG|NP\x5F000542\x2E1\x3Ap\x2EVal155Gly&NM\x5F000551\x2E3\x3Ac\x2E464T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191471T\x3EG&ENST00000256474\x2E2\x3Ac\x2E464T\x3EG|CA16621938|NONE_FOUND|2.5|evidence|6579|https://civicdb.org/links/evidence/6579|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||
3	10191471	1909	T	A	.	.	GN=VHL;VT=V155E_(c.464T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464T>A||V155E_(c.464T>A)|1909|VAL155GLU&C\x2E464T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal155Glu&NM\x5F000551\x2E3\x3Ac\x2E464T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191471T\x3EA&ENST00000256474\x2E2\x3Ac\x2E464T\x3EA|CA351756032|NONE_FOUND|10.0|evidence|5171|https://civicdb.org/links/evidence/5171|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191473	2013	T	A	.	.	GN=VHL;VT=Y156N_(c.466T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.466T>A||Y156N_(c.466T>A)|2013|TYR156ASN&C\x2E466T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ETyr156Asn&NM\x5F000551\x2E3\x3Ac\x2E466T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191473T\x3EA&ENST00000256474\x2E2\x3Ac\x2E466T\x3EA|CA351756038|NONE_FOUND|7.5|evidence|5416|https://civicdb.org/links/evidence/5416|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191473	1967	T	G	.	.	GN=VHL;VT=Y156D_(c.466T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.466T>G||Y156D_(c.466T>G)|1967|TYR156ASP&C\x2E466T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ETyr156Asp&NM\x5F000551\x2E3\x3Ac\x2E466T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191473T\x3EG&ENST00000256474\x2E2\x3Ac\x2E466T\x3EG|CA351756043|NONE_FOUND|7.5|evidence|5297|https://civicdb.org/links/evidence/5297|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191474	1946	A	G	.	.	GN=VHL;VT=Y156C_(c.467A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C_(c.467A>G)|1946|RS397516441&TYR156CYS&C\x2E467A\x3EG|ENST00000256474\x2E2\x3Ac\x2E467A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191474A\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr156Cys&NM\x5F000551\x2E3\x3Ac\x2E467A\x3EG|CA020394|43600|27.5|evidence|6516|https://civicdb.org/links/evidence/6516|24132471_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C_(c.467A>G)|1946|RS397516441&TYR156CYS&C\x2E467A\x3EG|ENST00000256474\x2E2\x3Ac\x2E467A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191474A\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr156Cys&NM\x5F000551\x2E3\x3Ac\x2E467A\x3EG|CA020394|43600|27.5|evidence|5417|https://civicdb.org/links/evidence/5417|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C_(c.467A>G)|1946|RS397516441&TYR156CYS&C\x2E467A\x3EG|ENST00000256474\x2E2\x3Ac\x2E467A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191474A\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr156Cys&NM\x5F000551\x2E3\x3Ac\x2E467A\x3EG|CA020394|43600|27.5|evidence|5463|https://civicdb.org/links/evidence/5463|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C_(c.467A>G)|1946|RS397516441&TYR156CYS&C\x2E467A\x3EG|ENST00000256474\x2E2\x3Ac\x2E467A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191474A\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr156Cys&NM\x5F000551\x2E3\x3Ac\x2E467A\x3EG|CA020394|43600|27.5|evidence|5298|https://civicdb.org/links/evidence/5298|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191475	1968	T	G	.	.	GN=VHL;VT=Y156*_(c.468T>G);CSQ=G|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.468T>G||Y156*_(c.468T>G)|1968|TYR156TER&Y156X&C\x2E468T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ETyr156Ter&NM\x5F000551\x2E3\x3Ac\x2E468T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191475T\x3EG&ENST00000256474\x2E2\x3Ac\x2E468T\x3EG|CA351756053|NONE_FOUND|7.5|evidence|5299|https://civicdb.org/links/evidence/5299|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191477	1745	C	T	.	.	GN=VHL;VT=T157I_(c.470C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I_(c.470C>T)|1745|RS869025660&THR157ILE&C\x2E470C\x3ET|ENST00000256474\x2E2\x3Ac\x2E470C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191477C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EThr157Ile&NM\x5F000551\x2E3\x3Ac\x2E470C\x3ET|CA357133|223223|25.0|evidence|6612|https://civicdb.org/links/evidence/6612|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I_(c.470C>T)|1745|RS869025660&THR157ILE&C\x2E470C\x3ET|ENST00000256474\x2E2\x3Ac\x2E470C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191477C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EThr157Ile&NM\x5F000551\x2E3\x3Ac\x2E470C\x3ET|CA357133|223223|25.0|evidence|6581|https://civicdb.org/links/evidence/6581|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I_(c.470C>T)|1745|RS869025660&THR157ILE&C\x2E470C\x3ET|ENST00000256474\x2E2\x3Ac\x2E470C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191477C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EThr157Ile&NM\x5F000551\x2E3\x3Ac\x2E470C\x3ET|CA357133|223223|25.0|evidence|4910|https://civicdb.org/links/evidence/4910|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I_(c.470C>T)|1745|RS869025660&THR157ILE&C\x2E470C\x3ET|ENST00000256474\x2E2\x3Ac\x2E470C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191477C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EThr157Ile&NM\x5F000551\x2E3\x3Ac\x2E470C\x3ET|CA357133|223223|25.0|evidence|5294|https://civicdb.org/links/evidence/5294|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10191479	1803	C	G	.	.	GN=VHL;VT=L158V_(c.472C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.472C>G||L158V_(c.472C>G)|1803|LEU158VAL&C\x2E472C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu158Val&NM\x5F000551\x2E3\x3Ac\x2E472C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191479C\x3EG&ENST00000256474\x2E2\x3Ac\x2E472C\x3EG|CA351756068|NONE_FOUND|22.5|evidence|5146|https://civicdb.org/links/evidence/5146|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,G|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.472C>G||L158V_(c.472C>G)|1803|LEU158VAL&C\x2E472C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu158Val&NM\x5F000551\x2E3\x3Ac\x2E472C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191479C\x3EG&ENST00000256474\x2E2\x3Ac\x2E472C\x3EG|CA351756068|NONE_FOUND|22.5|evidence|5464|https://civicdb.org/links/evidence/5464|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.472C>G||L158V_(c.472C>G)|1803|LEU158VAL&C\x2E472C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu158Val&NM\x5F000551\x2E3\x3Ac\x2E472C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191479C\x3EG&ENST00000256474\x2E2\x3Ac\x2E472C\x3EG|CA351756068|NONE_FOUND|22.5|evidence|4977|https://civicdb.org/links/evidence/4977|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191480	1738	T	C	.	.	GN=VHL;VT=L158P_(c.473T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P_(c.473T>C)|1738|RS121913346&LEU158PRO&C\x2E473T\x3EC|ENST00000256474\x2E2\x3Ac\x2E473T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191480T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu158Pro&NM\x5F000551\x2E3\x3Ac\x2E473T\x3EC|CA020399|182980|22.5|evidence|6613|https://civicdb.org/links/evidence/6613|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P_(c.473T>C)|1738|RS121913346&LEU158PRO&C\x2E473T\x3EC|ENST00000256474\x2E2\x3Ac\x2E473T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191480T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu158Pro&NM\x5F000551\x2E3\x3Ac\x2E473T\x3EC|CA020399|182980|22.5|evidence|5281|https://civicdb.org/links/evidence/5281|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P_(c.473T>C)|1738|RS121913346&LEU158PRO&C\x2E473T\x3EC|ENST00000256474\x2E2\x3Ac\x2E473T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191480T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu158Pro&NM\x5F000551\x2E3\x3Ac\x2E473T\x3EC|CA020399|182980|22.5|evidence|5103|https://civicdb.org/links/evidence/5103|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||
3	10191480	2137	TGAA	TC	.	.	GN=VHL;VT=L158fs_(c.474_476delGAAinsC);CSQ=-|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.474_476delGAAinsC||L158fs_(c.474_476delGAAinsC)|2137|LEU158FS&C\x2E474\x5F476DELGAAINSC|ENST00000256474\x2E2\x3Ac\x2E474\x5F476delGAAinsC|None|NONE_FOUND|10.0|evidence|5735|https://civicdb.org/links/evidence/5735|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191481	2098	GA	G	.	.	GN=VHL;VT=K159fs_(c.475delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.475delA||K159fs_(c.475delA)|2098|LYS159FS&C\x2E475DELA|ENST00000256474\x2E2\x3Ac\x2E475delA|CA020404|NONE_FOUND|7.5|evidence|5651|https://civicdb.org/links/evidence/5651|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191484	2040	A	ACA	.	.	GN=VHL;VT=K159fs_(c.477_478insCA);CSQ=CA|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.477_478insCA||K159fs_(c.477_478insCA)|2040|C\x2E477\x5F478INSCA&LYS159FS|ENST00000256474\x2E2\x3Ac\x2E477\x5F478insCA|CA645525053|NONE_FOUND|5.0|evidence|5496|https://civicdb.org/links/evidence/5496|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10191484	2032	AGA	A	.	.	GN=VHL;VT=E160FS_(c.478_479delGA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.478_479delGA||E160FS_(c.478_479delGA)|2032|GLU160FS&C\x2E478\x5F479DELGA|ENST00000256474\x2E2\x3Ac\x2E478\x5F479delGA|CA16621940|NONE_FOUND|5.0|evidence|5465|https://civicdb.org/links/evidence/5465|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10191485	1919	GAG	G	.	.	GN=VHL;VT=E160FS_(c.479_480delAG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.479_480delAG||E160FS_(c.479_480delAG)|1919|C\x2E479\x5F480DELAG&GLU160FS|NP\x5F000542\x2E1\x3Ap\x2EGlu160AlafsTer13&NM\x5F000551\x2E3\x3Ac\x2E479\x5F480delAG&NC\x5F000003\x2E11\x3Ag\x2E10191486\x5F10191487delAG&ENST00000256474\x2E2\x3Ac\x2E479\x5F480delAG|CA16621940|NONE_FOUND|5.0|evidence|5191|https://civicdb.org/links/evidence/5191|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191488	1804	C	T	.	.	GN=VHL;VT=R161*_(c.481C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.481C>T||R161*_(c.481C>T)|1804|RS5030818&ARG161TER&R161X&C\x2E481C\x3ET|ENST00000256474\x2E2\x3Ac\x2E481C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg161Ter&NM\x5F000551\x2E3\x3Ac\x2E481C\x3ET|CA020408|2217|40.0|evidence|6614|https://civicdb.org/links/evidence/6614|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.481C>T||R161*_(c.481C>T)|1804|RS5030818&ARG161TER&R161X&C\x2E481C\x3ET|ENST00000256474\x2E2\x3Ac\x2E481C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg161Ter&NM\x5F000551\x2E3\x3Ac\x2E481C\x3ET|CA020408|2217|40.0|evidence|6583|https://civicdb.org/links/evidence/6583|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.481C>T||R161*_(c.481C>T)|1804|RS5030818&ARG161TER&R161X&C\x2E481C\x3ET|ENST00000256474\x2E2\x3Ac\x2E481C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg161Ter&NM\x5F000551\x2E3\x3Ac\x2E481C\x3ET|CA020408|2217|40.0|evidence|5483|https://civicdb.org/links/evidence/5483|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.481C>T||R161*_(c.481C>T)|1804|RS5030818&ARG161TER&R161X&C\x2E481C\x3ET|ENST00000256474\x2E2\x3Ac\x2E481C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg161Ter&NM\x5F000551\x2E3\x3Ac\x2E481C\x3ET|CA020408|2217|40.0|evidence|5049|https://civicdb.org/links/evidence/5049|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.481C>T||R161*_(c.481C>T)|1804|RS5030818&ARG161TER&R161X&C\x2E481C\x3ET|ENST00000256474\x2E2\x3Ac\x2E481C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg161Ter&NM\x5F000551\x2E3\x3Ac\x2E481C\x3ET|CA020408|2217|40.0|evidence|5263|https://civicdb.org/links/evidence/5263|9829912_(PubMed)|Rare_Germline|accepted|Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.481C>T||R161*_(c.481C>T)|1804|RS5030818&ARG161TER&R161X&C\x2E481C\x3ET|ENST00000256474\x2E2\x3Ac\x2E481C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg161Ter&NM\x5F000551\x2E3\x3Ac\x2E481C\x3ET|CA020408|2217|40.0|evidence|5375|https://civicdb.org/links/evidence/5375|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||
3	10191488	1915	C	G	.	.	GN=VHL;VT=R161G_(c.481C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.481C>G||R161G_(c.481C>G)|1915|RS5030818&ARG161GLY&C\x2E481C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EArg161Gly&NM\x5F000551\x2E3\x3Ac\x2E481C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3EG&ENST00000256474\x2E2\x3Ac\x2E481C\x3EG|CA16621941|NONE_FOUND|7.5|evidence|6582|https://civicdb.org/links/evidence/6582|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.481C>G||R161G_(c.481C>G)|1915|RS5030818&ARG161GLY&C\x2E481C\x3EG|NP\x5F000542\x2E1\x3Ap\x2EArg161Gly&NM\x5F000551\x2E3\x3Ac\x2E481C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191488C\x3EG&ENST00000256474\x2E2\x3Ac\x2E481C\x3EG|CA16621941|NONE_FOUND|7.5|evidence|5353|https://civicdb.org/links/evidence/5353|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191489	1746	G	A	.	.	GN=VHL;VT=R161Q_(c.482G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5481|https://civicdb.org/links/evidence/5481|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5466|https://civicdb.org/links/evidence/5466|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5262|https://civicdb.org/links/evidence/5262|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5061|https://civicdb.org/links/evidence/5061|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|7891|https://civicdb.org/links/evidence/7891|11850829_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|4911|https://civicdb.org/links/evidence/4911|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|4|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5179|https://civicdb.org/links/evidence/5179|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5400|https://civicdb.org/links/evidence/5400|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q_(c.482G>A)|1746|RS730882035&ARG161GLN&C\x2E482G\x3EA|ENST00000256474\x2E2\x3Ac\x2E482G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg161Gln&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EA|CA020413|182983|65.0|evidence|5125|https://civicdb.org/links/evidence/5125|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191489	1855	G	C	.	.	GN=VHL;VT=R161P_(c.482G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>C||R161P_(c.482G>C)|1855|ARG161PRO&C\x2E482G\x3EC|NP\x5F000542\x2E1\x3Ap\x2EArg161Pro&NM\x5F000551\x2E3\x3Ac\x2E482G\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191489G\x3EC&ENST00000256474\x2E2\x3Ac\x2E482G\x3EC|CA351756111|NONE_FOUND|7.5|evidence|5401|https://civicdb.org/links/evidence/5401|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191489	2035	GA	G	.	.	GN=VHL;VT=C162FS_(c.483delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.483delA||C162FS_(c.483delA)|2035|CYS162FS&C\x2E483DELA|NP\x5F000542\x2E1\x3Ap\x2ECys162AlafsTer8&NM\x5F000551\x2E3\x3Ac\x2E483delA&NC\x5F000003\x2E11\x3Ag\x2E10191490del&ENST00000256474\x2E2\x3Ac\x2E483delA|CA658795183|NONE_FOUND|5.0|evidence|5482|https://civicdb.org/links/evidence/5482|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10191491	1772	T	C	.	.	GN=VHL;VT=C162R_(c.484T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R_(c.484T>C)|1772|CYS162ARG&C\x2E484T\x3EC&RS1553620313|NP\x5F000542\x2E1\x3Ap\x2ECys162Arg&NC\x5F000003\x2E11\x3Ag\x2E10191491T\x3EC&NM\x5F000551\x2E3\x3Ac\x2E484T\x3EC&ENST00000256474\x2E2\x3Ac\x2E484T\x3EC|CA351756117|496067|15.0|evidence|5349|https://civicdb.org/links/evidence/5349|8641976_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R_(c.484T>C)|1772|CYS162ARG&C\x2E484T\x3EC&RS1553620313|NP\x5F000542\x2E1\x3Ap\x2ECys162Arg&NC\x5F000003\x2E11\x3Ag\x2E10191491T\x3EC&NM\x5F000551\x2E3\x3Ac\x2E484T\x3EC&ENST00000256474\x2E2\x3Ac\x2E484T\x3EC|CA351756117|496067|15.0|evidence|5175|https://civicdb.org/links/evidence/5175|19270817_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R_(c.484T>C)|1772|CYS162ARG&C\x2E484T\x3EC&RS1553620313|NP\x5F000542\x2E1\x3Ap\x2ECys162Arg&NC\x5F000003\x2E11\x3Ag\x2E10191491T\x3EC&NM\x5F000551\x2E3\x3Ac\x2E484T\x3EC&ENST00000256474\x2E2\x3Ac\x2E484T\x3EC|CA351756117|496067|15.0|evidence|4939|https://civicdb.org/links/evidence/4939|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioma_(HPO_ID_HP:0001028)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|2|||||
3	10191492	1824	G	A	.	.	GN=VHL;VT=C162Y_(c.485G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>A||C162Y_(c.485G>A)|1824|RS397516444&CYS162TYR&C\x2E485G\x3EA|ENST00000256474\x2E2\x3Ac\x2E485G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191492G\x3EA&NP\x5F000542\x2E1\x3Ap\x2ECys162Tyr&NM\x5F000551\x2E3\x3Ac\x2E485G\x3EA|CA357010|223225|12.5|evidence|6615|https://civicdb.org/links/evidence/6615|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>A||C162Y_(c.485G>A)|1824|RS397516444&CYS162TYR&C\x2E485G\x3EA|ENST00000256474\x2E2\x3Ac\x2E485G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191492G\x3EA&NP\x5F000542\x2E1\x3Ap\x2ECys162Tyr&NM\x5F000551\x2E3\x3Ac\x2E485G\x3EA|CA357010|223225|12.5|evidence|5493|https://civicdb.org/links/evidence/5493|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10191492	1773	G	T	.	.	GN=VHL;VT=C162F_(c.485G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F_(c.485G>T)|1773|RS397516444&CYS162PHE&C\x2E485G\x3ET|ENST00000256474\x2E2\x3Ac\x2E485G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191492G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ECys162Phe&NM\x5F000551\x2E3\x3Ac\x2E485G\x3ET|CA020418|43604|22.5|evidence|6584|https://civicdb.org/links/evidence/6584|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F_(c.485G>T)|1773|RS397516444&CYS162PHE&C\x2E485G\x3ET|ENST00000256474\x2E2\x3Ac\x2E485G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191492G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ECys162Phe&NM\x5F000551\x2E3\x3Ac\x2E485G\x3ET|CA020418|43604|22.5|evidence|5189|https://civicdb.org/links/evidence/5189|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F_(c.485G>T)|1773|RS397516444&CYS162PHE&C\x2E485G\x3ET|ENST00000256474\x2E2\x3Ac\x2E485G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191492G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ECys162Phe&NM\x5F000551\x2E3\x3Ac\x2E485G\x3ET|CA020418|43604|22.5|evidence|5050|https://civicdb.org/links/evidence/5050|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F_(c.485G>T)|1773|RS397516444&CYS162PHE&C\x2E485G\x3ET|ENST00000256474\x2E2\x3Ac\x2E485G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191492G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ECys162Phe&NM\x5F000551\x2E3\x3Ac\x2E485G\x3ET|CA020418|43604|22.5|evidence|4940|https://civicdb.org/links/evidence/4940|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10191493	1774	C	G	.	.	GN=VHL;VT=C162W_(c.486C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W_(c.486C>G)|1774|RS869025662&CYS162TRP&C\x2E486C\x3EG|ENST00000256474\x2E2\x3Ac\x2E486C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191493C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ECys162Trp&NM\x5F000551\x2E3\x3Ac\x2E486C\x3EG|CA357016|223227|32.5|evidence|4941|https://civicdb.org/links/evidence/4941|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W_(c.486C>G)|1774|RS869025662&CYS162TRP&C\x2E486C\x3EG|ENST00000256474\x2E2\x3Ac\x2E486C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191493C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ECys162Trp&NM\x5F000551\x2E3\x3Ac\x2E486C\x3EG|CA357016|223227|32.5|evidence|6616|https://civicdb.org/links/evidence/6616|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W_(c.486C>G)|1774|RS869025662&CYS162TRP&C\x2E486C\x3EG|ENST00000256474\x2E2\x3Ac\x2E486C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191493C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ECys162Trp&NM\x5F000551\x2E3\x3Ac\x2E486C\x3EG|CA357016|223227|32.5|evidence|7895|https://civicdb.org/links/evidence/7895|11850829_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W_(c.486C>G)|1774|RS869025662&CYS162TRP&C\x2E486C\x3EG|ENST00000256474\x2E2\x3Ac\x2E486C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191493C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ECys162Trp&NM\x5F000551\x2E3\x3Ac\x2E486C\x3EG|CA357016|223227|32.5|evidence|5355|https://civicdb.org/links/evidence/5355|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W_(c.486C>G)|1774|RS869025662&CYS162TRP&C\x2E486C\x3EG|ENST00000256474\x2E2\x3Ac\x2E486C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191493C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ECys162Trp&NM\x5F000551\x2E3\x3Ac\x2E486C\x3EG|CA357016|223227|32.5|evidence|5267|https://civicdb.org/links/evidence/5267|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W_(c.486C>G)|1774|RS869025662&CYS162TRP&C\x2E486C\x3EG|ENST00000256474\x2E2\x3Ac\x2E486C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191493C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ECys162Trp&NM\x5F000551\x2E3\x3Ac\x2E486C\x3EG|CA357016|223227|32.5|evidence|6585|https://civicdb.org/links/evidence/6585|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||
3	10191495	2033	T	A	.	.	GN=VHL;VT=L163H_(c.488T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.488T>A||L163H_(c.488T>A)|2033|LEU163HIS&C\x2E488T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu163His&NM\x5F000551\x2E3\x3Ac\x2E488T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191495T\x3EA&ENST00000256474\x2E2\x3Ac\x2E488T\x3EA|CA351756137|NONE_FOUND|5.0|evidence|5467|https://civicdb.org/links/evidence/5467|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10191497	1845	C	T	.	.	GN=VHL;VT=Q164*_(c.490C>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.490C>T||Q164*_(c.490C>T)|1845|RS5030819&GLN164TER&Q164X&C\x2E490C\x3ET|ENST00000256474\x2E2\x3Ac\x2E490C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191497C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln164Ter&NM\x5F000551\x2E3\x3Ac\x2E490C\x3ET|CA357060|223228|27.5|evidence|5403|https://civicdb.org/links/evidence/5403|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.490C>T||Q164*_(c.490C>T)|1845|RS5030819&GLN164TER&Q164X&C\x2E490C\x3ET|ENST00000256474\x2E2\x3Ac\x2E490C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191497C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln164Ter&NM\x5F000551\x2E3\x3Ac\x2E490C\x3ET|CA357060|223228|27.5|evidence|5359|https://civicdb.org/links/evidence/5359|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.490C>T||Q164*_(c.490C>T)|1845|RS5030819&GLN164TER&Q164X&C\x2E490C\x3ET|ENST00000256474\x2E2\x3Ac\x2E490C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191497C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln164Ter&NM\x5F000551\x2E3\x3Ac\x2E490C\x3ET|CA357060|223228|27.5|evidence|5096|https://civicdb.org/links/evidence/5096|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.490C>T||Q164*_(c.490C>T)|1845|RS5030819&GLN164TER&Q164X&C\x2E490C\x3ET|ENST00000256474\x2E2\x3Ac\x2E490C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191497C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln164Ter&NM\x5F000551\x2E3\x3Ac\x2E490C\x3ET|CA357060|223228|27.5|evidence|5051|https://civicdb.org/links/evidence/5051|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191498	1856	A	G	.	.	GN=VHL;VT=Q164R_(c.491A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST|ENST00000256474.2:c.491A>G||Q164R_(c.491A>G)|1856|RS267607170&GLN164ARG&C\x2E491A\x3EG|ENST00000256474\x2E2\x3Ac\x2E491A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191498A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EGln164Arg&NM\x5F000551\x2E3\x3Ac\x2E491A\x3EG|CA020429|2238|10.0|evidence|5133|https://civicdb.org/links/evidence/5133|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191498	2079	A	T	.	.	GN=VHL;VT=Q164L_(c.491A>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.491A>T||Q164L_(c.491A>T)|2079|GLN164LEU&C\x2E491A\x3ET|NP\x5F000542\x2E1\x3Ap\x2EGln164Leu&NM\x5F000551\x2E3\x3Ac\x2E491A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191498A\x3ET&ENST00000256474\x2E2\x3Ac\x2E491A\x3ET|CA351756149|NONE_FOUND|7.5|evidence|6617|https://civicdb.org/links/evidence/6617|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||
3	10191503	1825	G	T	.	.	GN=VHL;VT=V166F_(c.496G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.496G>T||V166F_(c.496G>T)|1825|RS104893825&VAL166PHE&C\x2E496G\x3ET|ENST00000256474\x2E2\x3Ac\x2E496G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191503G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EVal166Phe&NM\x5F000551\x2E3\x3Ac\x2E496G\x3ET|CA020436|2224|7.5|evidence|5302|https://civicdb.org/links/evidence/5302|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191504	1775	T	A	.	.	GN=VHL;VT=V166D_(c.497T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.497T>A||V166D_(c.497T>A)|1775|VAL166ASP&C\x2E497T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal166Asp&NM\x5F000551\x2E3\x3Ac\x2E497T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191504T\x3EA&ENST00000256474\x2E2\x3Ac\x2E497T\x3EA|CA351756176|625254|10.0|evidence|4942|https://civicdb.org/links/evidence/4942|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10191506	1747	C	T	.	.	GN=VHL;VT=R167W_(c.499C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5769|https://civicdb.org/links/evidence/5769|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Epididymal_cyst_(HPO_ID_HP:0030424)&Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|6519|https://civicdb.org/links/evidence/6519|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5184|https://civicdb.org/links/evidence/5184|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cyst_(HPO_ID_HP:0000107)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|4912|https://civicdb.org/links/evidence/4912|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|6618|https://civicdb.org/links/evidence/6618|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|6416|https://civicdb.org/links/evidence/6416|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5468|https://civicdb.org/links/evidence/5468|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5484|https://civicdb.org/links/evidence/5484|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5545|https://civicdb.org/links/evidence/5545|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5265|https://civicdb.org/links/evidence/5265|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|4|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W_(c.499C>T)|1747|RS5030820&R126W&ARG167TRP&C\x2E499C\x3ET|ENST00000256474\x2E2\x3Ac\x2E499C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191506C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Trp&NM\x5F000551\x2E3\x3Ac\x2E499C\x3ET|CA020450|2218|80.0|evidence|5052|https://civicdb.org/links/evidence/5052|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191507	2458	G	C	.	.	GN=VHL;VT=R167P_(c.500G>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>C||R167P_(c.500G>C)|2458|ARG167PRO&C\x2E500G\x3EC&RS5030821|NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EC&NP\x5F000542\x2E1\x3Ap\x2EArg167Pro&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EC&ENST00000256474\x2E2\x3Ac\x2E500G\x3EC|CA351756177|428799|7.5|evidence|6620|https://civicdb.org/links/evidence/6620|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||
3	10191507	1916	G	T	.	.	GN=VHL;VT=R167L_(c.500G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>T||R167L_(c.500G>T)|1916|ARG167LEU&C\x2E500G\x3ET&RS5030821|ENST00000256474\x2E2\x3Ac\x2E500G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Leu&NM\x5F000551\x2E3\x3Ac\x2E500G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3ET|CA351756178|526685|7.5|evidence|6588|https://civicdb.org/links/evidence/6588|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>T||R167L_(c.500G>T)|1916|ARG167LEU&C\x2E500G\x3ET&RS5030821|ENST00000256474\x2E2\x3Ac\x2E500G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg167Leu&NM\x5F000551\x2E3\x3Ac\x2E500G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3ET|CA351756178|526685|7.5|evidence|5183|https://civicdb.org/links/evidence/5183|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191507	1739	G	A	.	.	GN=VHL;VT=R167Q_(c.500G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5264|https://civicdb.org/links/evidence/5264|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5469|https://civicdb.org/links/evidence/5469|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5487|https://civicdb.org/links/evidence/5487|12114495_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5402|https://civicdb.org/links/evidence/5402|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5546|https://civicdb.org/links/evidence/5546|12624160_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5062|https://civicdb.org/links/evidence/5062|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|4|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|6520|https://civicdb.org/links/evidence/6520|24132471_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Pheochromocytoma_(HPO_ID_HP:0002666)&Pancreatic_cysts_(HPO_ID_HP:0001737)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|6587|https://civicdb.org/links/evidence/6587|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|6619|https://civicdb.org/links/evidence/6619|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5354|https://civicdb.org/links/evidence/5354|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|6222|https://civicdb.org/links/evidence/6222|29396065_(PubMed)|Rare_Germline|accepted|Positive|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)&Hemangioblastoma_(HPO_ID_HP:0010797)&Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|4913|https://civicdb.org/links/evidence/4913|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|evidence|5485|https://civicdb.org/links/evidence/5485|20846682_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q_(c.500G>A)|1739|RS5030821&ARG167GLN&C\x2E500G\x3EA|ENST00000256474\x2E2\x3Ac\x2E500G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191507G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EArg167Gln&NM\x5F000551\x2E3\x3Ac\x2E500G\x3EA|CA020454|2216|87.5|assertion|4|https://civicdb.org/links/assertion/4||Rare_Germline|accepted|Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||||PP4&PP1&PM2&PM1&PS4||||
3	10191513	1887	T	C	.	.	GN=VHL;VT=L169P_(c.506T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.506T>C||L169P_(c.506T>C)|1887|RS1131690962&LEU169PRO&C\x2E506T\x3EC|ENST00000256474\x2E2\x3Ac\x2E506T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191513T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu169Pro&NM\x5F000551\x2E3\x3Ac\x2E506T\x3EC|CA351756191|428809|17.5|evidence|6589|https://civicdb.org/links/evidence/6589|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.506T>C||L169P_(c.506T>C)|1887|RS1131690962&LEU169PRO&C\x2E506T\x3EC|ENST00000256474\x2E2\x3Ac\x2E506T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191513T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu169Pro&NM\x5F000551\x2E3\x3Ac\x2E506T\x3EC|CA351756191|428809|17.5|evidence|5147|https://civicdb.org/links/evidence/5147|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.506T>C||L169P_(c.506T>C)|1887|RS1131690962&LEU169PRO&C\x2E506T\x3EC|ENST00000256474\x2E2\x3Ac\x2E506T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191513T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu169Pro&NM\x5F000551\x2E3\x3Ac\x2E506T\x3EC|CA351756191|428809|17.5|evidence|5197|https://civicdb.org/links/evidence/5197|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10191515	1806	G	T	.	.	GN=VHL;VT=V170F_(c.508G>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.508G>T||V170F_(c.508G>T)|1806|VAL170PHE&C\x2E508G\x3ET|NP\x5F000542\x2E1\x3Ap\x2EVal170Phe&NM\x5F000551\x2E3\x3Ac\x2E508G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191515G\x3ET&ENST00000256474\x2E2\x3Ac\x2E508G\x3ET|CA351756193|NONE_FOUND|7.5|evidence|4982|https://civicdb.org/links/evidence/4982|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191516	1826	T	A	.	.	GN=VHL;VT=V170D_(c.509T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D_(c.509T>A)|1826|VAL170ASP&C\x2E509T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal170Asp&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EA&ENST00000256474\x2E2\x3Ac\x2E509T\x3EA|CA351756195|NONE_FOUND|40.0|evidence|6522|https://civicdb.org/links/evidence/6522|24132471_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Spinal_hemangioblastoma_(HPO_ID_HP:0009713)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D_(c.509T>A)|1826|VAL170ASP&C\x2E509T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal170Asp&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EA&ENST00000256474\x2E2\x3Ac\x2E509T\x3EA|CA351756195|NONE_FOUND|40.0|evidence|5863|https://civicdb.org/links/evidence/5863|9681858_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D_(c.509T>A)|1826|VAL170ASP&C\x2E509T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal170Asp&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EA&ENST00000256474\x2E2\x3Ac\x2E509T\x3EA|CA351756195|NONE_FOUND|40.0|evidence|5029|https://civicdb.org/links/evidence/5029|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D_(c.509T>A)|1826|VAL170ASP&C\x2E509T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal170Asp&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EA&ENST00000256474\x2E2\x3Ac\x2E509T\x3EA|CA351756195|NONE_FOUND|40.0|evidence|5092|https://civicdb.org/links/evidence/5092|8956040_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D_(c.509T>A)|1826|VAL170ASP&C\x2E509T\x3EA|NP\x5F000542\x2E1\x3Ap\x2EVal170Asp&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EA&ENST00000256474\x2E2\x3Ac\x2E509T\x3EA|CA351756195|NONE_FOUND|40.0|evidence|5013|https://civicdb.org/links/evidence/5013|8730290_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191516	1935	T	G	.	.	GN=VHL;VT=V170G_(c.509T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>G||V170G_(c.509T>G)|1935|VAL170GLY&C\x2E509T\x3EG|NP\x5F000542\x2E1\x3Ap\x2EVal170Gly&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EG&ENST00000256474\x2E2\x3Ac\x2E509T\x3EG|CA351756196|NONE_FOUND|15.0|evidence|5303|https://civicdb.org/links/evidence/5303|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>G||V170G_(c.509T>G)|1935|VAL170GLY&C\x2E509T\x3EG|NP\x5F000542\x2E1\x3Ap\x2EVal170Gly&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EG&ENST00000256474\x2E2\x3Ac\x2E509T\x3EG|CA351756196|NONE_FOUND|15.0|evidence|6590|https://civicdb.org/links/evidence/6590|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>G||V170G_(c.509T>G)|1935|VAL170GLY&C\x2E509T\x3EG|NP\x5F000542\x2E1\x3Ap\x2EVal170Gly&NM\x5F000551\x2E3\x3Ac\x2E509T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191516T\x3EG&ENST00000256474\x2E2\x3Ac\x2E509T\x3EG|CA351756196|NONE_FOUND|15.0|evidence|5172|https://civicdb.org/links/evidence/5172|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10191530	1846	T	G	.	.	GN=VHL;VT=Y175D_(c.523T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.523T>G||Y175D_(c.523T>G)|1846|TYR175ASP&C\x2E523T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ETyr175Asp&NM\x5F000551\x2E3\x3Ac\x2E523T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191530T\x3EG&ENST00000256474\x2E2\x3Ac\x2E523T\x3EG|CA351756228|NONE_FOUND|7.5|evidence|5053|https://civicdb.org/links/evidence/5053|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191531	2138	AC	A	.	.	GN=VHL;VT=Y175FS_(c.525delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525delC||Y175FS_(c.525delC)|2138|C\x2E525DELC&TYR175FS|ENST00000256474\x2E2\x3Ac\x2E525delC|CA913185019|NONE_FOUND|7.5|evidence|5736|https://civicdb.org/links/evidence/5736|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10191532	1969	C	G	.	.	GN=VHL;VT=Y175*_(c.525C>G);CSQ=G|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175*_(c.525C>G)|1969|RS5030835&TYR175TER&Y175X&C\x2E525C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ETyr175Ter&NM\x5F000551\x2E3\x3Ac\x2E525C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191532C\x3EG&ENST00000256474\x2E2\x3Ac\x2E525C\x3EG|CA020466|182974|15.0|evidence|7005|https://civicdb.org/links/evidence/7005|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,G|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175*_(c.525C>G)|1969|RS5030835&TYR175TER&Y175X&C\x2E525C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ETyr175Ter&NM\x5F000551\x2E3\x3Ac\x2E525C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191532C\x3EG&ENST00000256474\x2E2\x3Ac\x2E525C\x3EG|CA020466|182974|15.0|evidence|5300|https://civicdb.org/links/evidence/5300|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,G|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175*_(c.525C>G)|1969|RS5030835&TYR175TER&Y175X&C\x2E525C\x3EG|NP\x5F000542\x2E1\x3Ap\x2ETyr175Ter&NM\x5F000551\x2E3\x3Ac\x2E525C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191532C\x3EG&ENST00000256474\x2E2\x3Ac\x2E525C\x3EG|CA020466|182974|15.0|evidence|5440|https://civicdb.org/links/evidence/5440|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191532	1932	C	A	.	.	GN=VHL;VT=Y175*_(c.525C>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>A||Y175*_(c.525C>A)|1932|C\x2E525C\x3EA&TYR175TER&Y175X|NM\x5F000551\x2E3\x3Ac\x2E525C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191532C\x3EA&NP\x5F000542\x2E1\x3Ap\x2ETyr175Ter&ENST00000256474\x2E2\x3Ac\x2E525C\x3EA|CA351756231|NONE_FOUND|0.0|evidence|6621|https://civicdb.org/links/evidence/6621|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||
3	10191532	1780	CA	C	.	.	GN=VHL;VT=R176fs_(c.526delA);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.526delA||R176fs_(c.526delA)|1780|ARG176FS&C\x2E526DELA|NP\x5F000542\x2E1\x3Ap\x2EArg176GlyfsTer26&NM\x5F000551\x2E3\x3Ac\x2E526del&NC\x5F000003\x2E11\x3Ag\x2E10191533del&ENST00000256474\x2E2\x3Ac\x2E526delA|CA16602180|625257|10.0|evidence|5166|https://civicdb.org/links/evidence/5166|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)||||C|4|||||
3	10191534	1907	GG	G	.	.	GN=VHL;VT=R176FS_(c.528delG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.528delG||R176FS_(c.528delG)|1907|C\x2E528DELG&ARG176FS|NP\x5F000542\x2E1\x3Ap\x2EArg177AspfsTer25&NM\x5F000551\x2E3\x3Ac\x2E528del&NC\x5F000003\x2E11\x3Ag\x2E10191535del&ENST00000256474\x2E2\x3Ac\x2E528delG|CA432423454|NONE_FOUND|17.5|evidence|5167|https://civicdb.org/links/evidence/5167|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.528delG||R176FS_(c.528delG)|1907|C\x2E528DELG&ARG176FS|NP\x5F000542\x2E1\x3Ap\x2EArg177AspfsTer25&NM\x5F000551\x2E3\x3Ac\x2E528del&NC\x5F000003\x2E11\x3Ag\x2E10191535del&ENST00000256474\x2E2\x3Ac\x2E528delG|CA432423454|NONE_FOUND|17.5|evidence|5643|https://civicdb.org/links/evidence/5643|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191536	1827	A	T	.	.	GN=VHL;VT=R177*_(c.529A>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.529A>T||R177*_(c.529A>T)|1827|ARG177TER&R177X&C\x2E529A\x3ET|NP\x5F000542\x2E1\x3Ap\x2EArg177Ter&NM\x5F000551\x2E3\x3Ac\x2E529A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191536A\x3ET&ENST00000256474\x2E2\x3Ac\x2E529A\x3ET|CA351756239|625258|7.5|evidence|5331|https://civicdb.org/links/evidence/5331|20518900_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|3|||||
3	10191540	1888	T	G	.	.	GN=VHL;VT=L178R_(c.533T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>G||L178R_(c.533T>G)|1888|LEU178ARG&C\x2E533T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu178Arg&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EG&ENST00000256474\x2E2\x3Ac\x2E533T\x3EG|CA351756248|NONE_FOUND|15.0|evidence|5774|https://civicdb.org/links/evidence/5774|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>G||L178R_(c.533T>G)|1888|LEU178ARG&C\x2E533T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu178Arg&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EG&ENST00000256474\x2E2\x3Ac\x2E533T\x3EG|CA351756248|NONE_FOUND|15.0|evidence|5148|https://civicdb.org/links/evidence/5148|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191540	1997	T	A	.	.	GN=VHL;VT=L178Q_(c.533T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST000002564742|ENST000002564742:c.533T>A||L178Q_(c.533T>A)|1997|RS5030822&LEU178GLN&C\x2E533T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu178Gln&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EA&ENST000002564742\x3Ac\x2E533T\x3EA|CA70052370|NONE_FOUND|12.5|evidence|7890|https://civicdb.org/links/evidence/7890|11850829_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST000002564742|ENST000002564742:c.533T>A||L178Q_(c.533T>A)|1997|RS5030822&LEU178GLN&C\x2E533T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu178Gln&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EA&ENST000002564742\x3Ac\x2E533T\x3EA|CA70052370|NONE_FOUND|12.5|evidence|5366|https://civicdb.org/links/evidence/5366|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191540	1748	T	C	.	.	GN=VHL;VT=L178P_(c.533T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.533T>C||L178P_(c.533T>C)|1748|RS5030822&LEU178PRO&C\x2E533T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu178Pro&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EC&ENST00000256474\x2E2\x3Ac\x2E533T\x3EC|CA351756245|NONE_FOUND|37.5|evidence|7004|https://civicdb.org/links/evidence/7004|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.533T>C||L178P_(c.533T>C)|1748|RS5030822&LEU178PRO&C\x2E533T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu178Pro&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EC&ENST00000256474\x2E2\x3Ac\x2E533T\x3EC|CA351756245|NONE_FOUND|37.5|evidence|5149|https://civicdb.org/links/evidence/5149|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||,C|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.533T>C||L178P_(c.533T>C)|1748|RS5030822&LEU178PRO&C\x2E533T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu178Pro&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EC&ENST00000256474\x2E2\x3Ac\x2E533T\x3EC|CA351756245|NONE_FOUND|37.5|evidence|5470|https://civicdb.org/links/evidence/5470|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.533T>C||L178P_(c.533T>C)|1748|RS5030822&LEU178PRO&C\x2E533T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu178Pro&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EC&ENST00000256474\x2E2\x3Ac\x2E533T\x3EC|CA351756245|NONE_FOUND|37.5|evidence|5198|https://civicdb.org/links/evidence/5198|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cyst_(HPO_ID_HP:0000107)&Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||,C|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.533T>C||L178P_(c.533T>C)|1748|RS5030822&LEU178PRO&C\x2E533T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu178Pro&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EC&ENST00000256474\x2E2\x3Ac\x2E533T\x3EC|CA351756245|NONE_FOUND|37.5|evidence|4983|https://civicdb.org/links/evidence/4983|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.533T>C||L178P_(c.533T>C)|1748|RS5030822&LEU178PRO&C\x2E533T\x3EC|NC\x5F000003\x2E11\x3Ag\x2E10191540T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu178Pro&NM\x5F000551\x2E3\x3Ac\x2E533T\x3EC&ENST00000256474\x2E2\x3Ac\x2E533T\x3EC|CA351756245|NONE_FOUND|37.5|evidence|4914|https://civicdb.org/links/evidence/4914|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10191545	1807	A	G	.	.	GN=VHL;VT=I180V_(c.538A>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST0|ENST00000256474.2:c.538A>G||I180V_(c.538A>G)|1807|RS377715747&ILE180VAL&C\x2E538A\x3EG|ENST00000256474\x2E2\x3Ac\x2E538A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191545A\x3EG&NP\x5F000542\x2E1\x3Ap\x2EIle180Val&NM\x5F000551\x2E3\x3Ac\x2E538A\x3EG|CA020469|161401|7.5|evidence|4984|https://civicdb.org/links/evidence/4984|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191555	1784	C	A	.	.	GN=VHL;VT=S183*_(c.548C>A);CSQ=A|stop_gained|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.548C>A||S183*_(c.548C>A)|1784|RS5030823&SER183TER&S183X&C\x2E548C\x3EA|ENST00000256474\x2E2\x3Ac\x2E548C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191555C\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer183Ter&NM\x5F000551\x2E3\x3Ac\x2E548C\x3EA|CA020473|2215|15.0|evidence|6592|https://civicdb.org/links/evidence/6592|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,A|stop_gained|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.548C>A||S183*_(c.548C>A)|1784|RS5030823&SER183TER&S183X&C\x2E548C\x3EA|ENST00000256474\x2E2\x3Ac\x2E548C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191555C\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer183Ter&NM\x5F000551\x2E3\x3Ac\x2E548C\x3EA|CA020473|2215|15.0|evidence|5471|https://civicdb.org/links/evidence/5471|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,A|stop_gained|VHL|7428|transcript|ENST00000|ENST00000256474.2:c.548C>A||S183*_(c.548C>A)|1784|RS5030823&SER183TER&S183X&C\x2E548C\x3EA|ENST00000256474\x2E2\x3Ac\x2E548C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191555C\x3EA&NP\x5F000542\x2E1\x3Ap\x2ESer183Ter&NM\x5F000551\x2E3\x3Ac\x2E548C\x3EA|CA020473|2215|15.0|evidence|5370|https://civicdb.org/links/evidence/5370|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Renal_Cell_Carcinoma_(DOID_4450)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|3|||||
3	10191558	1776	T	C	.	.	GN=VHL;VT=L184P_(c.551T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P_(c.551T>C)|1776|RS1064793878&LEU184PRO&C\x2E551T\x3EC|ENST00000256474\x2E2\x3Ac\x2E551T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191558T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu184Pro&NM\x5F000551\x2E3\x3Ac\x2E551T\x3EC|CA16617792|419447|12.5|evidence|5055|https://civicdb.org/links/evidence/5055|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P_(c.551T>C)|1776|RS1064793878&LEU184PRO&C\x2E551T\x3EC|ENST00000256474\x2E2\x3Ac\x2E551T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191558T\x3EC&NP\x5F000542\x2E1\x3Ap\x2ELeu184Pro&NM\x5F000551\x2E3\x3Ac\x2E551T\x3EC|CA16617792|419447|12.5|evidence|4943|https://civicdb.org/links/evidence/4943|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10191558	1808	T	G	.	.	GN=VHL;VT=L184R_(c.551T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.551T>G||L184R_(c.551T>G)|1808|LEU184ARG&C\x2E551T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu184Arg&NM\x5F000551\x2E3\x3Ac\x2E551T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191558T\x3EG&ENST00000256474\x2E2\x3Ac\x2E551T\x3EG|CA351756355|NONE_FOUND|7.5|evidence|6593|https://civicdb.org/links/evidence/6593|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,G|missense_variant|VHL|7428|transcript|ENST00|ENST00000256474.2:c.551T>G||L184R_(c.551T>G)|1808|LEU184ARG&C\x2E551T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu184Arg&NM\x5F000551\x2E3\x3Ac\x2E551T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191558T\x3EG&ENST00000256474\x2E2\x3Ac\x2E551T\x3EG|CA351756355|NONE_FOUND|7.5|evidence|5199|https://civicdb.org/links/evidence/5199|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191562	1809	C	G	.	.	GN=VHL;VT=Y185*_(c.555C>G);CSQ=G|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.555C>G||Y185*_(c.555C>G)|1809|RS864622109&TYR185TER&Y185X&C\x2E555C\x3EG|ENST00000256474\x2E2\x3Ac\x2E555C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191562C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr185Ter&NM\x5F000551\x2E3\x3Ac\x2E555C\x3EG|CA357075|223233|15.0|evidence|5170|https://civicdb.org/links/evidence/5170|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||,G|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.555C>G||Y185*_(c.555C>G)|1809|RS864622109&TYR185TER&Y185X&C\x2E555C\x3EG|ENST00000256474\x2E2\x3Ac\x2E555C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191562C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETyr185Ter&NM\x5F000551\x2E3\x3Ac\x2E555C\x3EG|CA357075|223233|15.0|evidence|5056|https://civicdb.org/links/evidence/5056|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191563	1778	G	A	.	.	GN=VHL;VT=E186K_(c.556G>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.556G>A||E186K_(c.556G>A)|1778|RS367545984&GLU186LYS&C\x2E556G\x3EA|ENST00000256474\x2E2\x3Ac\x2E556G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191563G\x3EA&NP\x5F000542\x2E1\x3Ap\x2EGlu186Lys&NM\x5F000551\x2E3\x3Ac\x2E556G\x3EA|CA020480|161403|5.0|evidence|4945|https://civicdb.org/links/evidence/4945|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|2|||||
3	10191563	1777	G	T	.	.	GN=VHL;VT=E186*_(c.556G>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.556G>T||E186*_(c.556G>T)|1777|RS367545984&GLU186TER&E186X&C\x2E556G\x3ET|ENST00000256474\x2E2\x3Ac\x2E556G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191563G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu186Ter&NM\x5F000551\x2E3\x3Ac\x2E556G\x3ET|CA16604432|381602|15.0|evidence|5057|https://civicdb.org/links/evidence/5057|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.556G>T||E186*_(c.556G>T)|1777|RS367545984&GLU186TER&E186X&C\x2E556G\x3ET|ENST00000256474\x2E2\x3Ac\x2E556G\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191563G\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGlu186Ter&NM\x5F000551\x2E3\x3Ac\x2E556G\x3ET|CA16604432|381602|15.0|evidence|4944|https://civicdb.org/links/evidence/4944|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||
3	10191568	2139	TC	T	.	.	GN=VHL;VT=L188fs_(c.562delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.562delC||L188fs_(c.562delC)|2139|LEU188FS&C\x2E562DELC|NP\x5F000542\x2E1\x3Ap\x2ELeu188TrpfsTer14&NM\x5F000551\x2E3\x3Ac\x2E562delC&NC\x5F000003\x2E11\x3Ag\x2E10191569del&ENST00000256474\x2E2\x3Ac\x2E562delC|CA432423671|NONE_FOUND|10.0|evidence|5737|https://civicdb.org/links/evidence/5737|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191569	1836	C	G	.	.	GN=VHL;VT=L188V_(c.562C>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.562C>G||L188V_(c.562C>G)|1836|RS5030824&LEU188VAL&C\x2E562C\x3EG|ENST00000256474\x2E2\x3Ac\x2E562C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191569C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ELeu188Val&NM\x5F000551\x2E3\x3Ac\x2E562C\x3EG|CA020488|2225|15.0|evidence|5409|https://civicdb.org/links/evidence/5409|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.562C>G||L188V_(c.562C>G)|1836|RS5030824&LEU188VAL&C\x2E562C\x3EG|ENST00000256474\x2E2\x3Ac\x2E562C\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191569C\x3EG&NP\x5F000542\x2E1\x3Ap\x2ELeu188Val&NM\x5F000551\x2E3\x3Ac\x2E562C\x3EG|CA020488|2225|15.0|evidence|7889|https://civicdb.org/links/evidence/7889|11850829_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191570	1852	T	C	.	.	GN=VHL;VT=L188P_(c.563T>C);CSQ=C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>C||L188P_(c.563T>C)|1852|LEU188PRO&C\x2E563T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ELeu188Pro&NM\x5F000551\x2E3\x3Ac\x2E563T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191570T\x3EC&ENST00000256474\x2E2\x3Ac\x2E563T\x3EC|CA351756399|NONE_FOUND|15.0|evidence|5282|https://civicdb.org/links/evidence/5282|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,C|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>C||L188P_(c.563T>C)|1852|LEU188PRO&C\x2E563T\x3EC|NP\x5F000542\x2E1\x3Ap\x2ELeu188Pro&NM\x5F000551\x2E3\x3Ac\x2E563T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E10191570T\x3EC&ENST00000256474\x2E2\x3Ac\x2E563T\x3EC|CA351756399|NONE_FOUND|15.0|evidence|5066|https://civicdb.org/links/evidence/5066|9829911_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191570	1861	T	A	.	.	GN=VHL;VT=L188Q_(c.563T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>A||L188Q_(c.563T>A)|1861|LEU188GLN&C\x2E563T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu188Gln&NM\x5F000551\x2E3\x3Ac\x2E563T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191570T\x3EA&ENST00000256474\x2E2\x3Ac\x2E563T\x3EA|CA351756398|NONE_FOUND|10.0|evidence|6061|https://civicdb.org/links/evidence/6061|7728151_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||
3	10191570	1924	T	G	.	.	GN=VHL;VT=L188R_(c.563T>G);CSQ=G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>G||L188R_(c.563T>G)|1924|LEU188ARG&C\x2E563T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu188Arg&NM\x5F000551\x2E3\x3Ac\x2E563T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191570T\x3EG&ENST00000256474\x2E2\x3Ac\x2E563T\x3EG|CA351756400|NONE_FOUND|7.5|evidence|6595|https://civicdb.org/links/evidence/6595|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,G|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>G||L188R_(c.563T>G)|1924|LEU188ARG&C\x2E563T\x3EG|NP\x5F000542\x2E1\x3Ap\x2ELeu188Arg&NM\x5F000551\x2E3\x3Ac\x2E563T\x3EG&NC\x5F000003\x2E11\x3Ag\x2E10191570T\x3EG&ENST00000256474\x2E2\x3Ac\x2E563T\x3EG|CA351756400|NONE_FOUND|7.5|evidence|5200|https://civicdb.org/links/evidence/5200|21463266_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Renal_cyst_(HPO_ID_HP:0000107)&Multiple_renal_cysts_(HPO_ID_HP:0005562)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191577	1958	CC	C	.	.	GN=VHL;VT=H191FS_(c.571delC);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.571delC||H191FS_(c.571delC)|1958|HIS191FS&C\x2E571DELC|NP\x5F000542\x2E1\x3Ap\x2EHis191ThrfsTer11&NM\x5F000551\x2E3\x3Ac\x2E571delC&NC\x5F000003\x2E11\x3Ag\x2E10191578del&ENST00000256474\x2E2\x3Ac\x2E571delC|CA658795182|NONE_FOUND|7.5|evidence|5275|https://civicdb.org/links/evidence/5275|9829912_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||
3	10191587	2022	GTG	G	.	.	GN=VHL;VT=V194FS_(c.581_582delTG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.581_582delTG||V194FS_(c.581_582delTG)|2022|VAL194FS&C\x2E581\x5F582DELTG|NP\x5F000542\x2E1\x3Ap\x2EVal194AlafsTer\x3F&NM\x5F000551\x2E3\x3Ac\x2E581\x5F582delT&NC\x5F000003\x2E11\x3Ag\x2E10191588\x5F10191589del&ENST00000256474\x2E2\x3Ac\x2E581\x5F582delTG|CA70052556|NONE_FOUND|7.5|evidence|5441|https://civicdb.org/links/evidence/5441|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||
3	10191590	1810	C	T	.	.	GN=VHL;VT=Q195*_(c.583C>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|5097|https://civicdb.org/links/evidence/5097|17661816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|5404|https://civicdb.org/links/evidence/5404|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|5472|https://civicdb.org/links/evidence/5472|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|6623|https://civicdb.org/links/evidence/6623|25867206_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Endolymphatic_sac_tumor_(HPO_ID_HP:0030393)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|5360|https://civicdb.org/links/evidence/5360|8707293_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|5691|https://civicdb.org/links/evidence/5691|23298237_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|5134|https://civicdb.org/links/evidence/5134|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Cerebellar_hemangioblastoma_(HPO_ID_HP:0006880)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)|C|4|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|4987|https://civicdb.org/links/evidence/4987|7987306_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|3|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|evidence|6596|https://civicdb.org/links/evidence/6596|26763786_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|1|||||,T|stop_gained|VHL|7428|transcript|ENST|ENST00000256474.2:c.583C>T||Q195*_(c.583C>T)|1810|RS5030825&GLN195TER&Q195X&C\x2E583C\x3ET|ENST00000256474\x2E2\x3Ac\x2E583C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191590C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EGln195Ter&NM\x5F000551\x2E3\x3Ac\x2E583C\x3ET|CA70052558|428794|60.0|assertion|18|https://civicdb.org/links/assertion/18||Rare_Germline|accepted|Pathogenic|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||||PP4&PM2&PVS1||||
3	10191590	2140	CAG	C	.	.	GN=VHL;VT=Q195fs_(c.584_585delAG);CSQ=-|frameshift_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.584_585delAG||Q195fs_(c.584_585delAG)|2140|GLN195FS&C\x2E584\x5F585DELAG|ENST00000256474\x2E2\x3Ac\x2E584\x5F585delAG|CA645529570|NONE_FOUND|10.0|evidence|5738|https://civicdb.org/links/evidence/5738|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191593	1913	A	T	.	.	GN=VHL;VT=K196*_(c.586A>T);CSQ=T|stop_gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.586A>T||K196*_(c.586A>T)|1913|RS281860296&LYS196TER&K196X&C\x2E586A\x3ET|ENST00000256474\x2E2\x3Ac\x2E586A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191593A\x3ET&NP\x5F000542\x2E1\x3Ap\x2ELys196Ter&NM\x5F000551\x2E3\x3Ac\x2E586A\x3ET|CA020507|196284|5.0|evidence|5176|https://civicdb.org/links/evidence/5176|19270817_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	10191595	2141	AG	A	.	.	GN=VHL;VT=D197FS_(c.589delG);CSQ=-|frameshift_truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.589delG||D197FS_(c.589delG)|2141|ASP197FS&C\x2E589DELG|NP\x5F000542\x2E1\x3Ap\x2EAsp197ThrfsTer5&NM\x5F000551\x2E3\x3Ac\x2E589del&NC\x5F000003\x2E11\x3Ag\x2E10191596del&ENST00000256474\x2E2\x3Ac\x2E589delG|CA913189233|NONE_FOUND|10.0|evidence|5739|https://civicdb.org/links/evidence/5739|17024664_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|4|||||
3	10191600	2010	T	A	.	.	GN=VHL;VT=L198Q__(c.593T>A);CSQ=A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.593T>A||L198Q__(c.593T>A)|2010|LEU198GLN&C\x2E593T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu198Gln&NM\x5F000551\x2E3\x3Ac\x2E593T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191600T\x3EA&ENST00000256474\x2E2\x3Ac\x2E593T\x3EA|CA351756548|NONE_FOUND|12.5|evidence|5410|https://civicdb.org/links/evidence/5410|12000816_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|3|||||,A|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.593T>A||L198Q__(c.593T>A)|2010|LEU198GLN&C\x2E593T\x3EA|NP\x5F000542\x2E1\x3Ap\x2ELeu198Gln&NM\x5F000551\x2E3\x3Ac\x2E593T\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191600T\x3EA&ENST00000256474\x2E2\x3Ac\x2E593T\x3EA|CA351756548|NONE_FOUND|12.5|evidence|5473|https://civicdb.org/links/evidence/5473|20660572_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)|C|2|||||
3	10191605	631	C	T	.	.	GN=VHL;VT=R200W_(c.598C>T);CSQ=T|missense_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.598C>T||R200W_(c.598C>T)|631|RS28940298&C\x2E598C\x3ET&ARG200TRP|NC\x5F000003\x2E11\x3Ag\x2E10191605C\x3ET&ENST00000256474\x2E2\x3Ac\x2E598C\x3ET&NP\x5F000542\x2E1\x3Ap\x2EArg200Trp&NM\x5F000551\x2E3\x3Ac\x2E598C\x3ET|CA020510|2232|10.0|evidence|1608|https://civicdb.org/links/evidence/1608|27518686_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Chuvash_Polycythemia_(DOID_0060474)|Ruxolitinib_(NCIt_ID_C77888)||Polycythemia_(HPO_ID_HP:0001901)|C|4|||||
3	10191647	2488	T	G	.	.	GN=VHL;VT=*214G_(c.640T>G);CSQ=G|stop_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.640T>G||*214G_(c.640T>G)|2488|X\x20\x3E\x20GLY\x20\x2B\x2014AA&C\x2E640T\x3EG&TER214GLY&X214G|ENSP00000256474\x2E2\x3Ap\x2ETer214Gly&NP\x5F000542\x2E1\x3Ap\x2ETer214Gly&NM\x5F000551\x2E3\x3Ac\x2E640T\x3EG&ENST00000256474\x2E2\x3Ac\x2E640T\x3EG|CA351756720|NONE_FOUND|5.0|evidence|6723|https://civicdb.org/links/evidence/6723|12673678_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10191648	1986	G	T	.	.	GN=VHL;VT=*214L_(c.641G>T);CSQ=T|stop_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.641G>T||*214L_(c.641G>T)|1986|RS869025668&\x2A214LEXT\x2A15&X214L|NC\x5F000003\x2E11\x3Ag\x2E10191648G\x3ET&NP\x5F000542\x2E1\x3Ap\x2ETer214Leu&ENST00000256474\x2E2\x3Ac\x2E641G\x3ET&NM\x5F000551\x3Ac\x2E641G\x3ET|CA357103|223236|10.0|evidence|5334|https://civicdb.org/links/evidence/5334|20560986_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Neuroendocrine_neoplasm_(HPO_ID_HP:0100634)|C|4|||||
3	10191648	2489	G	GC	.	.	GN=VHL;VT=*214C_(c.641_642insC);CSQ=C|stop_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.641_642insC||*214C_(c.641_642insC)|2489|C\x2E641INSC&TER214CYS&X214C|ENST00000256474\x2E2\x3Ac\x2E641\x5F642insC|CA913189243|NONE_FOUND|5.0|evidence|6724|https://civicdb.org/links/evidence/6724|12673678_(PubMed)|Rare_Germline|accepted|N/A|N/A|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10191649	1988	A	T	.	.	GN=VHL;VT=*214C_(c.642A>T);CSQ=T|stop_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.642A>T||*214C_(c.642A>T)|1988|RS1559430011&TER214CYS&X214C&C\x2E642A\x3ET|NP\x5F000542\x2E1\x3Ap\x2ETer214Cys&NM\x5F000551\x2E3\x3Ac\x2E642A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E10191649A\x3ET&ENST00000256474\x2E2\x3Ac\x2E642A\x3ET|CA351756724|625270|5.0|evidence|5336|https://civicdb.org/links/evidence/5336|20560986_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pheochromocytoma_(HPO_ID_HP:0002666)&Clear_cell_renal_cell_carcinoma_(HPO_ID_HP:0006770)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)&Pancreatic_endocrine_tumor_(HPO_ID_HP:0030405)&Neuroendocrine_neoplasm_(HPO_ID_HP:0100634)|C|2|||||
3	10191649	1987	A	G	.	.	GN=VHL;VT=*214W_(c.642A>G);CSQ=G|stop_lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.642A>G||*214W_(c.642A>G)|1987|TER214TRP&C\x2E642A\x3EG&NM\x5F000551\x3A\x2A214WEXT\x2A15|NC\x5F000003\x2E11\x3Ag\x2E10191649A\x3EG&ENST00000256474\x2E2\x3Ac\x2E642A\x3EG&NP\x5F000542\x2E1\x3Ap\x2ETer214Trp&NM\x5F000551\x2E3\x3Ac\x2E642A\x3EG|CA351756723|625269&36907|5.0|evidence|5335|https://civicdb.org/links/evidence/5335|20560986_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Pheochromocytoma_(HPO_ID_HP:0002666)|C|2|||||
3	10191656	2024	C	G	.	.	GN=VHL;VT=3'UTR_alteration_(c.639+10C>G);CSQ=G|3_prime_UTR_variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.639+10C>G||3'UTR_alteration_(c.639+10C>G)|2024|C\x2E639\x2B10C\x3EG|ENST00000256474\x2E2\x3Ac\x2E639\x2B10C\x3EG|CA16042064|NONE_FOUND|5.0|evidence|5443|https://civicdb.org/links/evidence/5443|11409863_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)||||C|2|||||
3	10191719	2152	C	A	.	.	GN=VHL;VT=3'UTR_alteration_(c.642+70C>A);CSQ=A|3_prime_UTR_variant|VHL|7428|transcript|None|||3'UTR_alteration_(c.642+70C>A)|2152|C\x2E\x2A70C\x3EA|NP\x5F000542\x2E1\x3Ap\x2E\x3D&NM\x5F000551\x2E3\x3Ac\x2E\x2A70C\x3EA&ENST00000256474\x2E2\x3Ac\x2E\x2A70C\x3EA&NC\x5F000003\x2E11\x3Ag\x2E10191719C\x3EA|CA658820858|NONE_FOUND|5.0|evidence|5777|https://civicdb.org/links/evidence/5777|22357542_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Von_Hippel-Lindau_Disease_(DOID_14175)|||Pancreatic_cysts_(HPO_ID_HP:0001737)&Renal_cell_carcinoma_(HPO_ID_HP:0005584)&Retinal_capillary_hemangioma_(HPO_ID_HP:0009711)&Hemangioblastoma_(HPO_ID_HP:0010797)|C|2|||||
3	37035039	747	A	T	.	.	GN=MLH1;VT=M1L;CSQ=T|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1A>T||M1L|747|MET1LEU|ENST00000231790\x2E2\x3Ac\x2E1A\x3ET&NC\x5F000003\x2E11\x3Ag\x2E37035039A\x3ET|CA352059785|NONE_FOUND|0.5|evidence|1811|https://civicdb.org/links/evidence/1811|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37035074	725	CG	C	.	.	GN=MLH1;VT=E13FS*3;CSQ=-|frameshift_truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.37delG||E13FS*3|725|RS63750081&GLU13ARGFS|NC\x5F000003\x2E11\x3Ag\x2E37035075del&ENST00000231790\x2E2\x3Ac\x2E37delG&NP\x5F000240\x2E1\x3Ap\x2EGlu13Argfs&NM\x5F000249\x2E3\x3Ac\x2E37delG|CA010006|90190|0.5|evidence|1788|https://civicdb.org/links/evidence/1788|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37038139	745	T	C	.	.	GN=MLH1;VT=V49A;CSQ=C|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.146T>C||V49A|745|VAL49ALA|NC\x5F000003\x2E11\x3Ag\x2E37038139T\x3EC&ENST00000231790\x2E2\x3Ac\x2E146T\x3EC|CA352035388|NONE_FOUND|0.5|evidence|1808|https://civicdb.org/links/evidence/1808|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37038187	759	G	A	.	.	GN=MLH1;VT=G65D;CSQ=A|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.194G>A||G65D|759|RS63751465&GLY65ASP|NC\x5F000003\x2E11\x3Ag\x2E37038187G\x3EA&ENST00000231790\x2E2\x3Ac\x2E194G\x3EA&NP\x5F000240\x2E1\x3Ap\x2EGly65Asp&NM\x5F000249\x2E3\x3Ac\x2E194G\x3EA|CA007735|89955|0.5|evidence|1823|https://civicdb.org/links/evidence/1823|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37038192	757	G	A	.	.	GN=MLH1;VT=G67R;CSQ=A|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.199G>A||G67R|757|RS63750206&GLY67ARG|NM\x5F000249\x2E3\x3Ac\x2E199G\x3EA&ENST00000231790\x2E2\x3Ac\x2E199G\x3EA&NP\x5F000240\x2E1\x3Ap\x2EGly67Arg&NC\x5F000003\x2E11\x3Ag\x2E37038192G\x3EA|CA008104|89992|0.5|evidence|1821|https://civicdb.org/links/evidence/1821|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37038196	758	T	G	.	.	GN=MLH1;VT=I68S;CSQ=G|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.203T>G||I68S|758|ILE68SER|NC\x5F000003\x2E11\x3Ag\x2E37038196T\x3EG&ENST00000231790\x2E2\x3Ac\x2E203T\x3EG|CA352035494|NONE_FOUND|0.5|evidence|1822|https://civicdb.org/links/evidence/1822|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37042536	741	C	T	.	.	GN=MLH1;VT=R100*;CSQ=T|stop_gained|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.298C>T||R100*|741|RS63751221&R100X&ARG100TER|NC\x5F000003\x2E11\x3Ag\x2E37042536C\x3ET&ENST00000231790\x2E2\x3Ac\x2E298C\x3ET&NP\x5F000240\x2E1\x3Ap\x2EArg100Ter&NM\x5F000249\x2E3\x3Ac\x2E298C\x3ET|CA009575|36550|0.5|evidence|1804|https://civicdb.org/links/evidence/1804|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37045935	743	C	T	.	.	GN=MLH1;VT=T117M;CSQ=T|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.350C>T||T117M|743|RS63750781&THR117MET|NC\x5F000003\x2E11\x3Ag\x2E37045935C\x3ET&ENST00000231790\x2E2\x3Ac\x2E350C\x3ET&NP\x5F000240\x2E1\x3Ap\x2EThr117Met&NM\x5F000249\x2E3\x3Ac\x2E350C\x3ET|CA009872|17094|0.5|evidence|1806|https://civicdb.org/links/evidence/1806|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37048546	753	C	T	.	.	GN=MLH1;VT=Q149*;CSQ=T|stop_gained|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.445C>T||Q149*|753|RS63751302&GLN149TER&Q149X|NC\x5F000003\x2E11\x3Ag\x2E37048546C\x3ET&ENST00000231790\x2E2\x3Ac\x2E445C\x3ET&NP\x5F000240\x2E1\x3Ap\x2EGln149Ter&NM\x5F000249\x2E3\x3Ac\x2E445C\x3ET|CA010427|90219|0.5|evidence|1817|https://civicdb.org/links/evidence/1817|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37053550	750	GT	G	.	.	GN=MLH1;VT=V213FS;CSQ=-|frameshift_truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.638delT||V213FS|750|VAL213FS|NC\x5F000003\x2E11\x3Ag\x2E37053551del&ENST00000231790\x2E2\x3Ac\x2E638delT|CA913102758|NONE_FOUND|0.5|evidence|1814|https://civicdb.org/links/evidence/1814|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37053589	754	C	T	.	.	GN=MLH1;VT=R226*;CSQ=T|stop_gained|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.676C>T||R226*|754|RS63751615&R128\x2A&ARG226TER&R226X|NC\x5F000003\x2E11\x3Ag\x2E37053589C\x3ET&ENST00000231790\x2E2\x3Ac\x2E676C\x3ET&NP\x5F000240\x2E1\x3Ap\x2EArg226Ter&NM\x5F000249\x2E3\x3Ac\x2E676C\x3ET|CA011496|17087|0.5|evidence|1818|https://civicdb.org/links/evidence/1818|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37056036	731	G	A	.	.	GN=MLH1;VT=c.790+1G>A;CSQ=A|splice_donor_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.790+1G>A||c.790+1G>A|731|RS267607789|ENST00000231790\x2E2\x3Ac\x2E790\x2B1G\x3EA&NC\x5F000003\x2E11\x3Ag\x2E37056036G\x3EA&NM\x5F000249\x2E3\x3Ac\x2E790\x2B1G\x3EA|CA012109|90356|0.5|evidence|1794|https://civicdb.org/links/evidence/1794|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37058999	749	C	G	.	.	GN=MLH1;VT=R265G;CSQ=G|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.793C>G||R265G|749|ARG265GLY|NC\x5F000003\x2E11\x3Ag\x2E37058999C\x3EG&ENST00000231790\x2E2\x3Ac\x2E793C\x3EG|CA352045752|NONE_FOUND|0.5|evidence|1813|https://civicdb.org/links/evidence/1813|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37067359	752	G	A	.	.	GN=MLH1;VT=A424T;CSQ=A|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1270G>A||A424T|752|RS377433038&ALA424THR|NC\x5F000003\x2E11\x3Ag\x2E37067359G\x3EA&ENST00000231790\x2E2\x3Ac\x2E1270G\x3EA&NP\x5F000240\x2E1\x3Ap\x2EAla424Thr&NM\x5F000249\x2E3\x3Ac\x2E1270G\x3EA|CA028060|220203|0.25|evidence|1816|https://civicdb.org/links/evidence/1816|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|1|||||
3	37067364	744	GC	G	.	.	GN=MLH1;VT=Q426FS;CSQ=-|frameshift_truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1276delC||Q426FS|744|GLN426FS|NC\x5F000003\x2E11\x3Ag\x2E37067365del&ENST00000231790\x2E2\x3Ac\x2E1276delC|CA913102760|NONE_FOUND|0.5|evidence|1807|https://civicdb.org/links/evidence/1807|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37070334	769	T	C	.	.	GN=MLH1;VT=M490T;CSQ=C|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1469T>C||M490T|769|MET490THR|NC\x5F000003\x2E11\x3Ag\x2E37070334T\x3EC&ENST00000231790\x2E2\x3Ac\x2E1469T\x3EC|CA352056416|NONE_FOUND|0.25|evidence|1833|https://civicdb.org/links/evidence/1833|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|1|||||
3	37081718	728	GT	AG	.	.	GN=MLH1;VT=V534R;CSQ=AG|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1600_1601delinsAG||V534R|728|VAL534ARG|NC\x5F000003\x2E11\x3Ag\x2E37081718\x5F37081719delinsAG&ENST00000231790\x2E2\x3Ac\x2E1600\x5F1601delinsAG|CA913102764|NONE_FOUND|0.25|evidence|1791|https://civicdb.org/links/evidence/1791|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|1|||||
3	37081725	756	CT	C	.	.	GN=MLH1;VT=P536FS;CSQ=-|frameshift_truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1608del||P536FS|756|PRO536FS|ENST00000231790\x2E2\x3Ac\x2E1608del&NC\x5F000003\x2E11\x3Ag\x2E37081726del|CA913102765|NONE_FOUND|0.5|evidence|1820|https://civicdb.org/links/evidence/1820|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37081770	751	A	C	.	.	GN=MLH1;VT=N551T;CSQ=C|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1652A>C||N551T|751|RS63750271&ASN551THR|NC\x5F000003\x2E11\x3Ag\x2E37081770A\x3EC&ENST00000231790\x2E2\x3Ac\x2E1652A\x3EC&NP\x5F000240\x2E1\x3Ap\x2EAsn551Thr&NM\x5F000249\x2E3\x3Ac\x2E1652A\x3EC|CA006238|89819|0.25|evidence|1815|https://civicdb.org/links/evidence/1815|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|1|||||
3	37089093	730	AGG	A	.	.	GN=MLH1;VT=G606FS*2;CSQ=-|frameshift_truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1816_1817delGG||G606FS*2|730|GLY606FS|NC\x5F000003\x2E11\x3Ag\x2E37089094\x5F37089095del&ENST00000231790\x2E2\x3Ac\x2E1816\x5F1817delGG|CA913102766|NONE_FOUND|0.5|evidence|1793|https://civicdb.org/links/evidence/1793|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37089129	733	GAAG	G	.	.	GN=MLH1;VT=K618DEL;CSQ=-|inframe_deletion|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1852_1854delAAG||K618DEL|733|LYS618DEL&RS63751247|NP\x5F000240\x2E1\x3Ap\x2ELys618del&NM\x5F000249\x2E3\x3Ac\x2E1852\x5F1854delAAG&ENST00000231790\x2E2\x3Ac\x2E1852\x5F1854delAAG&NC\x5F000003\x2E11\x3Ag\x2E37089130\x5F37089132del|CA007087|17080|0.5|evidence|1796|https://civicdb.org/links/evidence/1796|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37090405	746	AC	A	.	.	GN=MLH1;VT=D667FS;CSQ=-|frameshift_truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2001del||D667FS|746|ASP667FS|ENST00000231790\x2E2\x3Ac\x2E2001del&NC\x5F000003\x2E11\x3Ag\x2E37090406del|CA913102767|NONE_FOUND|0.5|evidence|1810|https://civicdb.org/links/evidence/1810|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37090447	760	C	T	.	.	GN=MLH1;VT=A681V;CSQ=T|missense_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2042C>T||A681V|760|RS63750864&A440V&ALA681VAL|NC\x5F000003\x2E11\x3Ag\x2E37090447C\x3ET&ENST00000231790\x2E2\x3Ac\x2E2042C\x3ET&NP\x5F000240\x2E1\x3Ap\x2EAla681Val&NM\x5F000249\x2E3\x3Ac\x2E2042C\x3ET|CA008313|90011|0.5|evidence|1824|https://civicdb.org/links/evidence/1824|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37090463	735	CC	C	.	.	GN=MLH1;VT=R687FS;CSQ=-|frameshift_variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2059delC||R687FS|735|RS863225381&ARG687GLYFS|NC\x5F000003\x2E11\x3Ag\x2E37090464del&ENST00000231790\x2E2\x3Ac\x2E2059delC&NP\x5F000240\x2E1\x3Ap\x2EArg687Glyfs&NM\x5F000249\x2E3\x3Ac\x2E2059delC|CA279809|218022|0.5|evidence|1798|https://civicdb.org/links/evidence/1798|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|2|||||
3	37092143	748	A	T	.	.	GN=MLH1;VT=*757L;CSQ=T|stop_lost|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2270A>T||*757L|748|X757L|NC\x5F000003\x2E11\x3Ag\x2E37092143A\x3ET&ENST00000231790\x2E2\x3Ac\x2E2270A\x3ET|CA352069936|NONE_FOUND|0.25|evidence|1812|https://civicdb.org/links/evidence/1812|25111426_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Lynch_Syndrome_(DOID_3883)||||E|1|||||
3	38182641	424	T	C	.	.	GN=MYD88;VT=L265P;CSQ=C|gain_of_function_variant&missense_variant|MYD88|4615|transcript|ENST00000396334.3|||L265P|424|LEU273PRO&L273P&LEU265PRO|NC\x5F000003\x2E11\x3Ag\x2E38182641T\x3EC|CA130043|37055|31.0|evidence|1489|https://civicdb.org/links/evidence/1489|24943832_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)||||B|2|||||,C|gain_of_function_variant&missense_variant|MYD88|4615|transcript|ENST00000396334.3|||L265P|424|LEU273PRO&L273P&LEU265PRO|NC\x5F000003\x2E11\x3Ag\x2E38182641T\x3EC|CA130043|37055|31.0|evidence|986|https://civicdb.org/links/evidence/986|25853747_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Waldenström's_Macroglobulinemia_(DOID_)|Ibrutinib_(NCIt_ID_C81934)|||B|4|||||,C|gain_of_function_variant&missense_variant|MYD88|4615|transcript|ENST00000396334.3|||L265P|424|LEU273PRO&L273P&LEU265PRO|NC\x5F000003\x2E11\x3Ag\x2E38182641T\x3EC|CA130043|37055|31.0|evidence|1641|https://civicdb.org/links/evidence/1641|22931316_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Waldenström's_Macroglobulinemia_(DOID_)|IMG-2005-5&IRAK-1/4_Inhibitor|Substitutes||D|1|||||
3	41266124	1285	A	G	.	.	GN=CTNNB1;VT=T41A;CSQ=G|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.121A>G||T41A|1285|RS121913412&THR41ALA|ENST00000349496\x2E5\x3Ac\x2E121A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E41266124A\x3EG&NP\x5F001895\x2E1\x3Ap\x2EThr41Ala&NM\x5F001904\x2E3\x3Ac\x2E121A\x3EG|CA127269|17580|55.0|evidence|5070|https://civicdb.org/links/evidence/5070|22766794_(PubMed)|Somatic|accepted|Positive|Supports|Desmoid_Fibromatosis||||B|4|||||,G|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.121A>G||T41A|1285|RS121913412&THR41ALA|ENST00000349496\x2E5\x3Ac\x2E121A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E41266124A\x3EG&NP\x5F001895\x2E1\x3Ap\x2EThr41Ala&NM\x5F001904\x2E3\x3Ac\x2E121A\x3EG|CA127269|17580|55.0|evidence|3044|https://civicdb.org/links/evidence/3044|18832571_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Desmoid_Fibromatosis||||B|3|||||,G|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.121A>G||T41A|1285|RS121913412&THR41ALA|ENST00000349496\x2E5\x3Ac\x2E121A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E41266124A\x3EG&NP\x5F001895\x2E1\x3Ap\x2EThr41Ala&NM\x5F001904\x2E3\x3Ac\x2E121A\x3EG|CA127269|17580|55.0|evidence|2973|https://civicdb.org/links/evidence/2973|18832571_(PubMed)|Somatic|accepted|Positive|Supports|Desmoid_Fibromatosis||||B|4|||||
3	41266136	1287	T	C	.	.	GN=CTNNB1;VT=S45P;CSQ=C|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.133T>C||S45P|1287|RS121913407&SER45PRO|ENST00000349496\x2E5\x3Ac\x2E133T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E41266136T\x3EC&NP\x5F001895\x2E1\x3Ap\x2ESer45Pro&NM\x5F001904\x2E3\x3Ac\x2E133T\x3EC|CA127285|17589|35.0|evidence|5072|https://civicdb.org/links/evidence/5072|22766794_(PubMed)|Somatic|accepted|Positive|Supports|Desmoid_Fibromatosis||||B|3|||||,C|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.133T>C||S45P|1287|RS121913407&SER45PRO|ENST00000349496\x2E5\x3Ac\x2E133T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E41266136T\x3EC&NP\x5F001895\x2E1\x3Ap\x2ESer45Pro&NM\x5F001904\x2E3\x3Ac\x2E133T\x3EC|CA127285|17589|35.0|evidence|3043|https://civicdb.org/links/evidence/3043|18832571_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Desmoid_Fibromatosis||||B|1|||||,C|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.133T>C||S45P|1287|RS121913407&SER45PRO|ENST00000349496\x2E5\x3Ac\x2E133T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E41266136T\x3EC&NP\x5F001895\x2E1\x3Ap\x2ESer45Pro&NM\x5F001904\x2E3\x3Ac\x2E133T\x3EC|CA127285|17589|35.0|evidence|2975|https://civicdb.org/links/evidence/2975|18832571_(PubMed)|Somatic|accepted|Positive|Supports|Desmoid_Fibromatosis||||B|3|||||
3	41266137	1286	C	T	.	.	GN=CTNNB1;VT=S45F;CSQ=T|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|RS121913409&SER45PHE|ENST00000349496\x2E5\x3Ac\x2E134C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E41266137C\x3ET&NP\x5F001895\x2E1\x3Ap\x2ESer45Phe&NM\x5F001904\x2E3\x3Ac\x2E134C\x3ET|CA127283|17588|60.0|evidence|6049|https://civicdb.org/links/evidence/6049|24788118_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Desmoid_Fibromatosis|Meloxicam_(NCIt_ID_C61439)|||C|2|||||,T|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|RS121913409&SER45PHE|ENST00000349496\x2E5\x3Ac\x2E134C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E41266137C\x3ET&NP\x5F001895\x2E1\x3Ap\x2ESer45Phe&NM\x5F001904\x2E3\x3Ac\x2E134C\x3ET|CA127283|17588|60.0|evidence|5071|https://civicdb.org/links/evidence/5071|22766794_(PubMed)|None|accepted|Positive|Supports|Desmoid_Fibromatosis||||B|4|||||,T|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|RS121913409&SER45PHE|ENST00000349496\x2E5\x3Ac\x2E134C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E41266137C\x3ET&NP\x5F001895\x2E1\x3Ap\x2ESer45Phe&NM\x5F001904\x2E3\x3Ac\x2E134C\x3ET|CA127283|17588|60.0|evidence|2974|https://civicdb.org/links/evidence/2974|18832571_(PubMed)|Somatic|accepted|Positive|Supports|Desmoid_Fibromatosis||||B|4|||||,T|missense_variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|RS121913409&SER45PHE|ENST00000349496\x2E5\x3Ac\x2E134C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E41266137C\x3ET&NP\x5F001895\x2E1\x3Ap\x2ESer45Phe&NM\x5F001904\x2E3\x3Ac\x2E134C\x3ET|CA127283|17588|60.0|evidence|2976|https://civicdb.org/links/evidence/2976|18832571_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Desmoid_Fibromatosis||||B|3|||||
3	105439026	643	G	A	.	.	GN=CBLB;VT=RS2305035;CSQ=A|polymorphic_sequence_variant&synonymous_variant|CBLB|868|transcript|ENST00000264122.4|ENST00000264122.4:c.1272C>T||RS2305035|643|D424D|ENST00000264122\x2E4\x3Ac\x2E1272C\x3ET&NM\x5F001321788\x2E1\x3Ac\x2E1272C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E105439026G\x3EA|CA2524814|NONE_FOUND|10.0|evidence|1637|https://civicdb.org/links/evidence/1637|26732495_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|2|||||
3	138665163	198	G	C	.	.	GN=FOXL2;VT=C134W;CSQ=C|missense_variant|FOXL2|668|transcript|ENST00000330315.3|||C134W|198||NC\x5F000003\x2E11\x3Ag\x2E138665163G\x3EC|CA16602790||70.0|evidence|6034|https://civicdb.org/links/evidence/6034|26033501_(PubMed)|Somatic|accepted|Positive|Supports|Ovarian_Sex-cord_Stromal_Tumor_(DOID_0080369)||||A|5|||||,C|missense_variant|FOXL2|668|transcript|ENST00000330315.3|||C134W|198||NC\x5F000003\x2E11\x3Ag\x2E138665163G\x3EC|CA16602790||70.0|evidence|479|https://civicdb.org/links/evidence/479|20693978_(PubMed)|Somatic|accepted|Positive|Supports|Ovarian_Granulosa_Cell_Tumor_(DOID_2999)||||B|4|||||
3	178921567	1653	A	G	.	.	GN=PIK3CA;VT=D350G;CSQ=G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1049A>G||D350G|1653|ASP350GLY|NP\x5F006209\x2E2\x3Ap\x2EAsp350Gly&NM\x5F006218\x2E2\x3Ac\x2E1049A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E178921567A\x3EG&ENST00000263967\x2E3\x3Ac\x2E1049A\x3EG|CA355281594|NONE_FOUND|2.0|evidence|4784|https://civicdb.org/links/evidence/4784|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||
3	178927980	931	T	C	.	.	GN=PIK3CA;VT=C420R;CSQ=C|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1258T>C||C420R|931|CYS420ARG&RS121913272|ENST00000263967\x2E3\x3Ac\x2E1258T\x3EC&NC\x5F000003\x2E11\x3Ag\x2E178927980T\x3EC&NP\x5F006209\x2E2\x3Ap\x2ECys420Arg&NM\x5F006218\x2E3\x3Ac\x2E1258T\x3EC|CA180900|31945|0.0|evidence|2346|https://civicdb.org/links/evidence/2346|26920887_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Trastuzumab_Emtansine_(NCIt_ID_C82492)|||D|3|||||
3	178928226	294	C	T	.	.	GN=PIK3CA;VT=P471L;CSQ=T|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1412C>T||P471L|294|RS1057519872&PRO471LEU|NP\x5F006209\x2E2\x3Ap\x2EPro471Leu&NM\x5F006218\x2E3\x3Ac\x2E1412C\x3ET&ENST00000263967\x2E3\x3Ac\x2E1412C\x3ET&NC\x5F000003\x2E11\x3Ag\x2E178928226C\x3ET|CA16602799|376359|7.5|evidence|739|https://civicdb.org/links/evidence/739|26466009_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Merkel_Cell_Carcinoma_(DOID_3965)|Idelalisib_(NCIt_ID_C78825)|||C|3|||||
3	178936082	103	G	A	.	.	GN=PIK3CA;VT=E542K;CSQ=A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|83|https://civicdb.org/links/evidence/83|24559322_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||B|4|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|256|https://civicdb.org/links/evidence/256|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||B|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|310|https://civicdb.org/links/evidence/310|21558396_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|PI3K-alpha_Inhibitor_MEN1611_(NCIt_ID_C158603)|||D|4|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|1549|https://civicdb.org/links/evidence/1549|26787751_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Squamous_Cell_Carcinoma_(DOID_5520)|Apitolisib_(NCIt_ID_C91731)|||C|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|1626|https://civicdb.org/links/evidence/1626|19706758_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Cancer_(DOID_1781)|Perifosine_(NCIt_ID_C1727)&Temsirolimus_(NCIt_ID_C1844)|Substitutes||D|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|7315|https://civicdb.org/links/evidence/7315|31091374_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Alpelisib_(NCIt_ID_C94214)&Fulvestrant_(NCIt_ID_C1379)|Combination||A|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|311|https://civicdb.org/links/evidence/311|15647370_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Sirolimus_(NCIt_ID_C1212)|||D|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|RS121913273&GLU542LYS|NC\x5F000003\x2E11\x3Ag\x2E178936082G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1624G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu542Lys&NM\x5F006218\x2E3\x3Ac\x2E1624G\x3EA|CA333572|31944|95.0|evidence|385|https://civicdb.org/links/evidence/385|19223544_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|3|||||
3	178936091	104	G	A	.	.	GN=PIK3CA;VT=E545K;CSQ=A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|1171|https://civicdb.org/links/evidence/1171|16906227_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)|||D|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|3722|https://civicdb.org/links/evidence/3722|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|710|https://civicdb.org/links/evidence/710|23888070_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Akt_Inhibitor_MK2206_(NCIt_ID_C90581)&Pictilisib|Substitutes||D|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|1453|https://civicdb.org/links/evidence/1453|18829560_(PubMed)|Somatic|accepted|Resistance|Supports|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Trastuzumab_(NCIt_ID_C1647)|||D|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|1550|https://civicdb.org/links/evidence/1550|26787751_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Apitolisib_(NCIt_ID_C91731)|||C|1|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|1670|https://civicdb.org/links/evidence/1670|27304188_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)&Afatinib_(NCIt_ID_C66940)|Substitutes||B|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2036|https://civicdb.org/links/evidence/2036|26920887_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Trastuzumab_Emtansine_(NCIt_ID_C82492)|||D|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2037|https://civicdb.org/links/evidence/2037|19223544_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||C|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2040|https://civicdb.org/links/evidence/2040|19513541_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|PI103|||D|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2984|https://civicdb.org/links/evidence/2984|27489350_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cervix_Carcinoma_(DOID_2893)|Pictilisib|||D|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2985|https://civicdb.org/links/evidence/2985|27489350_(PubMed)|Somatic|accepted|Resistance|Supports|Cervix_Carcinoma_(DOID_2893)|Cisplatin_(NCIt_ID_C376)|||D|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|387|https://civicdb.org/links/evidence/387|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||C|3|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2034|https://civicdb.org/links/evidence/2034|20453058_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Pictilisib_Bismesylate_(NCIt_ID_C82380)|||D|2|||||,A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|RS104886003&GLU545LYS|NC\x5F000003\x2E11\x3Ag\x2E178936091G\x3EA&ENST00000263967\x2E3\x3Ac\x2E1633G\x3EA&NP\x5F006209\x2E2\x3Ap\x2EGlu545Lys&NM\x5F006218\x2E3\x3Ac\x2E1633G\x3EA|CA123334|13655|57.0|evidence|2106|https://civicdb.org/links/evidence/2106|19903786_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Rectum_Cancer_(DOID_1993)||||B|2|||||
3	178936092	883	A	G	.	.	GN=PIK3CA;VT=E545G;CSQ=G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1634A>G||E545G|883|GLU545GLY&RS121913274|ENST00000263967\x2E3\x3Ac\x2E1634A\x3EG&NC\x5F000003\x2E11\x3Ag\x2E178936092A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EGlu545Gly&NM\x5F006218\x2E3\x3Ac\x2E1634A\x3EG|CA123336|13656|2.0|evidence|3724|https://civicdb.org/links/evidence/3724|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||
3	178948091	3001	G	A	.	.	GN=PIK3CA;VT=V955I;CSQ=A|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|||V955I|3001|VAL955ILE||CA355281422||0.0|evidence|8063|https://civicdb.org/links/evidence/8063|28424201_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|4|||||
3	178952085	107	A	G	.	.	GN=PIK3CA;VT=H1047R;CSQ=G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|258|https://civicdb.org/links/evidence/258|19223544_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||B|2|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|314|https://civicdb.org/links/evidence/314|21558396_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|PI3K-alpha_Inhibitor_MEN1611_(NCIt_ID_C158603)|||D|4|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|3733|https://civicdb.org/links/evidence/3733|22180495_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1363|https://civicdb.org/links/evidence/1363|23619167_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Cancer_(DOID_11934)|Cetuximab_(NCIt_ID_C1723)&Dactolisib_(NCIt_ID_C74072)|Combination||D|2|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1447|https://civicdb.org/links/evidence/1447|19029981_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Dactolisib_(NCIt_ID_C74072)|||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1505|https://civicdb.org/links/evidence/1505|22294718_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Capivasertib_(NCIt_ID_C102564)&Trastuzumab_(NCIt_ID_C1647)|Combination||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1506|https://civicdb.org/links/evidence/1506|22294718_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Capivasertib_(NCIt_ID_C102564)&Lapatinib_(NCIt_ID_C26653)|Combination||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1361|https://civicdb.org/links/evidence/1361|25855885_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Cancer_(DOID_11934)|Dactolisib_(NCIt_ID_C74072)|||D|1|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1362|https://civicdb.org/links/evidence/1362|23619167_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Cancer_(DOID_11934)|Dactolisib_(NCIt_ID_C74072)|||D|2|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1623|https://civicdb.org/links/evidence/1623|27445490_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Everolimus_(NCIt_ID_C48387)&Fulvestrant_(NCIt_ID_C1379)|Combination||C|2|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1625|https://civicdb.org/links/evidence/1625|19706758_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Cancer_(DOID_1781)|Perifosine_(NCIt_ID_C1727)&Temsirolimus_(NCIt_ID_C1844)|Substitutes||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|2102|https://civicdb.org/links/evidence/2102|20453058_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Trastuzumab_(NCIt_ID_C1647)|||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|2103|https://civicdb.org/links/evidence/2103|26920887_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Her2-receptor_Positive_Breast_Cancer_(DOID_0060079)|Trastuzumab_Emtansine_(NCIt_ID_C82492)|||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|388|https://civicdb.org/links/evidence/388|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||C|2|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1401|https://civicdb.org/links/evidence/1401|25550549_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Cancer_(DOID_11934)|Alpelisib_(NCIt_ID_C94214)|||D|1|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|1465|https://civicdb.org/links/evidence/1465|26589432_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Squamous_Cell_Carcinoma_(DOID_5520)|Taselisib_(NCIt_ID_C116876)|||D|2|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|8364|https://civicdb.org/links/evidence/8364|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Akt_Inhibitor_MK2206_(NCIt_ID_C90581)|Combination||D|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|2105|https://civicdb.org/links/evidence/2105|17590872_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|3|||||,G|missense_variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|RS121913279&HIS1047ARG|NC\x5F000003\x2E11\x3Ag\x2E178952085A\x3EG&ENST00000263967\x2E3\x3Ac\x2E3140A\x3EG&NP\x5F006209\x2E2\x3Ap\x2EHis1047Arg&NM\x5F006218\x2E3\x3Ac\x2E3140A\x3EG|CA123326|13652|81.0|evidence|2100|https://civicdb.org/links/evidence/2100|17202311_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|2|||||
4	1803568	628	C	G	.	.	GN=FGFR3;VT=S249C;CSQ=G|missense_variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|RS121913483&SER249CYS|NC\x5F000004\x2E11\x3Ag\x2E1803568C\x3EG|CA126380|16339|5.0|evidence|1603|https://civicdb.org/links/evidence/1603|25766722_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Urothelial_Carcinoma_(DOID_2671)|Pazopanib_(NCIt_ID_C74547)|||C|2|||||
4	1806099	196	A	G	.	.	GN=FGFR3;VT=Y375C;CSQ=G|missense_variant|FGFR3|2261|transcript|ENST00000340107.4|ENST00000340107.4:c.1124A>G||Y375C|196|Y373C&TYR375CYS|ENST00000340107\x2E4\x3Ac\x2E1124A\x3EG&NP\x5F000133\x2E1\x3Ap\x2ETyr373Cys&NM\x5F001163213\x2E1\x3Ac\x2E1124A\x3EG&NC\x5F000004\x2E11\x3Ag\x2E1806099A\x3EG|CA341413|16342|15.0|evidence|477|https://civicdb.org/links/evidence/477|20542753_(PubMed)|Somatic|accepted|Positive|Supports|Bladder_Carcinoma_(DOID_4007)||||B|3|||||
4	55141036	247	T	C	.	.	GN=PDGFRA;VT=V561A;CSQ=C|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>C||V561A|247|RS121908586&VAL561ALA|NP\x5F006197\x2E1\x3Ap\x2EVal561Ala&NM\x5F006206\x2E5\x3Ac\x2E1682T\x3EC&NC\x5F000004\x2E11\x3Ag\x2E55141036T\x3EC&ENST00000257290\x2E5\x3Ac\x2E1682T\x3EC|CA16602796|376354|3.0|evidence|652|https://civicdb.org/links/evidence/652|12949711_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||D|3|||||
4	55141036	941	T	A	.	.	GN=PDGFRA;VT=V561D;CSQ=A|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|ENST00000257290\x2E5\x3Ac\x2E1682T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55141036T\x3EA&NP\x5F006197\x2E1\x3Ap\x2EVal561Asp&NM\x5F006206\x2E5\x3Ac\x2E1682T\x3EA|CA123203|13546|8.5|evidence|4056|https://civicdb.org/links/evidence/4056|18955458_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Sunitinib_(NCIt_ID_C71622)|||D|2|||||,A|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|ENST00000257290\x2E5\x3Ac\x2E1682T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55141036T\x3EA&NP\x5F006197\x2E1\x3Ap\x2EVal561Asp&NM\x5F006206\x2E5\x3Ac\x2E1682T\x3EA|CA123203|13546|8.5|evidence|5347|https://civicdb.org/links/evidence/5347|18955458_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,A|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|ENST00000257290\x2E5\x3Ac\x2E1682T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55141036T\x3EA&NP\x5F006197\x2E1\x3Ap\x2EVal561Asp&NM\x5F006206\x2E5\x3Ac\x2E1682T\x3EA|CA123203|13546|8.5|evidence|2454|https://civicdb.org/links/evidence/2454|14645423_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,A|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|ENST00000257290\x2E5\x3Ac\x2E1682T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55141036T\x3EA&NP\x5F006197\x2E1\x3Ap\x2EVal561Asp&NM\x5F006206\x2E5\x3Ac\x2E1682T\x3EA|CA123203|13546|8.5|evidence|2474|https://civicdb.org/links/evidence/2474|18955451_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|1|||||
4	55141083	862	C	T	.	.	GN=PDGFRA;VT=P577S;CSQ=T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1729C>T||P577S|862|RS1057519811&PRO577SER|ENST00000257290\x2E5\x3Ac\x2E1729C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55141083C\x3ET&NP\x5F006197\x2E1\x3Ap\x2EPro577Ser&NM\x5F006206\x2E4\x3Ac\x2E1729C\x3ET|CA16602636|376181|3.0|evidence|1974|https://civicdb.org/links/evidence/1974|24132921_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Imatinib_(NCIt_ID_C62035)&Crenolanib_(NCIt_ID_C64639)|Substitutes||D|3|||||
4	55144547	577	C	T	.	.	GN=PDGFRA;VT=FIP1L1-PDGFRA_T674I;CSQ=T|transcript_fusion&missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2021C>T||FIP1L1-PDGFRA_T674I|577|RS121908587&THR674ILE|NP\x5F006197\x2E1\x3Ap\x2EThr674Ile&NM\x5F006206\x2E5\x3Ac\x2E2021C\x3ET&ENST00000257290\x2E5\x3Ac\x2E2021C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55144547C\x3ET|CA123215|13550|15.5|evidence|7020|https://civicdb.org/links/evidence/7020|21818111_(PubMed)|Somatic|accepted|Resistance|Supports|Myeloid_And_Lymphoid_Neoplasms_With_Eosinophilia_And_Abnormalities_Of_PDGFRA,_PDGFRB,_And_FGFR1_(DOID_0080164)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,T|transcript_fusion&missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2021C>T||FIP1L1-PDGFRA_T674I|577|RS121908587&THR674ILE|NP\x5F006197\x2E1\x3Ap\x2EThr674Ile&NM\x5F006206\x2E5\x3Ac\x2E2021C\x3ET&ENST00000257290\x2E5\x3Ac\x2E2021C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55144547C\x3ET|CA123215|13550|15.5|evidence|1446|https://civicdb.org/links/evidence/1446|12660384_(PubMed)|Somatic|accepted|Resistance|Supports|Myeloid_And_Lymphoid_Neoplasms_With_Eosinophilia_And_Abnormalities_Of_PDGFRA,_PDGFRB,_And_FGFR1_(DOID_0080164)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,T|transcript_fusion&missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2021C>T||FIP1L1-PDGFRA_T674I|577|RS121908587&THR674ILE|NP\x5F006197\x2E1\x3Ap\x2EThr674Ile&NM\x5F006206\x2E5\x3Ac\x2E2021C\x3ET&ENST00000257290\x2E5\x3Ac\x2E2021C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55144547C\x3ET|CA123215|13550|15.5|evidence|1779|https://civicdb.org/links/evidence/1779|24407160_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Myeloid_And_Lymphoid_Neoplasms_With_Eosinophilia_And_Abnormalities_Of_PDGFRA,_PDGFRB,_And_FGFR1_(DOID_0080164)|Ponatinib_(NCIt_ID_C95777)|||D|3|||||
4	55152090	863	G	A	.	.	GN=PDGFRA;VT=R841K;CSQ=A|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2522G>A||R841K|863|RS1057519813&ARG841LYS|ENST00000257290\x2E5\x3Ac\x2E2522G\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55152090G\x3EA&NP\x5F006197\x2E1\x3Ap\x2EArg841Lys&NM\x5F006206\x2E4\x3Ac\x2E2522G\x3EA|CA16602638|376183|3.0|evidence|1975|https://civicdb.org/links/evidence/1975|24132921_(PubMed)|None|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Imatinib_(NCIt_ID_C62035)&Crenolanib_(NCIt_ID_C64639)|Substitutes||D|3|||||
4	55152092	100	G	T	.	.	GN=PDGFRA;VT=D842Y;CSQ=T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2524G>T||D842Y|100|RS121913265&ASP842TYR|NP\x5F006197\x2E1\x3Ap\x2EAsp842Tyr&NM\x5F006206\x2E5\x3Ac\x2E2524G\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55152092G\x3ET&ENST00000257290\x2E5\x3Ac\x2E2524G\x3ET|CA16602703|376250|4.0|evidence|45|https://civicdb.org/links/evidence/45|22745105_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Crenolanib_(NCIt_ID_C64639)|||D|4|||||
4	55152092	98	GA	AT	.	.	GN=PDGFRA;VT=D842I;CSQ=AT|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2524_2525delinsAT||D842I|98|ASP842ILE|NM\x5F006206\x2E5\x3Ac\x2E2524\x5F2525delGAinsAT&NP\x5F006197\x2E1\x3Ap\x2EAsp842Ile&ENST00000257290\x2E5\x3Ac\x2E2524\x5F2525delinsAT&NC\x5F000004\x2E11\x3Ag\x2E55152092\x5F55152093delinsAT|CA16602522|376055|4.0|evidence|43|https://civicdb.org/links/evidence/43|22745105_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Crenolanib_(NCIt_ID_C64639)|||D|4|||||
4	55152093	99	A	T	.	.	GN=PDGFRA;VT=D842V;CSQ=T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|15|https://civicdb.org/links/evidence/15|15928335_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||B|4|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|16|https://civicdb.org/links/evidence/16|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||B|4|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|44|https://civicdb.org/links/evidence/44|22745105_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Crenolanib_(NCIt_ID_C64639)|||D|4|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|738|https://civicdb.org/links/evidence/738|26130666_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||B|4|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|651|https://civicdb.org/links/evidence/651|12949711_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||D|3|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|4060|https://civicdb.org/links/evidence/4060|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Sunitinib_(NCIt_ID_C71622)|||D|2|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|2463|https://civicdb.org/links/evidence/2463|14645423_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|2478|https://civicdb.org/links/evidence/2478|14645423_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|4597|https://civicdb.org/links/evidence/4597|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|3|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|5346|https://civicdb.org/links/evidence/5346|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|RS121908585&ASP842VAL|NC\x5F000004\x2E11\x3Ag\x2E55152093A\x3ET&ENST00000257290\x2E5\x3Ac\x2E2525A\x3ET&NP\x5F006197\x2E1\x3Ap\x2EAsp842Val&NM\x5F006206\x2E4\x3Ac\x2E2525A\x3ET|CA123194|13543|100.5|evidence|2|https://civicdb.org/links/evidence/2|15146165_(PubMed)|Somatic|accepted|Negative|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)||||B|3|||||
4	55152093	102	ACATC	TCATG	.	.	GN=PDGFRA;VT=D842_I843delinsVM;CSQ=TCATG|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|||D842_I843delinsVM|102||NC\x5F000004\x2E11\x3Ag\x2E55152093\x5F55152097delinsTCATG|CA658820703|NONE_FOUND|4.0|evidence|47|https://civicdb.org/links/evidence/47|22745105_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Crenolanib_(NCIt_ID_C64639)|||D|4|||||
4	55152094	101	CATC	C	.	.	GN=PDGFRA;VT=I843DEL;CSQ=-|inframe_deletion|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2527_2529delATC||I843DEL|101|DELI843|ENST00000257290\x2E5\x3Ac\x2E2527\x5F2529delATC&NC\x5F000004\x2E11\x3Ag\x2E55152095\x5F55152097del|CA645526434|NONE_FOUND|5.0|evidence|1309|https://civicdb.org/links/evidence/1309|14645423_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,-|inframe_deletion|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2527_2529delATC||I843DEL|101|DELI843|ENST00000257290\x2E5\x3Ac\x2E2527\x5F2529delATC&NC\x5F000004\x2E11\x3Ag\x2E55152095\x5F55152097del|CA645526434|NONE_FOUND|5.0|evidence|46|https://civicdb.org/links/evidence/46|22745105_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Crenolanib_(NCIt_ID_C64639)|||D|3|||||
4	55152101	864	C	T	.	.	GN=PDGFRA;VT=H845Y;CSQ=T|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2533C>T||H845Y|864|RS1057519814&HIS845TYR|ENST00000257290\x2E5\x3Ac\x2E2533C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55152101C\x3ET&NP\x5F006197\x2E1\x3Ap\x2EHis845Tyr&NM\x5F006206\x2E4\x3Ac\x2E2533C\x3ET|CA16602639|376184|3.0|evidence|1976|https://civicdb.org/links/evidence/1976|24132921_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Imatinib_(NCIt_ID_C62035)&Crenolanib_(NCIt_ID_C64639)|Substitutes||D|3|||||
4	55152126	865	G	A	.	.	GN=PDGFRA;VT=G853D;CSQ=A|missense_variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2558G>A||G853D|865|RS763576329&GLY853ASP|ENST00000257290\x2E5\x3Ac\x2E2558G\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55152126G\x3EA&NP\x5F006197\x2E1\x3Ap\x2EGly853Asp&NM\x5F006206\x2E4\x3Ac\x2E2558G\x3EA|CA16602640|376185|3.0|evidence|1977|https://civicdb.org/links/evidence/1977|24132921_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Imatinib_(NCIt_ID_C62035)&Crenolanib_(NCIt_ID_C64639)|Substitutes||D|3|||||
4	55592185	946	T	TGCCTAT	.	.	GN=KIT;VT=Y503_F504insAY;CSQ=GCCTAT|inframe_insertion|KIT|3815|transcript|ENST00000288135.5|||Y503_F504insAY|946||NC\x5F000004\x2E11\x3Ag\x2E55592185\x5F55592186insGCCTAT|CA645516719||2.0|evidence|2484|https://civicdb.org/links/evidence/2484|14645423_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||
4	55593464	201	A	C	.	.	GN=KIT;VT=M541L;CSQ=C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1621A>C||M541L|201|RS3822214&MET541LEU|NC\x5F000004\x2E11\x3Ag\x2E55593464A\x3EC&ENST00000288135\x2E5\x3Ac\x2E1621A\x3EC&NP\x5F000213\x2E1\x3Ap\x2EMet541Leu&NM\x5F000222\x2E2\x3Ac\x2E1621A\x3EC|CA160347|41599|25.0|evidence|485|https://civicdb.org/links/evidence/485|16307017_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)||||B|4|||||,C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1621A>C||M541L|201|RS3822214&MET541LEU|NC\x5F000004\x2E11\x3Ag\x2E55593464A\x3EC&ENST00000288135\x2E5\x3Ac\x2E1621A\x3EC&NP\x5F000213\x2E1\x3Ap\x2EMet541Leu&NM\x5F000222\x2E2\x3Ac\x2E1621A\x3EC|CA160347|41599|25.0|evidence|1423|https://civicdb.org/links/evidence/1423|25015329_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Leukemia_(DOID_1036)|Imatinib_(NCIt_ID_C62035)|||C|2|||||
4	55593581	948	GAAACCCATGTATGAAGTACAGTGG	G	.	.	GN=KIT;VT=K550_W557del;CSQ=-|inframe_deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1648_1671del_AAACCCATGTATGAAGTACAGTGG||K550_W557del|948||ENST00000288135\x2E5\x3Ac\x2E1648\x5F1671del\x20AAACCCATGTATGAAGTACAGTGG|CA645516733|NONE_FOUND|4.0|evidence|4583|https://civicdb.org/links/evidence/4583|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Ponatinib_(NCIt_ID_C95777)&Regorafenib_(NCIt_ID_C78204)&Imatinib_(NCIt_ID_C62035)&Sunitinib_(NCIt_ID_C71622)|Substitutes||D|4|||||
4	55593581	949	GAAACCCATGTATGAAGTACAGTGGAAG	G	.	.	GN=KIT;VT=K550_K558del;CSQ=-|inframe_deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1648_1674del27||K550_K558del|949|KPMYEVQWK550\x2D558DEL&RS121913234|ENST00000288135\x2E5\x3Ac\x2E1648\x5F1674del27&NC\x5F000004\x2E11\x3Ag\x2E55593582\x5F55593608del27&NP\x5F000213\x2E1\x3Ap\x2ELys550\x5FLys558del&NM\x5F000222\x2E2\x3Ac\x2E1648\x5F1674del27|CA123524|13857|5.0|evidence|4062|https://civicdb.org/links/evidence/4062|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|2|||||
4	55593581	2696	GAAACCCATGTATGAAGTACAGTGGAAGGTT	G	.	.	GN=KIT;VT=K550_K559DEL;CSQ=-||KIT|3815|transcript|ENST00000288135.5|||K550_K559DEL|2696|||CA645516734||5.0|evidence|7289|https://civicdb.org/links/evidence/7289|18955458_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|2|||||
4	55593602	961	GTGGAAG	G	.	.	GN=KIT;VT=W557_K558DELWK;CSQ=-||KIT|3815|transcript|ENST00000288135.5|||W557_K558DELWK|961|||CA356974|222957|14.5|evidence|4087|https://civicdb.org/links/evidence/4087|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)&Regorafenib_(NCIt_ID_C78204)|Substitutes||D|2|||||,-||KIT|3815|transcript|ENST00000288135.5|||W557_K558DELWK|961|||CA356974|222957|14.5|evidence|4082|https://civicdb.org/links/evidence/4082|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|3|||||,-||KIT|3815|transcript|ENST00000288135.5|||W557_K558DELWK|961|||CA356974|222957|14.5|evidence|2481|https://civicdb.org/links/evidence/2481|14645423_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,-||KIT|3815|transcript|ENST00000288135.5|||W557_K558DELWK|961|||CA356974|222957|14.5|evidence|4084|https://civicdb.org/links/evidence/4084|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Ponatinib_(NCIt_ID_C95777)&Imatinib_(NCIt_ID_C62035)|Substitutes||D|3|||||
4	55593605	964	GAAGGTT	G	.	.	GN=KIT;VT=K558_V559del;CSQ=-||KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1672_1677delAAGGTT||K558_V559del|964||ENST00000288135\x2E5\x3Ac\x2E1672\x5F1677delAAGGTT|CA645516838|NONE_FOUND|5.0|evidence|4095|https://civicdb.org/links/evidence/4095|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|2|||||
4	55593610	968	T	A	.	.	GN=KIT;VT=V559D;CSQ=A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1676T>A||V559D|968|VAL559ASP&RS121913517|ENST00000288135\x2E5\x3Ac\x2E1676T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55593610T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal559Asp&NM\x5F000222\x2E2\x3Ac\x2E1676T\x3EA|CA123522|13856|11.5|evidence|3028|https://civicdb.org/links/evidence/3028|22114577_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1676T>A||V559D|968|VAL559ASP&RS121913517|ENST00000288135\x2E5\x3Ac\x2E1676T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55593610T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal559Asp&NM\x5F000222\x2E2\x3Ac\x2E1676T\x3EA|CA123522|13856|11.5|evidence|3029|https://civicdb.org/links/evidence/3029|16046538_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Sunitinib_(NCIt_ID_C71622)&Dasatinib_(NCIt_ID_C38713)&Tandutinib_(NCIt_ID_C48404)&PD-180970&Imatinib_(NCIt_ID_C62035)|Substitutes||D|2|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1676T>A||V559D|968|VAL559ASP&RS121913517|ENST00000288135\x2E5\x3Ac\x2E1676T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55593610T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal559Asp&NM\x5F000222\x2E2\x3Ac\x2E1676T\x3EA|CA123522|13856|11.5|evidence|4459|https://civicdb.org/links/evidence/4459|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Ponatinib_(NCIt_ID_C95777)&Imatinib_(NCIt_ID_C62035)&Regorafenib_(NCIt_ID_C78204)|Substitutes||D|2|||||
4	55593611	202	TGTT	T	.	.	GN=KIT;VT=V560DEL;CSQ=-|inframe_deletion&amino_acid_deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1675_1677delGTT||V560DEL|202|V556DEL&V555DEL&V559DEL&VAL560DEL|NP\x5F000213\x2E1\x3Ap\x2EVal560del&NM\x5F000222\x2E2\x3Ac\x2E1675\x5F1677delGTT&ENST00000288135\x2E5\x3Ac\x2E1675\x5F1677delGTT&NC\x5F000004\x2E11\x3Ag\x2E55593612\x5F55593614del|CA123529|13859|14.5|evidence|486|https://civicdb.org/links/evidence/486|15201427_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thymic_Carcinoma_(DOID_3284)|Imatinib_(NCIt_ID_C62035)|||C|5|||||
4	55593613	971	T	A	.	.	GN=KIT;VT=V560D;CSQ=A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|RS121913521&VAL560ASP|NC\x5F000004\x2E11\x3Ag\x2E55593613T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal560Asp&NM\x5F000222\x2E2\x3Ac\x2E1679T\x3EA&ENST00000288135\x2E5\x3Ac\x2E1679T\x3EA|CA16602396|375914|14.5|evidence|4127|https://civicdb.org/links/evidence/4127|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)&Ponatinib_(NCIt_ID_C95777)&Imatinib_(NCIt_ID_C62035)&Regorafenib_(NCIt_ID_C78204)|Substitutes||D|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|RS121913521&VAL560ASP|NC\x5F000004\x2E11\x3Ag\x2E55593613T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal560Asp&NM\x5F000222\x2E2\x3Ac\x2E1679T\x3EA&ENST00000288135\x2E5\x3Ac\x2E1679T\x3EA|CA16602396|375914|14.5|evidence|4122|https://civicdb.org/links/evidence/4122|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|RS121913521&VAL560ASP|NC\x5F000004\x2E11\x3Ag\x2E55593613T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal560Asp&NM\x5F000222\x2E2\x3Ac\x2E1679T\x3EA&ENST00000288135\x2E5\x3Ac\x2E1679T\x3EA|CA16602396|375914|14.5|evidence|4077|https://civicdb.org/links/evidence/4077|18955458_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Sunitinib_(NCIt_ID_C71622)|||D|2|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|RS121913521&VAL560ASP|NC\x5F000004\x2E11\x3Ag\x2E55593613T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EVal560Asp&NM\x5F000222\x2E2\x3Ac\x2E1679T\x3EA&ENST00000288135\x2E5\x3Ac\x2E1679T\x3EA|CA16602396|375914|14.5|evidence|5348|https://civicdb.org/links/evidence/5348|18955458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||
4	55593613	972	T	G	.	.	GN=KIT;VT=V560G;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>G||V560G|972|VAL560GLY&RS121913521|ENST00000288135\x2E5\x3Ac\x2E1679T\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55593613T\x3EG&NP\x5F000213\x2E1\x3Ap\x2EVal560Gly&NM\x5F000222\x2E2\x3Ac\x2E1679T\x3EG|CA16602398|376735&375916|5.0|evidence|7395|https://civicdb.org/links/evidence/7395|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Regorafenib_(NCIt_ID_C78204)&Imatinib_(NCIt_ID_C62035)&Ponatinib_(NCIt_ID_C95777)|Substitutes||D|3|||||,G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>G||V560G|972|VAL560GLY&RS121913521|ENST00000288135\x2E5\x3Ac\x2E1679T\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55593613T\x3EG&NP\x5F000213\x2E1\x3Ap\x2EVal560Gly&NM\x5F000222\x2E2\x3Ac\x2E1679T\x3EG|CA16602398|376735&375916|5.0|evidence|2469|https://civicdb.org/links/evidence/2469|14645423_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||
4	55593661	72	T	C	.	.	GN=KIT;VT=L576P;CSQ=C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|LEU576PRO&RS121913513|NC\x5F000004\x2E11\x3Ag\x2E55593661T\x3EC&ENST00000288135\x2E5\x3Ac\x2E1727T\x3EC&NP\x5F000213\x2E1\x3Ap\x2ELeu576Pro&NM\x5F000222\x2E2\x3Ac\x2E1727T\x3EC|CA16602401|375919|16.0|evidence|4141|https://civicdb.org/links/evidence/4141|25317746_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|2|||||,C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|LEU576PRO&RS121913513|NC\x5F000004\x2E11\x3Ag\x2E55593661T\x3EC&ENST00000288135\x2E5\x3Ac\x2E1727T\x3EC&NP\x5F000213\x2E1\x3Ap\x2ELeu576Pro&NM\x5F000222\x2E2\x3Ac\x2E1727T\x3EC|CA16602401|375919|16.0|evidence|4136|https://civicdb.org/links/evidence/4136|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|2|||||,C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|LEU576PRO&RS121913513|NC\x5F000004\x2E11\x3Ag\x2E55593661T\x3EC&ENST00000288135\x2E5\x3Ac\x2E1727T\x3EC&NP\x5F000213\x2E1\x3Ap\x2ELeu576Pro&NM\x5F000222\x2E2\x3Ac\x2E1727T\x3EC|CA16602401|375919|16.0|evidence|303|https://civicdb.org/links/evidence/303|17372901_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||,C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|LEU576PRO&RS121913513|NC\x5F000004\x2E11\x3Ag\x2E55593661T\x3EC&ENST00000288135\x2E5\x3Ac\x2E1727T\x3EC&NP\x5F000213\x2E1\x3Ap\x2ELeu576Pro&NM\x5F000222\x2E2\x3Ac\x2E1727T\x3EC|CA16602401|375919|16.0|evidence|34|https://civicdb.org/links/evidence/34|19671763_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Sorafenib_(NCIt_ID_C61948)&Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)|Substitutes||D|3|||||,C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|LEU576PRO&RS121913513|NC\x5F000004\x2E11\x3Ag\x2E55593661T\x3EC&ENST00000288135\x2E5\x3Ac\x2E1727T\x3EC&NP\x5F000213\x2E1\x3Ap\x2ELeu576Pro&NM\x5F000222\x2E2\x3Ac\x2E1727T\x3EC|CA16602401|375919|16.0|evidence|42|https://civicdb.org/links/evidence/42|19671763_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dasatinib_(NCIt_ID_C38713)|||D|3|||||
4	55593668	977	TGAT	T	.	.	GN=KIT;VT=D579DEL;CSQ=-|inframe_deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1735_1737delGAT||D579DEL|977|ASP579DEL|NC\x5F000004\x2E11\x3Ag\x2E55593669\x5F55593671delGAT&NP\x5F000213\x2E1\x3Ap\x2EAsp579del&NM\x5F000222\x2E2\x3Ac\x2E1735\x5F1737delGAT&ENST00000288135\x2E5\x3Ac\x2E1735\x5F1737delGAT|CA16611553|409725|12.5|evidence|4142|https://civicdb.org/links/evidence/4142|18955458_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||C|2|||||,-|inframe_deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1735_1737delGAT||D579DEL|977|ASP579DEL|NC\x5F000004\x2E11\x3Ag\x2E55593669\x5F55593671delGAT&NP\x5F000213\x2E1\x3Ap\x2EAsp579del&NM\x5F000222\x2E2\x3Ac\x2E1735\x5F1737delGAT&ENST00000288135\x2E5\x3Ac\x2E1735\x5F1737delGAT|CA16611553|409725|12.5|evidence|2487|https://civicdb.org/links/evidence/2487|14645423_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55594180	1659	G	A	.	.	GN=KIT;VT=S628N;CSQ=A|missense_variant|KIT|3815|transcript|None|||S628N|1659|S624N||CA356908374||9.5|evidence|7463|https://civicdb.org/links/evidence/7463|25317746_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Melanoma_(DOID_1909)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,A|missense_variant|KIT|3815|transcript|None|||S628N|1659|S624N||CA356908374||9.5|evidence|4791|https://civicdb.org/links/evidence/4791|25317746_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|2|||||
4	55594221	978	A	G	.	.	GN=KIT;VT=K642E;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|LYS642GLU&RS121913512|ENST00000288135\x2E5\x3Ac\x2E1924A\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55594221A\x3EG&NP\x5F000213\x2E1\x3Ap\x2ELys642Glu&NM\x5F000222\x2E2\x3Ac\x2E1924A\x3EG|CA123547|13866|10.0|evidence|4147|https://civicdb.org/links/evidence/4147|21523734_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dasatinib_(NCIt_ID_C38713)|||C|None|||||,G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|LYS642GLU&RS121913512|ENST00000288135\x2E5\x3Ac\x2E1924A\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55594221A\x3EG&NP\x5F000213\x2E1\x3Ap\x2ELys642Glu&NM\x5F000222\x2E2\x3Ac\x2E1924A\x3EG|CA123547|13866|10.0|evidence|2889|https://civicdb.org/links/evidence/2889|18510589_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Mucosal_Melanoma_(DOID_0050929)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|LYS642GLU&RS121913512|ENST00000288135\x2E5\x3Ac\x2E1924A\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55594221A\x3EG&NP\x5F000213\x2E1\x3Ap\x2ELys642Glu&NM\x5F000222\x2E2\x3Ac\x2E1924A\x3EG|CA123547|13866|10.0|evidence|7397|https://civicdb.org/links/evidence/7397|25239608_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)&Ponatinib_(NCIt_ID_C95777)|Substitutes||D|3|||||,G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|LYS642GLU&RS121913512|ENST00000288135\x2E5\x3Ac\x2E1924A\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55594221A\x3EG&NP\x5F000213\x2E1\x3Ap\x2ELys642Glu&NM\x5F000222\x2E2\x3Ac\x2E1924A\x3EG|CA123547|13866|10.0|evidence|2472|https://civicdb.org/links/evidence/2472|14645423_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||
4	55594258	73	T	C	.	.	GN=KIT;VT=V654A;CSQ=C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1961T>C||V654A|73|VAL654ALA&RS121913523|ENST00000288135\x2E5\x3Ac\x2E1961T\x3EC&NP\x5F000213\x2E1\x3Ap\x2EVal654Ala&NM\x5F000222\x2E2\x3Ac\x2E1961T\x3EC&NC\x5F000004\x2E11\x3Ag\x2E55594258T\x3EC|CA16602402|375921|18.0|evidence|304|https://civicdb.org/links/evidence/304|16638875_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)|||B|3|||||,C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1961T>C||V654A|73|VAL654ALA&RS121913523|ENST00000288135\x2E5\x3Ac\x2E1961T\x3EC&NP\x5F000213\x2E1\x3Ap\x2EVal654Ala&NM\x5F000222\x2E2\x3Ac\x2E1961T\x3EC&NC\x5F000004\x2E11\x3Ag\x2E55594258T\x3EC|CA16602402|375921|18.0|evidence|249|https://civicdb.org/links/evidence/249|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||D|3|||||
4	55595519	1267	C	T	.	.	GN=KIT;VT=T670I;CSQ=T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|RS121913516&THR670ILE|ENST00000288135\x2E5\x3Ac\x2E2009C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55595519C\x3ET&NP\x5F000213\x2E1\x3Ap\x2EThr670Ile&NM\x5F000222\x2E2\x3Ac\x2E2009C\x3ET|CA16602525|376058|21.5|evidence|7417|https://civicdb.org/links/evidence/7417|25239608_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)&Ponatinib_(NCIt_ID_C95777)|Substitutes||D|5|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|RS121913516&THR670ILE|ENST00000288135\x2E5\x3Ac\x2E2009C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55595519C\x3ET&NP\x5F000213\x2E1\x3Ap\x2EThr670Ile&NM\x5F000222\x2E2\x3Ac\x2E2009C\x3ET|CA16602525|376058|21.5|evidence|7416|https://civicdb.org/links/evidence/7416|25239608_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||D|5|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|RS121913516&THR670ILE|ENST00000288135\x2E5\x3Ac\x2E2009C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55595519C\x3ET&NP\x5F000213\x2E1\x3Ap\x2EThr670Ile&NM\x5F000222\x2E2\x3Ac\x2E2009C\x3ET|CA16602525|376058|21.5|evidence|4510|https://civicdb.org/links/evidence/4510|25239608_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Regorafenib_(NCIt_ID_C78204)|||D|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|RS121913516&THR670ILE|ENST00000288135\x2E5\x3Ac\x2E2009C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55595519C\x3ET&NP\x5F000213\x2E1\x3Ap\x2EThr670Ile&NM\x5F000222\x2E2\x3Ac\x2E2009C\x3ET|CA16602525|376058|21.5|evidence|2924|https://civicdb.org/links/evidence/2924|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55599299	1264	T	G	.	.	GN=KIT;VT=C809G;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2425T>G||C809G|1264|CYS809GLY|NP\x5F000213\x2E1\x3Ap\x2ECys809Gly&NM\x5F000222\x2E2\x3Ac\x2E2425T\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55599299T\x3EG&ENST00000288135\x2E5\x3Ac\x2E2425T\x3EG|CA356911727|NONE_FOUND|7.5|evidence|2920|https://civicdb.org/links/evidence/2920|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55599320	983	G	C	.	.	GN=KIT;VT=D816H;CSQ=C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2446G>C||D816H|983|RS121913506&ASP816HIS|ENST00000288135\x2E5\x3Ac\x2E2446G\x3EC&NC\x5F000004\x2E11\x3Ag\x2E55599320G\x3EC&NP\x5F000213\x2E1\x3Ap\x2EAsp816His&NM\x5F000222\x2E2\x3Ac\x2E2446G\x3EC|CA123540|13863|7.5|evidence|2923|https://civicdb.org/links/evidence/2923|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55599321	65	A	T	.	.	GN=KIT;VT=D816V;CSQ=T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|RS121913507&ASP816VAL|NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET|CA123513|13852|67.0|evidence|26|https://civicdb.org/links/evidence/26|16384925_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|RS121913507&ASP816VAL|NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET|CA123513|13852|67.0|evidence|1726|https://civicdb.org/links/evidence/1726|26464169_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Systemic_Mastocytosis_(DOID_349)||||B|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|RS121913507&ASP816VAL|NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET|CA123513|13852|67.0|evidence|7465|https://civicdb.org/links/evidence/7465|25317746_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Dasatinib_(NCIt_ID_C38713)&Imatinib_(NCIt_ID_C62035)|Substitutes||C|2|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|RS121913507&ASP816VAL|NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET|CA123513|13852|67.0|evidence|1725|https://civicdb.org/links/evidence/1725|27355533_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Systemic_Mastocytosis_(DOID_349)|Midostaurin_(NCIt_ID_C1872)|||B|4|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|RS121913507&ASP816VAL|NC\x5F000004\x2E11\x3Ag\x2E55599321A\x3ET&ENST00000288135\x2E5\x3Ac\x2E2447A\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp816Val&NM\x5F000222\x2E2\x3Ac\x2E2447A\x3ET|CA123513|13852|67.0|evidence|2451|https://civicdb.org/links/evidence/2451|14645423_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||
4	55599322	1559	C	G	.	.	GN=KIT;VT=D816E;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2448C>G||D816E|1559|D812E|ENST00000288135\x2E5\x3Ac\x2E2448C\x3EG|CA356911882|NONE_FOUND|8.0|evidence|7401|https://civicdb.org/links/evidence/7401|25239608_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Ponatinib_(NCIt_ID_C95777)|||D|4|||||,G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2448C>G||D816E|1559|D812E|ENST00000288135\x2E5\x3Ac\x2E2448C\x3EG|CA356911882|NONE_FOUND|8.0|evidence|4631|https://civicdb.org/links/evidence/4631|25239608_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Sunitinib_(NCIt_ID_C71622)&Imatinib_(NCIt_ID_C62035)|Substitutes||D|4|||||
4	55599332	986	G	T	.	.	GN=KIT;VT=D820Y;CSQ=T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2458G>T||D820Y|986|RS1057519710&ASP820TYR|ENST00000288135\x2E5\x3Ac\x2E2458G\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599332G\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp820Tyr&NM\x5F000222\x2E2\x3Ac\x2E2458G\x3ET|CA16602408|375928|14.5|evidence|2888|https://civicdb.org/links/evidence/2888|19035443_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Sunitinib_(NCIt_ID_C71622)|||D|2|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2458G>T||D820Y|986|RS1057519710&ASP820TYR|ENST00000288135\x2E5\x3Ac\x2E2458G\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599332G\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp820Tyr&NM\x5F000222\x2E2\x3Ac\x2E2458G\x3ET|CA16602408|375928|14.5|evidence|4589|https://civicdb.org/links/evidence/4589|22614970_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Regorafenib_(NCIt_ID_C78204)|||C|2|||||,T|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2458G>T||D820Y|986|RS1057519710&ASP820TYR|ENST00000288135\x2E5\x3Ac\x2E2458G\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55599332G\x3ET&NP\x5F000213\x2E1\x3Ap\x2EAsp820Tyr&NM\x5F000222\x2E2\x3Ac\x2E2458G\x3ET|CA16602408|375928|14.5|evidence|2886|https://civicdb.org/links/evidence/2886|21642685_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55599333	1266	A	G	.	.	GN=KIT;VT=D820G;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2459A>G||D820G|1266|RS121913682&ASP820GLY|ENST00000288135\x2E5\x3Ac\x2E2459A\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55599333A\x3EG&NP\x5F000213\x2E1\x3Ap\x2EAsp820Gly&NM\x5F000222\x2E2\x3Ac\x2E2459A\x3EG|CA123516|13853|7.5|evidence|2922|https://civicdb.org/links/evidence/2922|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55599333	1265	A	C	.	.	GN=KIT;VT=D820A;CSQ=C|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2459A>C||D820A|1265|ASP820ALA|NP\x5F000213\x2E1\x3Ap\x2EAsp820Ala&NM\x5F000222\x2E2\x3Ac\x2E2459A\x3EC&NC\x5F000004\x2E11\x3Ag\x2E55599333A\x3EC&ENST00000288135\x2E5\x3Ac\x2E2459A\x3EC|CA356911952|NONE_FOUND|7.5|evidence|2921|https://civicdb.org/links/evidence/2921|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55599338	987	A	C	.	.	GN=KIT;VT=N822H;CSQ=C|missense_variant|KIT|3815|transcript|None|||N822H|987|||CA356911968||0.0|evidence|2445|https://civicdb.org/links/evidence/2445|14645423_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||
4	55599340	1263	T	A	.	.	GN=KIT;VT=N822K;CSQ=A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|2918|https://civicdb.org/links/evidence/2918|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|2448|https://civicdb.org/links/evidence/2448|14645423_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|7370|https://civicdb.org/links/evidence/7370|21482694_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)|Sunitinib_(NCIt_ID_C71622)&Sorafenib_(NCIt_ID_C61948)|Substitutes||D|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|4169|https://civicdb.org/links/evidence/4169|25239608_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Regorafenib_(NCIt_ID_C78204)|||D|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|4167|https://civicdb.org/links/evidence/4167|25239608_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Ponatinib_(NCIt_ID_C95777)|||D|3|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|7379|https://civicdb.org/links/evidence/7379|21482694_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Ponatinib_(NCIt_ID_C95777)|||D|2|||||,A|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|RS121913514&ASN822LYS|ENST00000288135\x2E5\x3Ac\x2E2466T\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EA&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EA|CA16602411|375931|24.5|evidence|7414|https://civicdb.org/links/evidence/7414|25239608_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)&Sunitinib_(NCIt_ID_C71622)|Substitutes||D|4|||||
4	55599340	1403	T	G	.	.	GN=KIT;VT=N822K;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>G||N822K|1403|RS121913514|NC\x5F000004\x2E11\x3Ag\x2E55599340T\x3EG&NM\x5F000222\x2E2\x3Ac\x2E2466T\x3EG&ENST00000288135\x2E5\x3Ac\x2E2466T\x3EG&NP\x5F000213\x2E1\x3Ap\x2EAsn822Lys|CA16602412|375932|5.0|evidence|4595|https://civicdb.org/links/evidence/4595|22614970_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Regorafenib_(NCIt_ID_C78204)|||C|2|||||
4	55599341	989	T	G	.	.	GN=KIT;VT=Y823D;CSQ=G|missense_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2467T>G||Y823D|989|RS1057519761&TYR823ASP|ENST00000288135\x2E5\x3Ac\x2E2467T\x3EG&NC\x5F000004\x2E11\x3Ag\x2E55599341T\x3EG&NP\x5F000213\x2E1\x3Ap\x2ETyr823Asp&NM\x5F000222\x2E2\x3Ac\x2E2467T\x3EG|CA16602561|376101|7.5|evidence|2919|https://civicdb.org/links/evidence/2919|16954519_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)|||C|3|||||
4	55602664	990	G	C	.	.	GN=KIT;VT=A829P;CSQ=C|missense_variant|KIT|3815|transcript|None|||A829P|990|||CA16602413||8.0|evidence|7415|https://civicdb.org/links/evidence/7415|25239608_(PubMed)|Somatic|accepted|Resistance|Supports|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Imatinib_(NCIt_ID_C62035)&Sunitinib_(NCIt_ID_C71622)|Substitutes||D|4|||||,C|missense_variant|KIT|3815|transcript|None|||A829P|990|||CA16602413||8.0|evidence|7413|https://civicdb.org/links/evidence/7413|25239608_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Gastrointestinal_Stromal_Tumor_(DOID_9253)|Ponatinib_(NCIt_ID_C95777)|||D|4|||||
4	55602765	482	G	C	.	.	GN=KIT;VT=RS3733542;CSQ=C|synonymous_variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2586G>C||RS3733542|482|LEU862\x3D|ENST00000288135\x2E5\x3Ac\x2E2586G\x3EC&NP\x5F000213\x2E1\x3Ap\x2ELeu862\x3D&NM\x5F000222\x2E2\x3Ac\x2E2586G\x3EC&NC\x5F000004\x2E11\x3Ag\x2E55602765G\x3EC|CA2923796|255572|5.0|evidence|1136|https://civicdb.org/links/evidence/1136|24178622_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Selumetinib_(NCIt_ID_C66939)|||B|1|||||
4	55955969	467	C	T	.	.	GN=KDR;VT=A1065T;CSQ=T|missense_variant|KDR|3791|transcript|ENST00000263923.4|ENST00000263923.4:c.3193G>A||A1065T|467|RS56302315&ALA1065THR|ENST00000263923\x2E4\x3Ac\x2E3193G\x3EA&NP\x5F002244\x2E1\x3Ap\x2EAla1065Thr&NM\x5F002253\x2E2\x3Ac\x2E3193G\x3EA&NC\x5F000004\x2E11\x3Ag\x2E55955969C\x3ET|CA2924178|NONE_FOUND|3.0|evidence|1106|https://civicdb.org/links/evidence/1106|19723655_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Angiosarcoma_(DOID_0001816)|Sorafenib_(NCIt_ID_C61948)&Sunitinib_(NCIt_ID_C71622)|Substitutes||D|3|||||
4	55961059	502	G	A	.	.	GN=KDR;VT=R961W;CSQ=A|missense_variant|KDR|3791|transcript|ENST00000263923.4|ENST00000263923.4:c.2881C>T||R961W|502|RS530419081&ARG961TRP|ENST00000263923\x2E4\x3Ac\x2E2881C\x3ET&NP\x5F002244\x2E1\x3Ap\x2EArg961Trp&NM\x5F002253\x2E2\x3Ac\x2E2881C\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55961059G\x3EA|CA2924278|NONE_FOUND|2.5|evidence|1191|https://civicdb.org/links/evidence/1191|27004155_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Adenocarcinoma_(DOID_0050861)|Regorafenib_(NCIt_ID_C78204)|||C|1|||||
4	55968180	468	T	A	.	.	GN=KDR;VT=D717V;CSQ=A|missense_variant|KDR|3791|transcript|ENST00000263923.4|ENST00000263923.4:c.2150A>T||D717V|468|ASP717VAL|ENST00000263923\x2E4\x3Ac\x2E2150A\x3ET&NC\x5F000004\x2E11\x3Ag\x2E55968180T\x3EA|CA356908090|NONE_FOUND|3.0|evidence|1107|https://civicdb.org/links/evidence/1107|19723655_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Angiosarcoma_(DOID_0001816)|Sorafenib_(NCIt_ID_C61948)&Sunitinib_(NCIt_ID_C71622)|Substitutes||D|3|||||
4	89052323	260	G	T	.	.	GN=ABCG2;VT=Q141K;CSQ=T|missense_variant|ABCG2|9429|transcript|ENST00000237612.3|||Q141K|260|GLN141LYS|NC\x5F000004\x2E11\x3Ag\x2E89052323G\x3ET|CA129179|30389|15.0|evidence|671|https://civicdb.org/links/evidence/671|22112610_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Ovarian_Cancer_(DOID_2394)||||B|3|||||
5	1286516	421	C	A	.	.	GN=TERT;VT=RS2736100;CSQ=A|polymorphic_sequence_variant&coding_transcript_intron_variant|TERT|7015|transcript|ENST00000310581.5|ENST00000310581.5:c.1574-3777G>T||RS2736100|421||NP\x5F001180305\x2E1\x3Ap\x2E\x3D&NM\x5F001193376\x2E1\x3Ac\x2E1574\x2D3777G\x3ET&ENST00000310581\x2E5\x3Ac\x2E1574\x2D3777G\x3ET&NC\x5F000005\x2E9\x3Ag\x2E1286516C\x3EA|CA11915794|375480|10.0|evidence|980|https://civicdb.org/links/evidence/980|26765760_(PubMed)|Common_Germline|accepted|Positive|Supports|Brain_Glioma_(DOID_0060108)||||B|2|||||
5	1295228	248	G	A	.	.	GN=TERT;VT=C228T;CSQ=A|regulatory_region_variant|TERT|7015|transcript|ENST00000310581.5|||C228T|248|\x2D124C\x3ET|NC\x5F000005\x2E9\x3Ag\x2E1295228G\x3EA|CA557858711|NONE_FOUND|40.0|evidence|1646|https://civicdb.org/links/evidence/1646|25121551_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Cancer_(DOID_1781)||||B|3|||||,A|regulatory_region_variant|TERT|7015|transcript|ENST00000310581.5|||C228T|248|\x2D124C\x3ET|NC\x5F000005\x2E9\x3Ag\x2E1295228G\x3EA|CA557858711|NONE_FOUND|40.0|evidence|655|https://civicdb.org/links/evidence/655|25024077_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||
5	170837547	87	G	GTCTG	.	.	GN=NPM1;VT=W288FS;CSQ=TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&RS587776806&NPM1\x2DA|ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|152|https://civicdb.org/links/evidence/152|21719597_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|NSC348884|||D|3|||||,TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&RS587776806&NPM1\x2DA|ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|153|https://civicdb.org/links/evidence/153|15659725_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Induction_Therapy_(NCIt_ID_C158876)|||E|3|||||,TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&RS587776806&NPM1\x2DA|ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|121|https://civicdb.org/links/evidence/121|21067377_(PubMed)|Somatic|accepted|Positive|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,TCTG|frameshift_elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|TRP288FS&RS587776806&NPM1\x2DA|ENST00000517671\x2E1\x3Ac\x2E860\x5F863dupTCTG&NP\x5F002511\x2E1\x3Ap\x2ETrp288Cysfs&NC\x5F000005\x2E9\x3Ag\x2E170837544\x5F170837547dupTCTG&NM\x5F002520\x2E6\x3Ac\x2E860\x5F863dupTCTG|CA280199|13998|43.75|evidence|109|https://civicdb.org/links/evidence/109|21067377_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||
5	176942767	814	G	A	.	.	GN=DDX41;VT=R164W;CSQ=A|missense_variant|DDX41|51428|transcript|ENST00000507955.1|||R164W|814|||CA358665||7.5|evidence|1887|https://civicdb.org/links/evidence/1887|26712909_(PubMed)|Rare_Germline|accepted|Positive|Supports|Hematologic_Cancer_(DOID_2531)||||C|3|||||
6	117630062	517	A	G	.	.	GN=ROS1;VT=CD74-ROS1_L2155S;CSQ=G|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_L2155S|517||NC\x5F000006\x2E11\x3Ag\x2E117630062A\x3EG|CA365440144|NONE_FOUND|3.0|evidence|1256|https://civicdb.org/links/evidence/1256|25688157_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|TAE684&Foretinib_(NCIt_ID_C80058)&Crizotinib_(NCIt_ID_C74061)|Substitutes||D|3|||||
6	117631376	518	C	G	.	.	GN=ROS1;VT=CD74-ROS1_G2101A;CSQ=G|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2101A|518||NC\x5F000006\x2E11\x3Ag\x2E117631376C\x3EG|CA365440505|NONE_FOUND|4.0|evidence|1260|https://civicdb.org/links/evidence/1260|25688157_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Foretinib_(NCIt_ID_C80058)|||D|2|||||,G|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2101A|518||NC\x5F000006\x2E11\x3Ag\x2E117631376C\x3EG|CA365440505|NONE_FOUND|4.0|evidence|1259|https://civicdb.org/links/evidence/1259|25688157_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|2|||||
6	117638347	1271	C	T	.	.	GN=ROS1;VT=G2032R;CSQ=T|missense_variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG|ENST00000368508\x2E3\x3Ac\x2E6094G\x3EA&NP\x5F002935\x2E2\x3Ap\x2EGly2032Arg&NM\x5F002944\x2E2\x3Ac\x2E6094G\x3EA&NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|2.5|evidence|2934|https://civicdb.org/links/evidence/2934|23724914_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|1|||||
6	117638347	465	C	T	.	.	GN=ROS1;VT=CD74-ROS1_G2032R;CSQ=T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1255|https://civicdb.org/links/evidence/1255|25688157_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Foretinib_(NCIt_ID_C80058)|||D|2|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1250|https://civicdb.org/links/evidence/1250|26372962_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|AZD3463&Ceritinib_(NCIt_ID_C115112)&Brigatinib_(NCIt_ID_C98831)&Crizotinib_(NCIt_ID_C74061)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1249|https://civicdb.org/links/evidence/1249|26372962_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Cabozantinib_(NCIt_ID_C52200)&Foretinib_(NCIt_ID_C80058)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1254|https://civicdb.org/links/evidence/1254|25688157_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|3|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1251|https://civicdb.org/links/evidence/1251|25733882_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Lorlatinib_(NCIt_ID_C113655)|||D|3|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1100|https://civicdb.org/links/evidence/1100|23724914_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Crizotinib_(NCIt_ID_C74061)|||C|4|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|||CD74-ROS1_G2032R|465||NC\x5F000006\x2E11\x3Ag\x2E117638347C\x3ET|CA16602597|376139|31.5|evidence|1101|https://civicdb.org/links/evidence/1101|25351743_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Cabozantinib_(NCIt_ID_C52200)|||D|3|||||
6	117638365	516	G	T	.	.	GN=ROS1;VT=CD74-ROS1_L2026M;CSQ=T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||CD74-ROS1_L2026M|516||ENST00000368508\x2E3\x3Ac\x2E6076C\x3EA&NC\x5F000006\x2E11\x3Ag\x2E117638365G\x3ET|CA365441006|NONE_FOUND|9.0|evidence|1257|https://civicdb.org/links/evidence/1257|25688157_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|2|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||CD74-ROS1_L2026M|516||ENST00000368508\x2E3\x3Ac\x2E6076C\x3EA&NC\x5F000006\x2E11\x3Ag\x2E117638365G\x3ET|CA365441006|NONE_FOUND|9.0|evidence|1253|https://civicdb.org/links/evidence/1253|25733882_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Lorlatinib_(NCIt_ID_C113655)|||D|3|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||CD74-ROS1_L2026M|516||ENST00000368508\x2E3\x3Ac\x2E6076C\x3EA&NC\x5F000006\x2E11\x3Ag\x2E117638365G\x3ET|CA365441006|NONE_FOUND|9.0|evidence|1252|https://civicdb.org/links/evidence/1252|25733882_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||D|2|||||,T|transcript_fusion&missense_variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||CD74-ROS1_L2026M|516||ENST00000368508\x2E3\x3Ac\x2E6076C\x3EA&NC\x5F000006\x2E11\x3Ag\x2E117638365G\x3ET|CA365441006|NONE_FOUND|9.0|evidence|1258|https://civicdb.org/links/evidence/1258|25688157_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Foretinib_(NCIt_ID_C80058)|||D|2|||||
6	152415537	692	T	C	.	.	GN=ESR1;VT=S463P;CSQ=C|missense_variant|ESR1|2099|transcript|ENST00000440973.1|ENST00000440973.1:c.1387T>C||S463P|692|SER463PRO|ENST00000440973\x2E1\x3Ac\x2E1387T\x3EC&NC\x5F000006\x2E11\x3Ag\x2E152415537T\x3EC|CA16602414|375934|2.0|evidence|1727|https://civicdb.org/links/evidence/1727|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Estrogen-receptor_Positive_Breast_Cancer_(DOID_0060075)|Aromatase_Inhibitor_(NCIt_ID_C1740)|||D|2|||||
6	152419920	46	TC	AG	.	.	GN=ESR1;VT=L536Q;CSQ=AG|missense_variant|ESR1|2099|transcript|ENST00000440973.1|||L536Q|46|LEU536GLN|NC\x5F000006\x2E11\x3Ag\x2E152419920\x5F152419921delinsAG|CA645542628|NONE_FOUND|8.0|evidence|290|https://civicdb.org/links/evidence/290|24185510_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Fulvestrant_(NCIt_ID_C1379)&Tamoxifen_(NCIt_ID_C62078)|Substitutes||D|5|||||,AG|missense_variant|ESR1|2099|transcript|ENST00000440973.1|||L536Q|46|LEU536GLN|NC\x5F000006\x2E11\x3Ag\x2E152419920\x5F152419921delinsAG|CA645542628|NONE_FOUND|8.0|evidence|242|https://civicdb.org/links/evidence/242|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Hormone_Therapy_(NCIt_ID_C15445)|||D|3|||||
6	152419922	49	T	A	.	.	GN=ESR1;VT=Y537N;CSQ=A|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1609T>A||Y537N|49|GLY537ASN|ENST00000206249\x2E3\x3Ac\x2E1609T\x3EA&NC\x5F000006\x2E11\x3Ag\x2E152419922T\x3EA|CA366085693|NONE_FOUND|8.0|evidence|293|https://civicdb.org/links/evidence/293|24185510_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Fulvestrant_(NCIt_ID_C1379)&Tamoxifen_(NCIt_ID_C62078)|Substitutes||D|5|||||,A|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1609T>A||Y537N|49|GLY537ASN|ENST00000206249\x2E3\x3Ac\x2E1609T\x3EA&NC\x5F000006\x2E11\x3Ag\x2E152419922T\x3EA|CA366085693|NONE_FOUND|8.0|evidence|245|https://civicdb.org/links/evidence/245|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Hormone_Therapy_(NCIt_ID_C15445)|||D|3|||||
6	152419923	48	A	G	.	.	GN=ESR1;VT=Y537C;CSQ=G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>G||Y537C|48|GLY537CYS|NC\x5F000006\x2E11\x3Ag\x2E152419923A\x3EG&ENST00000206249\x2E3\x3Ac\x2E1610A\x3EG|CA366085697|NONE_FOUND|8.0|evidence|292|https://civicdb.org/links/evidence/292|24185510_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Fulvestrant_(NCIt_ID_C1379)&Tamoxifen_(NCIt_ID_C62078)|Substitutes||D|5|||||,G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>G||Y537C|48|GLY537CYS|NC\x5F000006\x2E11\x3Ag\x2E152419923A\x3EG&ENST00000206249\x2E3\x3Ac\x2E1610A\x3EG|CA366085697|NONE_FOUND|8.0|evidence|244|https://civicdb.org/links/evidence/244|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Hormone_Therapy_(NCIt_ID_C15445)|||D|3|||||
6	152419923	50	A	C	.	.	GN=ESR1;VT=Y537S;CSQ=C|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>C||Y537S|50|GLY537SER|ENST00000206249\x2E3\x3Ac\x2E1610A\x3EC&NC\x5F000006\x2E11\x3Ag\x2E152419923A\x3EC|CA366085696|NONE_FOUND|8.0|evidence|294|https://civicdb.org/links/evidence/294|24185510_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Fulvestrant_(NCIt_ID_C1379)&Tamoxifen_(NCIt_ID_C62078)|Substitutes||D|5|||||,C|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>C||Y537S|50|GLY537SER|ENST00000206249\x2E3\x3Ac\x2E1610A\x3EC&NC\x5F000006\x2E11\x3Ag\x2E152419923A\x3EC|CA366085696|NONE_FOUND|8.0|evidence|246|https://civicdb.org/links/evidence/246|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Hormone_Therapy_(NCIt_ID_C15445)|||D|3|||||
6	152419926	47	A	G	.	.	GN=ESR1;VT=D538G;CSQ=G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|4814|https://civicdb.org/links/evidence/4814|27556863_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Breast_Cancer_(DOID_1612)|Letrozole_(NCIt_ID_C1527)&Palbociclib_(NCIt_ID_C49176)|Combination||B|2|||||,G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|291|https://civicdb.org/links/evidence/291|24185510_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Fulvestrant_(NCIt_ID_C1379)&Tamoxifen_(NCIt_ID_C62078)|Substitutes||D|5|||||,G|missense_variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|ENST00000206249\x2E3\x3Ac\x2E1613A\x3EG&NC\x5F000006\x2E11\x3Ag\x2E152419926A\x3EG|CA366085705|NONE_FOUND|18.0|evidence|243|https://civicdb.org/links/evidence/243|24185512_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Hormone_Therapy_(NCIt_ID_C15445)|||D|3|||||
7	6426892	367	C	T	.	.	GN=RAC1;VT=P29S;CSQ=T|missense_variant|RAC1|5879|transcript|ENST00000356142.4|ENST00000356142.4:c.85C>T||P29S|367|PRO29SER|NC\x5F000007\x2E13\x3Ag\x2E6426892C\x3ET&ENST00000356142\x2E4\x3Ac\x2E85C\x3ET|CA16602801|376362|4.0|evidence|873|https://civicdb.org/links/evidence/873|25056119_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Vemurafenib_(NCIt_ID_C64768)|Substitutes||D|4|||||
7	55221822	996	C	T	.	.	GN=EGFR;VT=A289V;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.866C>T||A289V|996|ALA289VAL&RS149840192|ENST00000275493\x2E2\x3Ac\x2E866C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55221822C\x3ET&NP\x5F005219\x2E2\x3Ap\x2EAla289Val&NM\x5F005228\x2E4\x3Ac\x2E866C\x3ET|CA16602664|376209|3.0|evidence|4188|https://civicdb.org/links/evidence/4188|17177598_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Malignant_Glioma_(DOID_3070)|Erlotinib_(NCIt_ID_C65530)|||D|3|||||
7	55227884	454	C	T	.	.	GN=EGFR;VT=R451C;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1351C>T||R451C|454|RS377567759&ARG451CYS|NP\x5F001333827\x2E1\x3Ap\x2EArg451Cys&NM\x5F001346898\x2E1\x3Ac\x2E1351C\x3ET&ENST00000275493\x2E2\x3Ac\x2E1351C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55227884C\x3ET|CA158917074|NONE_FOUND|2.0|evidence|1081|https://civicdb.org/links/evidence/1081|26888827_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Futuximab/Modotuximab_Mixture_(NCIt_ID_C91381)&Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||D|2|||||
7	55227926	443	G	A	.	.	GN=EGFR;VT=G465R;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1393G>A||G465R|443|GLY465ARG|NC\x5F000007\x2E13\x3Ag\x2E55227926G\x3EA&ENST00000275493\x2E2\x3Ac\x2E1393G\x3EA|CA367579504|NONE_FOUND|20.0|evidence|1058|https://civicdb.org/links/evidence/1058|26888827_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||C|4|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1393G>A||G465R|443|GLY465ARG|NC\x5F000007\x2E13\x3Ag\x2E55227926G\x3EA&ENST00000275493\x2E2\x3Ac\x2E1393G\x3EA|CA367579504|NONE_FOUND|20.0|evidence|1057|https://civicdb.org/links/evidence/1057|26888827_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Futuximab/Modotuximab_Mixture_(NCIt_ID_C91381)|||C|4|||||
7	55227933	455	A	C	.	.	GN=EGFR;VT=K467T;CSQ=C|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1400A>C||K467T|455|LYS467THR|NC\x5F000007\x2E13\x3Ag\x2E55227933A\x3EC&ENST00000275493\x2E2\x3Ac\x2E1400A\x3EC|CA367579521|N/A|6.0|evidence|1082|https://civicdb.org/links/evidence/1082|26888827_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Futuximab/Modotuximab_Mixture_(NCIt_ID_C91381)&Panitumumab_(NCIt_ID_C1857)|Substitutes||D|3|||||,C|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1400A>C||K467T|455|LYS467THR|NC\x5F000007\x2E13\x3Ag\x2E55227933A\x3EC&ENST00000275493\x2E2\x3Ac\x2E1400A\x3EC|CA367579521|N/A|6.0|evidence|1083|https://civicdb.org/links/evidence/1083|26888827_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|3|||||
7	55228009	453	C	A	.	.	GN=EGFR;VT=S492R;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG|NM\x5F005228\x2E4\x3Ac\x2E1476C\x3EA&NP\x5F005219\x2E2\x3Ap\x2ESer492Arg&NC\x5F000007\x2E13\x3Ag\x2E55228009C\x3EA&ENST00000275493\x2E2\x3Ac\x2E1476C\x3EA|CA16602784|376341|23.0|evidence|1080|https://civicdb.org/links/evidence/1080|26888827_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|4|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG|NM\x5F005228\x2E4\x3Ac\x2E1476C\x3EA&NP\x5F005219\x2E2\x3Ap\x2ESer492Arg&NC\x5F000007\x2E13\x3Ag\x2E55228009C\x3EA&ENST00000275493\x2E2\x3Ac\x2E1476C\x3EA|CA16602784|376341|23.0|evidence|1078|https://civicdb.org/links/evidence/1078|22270724_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|2|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG|NM\x5F005228\x2E4\x3Ac\x2E1476C\x3EA&NP\x5F005219\x2E2\x3Ap\x2ESer492Arg&NC\x5F000007\x2E13\x3Ag\x2E55228009C\x3EA&ENST00000275493\x2E2\x3Ac\x2E1476C\x3EA|CA16602784|376341|23.0|evidence|717|https://civicdb.org/links/evidence/717|22270724_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|4|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG|NM\x5F005228\x2E4\x3Ac\x2E1476C\x3EA&NP\x5F005219\x2E2\x3Ap\x2ESer492Arg&NC\x5F000007\x2E13\x3Ag\x2E55228009C\x3EA&ENST00000275493\x2E2\x3Ac\x2E1476C\x3EA|CA16602784|376341|23.0|evidence|1079|https://civicdb.org/links/evidence/1079|26888827_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Futuximab/Modotuximab_Mixture_(NCIt_ID_C91381)|Substitutes||D|4|||||
7	55241707	134	G	A	.	.	GN=EGFR;VT=G719S;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|RS28929495&GLY719SER|NP\x5F005219\x2E2\x3Ap\x2EGly719Ser&NM\x5F005228\x2E4\x3Ac\x2E2155G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55241707G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2155G\x3EA|CA126722|16612|23.0|evidence|4190|https://civicdb.org/links/evidence/4190|19147750_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|RS28929495&GLY719SER|NP\x5F005219\x2E2\x3Ap\x2EGly719Ser&NM\x5F005228\x2E4\x3Ac\x2E2155G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55241707G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2155G\x3EA|CA126722|16612|23.0|evidence|1736|https://civicdb.org/links/evidence/1736|26124334_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Gefitinib_(NCIt_ID_C1855)|Substitutes||B|3|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|RS28929495&GLY719SER|NP\x5F005219\x2E2\x3Ap\x2EGly719Ser&NM\x5F005228\x2E4\x3Ac\x2E2155G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55241707G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2155G\x3EA|CA126722|16612|23.0|evidence|787|https://civicdb.org/links/evidence/787|24894453_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|4|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|RS28929495&GLY719SER|NP\x5F005219\x2E2\x3Ap\x2EGly719Ser&NM\x5F005228\x2E4\x3Ac\x2E2155G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55241707G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2155G\x3EA|CA126722|16612|23.0|evidence|274|https://civicdb.org/links/evidence/274|15118125_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||D|4|||||
7	55241708	999	G	C	.	.	GN=EGFR;VT=G719A;CSQ=C|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2156G>C||G719A|999|GLY719ALA&RS121913428|ENST00000275493\x2E2\x3Ac\x2E2156G\x3EC&NC\x5F000007\x2E13\x3Ag\x2E55241708G\x3EC&NP\x5F005219\x2E2\x3Ap\x2EGly719Ala&NM\x5F005228\x2E4\x3Ac\x2E2156G\x3EC|CA135775|45225|5.0|evidence|6181|https://civicdb.org/links/evidence/6181|23749122_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||C|2|||||,C|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2156G>C||G719A|999|GLY719ALA&RS121913428|ENST00000275493\x2E2\x3Ac\x2E2156G\x3EC&NC\x5F000007\x2E13\x3Ag\x2E55241708G\x3EC&NP\x5F005219\x2E2\x3Ap\x2EGly719Ala&NM\x5F005228\x2E4\x3Ac\x2E2156G\x3EC|CA135775|45225|5.0|evidence|2508|https://civicdb.org/links/evidence/2508|20038723_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||C|None|||||
7	55241722	317	G	A	.	.	GN=EGFR;VT=G724S;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2170G>A||G724S|317|RS1051753269&GLY724SER|NP\x5F005219\x2E2\x3Ap\x2EGly724Ser&NM\x5F005228\x2E4\x3Ac\x2E2170G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2170G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55241722G\x3EA|CA16602800|376360|4.0|evidence|786|https://civicdb.org/links/evidence/786|24894453_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|4|||||
7	55242464	1002	AGGAATTAAGAGAAGC	A	.	.	GN=EGFR;VT=E746_A750del;CSQ=-|inframe_deletion|EGFR|1956|transcript|ENST00000275493.2|||E746_A750del|1002|E746\x5FA750DELELREA&RS121913421||CA175996|163343|17.5|evidence|4198|https://civicdb.org/links/evidence/4198|15329413_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||C|4|||||,-|inframe_deletion|EGFR|1956|transcript|ENST00000275493.2|||E746_A750del|1002|E746\x5FA750DELELREA&RS121913421||CA175996|163343|17.5|evidence|2513|https://civicdb.org/links/evidence/2513|15329413_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Bronchiolo-alveolar_Adenocarcinoma_(DOID_4926)|Erlotinib_(NCIt_ID_C65530)|||C|3|||||
7	55242467	724	A	G	.	.	GN=EGFR;VT=E746G;CSQ=G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2237A>G||E746G|724|GLU746GLY|NC\x5F000007\x2E13\x3Ag\x2E55242467A\x3EG&ENST00000275493\x2E2\x3Ac\x2E2237A\x3EG|CA367584149|NONE_FOUND|2.5|evidence|1787|https://civicdb.org/links/evidence/1787|26773740_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|1|||||
7	55242469	1012	TTAAGAGAAGCAACATCTC	T	.	.	GN=EGFR;VT=L747_P753delinsS;CSQ=-|inframe_deletion|EGFR|1956|transcript|ENST00000275493.2|||L747_P753delinsS|1012|RS121913438||CA126710|16608|0.0|evidence|4266|https://civicdb.org/links/evidence/4266|19147750_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||
7	55242487	460	C	T	.	.	GN=EGFR;VT=P753S;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2257C>T||P753S|460|RS121913231&PRO753SER|NP\x5F005219\x2E2\x3Ap\x2EPro753Ser&NM\x5F005228\x2E4\x3Ac\x2E2257C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2257C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55242487C\x3ET|CA4266020|376081|7.5|evidence|1089|https://civicdb.org/links/evidence/1089|24934779_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Squamous_Cell_Carcinoma_(DOID_3151)|Sirolimus_(NCIt_ID_C1212)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
7	55242500	723	A	G	.	.	GN=EGFR;VT=K757R;CSQ=G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2270A>G||K757R|723||NC\x5F000007\x2E13\x3Ag\x2E55242500A\x3EG&ENST00000275493\x2E2\x3Ac\x2E2270A\x3EG|CA4266023|NONE_FOUND|7.5|evidence|1786|https://civicdb.org/links/evidence/1786|26773740_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|3|||||
7	55242511	712	G	T	.	.	GN=EGFR;VT=D761Y;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2281G>T||D761Y|712|RS121913418&ASP761TYR|NC\x5F000007\x2E13\x3Ag\x2E55242511G\x3ET&NP\x5F005219\x2E2\x3Ap\x2EAsp761Tyr&NM\x5F005228\x2E4\x3Ac\x2E2281G\x3ET&ENST00000275493\x2E2\x3Ac\x2E2281G\x3ET|CA135827|45244|7.5|evidence|1763|https://civicdb.org/links/evidence/1763|17085664_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Gefitinib_(NCIt_ID_C1855)|Substitutes||C|3|||||
7	55248992	1515	T	TTCCAGGAAGCCT	.	.	GN=EGFR;VT=A763_Y764insFQEA;CSQ=TCCAGGAAGCCT|inframe_insertion|EGFR|1956|transcript|ENST00000275493.2|||A763_Y764insFQEA|1515|RS397517106|NM\x5F001346898\x2E1\x3Ac\x2E2290\x5F2291insTCCAGGAAGCCT&NC\x5F000007\x2E13\x3Ag\x2E55248992\x5F55248993insTCCAGGAAGCCT&NP\x5F001333827\x2E1\x3Ap\x2EAla763\x5FTyr764insPheGlnGluAla|CA135833|NONE_FOUND|0.0|evidence|4497|https://civicdb.org/links/evidence/4497|24353160_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||
7	55249000	1579	G	GGCCAGCGTG	.	.	GN=EGFR;VT=A767_V769dupASV;CSQ=GCCAGCGTG|inframe_insertion|EGFR|1956|transcript|ENST00000275493.2|||A767_V769dupASV|1579|||CA180588||0.0|evidence|4665|https://civicdb.org/links/evidence/4665|24353160_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||
7	55249005	562	G	T	.	.	GN=EGFR;VT=S768I;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|RS121913465&SER768ILE|NP\x5F005219\x2E2\x3Ap\x2ESer768Ile&NM\x5F005228\x2E4\x3Ac\x2E2303G\x3ET&ENST00000275493\x2E2\x3Ac\x2E2303G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249005G\x3ET|CA135840|45251|17.5|evidence|4273|https://civicdb.org/links/evidence/4273|22895145_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|RS121913465&SER768ILE|NP\x5F005219\x2E2\x3Ap\x2ESer768Ile&NM\x5F005228\x2E4\x3Ac\x2E2303G\x3ET&ENST00000275493\x2E2\x3Ac\x2E2303G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249005G\x3ET|CA135840|45251|17.5|evidence|4274|https://civicdb.org/links/evidence/4274|19147750_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|RS121913465&SER768ILE|NP\x5F005219\x2E2\x3Ap\x2ESer768Ile&NM\x5F005228\x2E4\x3Ac\x2E2303G\x3ET&ENST00000275493\x2E2\x3Ac\x2E2303G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249005G\x3ET|CA135840|45251|17.5|evidence|2906|https://civicdb.org/links/evidence/2906|27211795_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||C|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|RS121913465&SER768ILE|NP\x5F005219\x2E2\x3Ap\x2ESer768Ile&NM\x5F005228\x2E4\x3Ac\x2E2303G\x3ET&ENST00000275493\x2E2\x3Ac\x2E2303G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249005G\x3ET|CA135840|45251|17.5|evidence|1394|https://civicdb.org/links/evidence/1394|25521405_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|RS121913465&SER768ILE|NP\x5F005219\x2E2\x3Ap\x2ESer768Ile&NM\x5F005228\x2E4\x3Ac\x2E2303G\x3ET&ENST00000275493\x2E2\x3Ac\x2E2303G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249005G\x3ET|CA135840|45251|17.5|evidence|1395|https://civicdb.org/links/evidence/1395|20522446_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)|||C|2|||||
7	55249009	736	G	GGCCAGCGTG	.	.	GN=EGFR;VT=V769_770insASV;CSQ=GCCAGCGTG|direct_tandem_duplication|EGFR|1956|transcript|ENST00000275493.2|||V769_770insASV|736|VAL769\x5FASP770INSALASERVAL|NM\x5F005228\x2E4\x3Ac\x2E2300\x5F2308dupCCAGCGTGG|CA180588|177678|7.5|evidence|1799|https://civicdb.org/links/evidence/1799|26773740_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|3|||||
7	55249012	1514	C	CGGGTTA	.	.	GN=EGFR;VT=D770_N771insGL;CSQ=GGGTTA|inframe_insertion|EGFR|1956|transcript|ENST00000275493.2|||D770_N771insGL|1514|RS397517111|NP\x5F005219\x2E2\x3Ap\x2ECys770\x5FGly771insGlyLeu&NM\x5F005228\x2E3\x3Ac\x2E2310\x5F2311insGGGTTA&NC\x5F000007\x2E13\x3Ag\x2E55249012\x5F55249013insGGGTTA|CA645561585|45257|0.0|evidence|4494|https://civicdb.org/links/evidence/4494|24353160_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||
7	55249012	1566	C	CGGCACA	.	.	GN=EGFR;VT=D770_N771insGT;CSQ=GGCACA|inframe_insertion|EGFR|1956|transcript|ENST00000275493.2|||D770_N771insGT|1566||NP\x5F005219\x2E2\x3Ap\x2ECys770\x5FGly771insGlyThr&NM\x5F005228\x2E3\x3Ac\x2E2310\x5F2311insGGCACA&NC\x5F000007\x2E13\x3Ag\x2E55249012\x5F55249013insGGCACA|CA645561586||0.0|evidence|4643|https://civicdb.org/links/evidence/4643|23371856_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||
7	55249071	34	C	T	.	.	GN=EGFR;VT=T790M;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|642|https://civicdb.org/links/evidence/642|18227510_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)&Multikinase_Inhibitor_AEE788_(NCIt_ID_C48369)|Sequential||D|5|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|646|https://civicdb.org/links/evidence/646|25923550_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Rociletinib_(NCIt_ID_C99905)|||B|4|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|238|https://civicdb.org/links/evidence/238|25668228_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||A|5|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|239|https://civicdb.org/links/evidence/239|15728811_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||B|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|240|https://civicdb.org/links/evidence/240|21430269_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||B|4|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|277|https://civicdb.org/links/evidence/277|24636847_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Pemetrexed_(NCIt_ID_C61614)|Combination||C|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|278|https://civicdb.org/links/evidence/278|24658966_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Staurosporine_(NCIt_ID_C1237)|||E|1|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|963|https://civicdb.org/links/evidence/963|24893891_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)|||D|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|965|https://civicdb.org/links/evidence/965|25923549_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)|||B|4|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|966|https://civicdb.org/links/evidence/966|26720284_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)|||B|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|967|https://civicdb.org/links/evidence/967|26515464_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)&Rociletinib_(NCIt_ID_C99905)|Substitutes||D|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|3810|https://civicdb.org/links/evidence/3810|19147750_(PubMed)|Somatic|accepted||Supports|Cancer_(DOID_162)|Erlotinib_(NCIt_ID_C65530)|||D|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|1391|https://civicdb.org/links/evidence/1391|23470965_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||B|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|762|https://civicdb.org/links/evidence/762|24065731_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Rociletinib_(NCIt_ID_C99905)|||D|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|1592|https://civicdb.org/links/evidence/1592|26729184_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)|||A|5|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|1667|https://civicdb.org/links/evidence/1667|27304188_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)&Afatinib_(NCIt_ID_C66940)|Substitutes||B|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|1397|https://civicdb.org/links/evidence/1397|26181354_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Osimertinib_(NCIt_ID_C116377)|||C|1|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|1863|https://civicdb.org/links/evidence/1863|24035188_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)|||B|4|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|1867|https://civicdb.org/links/evidence/1867|27959700_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)|||A|5|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2157|https://civicdb.org/links/evidence/2157|26269204_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Osimertinib_(NCIt_ID_C116377)|||C|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2158|https://civicdb.org/links/evidence/2158|15737014_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||C|None|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2159|https://civicdb.org/links/evidence/2159|17020982_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||C|None|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2160|https://civicdb.org/links/evidence/2160|18408761_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Lapatinib_(NCIt_ID_C26653)|||D|4|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2162|https://civicdb.org/links/evidence/2162|16818618_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Neratinib_(NCIt_ID_C49094)|||D|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2163|https://civicdb.org/links/evidence/2163|18408761_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)|||D|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2164|https://civicdb.org/links/evidence/2164|21732342_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)|||D|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2165|https://civicdb.org/links/evidence/2165|18408761_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Canertinib_(NCIt_ID_C77588)|||D|2|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|2161|https://civicdb.org/links/evidence/2161|18089823_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||D|3|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|370|https://civicdb.org/links/evidence/370|24729716_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||,T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|RS121434569&THR790MET|NP\x5F005219\x2E2\x3Ap\x2EThr790Met&NM\x5F005228\x2E4\x3Ac\x2E2369C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E55249071C\x3ET&ENST00000275493\x2E2\x3Ac\x2E2369C\x3ET|CA090928|16613|376.25|evidence|369|https://civicdb.org/links/evidence/369|24623981_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||
7	55249091	415	T	A	.	.	GN=EGFR;VT=C797S;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2389T>A||C797S|415|RS1057519861&CYS797SER|NP\x5F005219\x2E2\x3Ap\x2ECys797Ser&NM\x5F005228\x2E4\x3Ac\x2E2389T\x3EA&ENST00000275493\x2E2\x3Ac\x2E2389T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55249091T\x3EA|CA16602785|376342|17.5|evidence|1396|https://civicdb.org/links/evidence/1396|26181354_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Osimertinib_(NCIt_ID_C116377)|||C|1|||||,A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2389T>A||C797S|415|RS1057519861&CYS797SER|NP\x5F005219\x2E2\x3Ap\x2ECys797Ser&NM\x5F005228\x2E4\x3Ac\x2E2389T\x3EA&ENST00000275493\x2E2\x3Ac\x2E2389T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55249091T\x3EA|CA16602785|376342|17.5|evidence|964|https://civicdb.org/links/evidence/964|25939061_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Osimertinib_(NCIt_ID_C116377)|||B|3|||||
7	55249092	1574	G	A	.	.	GN=EGFR;VT=C797Y;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2390G>A||C797Y|1574|CYS797TYR&C752Y&C744Y|NP\x5F005219\x2E2\x3Ap\x2ECys797Tyr&NC\x5F000007\x2E13\x3Ag\x2E55249092G\x3EA&NM\x5F005228\x2E3\x3Ac\x2E2390G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2390G\x3EA|CA367578897|NONE_FOUND|0.0|evidence|4658|https://civicdb.org/links/evidence/4658|20942962_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Malignant_Mesothelioma_(DOID_1790)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||
7	55249118	1895	A	G	.	.	GN=EGFR;VT=K806E;CSQ=G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2416A>G||K806E|1895|LYS806GLU|ENST00000275493\x2E2\x3Ac\x2E2416A\x3EG|CA4266068|NONE_FOUND|5.0|evidence|4239|https://civicdb.org/links/evidence/4239|21531810_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||C|2|||||
7	55259418	1896	A	T	.	.	GN=EGFR;VT=N826Y;CSQ=T|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2476A>T||N826Y|1896|ASN826TYR|ENST00000275493\x2E2\x3Ac\x2E2476A\x3ET|CA367580076|NONE_FOUND|5.0|evidence|4244|https://civicdb.org/links/evidence/4244|21531810_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||C|2|||||
7	55259434	1017	G	A	.	.	GN=EGFR;VT=R831H;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2492G>A||R831H|1017|ARG831HIS&RS150036236|NC\x5F000007\x2E13\x3Ag\x2E55259434G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2492G\x3EA|CA4266102|NONE_FOUND|0.0|evidence|4279|https://civicdb.org/links/evidence/4279|20942962_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Malignant_Mesothelioma_(DOID_1790)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||
7	55259515	33	T	G	.	.	GN=EGFR;VT=L858R;CSQ=G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|229|https://civicdb.org/links/evidence/229|24736073_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||B|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|276|https://civicdb.org/links/evidence/276|15118125_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||D|4|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|879|https://civicdb.org/links/evidence/879|23816960_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||B|4|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|883|https://civicdb.org/links/evidence/883|22452895_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||B|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|885|https://civicdb.org/links/evidence/885|22285168_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||B|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|968|https://civicdb.org/links/evidence/968|26515464_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)|||D|2|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|982|https://civicdb.org/links/evidence/982|24439929_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||B|4|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|275|https://civicdb.org/links/evidence/275|24457318_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||B|4|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|1665|https://civicdb.org/links/evidence/1665|18509184_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||B|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2621|https://civicdb.org/links/evidence/2621|20038723_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||B|4|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2624|https://civicdb.org/links/evidence/2624|15329413_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)|||C|1|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2625|https://civicdb.org/links/evidence/2625|24893891_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gefitinib_(NCIt_ID_C1855)|||D|2|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2626|https://civicdb.org/links/evidence/2626|18408761_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Lapatinib_(NCIt_ID_C26653)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2628|https://civicdb.org/links/evidence/2628|16818618_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Neratinib_(NCIt_ID_C49094)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2629|https://civicdb.org/links/evidence/2629|18408761_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)|||D|2|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2631|https://civicdb.org/links/evidence/2631|18408761_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Canertinib_(NCIt_ID_C77588)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2634|https://civicdb.org/links/evidence/2634|22370314_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)|||B|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4265|https://civicdb.org/links/evidence/4265|17877814_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Erlotinib_(NCIt_ID_C65530)|||D|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4284|https://civicdb.org/links/evidence/4284|18408761_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4285|https://civicdb.org/links/evidence/4285|21132006_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4286|https://civicdb.org/links/evidence/4286|24353160_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4287|https://civicdb.org/links/evidence/4287|27612423_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4288|https://civicdb.org/links/evidence/4288|22235099_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4290|https://civicdb.org/links/evidence/4290|27032107_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||C|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4291|https://civicdb.org/links/evidence/4291|27102076_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4292|https://civicdb.org/links/evidence/4292|27102076_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4293|https://civicdb.org/links/evidence/4293|24893891_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Small_Cell_Carcinoma_(DOID_5409)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4294|https://civicdb.org/links/evidence/4294|24893891_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Hematologic_Cancer_(DOID_2531)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4295|https://civicdb.org/links/evidence/4295|17177598_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Malignant_Glioma_(DOID_3070)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2994|https://civicdb.org/links/evidence/2994|24868098_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||A|5|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2997|https://civicdb.org/links/evidence/2997|23982599_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)|||A|5|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|4860|https://civicdb.org/links/evidence/4860|26768165_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||B|5|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2632|https://civicdb.org/links/evidence/2632|15329413_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||C|2|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|3811|https://civicdb.org/links/evidence/3811|19147750_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)&Multikinase_Inhibitor_AEE788_(NCIt_ID_C48369)|Substitutes||D|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|6183|https://civicdb.org/links/evidence/6183|27022112_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Does_Not_Support|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)|||B|2|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|2627|https://civicdb.org/links/evidence/2627|18089823_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||D|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|evidence|347|https://civicdb.org/links/evidence/347|24662454_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|3|||||,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|assertion|5|https://civicdb.org/links/assertion/5||Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Gefitinib_(NCIt_ID_C1855)|Substitutes|||||Tier_I_-_Level_A|Non-Small_Cell_Lung_Cancer_(v3.2018)|True|True,G|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|RS121434568&LEU858ARG|NP\x5F005219\x2E2\x3Ap\x2ELeu858Arg&ENST00000275493\x2E2\x3Ac\x2E2573T\x3EG&NM\x5F005228\x2E4\x3Ac\x2E2573T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E55259515T\x3EG|CA126713|376280&376282&16609|331.5|assertion|6|https://civicdb.org/links/assertion/6||Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Afatinib_(NCIt_ID_C66940)||||||Tier_I_-_Level_A|Non-Small_Cell_Lung_Cancer_(v3.2018)|True|True
7	55259532	1187	G	A	.	.	GN=EGFR;VT=A864T;CSQ=A|missense_variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2590G>A||A864T|1187|ALA864THR&A819T&A811T|NP\x5F005219\x2E2\x3Ap\x2EAla864Thr&NM\x5F005228\x2E3\x3Ac\x2E2590G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E55259532G\x3EA&ENST00000275493\x2E2\x3Ac\x2E2590G\x3EA|CA367580302|NONE_FOUND|0.0|evidence|4495|https://civicdb.org/links/evidence/4495|19147750_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)|||D|None|||||
7	87138645	263	A	G	.	.	GN=ABCB1;VT=I1145I;CSQ=G|synonymous_variant|ABCB1|5243|transcript|ENST00000265724.3|ENST00000265724.3:c.3435T>C||I1145I|263|ILE1145\x3D&3435C\x2DT&RS1045642&T3435C|ENST00000265724\x2E3\x3Ac\x2E3435T\x3EC&NC\x5F000007\x2E13\x3Ag\x2E87138645A\x3EG&NP\x5F000918\x2E2\x3Ap\x2EIle1145\x3D&NM\x5F000927\x2E4\x3Ac\x2E3435T\x3EC|CA4327768|225939|25.0|evidence|675|https://civicdb.org/links/evidence/675|22296372_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Cisplatin_(NCIt_ID_C376)&Carboplatin_(NCIt_ID_C1282)|Substitutes||B|2|||||,G|synonymous_variant|ABCB1|5243|transcript|ENST00000265724.3|ENST00000265724.3:c.3435T>C||I1145I|263|ILE1145\x3D&3435C\x2DT&RS1045642&T3435C|ENST00000265724\x2E3\x3Ac\x2E3435T\x3EC&NC\x5F000007\x2E13\x3Ag\x2E87138645A\x3EG&NP\x5F000918\x2E2\x3Ap\x2EIle1145\x3D&NM\x5F000927\x2E4\x3Ac\x2E3435T\x3EC|CA4327768|225939|25.0|evidence|1076|https://civicdb.org/links/evidence/1076|22906996_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||
7	87160618	451	A	C	.	.	GN=ABCB1;VT=S893A/T;CSQ=C|missense_variant|ABCB1|5243|transcript|ENST00000265724.3|||S893A/T|451|RS2032582|NC\x5F000007\x2E13\x3Ag\x2E87160618A\x3EC|CA179699|166622&166619|15.0|evidence|1075|https://civicdb.org/links/evidence/1075|22906996_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||
7	87160618	262	A	T	.	.	GN=ABCB1;VT=S893T;CSQ=T|missense_variant|ABCB1|5243|transcript|ENST00000265724.3|ENST00000265724.3:c.2677T>A||S893T|262|RS2032582&SER893THR&A893S|ENST00000265724\x2E3\x3Ac\x2E2677T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E87160618A\x3ET&NP\x5F000918\x2E2\x3Ap\x2ESer893Thr&NM\x5F000927\x2E4\x3Ac\x2E2677T\x3EA|CA179696|166619|15.0|evidence|674|https://civicdb.org/links/evidence/674|16467099_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Paclitaxel_(NCIt_ID_C1411)|||B|3|||||
7	116423407	649	G	A	.	.	GN=MET;VT=D1228N;CSQ=A|missense_variant|MET|4233|transcript|ENST00000397752.3|ENST00000397752.3:c.3682G>A||D1228N|649|ASP1246ASN&D1246N|ENST00000397752\x2E3\x3Ac\x2E3682G\x3EA&NC\x5F000007\x2E13\x3Ag\x2E116423407G\x3EA&NP\x5F001120972\x2E1\x3Ap\x2EAsp1246Asn&NM\x5F001127500\x2E2\x3Ac\x2E3736G\x3EA|CA257000|13884|5.0|evidence|1652|https://civicdb.org/links/evidence/1652|27343442_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||
7	116423408	798	A	T	.	.	GN=MET;VT=D1228V;CSQ=T|missense_variant|MET|4233|transcript|ENST00000397752.3|ENST00000397752.3:c.3683A>T||D1228V|798|ASP1228VAL|NC\x5F000007\x2E13\x3Ag\x2E116423408A\x3ET&ENST00000397752\x2E3\x3Ac\x2E3683A\x3ET|CA368991571|NONE_FOUND|20.0|evidence|1864|https://civicdb.org/links/evidence/1864|27694386_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Cabozantinib_(NCIt_ID_C52200)|||C|4|||||,T|missense_variant|MET|4233|transcript|ENST00000397752.3|ENST00000397752.3:c.3683A>T||D1228V|798|ASP1228VAL|NC\x5F000007\x2E13\x3Ag\x2E116423408A\x3ET&ENST00000397752\x2E3\x3Ac\x2E3683A\x3ET|CA368991571|NONE_FOUND|20.0|evidence|1865|https://civicdb.org/links/evidence/1865|27694386_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Savolitinib_(NCIt_ID_C104732)|||C|4|||||
7	128846398	1570	C	T	.	.	GN=SMO;VT=L412F;CSQ=T|missense_variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1234C>T||L412F|1570||ENST00000249373\x2E3\x3Ac\x2E1234C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E128846398C\x3ET&NP\x5F005622\x2E1\x3Ap\x2ELeu412Phe&NM\x5F005631\x2E4\x3Ac\x2E1234C\x3ET|CA10584652|245609|0.0|evidence|4654|https://civicdb.org/links/evidence/4654|26822128_(PubMed)|Somatic|accepted|Resistance|Supports|Basal_Cell_Carcinoma_(DOID_2513)|Vismodegib_(NCIt_ID_C74038)|||C|None|||||,T|missense_variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1234C>T||L412F|1570||ENST00000249373\x2E3\x3Ac\x2E1234C\x3ET&NC\x5F000007\x2E13\x3Ag\x2E128846398C\x3ET&NP\x5F005622\x2E1\x3Ap\x2ELeu412Phe&NM\x5F005631\x2E4\x3Ac\x2E1234C\x3ET|CA10584652|245609|0.0|evidence|4653|https://civicdb.org/links/evidence/4653|25759020_(PubMed)|Somatic|accepted|Resistance|Supports|Basal_Cell_Carcinoma_(DOID_2513)|Vismodegib_(NCIt_ID_C74038)|||D|None|||||
7	128849189	299	G	C	.	.	GN=SMO;VT=D473H;CSQ=C|missense_variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1417G>A||D473H|299|ASP473HIS|NC\x5F000007\x2E13\x3Ag\x2E128849189G\x3EC&ENST00000249373\x2E3\x3Ac\x2E1417G\x3EA&NP\x5F005622\x2E1\x3Ap\x2EAsp473His&NM\x5F005631\x2E4\x3Ac\x2E1417G\x3EA|CA16602418|375938|13.5|evidence|755|https://civicdb.org/links/evidence/755|25759020_(PubMed)|Somatic|accepted|Resistance|Supports|Basal_Cell_Carcinoma_(DOID_2513)|Vismodegib_(NCIt_ID_C74038)|||D|3|||||,C|missense_variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1417G>A||D473H|299|ASP473HIS|NC\x5F000007\x2E13\x3Ag\x2E128849189G\x3EC&ENST00000249373\x2E3\x3Ac\x2E1417G\x3EA&NP\x5F005622\x2E1\x3Ap\x2EAsp473His&NM\x5F005631\x2E4\x3Ac\x2E1417G\x3EA|CA16602418|375938|13.5|evidence|745|https://civicdb.org/links/evidence/745|19726788_(PubMed)|Somatic|accepted|Resistance|Supports|Brain_Medulloblastoma_(DOID_0060105)|Vismodegib_(NCIt_ID_C74038)|||C|3|||||,C|missense_variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1417G>A||D473H|299|ASP473HIS|NC\x5F000007\x2E13\x3Ag\x2E128849189G\x3EC&ENST00000249373\x2E3\x3Ac\x2E1417G\x3EA&NP\x5F005622\x2E1\x3Ap\x2EAsp473His&NM\x5F005631\x2E4\x3Ac\x2E1417G\x3EA|CA16602418|375938|13.5|evidence|1099|https://civicdb.org/links/evidence/1099|22550175_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Brain_Medulloblastoma_(DOID_0060105)|Patidegib_(NCIt_ID_C80063)|||D|3|||||
7	140434507	2224	G	T	.	.	GN=BRAF;VT=P731T;CSQ=T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.2193G>T||P731T|2224|PRO731THR|ENST00000288602\x2E6\x3Ac\x2E2193G\x3ET|CA369537254|NONE_FOUND|5.0|evidence|5972|https://civicdb.org/links/evidence/5972|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
7	140434515	1198	G	A	.	.	GN=BRAF;VT=A728V;CSQ=A|missense_variant|BRAF|673|transcript|None|||A728V|1198|A336V||CA369537269||0.0|evidence|7614|https://civicdb.org/links/evidence/7614|15035987_(PubMed)|Somatic|accepted|Gain_of_Function|Supports|Cancer_(DOID_162)||||D|3|||||
7	140453118	2223	C	T	.	.	GN=BRAF;VT=G606E;CSQ=T|missense_variant|BRAF|673|transcript|ENST00000288602.6|||G606E|2223|GLY606GLU||CA369542941|NONE_FOUND|5.0|evidence|5970|https://civicdb.org/links/evidence/5970|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
7	140453134	584	T	C	.	.	GN=BRAF;VT=K601E;CSQ=C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1801A>G||K601E|584|RS121913364&LYS601GLU|ENST00000288602\x2E6\x3Ac\x2E1801A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453134T\x3EC&NP\x5F004324\x2E2\x3Ap\x2ELys601Glu&NM\x5F004333\x2E4\x3Ac\x2E1801A\x3EG|CA123645|13966|3.0|evidence|1462|https://civicdb.org/links/evidence/1462|22798288_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Vemurafenib_(NCIt_ID_C64768)|Substitutes||D|3|||||
7	140453135	11	CA	AT	.	.	GN=BRAF;VT=V600D;CSQ=AT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|VAL600ASP&RS121913377|NC\x5F000007\x2E13\x3Ag\x2E140453135\x5F140453136delinsAT&ENST00000288602\x2E6\x3Ac\x2E1799\x5F1800delTGinsAT&NP\x5F004324\x2E2\x3Ap\x2EVal600Asp&NM\x5F004333\x2E4\x3Ac\x2E1799\x5F1800delTGinsAT|CA16602419|375939|40.0|evidence|7629|https://civicdb.org/links/evidence/7629|31580757_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Mitogen-Activated_Protein_Kinase_Kinase_Inhibitor_(NCIt_ID_C69145)&BRAF_Inhibitor_(NCIt_ID_C155322)|Combination||C|3|||||,AT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|VAL600ASP&RS121913377|NC\x5F000007\x2E13\x3Ag\x2E140453135\x5F140453136delinsAT&ENST00000288602\x2E6\x3Ac\x2E1799\x5F1800delTGinsAT&NP\x5F004324\x2E2\x3Ap\x2EVal600Asp&NM\x5F004333\x2E4\x3Ac\x2E1799\x5F1800delTGinsAT|CA16602419|375939|40.0|evidence|7616|https://civicdb.org/links/evidence/7616|31580757_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|BRAF_Inhibitor_(NCIt_ID_C155322)|||C|3|||||,AT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|VAL600ASP&RS121913377|NC\x5F000007\x2E13\x3Ag\x2E140453135\x5F140453136delinsAT&ENST00000288602\x2E6\x3Ac\x2E1799\x5F1800delTGinsAT&NP\x5F004324\x2E2\x3Ap\x2EVal600Asp&NM\x5F004333\x2E4\x3Ac\x2E1799\x5F1800delTGinsAT|CA16602419|375939|40.0|evidence|4488|https://civicdb.org/links/evidence/4488|18287029_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,AT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|VAL600ASP&RS121913377|NC\x5F000007\x2E13\x3Ag\x2E140453135\x5F140453136delinsAT&ENST00000288602\x2E6\x3Ac\x2E1799\x5F1800delTGinsAT&NP\x5F004324\x2E2\x3Ap\x2EVal600Asp&NM\x5F004333\x2E4\x3Ac\x2E1799\x5F1800delTGinsAT|CA16602419|375939|40.0|evidence|4489|https://civicdb.org/links/evidence/4489|20551065_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,AT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|VAL600ASP&RS121913377|NC\x5F000007\x2E13\x3Ag\x2E140453135\x5F140453136delinsAT&ENST00000288602\x2E6\x3Ac\x2E1799\x5F1800delTGinsAT&NP\x5F004324\x2E2\x3Ap\x2EVal600Asp&NM\x5F004333\x2E4\x3Ac\x2E1799\x5F1800delTGinsAT|CA16602419|375939|40.0|evidence|94|https://civicdb.org/links/evidence/94|23463675_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||B|5|||||
7	140453136	12	A	T	.	.	GN=BRAF;VT=V600E;CSQ=T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3739|https://civicdb.org/links/evidence/3739|25666295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5903|https://civicdb.org/links/evidence/5903|28078132_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_Dimethyl_Sulfoxide_(NCIt_ID_C152711)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5902|https://civicdb.org/links/evidence/5902|28480077_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_Dimethyl_Sulfoxide_(NCIt_ID_C152711)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5904|https://civicdb.org/links/evidence/5904|25435907_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_Dimethyl_Sulfoxide_(NCIt_ID_C152711)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5906|https://civicdb.org/links/evidence/5906|26687137_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cholangiocarcinoma_(DOID_4947)|Vemurafenib_(NCIt_ID_C64768)&Panitumumab_(NCIt_ID_C1857)&Irinotecan_(NCIt_ID_C62040)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3777|https://civicdb.org/links/evidence/3777|25524464_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ganglioglioma_(DOID_5078)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3787|https://civicdb.org/links/evidence/3787|26490654_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cystadenocarcinoma_(DOID_3605)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1749|https://civicdb.org/links/evidence/1749|20818844_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|126|https://civicdb.org/links/evidence/126|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3757|https://civicdb.org/links/evidence/3757|25524477_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3755|https://civicdb.org/links/evidence/3755|26557775_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3750|https://civicdb.org/links/evidence/3750|23569304_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2135|https://civicdb.org/links/evidence/2135|22663011_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2121|https://civicdb.org/links/evidence/2121|19571295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Bevacizumab_(NCIt_ID_C2039)|||B|None|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|82|https://civicdb.org/links/evidence/82|24586605_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Melanoma_(DOID_1909)||||B|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2503|https://civicdb.org/links/evidence/2503|21882184_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1408|https://civicdb.org/links/evidence/1408|22281684_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Cetuximab_(NCIt_ID_C1723)&Gefitinib_(NCIt_ID_C1855)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|816|https://civicdb.org/links/evidence/816|25989278_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2115|https://civicdb.org/links/evidence/2115|19001320_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|98|https://civicdb.org/links/evidence/98|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Bevacizumab_(NCIt_ID_C2039)&Capecitabine_(NCIt_ID_C1794)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5960|https://civicdb.org/links/evidence/5960|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|104|https://civicdb.org/links/evidence/104|24388723_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Melanoma_(DOID_1909)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1902|https://civicdb.org/links/evidence/1902|27729313_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Cetuximab_(NCIt_ID_C1723)&Irinotecan_(NCIt_ID_C62040)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5961|https://civicdb.org/links/evidence/5961|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Anaplastic_Thyroid_Carcinoma|Vemurafenib_(NCIt_ID_C64768)&Pertuzumab_(NCIt_ID_C38692)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1414|https://civicdb.org/links/evidence/1414|24987354_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||C|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1141|https://civicdb.org/links/evidence/1141|23934108_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Cobimetinib_(NCIt_ID_C68923)|||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1699|https://civicdb.org/links/evidence/1699|24997557_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Multiple_Myeloma_(DOID_9538)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1698|https://civicdb.org/links/evidence/1698|24997557_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Multiple_Myeloma_(DOID_9538)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|7157|https://civicdb.org/links/evidence/7157|21502544_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1405|https://civicdb.org/links/evidence/1405|26460303_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2362|https://civicdb.org/links/evidence/2362|19903786_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Colorectal_Cancer_(DOID_9256)||||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|80|https://civicdb.org/links/evidence/80|24570209_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5958|https://civicdb.org/links/evidence/5958|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|99|https://civicdb.org/links/evidence/99|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1005|https://civicdb.org/links/evidence/1005|26678033_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Selumetinib_(NCIt_ID_C66939)&Dactolisib_(NCIt_ID_C74072)|Combination||D|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1591|https://civicdb.org/links/evidence/1591|27460442_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|97|https://civicdb.org/links/evidence/97|23812671_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|PLX4720&Nutlin-3|Combination||D|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1413|https://civicdb.org/links/evidence/1413|25589621_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Panitumumab_(NCIt_ID_C1857)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1406|https://civicdb.org/links/evidence/1406|22608338_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Dabrafenib_(NCIt_ID_C82386)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|79|https://civicdb.org/links/evidence/79|21594703_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Cancer_(DOID_1781)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6178|https://civicdb.org/links/evidence/6178|28891408_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1579|https://civicdb.org/links/evidence/1579|26352686_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||B|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|103|https://civicdb.org/links/evidence/103|24594804_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1398|https://civicdb.org/links/evidence/1398|24508103_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6940|https://civicdb.org/links/evidence/6940|23020132_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|86|https://civicdb.org/links/evidence/86|24576830_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)&MEK_Inhibitor_PD0325901_(NCIt_ID_C52195)|Substitutes||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6975|https://civicdb.org/links/evidence/6975|29072975_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Anaplastic_Thyroid_Carcinoma|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5962|https://civicdb.org/links/evidence/5962|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Laryngeal_Squamous_Cell_Carcinoma_(DOID_2876)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|757|https://civicdb.org/links/evidence/757|25370471_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Pictilisib|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1421|https://civicdb.org/links/evidence/1421|25265494_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)&Cobimetinib_(NCIt_ID_C68923)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1589|https://civicdb.org/links/evidence/1589|27325282_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Panitumumab_(NCIt_ID_C1857)|Combination||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2137|https://civicdb.org/links/evidence/2137|18682506_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|106|https://civicdb.org/links/evidence/106|24396464_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6123|https://civicdb.org/links/evidence/6123|29431699_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)&Panitumumab_(NCIt_ID_C1857)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|7156|https://civicdb.org/links/evidence/7156|20008640_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|8507|https://civicdb.org/links/evidence/8507|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Erlotinib_(NCIt_ID_C65530)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|89|https://civicdb.org/links/evidence/89|19001320_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Sorafenib_(NCIt_ID_C61948)&Panitumumab_(NCIt_ID_C1857)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3758|https://civicdb.org/links/evidence/3758|25399551_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2118|https://civicdb.org/links/evidence/2118|19603024_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|7191|https://civicdb.org/links/evidence/7191|29948154_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Pediatric_Low-grade_Glioma_(PLGG)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|102|https://civicdb.org/links/evidence/102|24354346_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1428|https://civicdb.org/links/evidence/1428|23549875_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|GDC-0879&Dactolisib_(NCIt_ID_C74072)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|91|https://civicdb.org/links/evidence/91|23524406_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dabrafenib_(NCIt_ID_C82386)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|656|https://civicdb.org/links/evidence/656|25024077_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|96|https://civicdb.org/links/evidence/96|23845441_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|PLX4720&Pictilisib_Bismesylate_(NCIt_ID_C82380)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|107|https://civicdb.org/links/evidence/107|21594703_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1552|https://civicdb.org/links/evidence/1552|27404270_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|3017|https://civicdb.org/links/evidence/3017|27283860_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||A|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1940|https://civicdb.org/links/evidence/1940|27302369_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1430|https://civicdb.org/links/evidence/1430|27048246_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Gastrointestinal_Neuroendocrine_Tumor_(DOID_0050626)|Vemurafenib_(NCIt_ID_C64768)&Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|95|https://civicdb.org/links/evidence/95|24583796_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6938|https://civicdb.org/links/evidence/6938|25265492_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6124|https://civicdb.org/links/evidence/6124|29431699_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Adenocarcinoma_(DOID_0050861)|Trametinib_(NCIt_ID_C77908)&Panitumumab_(NCIt_ID_C1857)|Combination||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|2117|https://civicdb.org/links/evidence/2117|19603024_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Oxaliplatin_(NCIt_ID_C1181)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|90|https://civicdb.org/links/evidence/90|24576830_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|6045|https://civicdb.org/links/evidence/6045|26287849_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Anaplastic_Thyroid_Carcinoma|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|463|https://civicdb.org/links/evidence/463|23612012_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Multiple_Myeloma_(DOID_9538)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1409|https://civicdb.org/links/evidence/1409|21639808_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||A|5|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|5959|https://civicdb.org/links/evidence/5959|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1410|https://civicdb.org/links/evidence/1410|22356324_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|105|https://civicdb.org/links/evidence/105|21594703_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Papillary_Carcinoma_(DOID_3969)||||B|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|1127|https://civicdb.org/links/evidence/1127|21663470_(PubMed)|Somatic|accepted|Positive|Supports|Hairy_Cell_Leukemia_(DOID_285)||||B|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|evidence|8506|https://civicdb.org/links/evidence/8506|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)&Cetuximab_(NCIt_ID_C1723)&Irinotecan_(NCIt_ID_C62040)|Combination||D|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|assertion|20|https://civicdb.org/links/assertion/20||Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)|||||||Tier_I_-_Level_A|Colon_Cancer_(v2.2017)||True,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|assertion|10|https://civicdb.org/links/assertion/10||Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Cobimetinib_(NCIt_ID_C68923)&Vemurafenib_(NCIt_ID_C64768)|Combination|||||Tier_I_-_Level_A|Melanoma_(v2.2018)|True|True,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|VAL600GLU&RS113488022|ENST00000288602\x2E6\x3Ac\x2E1799T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453136A\x3ET&NP\x5F004324\x2E2\x3Ap\x2EVal600Glu&NM\x5F004333\x2E4\x3Ac\x2E1799T\x3EA|CA123643|376069&13961|1051.0|assertion|7|https://civicdb.org/links/assertion/7||Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination|||||Tier_I_-_Level_A|Melanoma_(v2.2018)|True|True
7	140453136	563	AC	TT	.	.	GN=BRAF;VT=V600K;CSQ=TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|1399|https://civicdb.org/links/evidence/1399|24508103_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|4|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|1400|https://civicdb.org/links/evidence/1400|26989536_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|3|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|2505|https://civicdb.org/links/evidence/2505|21343559_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||B|None|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|2506|https://civicdb.org/links/evidence/2506|22663011_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Trametinib_(NCIt_ID_C77908)|||B|None|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|4180|https://civicdb.org/links/evidence/4180|25524477_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|4181|https://civicdb.org/links/evidence/4181|25399551_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||B|3|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|6179|https://civicdb.org/links/evidence/6179|28891408_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|evidence|6965|https://civicdb.org/links/evidence/6965|25265494_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination||B|4|||||,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|assertion|11|https://civicdb.org/links/assertion/11||Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Cobimetinib_(NCIt_ID_C68923)&Vemurafenib_(NCIt_ID_C64768)|Combination|||||Tier_I_-_Level_A|Melanoma_(v2.2018)|True|True,TT|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|RS121913227&VAL600LYS|NP\x5F004324\x2E2\x3Ap\x2EVal600Lys&NM\x5F004333\x2E4\x3Ac\x2E1798\x5F1799delGTinsAA&NC\x5F000007\x2E13\x3Ag\x2E140453136\x5F140453137delinsTT&ENST00000288602\x2E6\x3Ac\x2E1798\x5F1799delinsAA|CA16602420|375941|97.5|assertion|13|https://civicdb.org/links/assertion/13||Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)&Trametinib_(NCIt_ID_C77908)|Combination|||||Tier_I_-_Level_A|Melanoma_(v2.2018)|True|True
7	140453142	2826	G	A	.	.	GN=BRAF;VT=A598V;CSQ=A|missense_variant|BRAF|673|transcript|ENST00000288602.6|||A598V|2826|ALA598VAL||CA369543099|NONE_FOUND|7.5|evidence|7635|https://civicdb.org/links/evidence/7635|31580757_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Melanoma_(DOID_1909)|Mitogen-Activated_Protein_Kinase_Kinase_Inhibitor_(NCIt_ID_C69145)&BRAF_Inhibitor_(NCIt_ID_C155322)|Combination||C|3|||||
7	140453145	583	A	T	.	.	GN=BRAF;VT=L597Q;CSQ=T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>A||L597Q|583|RS121913366&LEU597GLN|ENST00000288602\x2E6\x3Ac\x2E1790T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453145A\x3ET&NP\x5F004324\x2E2\x3Ap\x2ELeu597Gln&NM\x5F004333\x2E4\x3Ac\x2E1790T\x3EA|CA16602257|76687|14.5|evidence|5971|https://civicdb.org/links/evidence/5971|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>A||L597Q|583|RS121913366&LEU597GLN|ENST00000288602\x2E6\x3Ac\x2E1790T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453145A\x3ET&NP\x5F004324\x2E2\x3Ap\x2ELeu597Gln&NM\x5F004333\x2E4\x3Ac\x2E1790T\x3EA|CA16602257|76687|14.5|evidence|4905|https://civicdb.org/links/evidence/4905|24933606_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)|||C|3|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>A||L597Q|583|RS121913366&LEU597GLN|ENST00000288602\x2E6\x3Ac\x2E1790T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140453145A\x3ET&NP\x5F004324\x2E2\x3Ap\x2ELeu597Gln&NM\x5F004333\x2E4\x3Ac\x2E1790T\x3EA|CA16602257|76687|14.5|evidence|1461|https://civicdb.org/links/evidence/1461|22798288_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Vemurafenib_(NCIt_ID_C64768)|Substitutes||D|2|||||
7	140453145	288	A	C	.	.	GN=BRAF;VT=L597R;CSQ=C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>G||L597R|288|RS121913366&LEU597ARG|ENST00000288602\x2E6\x3Ac\x2E1790T\x3EG&NP\x5F004324\x2E2\x3Ap\x2ELeu597Arg&NM\x5F004333\x2E4\x3Ac\x2E1790T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453145A\x3EC|CA123649|13968|12.0|evidence|1458|https://civicdb.org/links/evidence/1458|22798288_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Vemurafenib_(NCIt_ID_C64768)|Substitutes||D|2|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>G||L597R|288|RS121913366&LEU597ARG|ENST00000288602\x2E6\x3Ac\x2E1790T\x3EG&NP\x5F004324\x2E2\x3Ap\x2ELeu597Arg&NM\x5F004333\x2E4\x3Ac\x2E1790T\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453145A\x3EC|CA123649|13968|12.0|evidence|728|https://civicdb.org/links/evidence/728|23715574_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|4|||||
7	140453145	582	AG	GA	.	.	GN=BRAF;VT=L597S;CSQ=GA|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1789_1790delCTinsTC||L597S|582|LEU597SER|ENST00000288602\x2E6\x3Ac\x2E1789\x5F1790delCTinsTC&NP\x5F004324\x2E2\x3Ap\x2ELeu597Ser&NM\x5F004333\x2E4\x3Ac\x2E1789\x5F1790delCTinsTC&NC\x5F000007\x2E13\x3Ag\x2E140453145\x5F140453146delinsGA|CA16602421|375942|9.5|evidence|1460|https://civicdb.org/links/evidence/1460|22798288_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|MEK_Inhibitor_TAK-733_(NCIt_ID_C84858)|||C|3|||||,GA|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1789_1790delCTinsTC||L597S|582|LEU597SER|ENST00000288602\x2E6\x3Ac\x2E1789\x5F1790delCTinsTC&NP\x5F004324\x2E2\x3Ap\x2ELeu597Ser&NM\x5F004333\x2E4\x3Ac\x2E1789\x5F1790delCTinsTC&NC\x5F000007\x2E13\x3Ag\x2E140453145\x5F140453146delinsGA|CA16602421|375942|9.5|evidence|1459|https://civicdb.org/links/evidence/1459|22798288_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Vemurafenib_(NCIt_ID_C64768)|Substitutes||D|2|||||
7	140453146	585	G	C	.	.	GN=BRAF;VT=L597V;CSQ=C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1789C>G||L597V|585|RS121913369&LEU597VAL|ENST00000288602\x2E6\x3Ac\x2E1789C\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453146G\x3EC&NP\x5F004324\x2E2\x3Ap\x2ELeu597Val&NM\x5F004333\x2E4\x3Ac\x2E1789C\x3EG|CA123651|13969|7.5|evidence|1463|https://civicdb.org/links/evidence/1463|22805292_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)|||C|3|||||
7	140453149	1627	C	G	.	.	GN=BRAF;VT=G596R;CSQ=G|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1786G>C||G596R|1627|GLY596ARG&G24R&G204R&RS121913361|ENST00000288602\x2E6\x3Ac\x2E1786G\x3EC&NC\x5F000007\x2E13\x3Ag\x2E140453149C\x3EG&NP\x5F004324\x2E2\x3Ap\x2EGly596Arg&NM\x5F004333\x2E4\x3Ac\x2E1786G\x3EC|CA16602422|375943|5.0|evidence|4729|https://civicdb.org/links/evidence/4729|22180495_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||D|1|||||,G|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1786G>C||G596R|1627|GLY596ARG&G24R&G204R&RS121913361|ENST00000288602\x2E6\x3Ac\x2E1786G\x3EC&NC\x5F000007\x2E13\x3Ag\x2E140453149C\x3EG&NP\x5F004324\x2E2\x3Ap\x2EGly596Arg&NM\x5F004333\x2E4\x3Ac\x2E1786G\x3EC|CA16602422|375943|5.0|evidence|5969|https://civicdb.org/links/evidence/5969|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
7	140453149	694	C	A	.	.	GN=BRAF;VT=G596C;CSQ=A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1786G>T||G596C|694|RS121913361&GLY596CYS|ENST00000288602\x2E6\x3Ac\x2E1786G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140453149C\x3EA&NP\x5F004324\x2E2\x3Ap\x2EGly596Cys&NM\x5F004333\x2E4\x3Ac\x2E1786G\x3ET|CA135098|44814|0.0|evidence|1738|https://civicdb.org/links/evidence/1738|27577079_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Trametinib_(NCIt_ID_C77908)&Dabrafenib_(NCIt_ID_C82386)|Combination||D|None|||||
7	140453154	611	T	C	.	.	GN=BRAF;VT=D594G;CSQ=C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|7760|https://civicdb.org/links/evidence/7760|28783719_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Trametinib_(NCIt_ID_C77908)|||D|2|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|7556|https://civicdb.org/links/evidence/7556|28783719_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Solid_Tumor_(DOID_)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|4472|https://civicdb.org/links/evidence/4472|26989027_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|6002|https://civicdb.org/links/evidence/6002|18794803_(PubMed)|None|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|U0126|||D|3|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|6001|https://civicdb.org/links/evidence/6001|18794803_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Sorafenib_(NCIt_ID_C61948)|||D|3|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|1551|https://civicdb.org/links/evidence/1551|27404270_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|1|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|1553|https://civicdb.org/links/evidence/1553|27404270_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|2|||||,C|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|RS121913338&ASP594GLY|ENST00000288602\x2E6\x3Ac\x2E1781A\x3EG&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EC&NP\x5F004324\x2E2\x3Ap\x2EAsp594Gly&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EG|CA123657|13972|36.0|evidence|1554|https://civicdb.org/links/evidence/1554|27404270_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||C|1|||||
7	140453154	579	T	G	.	.	GN=BRAF;VT=D594A;CSQ=G|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>C||D594A|579|RS121913338&ASP594ALA|NP\x5F004324\x2E2\x3Ap\x2EAsp594Ala&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3EC&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EG&ENST00000288602\x2E6\x3Ac\x2E1781A\x3EC|CA16602532|376070|0.75|evidence|1454|https://civicdb.org/links/evidence/1454|20141835_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Mitogen-Activated_Protein_Kinase_Kinase_Inhibitor_(NCIt_ID_C69145)&Sorafenib_(NCIt_ID_C61948)|Substitutes||E|3|||||
7	140453154	580	T	A	.	.	GN=BRAF;VT=D594V;CSQ=A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>T||D594V|580|RS121913338&ASP594VAL|ENST00000288602\x2E6\x3Ac\x2E1781A\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140453154T\x3EA&NP\x5F004324\x2E2\x3Ap\x2EAsp594Val&NM\x5F004333\x2E4\x3Ac\x2E1781A\x3ET|CA16602425|375946|0.75|evidence|1456|https://civicdb.org/links/evidence/1456|20141835_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Trametinib_(NCIt_ID_C77908)&Sorafenib_(NCIt_ID_C61948)|Substitutes||E|3|||||
7	140453193	1186	T	C	.	.	GN=BRAF;VT=N581S;CSQ=C|missense_variant|BRAF|673|transcript|None|||N581S|1186|RS121913370&N9S&N189S||CA180747||5.0|evidence|5967|https://civicdb.org/links/evidence/5967|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
7	140477794	658	A	T	.	.	GN=BRAF;VT=L505H;CSQ=T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1514T>A||L505H|658|LEU505HIS|NP\x5F004324\x2E2\x3Ap\x2ELeu505His&NM\x5F004333\x2E4\x3Ac\x2E1514T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140477794A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1514T\x3EA|CA369588358|NONE_FOUND|19.0|evidence|1668|https://civicdb.org/links/evidence/1668|24112705_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|4|||||,T|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1514T>A||L505H|658|LEU505HIS|NP\x5F004324\x2E2\x3Ap\x2ELeu505His&NM\x5F004333\x2E4\x3Ac\x2E1514T\x3EA&NC\x5F000007\x2E13\x3Ag\x2E140477794A\x3ET&ENST00000288602\x2E6\x3Ac\x2E1514T\x3EA|CA369588358|NONE_FOUND|19.0|evidence|1669|https://civicdb.org/links/evidence/1669|25515853_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||B|3|||||
7	140477837	522	TAGGTGCTGTCACATTCAA	T	.	.	GN=BRAF;VT=DEL_485-490;CSQ=-|inframe_deletion|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1453_1470del||DEL_485-490|522||ENST00000288602\x2E6\x3Ac\x2E1453\x5F1470del|unregistered|NONE_FOUND|3.0|evidence|1267|https://civicdb.org/links/evidence/1267|26732095_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Pan-RAF_Inhibitor_LY3009120_(NCIt_ID_C116861)|||D|3|||||
7	140477859	581	TT	CA	.	.	GN=BRAF;VT=K483M;CSQ=CA|loss_of_function_variant&missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1448_1449delinsTG||K483M|581|LYS483MET|ENST00000288602\x2E6\x3Ac\x2E1448\x5F1449delinsTG&NC\x5F000007\x2E13\x3Ag\x2E140477859\x5F140477860delinsCA|CA913112072|NONE_FOUND|0.75|evidence|1457|https://civicdb.org/links/evidence/1457|20141835_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Mitogen-Activated_Protein_Kinase_Kinase_Inhibitor_(NCIt_ID_C69145)&Sorafenib_(NCIt_ID_C61948)|Substitutes||E|3|||||
7	140481402	993	C	T	.	.	GN=BRAF;VT=G469E;CSQ=T|missense_variant|BRAF|673|transcript|None|||G469E|993|RS121913355||CA279970||6.0|evidence|6004|https://civicdb.org/links/evidence/6004|18794803_(PubMed)|Somatic|accepted||Supports|Skin_Melanoma_(DOID_8923)|U0126|||D|3|||||,T|missense_variant|BRAF|673|transcript|None|||G469E|993|RS121913355||CA279970||6.0|evidence|6003|https://civicdb.org/links/evidence/6003|18794803_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Sorafenib_(NCIt_ID_C61948)|||D|3|||||
7	140481402	992	C	G	.	.	GN=BRAF;VT=G469A;CSQ=G|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1406G>C||G469A|992|GLY469ALA&RS121913355|ENST00000288602\x2E6\x3Ac\x2E1406G\x3EC&NC\x5F000007\x2E13\x3Ag\x2E140481402C\x3EG&NP\x5F004324\x2E2\x3Ap\x2EGly469Ala&NM\x5F004333\x2E4\x3Ac\x2E1406G\x3EC|CA123655|13971|5.0|evidence|5965|https://civicdb.org/links/evidence/5965|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
7	140481411	2222	C	A	.	.	GN=BRAF;VT=G466V;CSQ=A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|RS121913351&GLY466VAL|ENST00000288602\x2E6\x3Ac\x2E1397G\x3ET&NP\x5F004324\x2E2\x3Ap\x2EGly466Val&NM\x5F004333\x2E4\x3Ac\x2E1397G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140481411C\x3EA|CA123647|13967|14.0|evidence|7552|https://civicdb.org/links/evidence/7552|28783719_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Panitumumab_(NCIt_ID_C1857)|Combination||D|3|||||,A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|RS121913351&GLY466VAL|ENST00000288602\x2E6\x3Ac\x2E1397G\x3ET&NP\x5F004324\x2E2\x3Ap\x2EGly466Val&NM\x5F004333\x2E4\x3Ac\x2E1397G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140481411C\x3EA|CA123647|13967|14.0|evidence|7553|https://civicdb.org/links/evidence/7553|28783719_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||,A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|RS121913351&GLY466VAL|ENST00000288602\x2E6\x3Ac\x2E1397G\x3ET&NP\x5F004324\x2E2\x3Ap\x2EGly466Val&NM\x5F004333\x2E4\x3Ac\x2E1397G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140481411C\x3EA|CA123647|13967|14.0|evidence|7554|https://civicdb.org/links/evidence/7554|28783719_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Solid_Tumor_(DOID_)|Vemurafenib_(NCIt_ID_C64768)|||D|3|||||,A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|RS121913351&GLY466VAL|ENST00000288602\x2E6\x3Ac\x2E1397G\x3ET&NP\x5F004324\x2E2\x3Ap\x2EGly466Val&NM\x5F004333\x2E4\x3Ac\x2E1397G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140481411C\x3EA|CA123647|13967|14.0|evidence|5968|https://civicdb.org/links/evidence/5968|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
7	140481417	1106	C	A	.	.	GN=BRAF;VT=G464V;CSQ=A|missense_variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1391G>T||G464V|1106|GLY464VAL&RS121913348|ENST00000288602\x2E6\x3Ac\x2E1391G\x3ET&NC\x5F000007\x2E13\x3Ag\x2E140481417C\x3EA&NP\x5F004324\x2E2\x3Ap\x2EGly464Val&NM\x5F004333\x2E4\x3Ac\x2E1391G\x3ET|CA135076|40364|5.0|evidence|5964|https://civicdb.org/links/evidence/5964|29320312_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Cancer_(DOID_162)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
8	38274849	515	G	T	.	.	GN=FGFR1;VT=N546K;CSQ=T|missense_variant|FGFR1|2260|transcript|ENST00000341462.5|ENST00000341462.5:c.1638C>A||N546K|515|RS779707422&ASN546LYS|NC\x5F000008\x2E10\x3Ag\x2E38274849G\x3ET&ENST00000341462\x2E5\x3Ac\x2E1638C\x3EA&NP\x5F075598\x2E2\x3Ap\x2EAsn546Lys&NM\x5F023110\x2E2\x3Ac\x2E1638C\x3EA|CA357830|224896|0.5|evidence|1246|https://civicdb.org/links/evidence/1246|26179511_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ewing_Sarcoma_Of_Bone_(DOID_3368)|Ponatinib_(NCIt_ID_C95777)|||E|2|||||
9	5070053	615	G	GG	.	.	GN=JAK2;VT=c.1641+1dup;CSQ=G||JAK2|3717|transcript|ENST00000381652.3|||c.1641+1dup|615||NC\x5F000009\x2E11\x3Ag\x2E5070053\x5F5070054insG|CA913189235||10.0|evidence|1568|https://civicdb.org/links/evidence/1568|27433843_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Pembrolizumab_(NCIt_ID_C106432)|||C|4|||||
9	5070054	1681	T	G	.	.	GN=JAK2;VT=F547_SPLICE_SITE_MUTATION;CSQ=G|splice_donor_variant|JAK2|3717|transcript|None|||F547_SPLICE_SITE_MUTATION|1681|||CA372825751||0.0|evidence|4825|https://civicdb.org/links/evidence/4825|27433843_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Pembrolizumab_(NCIt_ID_C106432)|||C|None|||||
9	5073770	64	G	T	.	.	GN=JAK2;VT=V617F;CSQ=T|gain_of_function_variant&missense_variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|RS77375493&VAL617PHE|ENST00000381652\x2E3\x3Ac\x2E1849G\x3ET&NP\x5F004963\x2E1\x3Ap\x2EVal617Phe&NM\x5F004972\x2E3\x3Ac\x2E1849G\x3ET&NC\x5F000009\x2E11\x3Ag\x2E5073770G\x3ET|CA124183|14662|83.0|evidence|20|https://civicdb.org/links/evidence/20|18394554_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Polycythemia_Vera_(DOID_8997)|Fedratinib_(NCIt_ID_C88293)|||D|3|||||,T|gain_of_function_variant&missense_variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|RS77375493&VAL617PHE|ENST00000381652\x2E3\x3Ac\x2E1849G\x3ET&NP\x5F004963\x2E1\x3Ap\x2EVal617Phe&NM\x5F004972\x2E3\x3Ac\x2E1849G\x3ET&NC\x5F000009\x2E11\x3Ag\x2E5073770G\x3ET|CA124183|14662|83.0|evidence|7|https://civicdb.org/links/evidence/7|19287384_(PubMed)|Somatic|accepted|Positive|Supports|Bone_Marrow_Cancer_(DOID_4960)||||B|4|||||,T|gain_of_function_variant&missense_variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|RS77375493&VAL617PHE|ENST00000381652\x2E3\x3Ac\x2E1849G\x3ET&NP\x5F004963\x2E1\x3Ap\x2EVal617Phe&NM\x5F004972\x2E3\x3Ac\x2E1849G\x3ET&NC\x5F000009\x2E11\x3Ag\x2E5073770G\x3ET|CA124183|14662|83.0|evidence|19|https://civicdb.org/links/evidence/19|16709929_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Polycythemia_Vera_(DOID_8997)||||B|4|||||,T|gain_of_function_variant&missense_variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|RS77375493&VAL617PHE|ENST00000381652\x2E3\x3Ac\x2E1849G\x3ET&NP\x5F004963\x2E1\x3Ap\x2EVal617Phe&NM\x5F004972\x2E3\x3Ac\x2E1849G\x3ET&NC\x5F000009\x2E11\x3Ag\x2E5073770G\x3ET|CA124183|14662|83.0|evidence|5|https://civicdb.org/links/evidence/5|16081687_(PubMed)|Somatic|accepted|Positive|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)||||B|4|||||,T|gain_of_function_variant&missense_variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|RS77375493&VAL617PHE|ENST00000381652\x2E3\x3Ac\x2E1849G\x3ET&NP\x5F004963\x2E1\x3Ap\x2EVal617Phe&NM\x5F004972\x2E3\x3Ac\x2E1849G\x3ET&NC\x5F000009\x2E11\x3Ag\x2E5073770G\x3ET|CA124183|14662|83.0|evidence|1|https://civicdb.org/links/evidence/1|16081687_(PubMed)|Somatic|accepted|Negative|Supports|Lymphoid_Leukemia_(DOID_10747)||||B|4|||||
9	8521481	792	C	T	.	.	GN=PTPRD;VT=V253I;CSQ=T|missense_variant|PTPRD|5789|transcript|ENST00000381196.4|||V253I|792|VAL253ILE|NC\x5F000009\x2E11\x3Ag\x2E8521481C\x3ET&NP\x5F002830\x2E1\x3Ap\x2EVal253Ile&NM\x5F002839\x2E3\x3Ac\x2E757G\x3EA|CA4984656|NONE_FOUND|10.0|evidence|1856|https://civicdb.org/links/evidence/1856|23800680_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Ewing_Sarcoma_Of_Bone_(DOID_3368)|Teprotumumab_(NCIt_ID_C95797)&Cixutumumab_(NCIt_ID_C79828)|Substitutes||C|4|||||
9	21975017	641	C	T	.	.	GN=CDKN2A;VT=RS3814960;CSQ=T|5_prime_UTR_exon_variant|CDKN2A|1029|transcript|ENST00000498124.1|||RS3814960|641||NC\x5F000009\x2E11\x3Ag\x2E21975017C\x3ET|CA12951936|NONE_FOUND|15.0|evidence|1635|https://civicdb.org/links/evidence/1635|27414035_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Esophagus_Squamous_Cell_Carcinoma_(DOID_3748)||||B|3|||||
9	80409488	604	T	G	.	.	GN=GNAQ;VT=Q209P;CSQ=G|missense_variant|GNAQ|2776|transcript|ENST00000286548.4|ENST00000286548.4:c.626A>C||Q209P|604|RS121913492&GLN209PRO|ENST00000286548\x2E4\x3Ac\x2E626A\x3EC&NP\x5F002063\x2E2\x3Ap\x2EGln209Pro&NM\x5F002072\x2E4\x3Ac\x2E626A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E80409488T\x3EG|CA16602436|375957|8.0|evidence|1537|https://civicdb.org/links/evidence/1537|24504448_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|PLX4720|||D|3|||||,G|missense_variant|GNAQ|2776|transcript|ENST00000286548.4|ENST00000286548.4:c.626A>C||Q209P|604|RS121913492&GLN209PRO|ENST00000286548\x2E4\x3Ac\x2E626A\x3EC&NP\x5F002063\x2E2\x3Ap\x2EGln209Pro&NM\x5F002072\x2E4\x3Ac\x2E626A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E80409488T\x3EG|CA16602436|375957|8.0|evidence|1533|https://civicdb.org/links/evidence/1533|24504448_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||
9	133738330	1021	A	G	.	.	GN=ABL1;VT=BCR-ABL_M244V;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|2636|https://civicdb.org/links/evidence/2636|12623848_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|2638|https://civicdb.org/links/evidence/2638|15930265_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|4302|https://civicdb.org/links/evidence/4302|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|4304|https://civicdb.org/links/evidence/4304|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|4305|https://civicdb.org/links/evidence/4305|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|4307|https://civicdb.org/links/evidence/4307|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|4308|https://civicdb.org/links/evidence/4308|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|6242|https://civicdb.org/links/evidence/6242|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|6994|https://civicdb.org/links/evidence/6994|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|7042|https://civicdb.org/links/evidence/7042|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|7771|https://civicdb.org/links/evidence/7771|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||BCR-ABL_M244V|1021|BCR\x2DABL1\x20MET244VAL&BCR\x2DABL1\x20M244V&BCR\x2DABL\x20MET244VAL&MET263VAL&M263V&RS121913456|ENST00000318560\x2E5\x3Ac\x2E730A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738330A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EMet244Val&NM\x5F005157\x2E5\x3Ac\x2E730A\x3EG|CA16602545|376084|49.0|evidence|7825|https://civicdb.org/links/evidence/7825|16775234_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|1|||||
9	133738342	1022	C	G	.	.	GN=ABL1;VT=BCR-ABL_L248V;CSQ=G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|6236|https://civicdb.org/links/evidence/6236|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Combination||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|2642|https://civicdb.org/links/evidence/2642|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|4310|https://civicdb.org/links/evidence/4310|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|2641|https://civicdb.org/links/evidence/2641|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|4311|https://civicdb.org/links/evidence/4311|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|7044|https://civicdb.org/links/evidence/7044|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|2644|https://civicdb.org/links/evidence/2644|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Dasatinib_(NCIt_ID_C38713)&Nilotinib_(NCIt_ID_C48375)|Substitutes||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|7029|https://civicdb.org/links/evidence/7029|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||BCR-ABL_L248V|1022|LEU248VAL&L267V&RS121913455|ENST00000318560\x2E5\x3Ac\x2E742C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133738342C\x3EG&NP\x5F005148\x2E2\x3Ap\x2ELeu248Val&NM\x5F005157\x2E5\x3Ac\x2E742C\x3EG|CA16602546|376085|33.0|evidence|6308|https://civicdb.org/links/evidence/6308|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||
9	133738343	2340	T	G	.	.	GN=ABL1;VT=BCR-ABL_L248R;CSQ=G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||BCR-ABL_L248R|2340|LEU248ARG|ENST00000318560\x2E5\x3Ac\x2E743T\x3EG|CA375263224|NONE_FOUND|7.0|evidence|7776|https://civicdb.org/links/evidence/7776|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||BCR-ABL_L248R|2340|LEU248ARG|ENST00000318560\x2E5\x3Ac\x2E743T\x3EG|CA375263224|NONE_FOUND|7.0|evidence|6243|https://civicdb.org/links/evidence/6243|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||BCR-ABL_L248R|2340|LEU248ARG|ENST00000318560\x2E5\x3Ac\x2E743T\x3EG|CA375263224|NONE_FOUND|7.0|evidence|6210|https://civicdb.org/links/evidence/6210|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||
9	133738349	1023	G	A	.	.	GN=ABL1;VT=BCR-ABL_G250E;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|2645|https://civicdb.org/links/evidence/2645|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|2646|https://civicdb.org/links/evidence/2646|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|2647|https://civicdb.org/links/evidence/2647|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|4313|https://civicdb.org/links/evidence/4313|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|4314|https://civicdb.org/links/evidence/4314|22371878_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|4316|https://civicdb.org/links/evidence/4316|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|4318|https://civicdb.org/links/evidence/4318|17264298_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|4320|https://civicdb.org/links/evidence/4320|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|2648|https://civicdb.org/links/evidence/2648|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|6244|https://civicdb.org/links/evidence/6244|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|6267|https://civicdb.org/links/evidence/6267|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|6993|https://civicdb.org/links/evidence/6993|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||BCR-ABL_G250E|1023|BCR\x2DABL1\x20GLY250GLU&BCR\x2DABL1\x20G250E&BCR\x2DABL\x20GLY250GLU&BCR\x2DABL\x20G269E&RS121913453|ENST00000318560\x2E5\x3Ac\x2E749G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738349G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGly250Glu&NM\x5F005157\x2E5\x3Ac\x2E749G\x3EA|CA16602547|376086|51.0|evidence|7041|https://civicdb.org/links/evidence/7041|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||B|1|||||
9	133738356	1024	G	C	.	.	GN=ABL1;VT=BCR-ABL_Q252H;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|2650|https://civicdb.org/links/evidence/2650|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|2651|https://civicdb.org/links/evidence/2651|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|4323|https://civicdb.org/links/evidence/4323|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|4327|https://civicdb.org/links/evidence/4327|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|6219|https://civicdb.org/links/evidence/6219|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|6245|https://civicdb.org/links/evidence/6245|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||BCR-ABL_Q252H|1024|BCR\x2DABL1\x20GLN252HIS&BCR\x2DABL1\x20Q252H&BCR\x2DABL\x20Q271H&RS121913458|ENST00000318560\x2E5\x3Ac\x2E756G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738356G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EGln252His&NM\x5F005157\x2E5\x3Ac\x2E756G\x3EC|CA16602548|376087|17.5|evidence|6274|https://civicdb.org/links/evidence/6274|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||
9	133738357	1025	T	C	.	.	GN=ABL1;VT=BCR-ABL_Y253H;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|4329|https://civicdb.org/links/evidence/4329|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|4331|https://civicdb.org/links/evidence/4331|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|4332|https://civicdb.org/links/evidence/4332|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|4334|https://civicdb.org/links/evidence/4334|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|4335|https://civicdb.org/links/evidence/4335|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|4336|https://civicdb.org/links/evidence/4336|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|4|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|6200|https://civicdb.org/links/evidence/6200|19652056_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|6237|https://civicdb.org/links/evidence/6237|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Combination||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|2654|https://civicdb.org/links/evidence/2654|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||D|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|6992|https://civicdb.org/links/evidence/6992|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|7040|https://civicdb.org/links/evidence/7040|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||B|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|7947|https://civicdb.org/links/evidence/7947|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||BCR-ABL_Y253H|1025|BCR\x2DABL1\x20TYR253HIS&BCR\x2DABL1\x20Y253H&BCR\x2DABL\x20TYR253HIS&TYR272HIS&Y272H&RS121913461|ENST00000318560\x2E5\x3Ac\x2E757T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133738357T\x3EC&NP\x5F005148\x2E2\x3Ap\x2ETyr253His&NM\x5F005157\x2E5\x3Ac\x2E757T\x3EC|CA122584|12627|74.5|evidence|7949|https://civicdb.org/links/evidence/7949|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||
9	133738358	1026	A	T	.	.	GN=ABL1;VT=Y253F;CSQ=T|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.758A>T||Y253F|1026|TYR272PHE&TYR253PHE&Y272F&RS121913460|NC\x5F000009\x2E11\x3Ag\x2E133738358A\x3ET&NP\x5F005148\x2E2\x3Ap\x2ETyr253Phe&NM\x5F005157\x2E5\x3Ac\x2E758A\x3ET&ENST00000318560\x2E5\x3Ac\x2E758A\x3ET|CA16602550|376089|6.5|evidence|4340|https://civicdb.org/links/evidence/4340|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,T|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.758A>T||Y253F|1026|TYR272PHE&TYR253PHE&Y272F&RS121913460|NC\x5F000009\x2E11\x3Ag\x2E133738358A\x3ET&NP\x5F005148\x2E2\x3Ap\x2ETyr253Phe&NM\x5F005157\x2E5\x3Ac\x2E758A\x3ET&ENST00000318560\x2E5\x3Ac\x2E758A\x3ET|CA16602550|376089|6.5|evidence|4345|https://civicdb.org/links/evidence/4345|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,T|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.758A>T||Y253F|1026|TYR272PHE&TYR253PHE&Y272F&RS121913460|NC\x5F000009\x2E11\x3Ag\x2E133738358A\x3ET&NP\x5F005148\x2E2\x3Ap\x2ETyr253Phe&NM\x5F005157\x2E5\x3Ac\x2E758A\x3ET&ENST00000318560\x2E5\x3Ac\x2E758A\x3ET|CA16602550|376089|6.5|evidence|2655|https://civicdb.org/links/evidence/2655|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,T|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.758A>T||Y253F|1026|TYR272PHE&TYR253PHE&Y272F&RS121913460|NC\x5F000009\x2E11\x3Ag\x2E133738358A\x3ET&NP\x5F005148\x2E2\x3Ap\x2ETyr253Phe&NM\x5F005157\x2E5\x3Ac\x2E758A\x3ET&ENST00000318560\x2E5\x3Ac\x2E758A\x3ET|CA16602550|376089|6.5|evidence|2657|https://civicdb.org/links/evidence/2657|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||
9	133738363	3	G	A	.	.	GN=ABL1;VT=BCR-ABL_E255K;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|233|https://civicdb.org/links/evidence/233|15194504_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|2659|https://civicdb.org/links/evidence/2659|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|2660|https://civicdb.org/links/evidence/2660|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|4|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|2661|https://civicdb.org/links/evidence/2661|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4347|https://civicdb.org/links/evidence/4347|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4348|https://civicdb.org/links/evidence/4348|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4350|https://civicdb.org/links/evidence/4350|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4352|https://civicdb.org/links/evidence/4352|17264298_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4353|https://civicdb.org/links/evidence/4353|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4355|https://civicdb.org/links/evidence/4355|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|4718|https://civicdb.org/links/evidence/4718|16775234_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|2662|https://civicdb.org/links/evidence/2662|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|6193|https://civicdb.org/links/evidence/6193|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Dasatinib_(NCIt_ID_C38713)|Combination||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|6194|https://civicdb.org/links/evidence/6194|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Dasatinib_(NCIt_ID_C38713)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|6214|https://civicdb.org/links/evidence/6214|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||D|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|6232|https://civicdb.org/links/evidence/6232|19652056_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|6282|https://civicdb.org/links/evidence/6282|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|6991|https://civicdb.org/links/evidence/6991|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||BCR-ABL_E255K|3|BCR\x2DABL1\x20GLU255LYS&BCR\x2DABL1\x20E255K&BCR\x2DABL\x20GLU255LYS&RS121913448&E274K|ENST00000318560\x2E5\x3Ac\x2E763G\x3EA&NP\x5F005148\x2E2\x3Ap\x2EGlu255Lys&NM\x5F005157\x2E5\x3Ac\x2E763G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133738363G\x3EA|CA16602551|376090|73.0|evidence|7039|https://civicdb.org/links/evidence/7039|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||
9	133738364	1173	A	T	.	.	GN=ABL1;VT=BCR-ABL_E255V;CSQ=T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|2656|https://civicdb.org/links/evidence/2656|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|2850|https://civicdb.org/links/evidence/2850|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|2851|https://civicdb.org/links/evidence/2851|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|4441|https://civicdb.org/links/evidence/4441|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|4443|https://civicdb.org/links/evidence/4443|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|4444|https://civicdb.org/links/evidence/4444|22371878_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|4447|https://civicdb.org/links/evidence/4447|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|4448|https://civicdb.org/links/evidence/4448|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|6971|https://civicdb.org/links/evidence/6971|19652056_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||BCR-ABL_E255V|1173|BCR\x2DABL1\x20GLU255VAL&BCR\x2DABL1\x20E274V&BCR\x2DABL\x20GLU255VAL&BCR\x2DABL\x20E274V&RS121913449|ENST00000318560\x2E5\x3Ac\x2E764A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133738364A\x3ET&NP\x5F005148\x2E2\x3Ap\x2EGlu255Val&NM\x5F005157\x2E5\x3Ac\x2E764A\x3ET|CA16602552|376091|47.0|evidence|6986|https://civicdb.org/links/evidence/6986|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||
9	133747520	1027	A	G	.	.	GN=ABL1;VT=BCR-ABL_D276G;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||BCR-ABL_D276G|1027|BCR\x2DABL1\x20D295G&BCR\x2DABL\x20D295G&BCR\x2DABL\x20ASP276GLY&RS121913447|NC\x5F000009\x2E11\x3Ag\x2E133747520A\x3EG&NM\x5F005157\x2E5\x3Ac\x2E827A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EAsp276Gly&ENST00000318560\x2E5\x3Ac\x2E827A\x3EG|CA200645023|NONE_FOUND|18.0|evidence|4360|https://civicdb.org/links/evidence/4360|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||BCR-ABL_D276G|1027|BCR\x2DABL1\x20D295G&BCR\x2DABL\x20D295G&BCR\x2DABL\x20ASP276GLY&RS121913447|NC\x5F000009\x2E11\x3Ag\x2E133747520A\x3EG&NM\x5F005157\x2E5\x3Ac\x2E827A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EAsp276Gly&ENST00000318560\x2E5\x3Ac\x2E827A\x3EG|CA200645023|NONE_FOUND|18.0|evidence|4359|https://civicdb.org/links/evidence/4359|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||BCR-ABL_D276G|1027|BCR\x2DABL1\x20D295G&BCR\x2DABL\x20D295G&BCR\x2DABL\x20ASP276GLY&RS121913447|NC\x5F000009\x2E11\x3Ag\x2E133747520A\x3EG&NM\x5F005157\x2E5\x3Ac\x2E827A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EAsp276Gly&ENST00000318560\x2E5\x3Ac\x2E827A\x3EG|CA200645023|NONE_FOUND|18.0|evidence|4357|https://civicdb.org/links/evidence/4357|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||BCR-ABL_D276G|1027|BCR\x2DABL1\x20D295G&BCR\x2DABL\x20D295G&BCR\x2DABL\x20ASP276GLY&RS121913447|NC\x5F000009\x2E11\x3Ag\x2E133747520A\x3EG&NM\x5F005157\x2E5\x3Ac\x2E827A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EAsp276Gly&ENST00000318560\x2E5\x3Ac\x2E827A\x3EG|CA200645023|NONE_FOUND|18.0|evidence|6246|https://civicdb.org/links/evidence/6246|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||BCR-ABL_D276G|1027|BCR\x2DABL1\x20D295G&BCR\x2DABL\x20D295G&BCR\x2DABL\x20ASP276GLY&RS121913447|NC\x5F000009\x2E11\x3Ag\x2E133747520A\x3EG&NM\x5F005157\x2E5\x3Ac\x2E827A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EAsp276Gly&ENST00000318560\x2E5\x3Ac\x2E827A\x3EG|CA200645023|NONE_FOUND|18.0|evidence|2666|https://civicdb.org/links/evidence/2666|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||BCR-ABL_D276G|1027|BCR\x2DABL1\x20D295G&BCR\x2DABL\x20D295G&BCR\x2DABL\x20ASP276GLY&RS121913447|NC\x5F000009\x2E11\x3Ag\x2E133747520A\x3EG&NM\x5F005157\x2E5\x3Ac\x2E827A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EAsp276Gly&ENST00000318560\x2E5\x3Ac\x2E827A\x3EG|CA200645023|NONE_FOUND|18.0|evidence|2663|https://civicdb.org/links/evidence/2663|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|2|||||
9	133747528	1526	G	A	.	.	GN=ABL1;VT=BCR-ABL_E279K;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.835G>A||BCR-ABL_E279K|1526|BCR\x2DABL\x20E298K&BCR\x2DABL1\x20GLU279LYS&BCR\x2DABL\x20GLU279LYS&BCR\x2DABL1\x20E279K|NP\x5F005148\x2E2\x3Ap\x2EGlu279Lys&NM\x5F005157\x2E5\x3Ac\x2E835G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133747528G\x3EA&ENST00000318560\x2E5\x3Ac\x2E835G\x3EA|CA375249162|NONE_FOUND|7.5|evidence|4543|https://civicdb.org/links/evidence/4543|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||
9	133747568	1183	A	T	.	.	GN=ABL1;VT=BCR-ABL_E292V;CSQ=T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.875A>T||BCR-ABL_E292V|1183|BCR\x2DABL1\x20GLU292VAL&BCR\x2DABL1\x20E292V&BCR\x2DABL\x20GLU292VAL&GLU311VAL&E311V|NP\x5F005148\x2E2\x3Ap\x2EGlu292Val&NM\x5F005157\x2E5\x3Ac\x2E875A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133747568A\x3ET&ENST00000318560\x2E5\x3Ac\x2E875A\x3ET|CA375249260|NONE_FOUND|2.0|evidence|2853|https://civicdb.org/links/evidence/2853|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|2|||||
9	133747585	1506	C	G	.	.	GN=ABL1;VT=L298V;CSQ=G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.892C>G||L298V|1506|LEU298VAL&L317V|NP\x5F005148\x2E2\x3Ap\x2ELeu298Val&NM\x5F005157\x2E5\x3Ac\x2E892C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133747585C\x3EG&ENST00000318560\x2E5\x3Ac\x2E892C\x3EG|CA375249299|NONE_FOUND|2.5|evidence|4475|https://civicdb.org/links/evidence/4475|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133747588	1231	G	C	.	.	GN=ABL1;VT=BCR-ABL_V299L;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|6241|https://civicdb.org/links/evidence/6241|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)&Imatinib_Mesylate_(NCIt_ID_C1687)|Combination||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|6216|https://civicdb.org/links/evidence/6216|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|7767|https://civicdb.org/links/evidence/7767|25686603_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|6982|https://civicdb.org/links/evidence/6982|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||B|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|6247|https://civicdb.org/links/evidence/6247|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|4538|https://civicdb.org/links/evidence/4538|22371878_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|4540|https://civicdb.org/links/evidence/4540|19779040_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||BCR-ABL_V299L|1231|BCR\x2DABL1\x20VAL299LEU&BCR\x2DABL1\x20V299L&RS1057519771&BCR\x2DABL\x20V318L&BCR\x2DABL\x20VAL299LEU|ENST00000318560\x2E5\x3Ac\x2E895G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133747588G\x3EC&NP\x5F005148\x2E2\x3Ap\x2EVal299Leu&NM\x5F005157\x2E5\x3Ac\x2E895G\x3EC|CA16602575|376117|22.0|evidence|2862|https://civicdb.org/links/evidence/2862|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|3|||||
9	133747592	1527	A	G	.	.	GN=ABL1;VT=BCR-ABL_Q300R;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.899A>G||BCR-ABL_Q300R|1527|BCR\x2DABL1\x20GLN300ARG&BCR\x2DABL1\x20Q300R&BCR\x2DABL\x20GLN300ARG&Q319R|NP\x5F005148\x2E2\x3Ap\x2EGln300Arg&NM\x5F005157\x2E5\x3Ac\x2E899A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133747592A\x3EG&ENST00000318560\x2E5\x3Ac\x2E899A\x3EG|CA375249312|NONE_FOUND|5.0|evidence|6983|https://civicdb.org/links/evidence/6983|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.899A>G||BCR-ABL_Q300R|1527|BCR\x2DABL1\x20GLN300ARG&BCR\x2DABL1\x20Q300R&BCR\x2DABL\x20GLN300ARG&Q319R|NP\x5F005148\x2E2\x3Ap\x2EGln300Arg&NM\x5F005157\x2E5\x3Ac\x2E899A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133747592A\x3EG&ENST00000318560\x2E5\x3Ac\x2E899A\x3EG|CA375249312|NONE_FOUND|5.0|evidence|4545|https://civicdb.org/links/evidence/4545|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133748270	1507	T	A	.	.	GN=ABL1;VT=BCR-ABL_F311I;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>A||BCR-ABL_F311I|1507|BCR\x2DABL1\x20PHE311ILE&BCR\x2DABL1\x20F311I&BCR\x2DABL\x20PHE311ILE&RS137853304&F330I|NP\x5F005148\x2E2\x3Ap\x2EPhe311Ile&NM\x5F005157\x2E5\x3Ac\x2E931T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748270T\x3EA&ENST00000318560\x2E5\x3Ac\x2E931T\x3EA|CA375249388|NONE_FOUND|5.0|evidence|4478|https://civicdb.org/links/evidence/4478|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||
9	133748270	1528	T	C	.	.	GN=ABL1;VT=BCR-ABL_F311L;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>C||BCR-ABL_F311L|1528|BCR\x2DABL1\x20PHE311LEU&BCR\x2DABL1\x20F311L&BCR\x2DABL\x20PHE311LEU&F330L&RS137853304|ENST00000318560\x2E5\x3Ac\x2E931T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748270T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe311Leu&NM\x5F005157\x2E5\x3Ac\x2E931T\x3EC|CA122587|12628|7.0|evidence|6238|https://civicdb.org/links/evidence/6238|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Combination||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>C||BCR-ABL_F311L|1528|BCR\x2DABL1\x20PHE311LEU&BCR\x2DABL1\x20F311L&BCR\x2DABL\x20PHE311LEU&F330L&RS137853304|ENST00000318560\x2E5\x3Ac\x2E931T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748270T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe311Leu&NM\x5F005157\x2E5\x3Ac\x2E931T\x3EC|CA122587|12628|7.0|evidence|4546|https://civicdb.org/links/evidence/4546|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||
9	133748282	2335	A	G	.	.	GN=ABL1;VT=BCR-ABL_T315A;CSQ=G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.943A>G||BCR-ABL_T315A|2335|T334A&THR315ALA|ENST00000318560\x2E5\x3Ac\x2E943A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748282A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EThr315Ala&NM\x5F005157\x2E5\x3Ac\x2E943A\x3EG|CA16602576|376118|5.0|evidence|7768|https://civicdb.org/links/evidence/7768|25686603_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.943A>G||BCR-ABL_T315A|2335|T334A&THR315ALA|ENST00000318560\x2E5\x3Ac\x2E943A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748282A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EThr315Ala&NM\x5F005157\x2E5\x3Ac\x2E943A\x3EG|CA16602576|376118|5.0|evidence|6190|https://civicdb.org/links/evidence/6190|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|3|||||
9	133748283	2	C	T	.	.	GN=ABL1;VT=BCR-ABL_T315I;CSQ=T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|234|https://civicdb.org/links/evidence/234|20537386_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||B|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|235|https://civicdb.org/links/evidence/235|15194504_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|1390|https://civicdb.org/links/evidence/1390|23190221_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||B|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|2667|https://civicdb.org/links/evidence/2667|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|2668|https://civicdb.org/links/evidence/2668|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|2669|https://civicdb.org/links/evidence/2669|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|4362|https://civicdb.org/links/evidence/4362|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|4364|https://civicdb.org/links/evidence/4364|21865346_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|4365|https://civicdb.org/links/evidence/4365|19779040_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|4369|https://civicdb.org/links/evidence/4369|25686603_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||C|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|4373|https://civicdb.org/links/evidence/4373|16775234_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|4376|https://civicdb.org/links/evidence/4376|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Dasatinib_(NCIt_ID_C38713)|||C|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|2670|https://civicdb.org/links/evidence/2670|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|4|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|6192|https://civicdb.org/links/evidence/6192|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)&Imatinib_Mesylate_(NCIt_ID_C1687)|Combination||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|6196|https://civicdb.org/links/evidence/6196|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Combination||D|2|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|6234|https://civicdb.org/links/evidence/6234|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Dasatinib_(NCIt_ID_C38713)|Combination||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|6235|https://civicdb.org/links/evidence/6235|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Dasatinib_(NCIt_ID_C38713)|Combination||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|6285|https://civicdb.org/links/evidence/6285|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|6990|https://civicdb.org/links/evidence/6990|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|7038|https://civicdb.org/links/evidence/7038|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|7777|https://civicdb.org/links/evidence/7777|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Axitinib_(NCIt_ID_C38718)&Ponatinib_(NCIt_ID_C95777)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|7778|https://civicdb.org/links/evidence/7778|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)|Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|7779|https://civicdb.org/links/evidence/7779|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||D|3|||||,T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_T315I|2|BCR\x2DABL1\x20THR315ILE&BCR\x2DABL1\x20T315I&BCR\x2DABL\x20THR315ILE&RS121913459&THR334ILE|NC\x5F000009\x2E11\x3Ag\x2E133748283C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1001C\x3ET&NP\x5F005148\x2E2\x3Ap\x2EThr315Ile&NM\x5F007313\x2E2\x3Ac\x2E1001C\x3ET|CA122575|12624|134.5|evidence|7780|https://civicdb.org/links/evidence/7780|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_(NCIt_ID_C62035)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||
9	133748288	1625	T	A	.	.	GN=ABL1;VT=BCR-ABL_F317I;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>A||BCR-ABL_F317I|1625|BCR\x2DABL1\x20PHE317ILE&BCR\x2DABL1\x20F317I&BCR\x2DABL\x20PHE317ILE&RS1057519773&F336I|ENST00000318560\x2E5\x3Ac\x2E949T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe317Ile&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EA|CA16602577|376119|3.0|evidence|6251|https://civicdb.org/links/evidence/6251|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>A||BCR-ABL_F317I|1625|BCR\x2DABL1\x20PHE317ILE&BCR\x2DABL1\x20F317I&BCR\x2DABL\x20PHE317ILE&RS1057519773&F336I|ENST00000318560\x2E5\x3Ac\x2E949T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe317Ile&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EA|CA16602577|376119|3.0|evidence|6217|https://civicdb.org/links/evidence/6217|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|1|||||
9	133748288	241	T	C	.	.	GN=ABL1;VT=BCR-ABL_F317L;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|639|https://civicdb.org/links/evidence/639|25349473_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||B|5|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|637|https://civicdb.org/links/evidence/637|18818391_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|5|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|638|https://civicdb.org/links/evidence/638|24236021_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Ponatinib_(NCIt_ID_C95777)|||D|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|2674|https://civicdb.org/links/evidence/2674|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|2675|https://civicdb.org/links/evidence/2675|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|2676|https://civicdb.org/links/evidence/2676|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|2680|https://civicdb.org/links/evidence/2680|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|4381|https://civicdb.org/links/evidence/4381|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|4382|https://civicdb.org/links/evidence/4382|22371878_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|4390|https://civicdb.org/links/evidence/4390|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|6215|https://civicdb.org/links/evidence/6215|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|6252|https://civicdb.org/links/evidence/6252|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|6270|https://civicdb.org/links/evidence/6270|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|6309|https://civicdb.org/links/evidence/6309|19779040_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|6978|https://civicdb.org/links/evidence/6978|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|7030|https://civicdb.org/links/evidence/7030|17264298_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|7045|https://civicdb.org/links/evidence/7045|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|2677|https://civicdb.org/links/evidence/2677|18191450_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Nilotinib_(NCIt_ID_C48375)&Bafetinib_(NCIt_ID_C62516)|Substitutes||D|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>C||BCR-ABL_F317L|241|RS1057519773&F317L&F336L|ENST00000318560\x2E5\x3Ac\x2E949T\x3EC&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EPhe317Leu&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EC|CA16602794|376094&376352|109.5|evidence|8509|https://civicdb.org/links/evidence/8509|12623848_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||
9	133748288	1525	T	G	.	.	GN=ABL1;VT=BCR-ABL_F317V;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||BCR-ABL_F317V|1525|BCR\x2DABL1\x20PHE317VAL&BCR\x2DABL1\x20F317V&BCR\x2DABL\x20PHE317VAL&RS1057519773&F336V|ENST00000318560\x2E5\x3Ac\x2E949T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe317Val&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EG|CA16602578|376120|7.0|evidence|4535|https://civicdb.org/links/evidence/4535|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||BCR-ABL_F317V|1525|BCR\x2DABL1\x20PHE317VAL&BCR\x2DABL1\x20F317V&BCR\x2DABL\x20PHE317VAL&RS1057519773&F336V|ENST00000318560\x2E5\x3Ac\x2E949T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe317Val&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EG|CA16602578|376120|7.0|evidence|6253|https://civicdb.org/links/evidence/6253|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||BCR-ABL_F317V|1525|BCR\x2DABL1\x20PHE317VAL&BCR\x2DABL1\x20F317V&BCR\x2DABL\x20PHE317VAL&RS1057519773&F336V|ENST00000318560\x2E5\x3Ac\x2E949T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748288T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe317Val&NM\x5F005157\x2E5\x3Ac\x2E949T\x3EG|CA16602578|376120|7.0|evidence|6208|https://civicdb.org/links/evidence/6208|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|3|||||
9	133748289	2343	T	C	.	.	GN=ABL1;VT=BCR-ABL_F317S;CSQ=C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.950T>C||BCR-ABL_F317S|2343|PHE317SER|ENST00000318560\x2E5\x3Ac\x2E950T\x3EC|CA375249431|NONE_FOUND|1.0|evidence|6218|https://civicdb.org/links/evidence/6218|15705718_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|1|||||
9	133748289	2359	T	G	.	.	GN=ABL1;VT=BCR-ABL_F317C;CSQ=G|missense_variant|ABL1|25|transcript|ENST00000318560.5|||BCR-ABL_F317C|2359|F336C&PHE317CYS|ENST00000318560\x3Ac\x2E950T\x3EG|CA16602579|376121|2.0|evidence|6250|https://civicdb.org/links/evidence/6250|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||
9	133748300	1657	GG	CT	.	.	GN=ABL1;VT=G340L;CSQ=CT|coding_sequence_variant|ABL1|25|transcript|ENST00000372348.2|||G340L|1657|GLY340LEU||unregistered||3.0|evidence|4788|https://civicdb.org/links/evidence/4788|26758680_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Imatinib_Mesylate_(NCIt_ID_C1687)&Dasatinib_(NCIt_ID_C38713)|Substitutes||D|3|||||
9	133748331	1529	A	G	.	.	GN=ABL1;VT=BCR-ABL_N331S;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.992A>G||BCR-ABL_N331S|1529|BCR\x2DABL1\x20ASN331SER&BCR\x2DABL1\x20N331S&BCR\x2DABL\x20ASN331SER&RS144448357&N350S|NP\x5F005148\x2E2\x3Ap\x2EAsn331Ser&NM\x5F005157\x2E5\x3Ac\x2E992A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748331A\x3EG&ENST00000318560\x2E5\x3Ac\x2E992A\x3EG|CA5285356|NONE_FOUND|2.5|evidence|4549|https://civicdb.org/links/evidence/4549|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133748333	1656	C	T	.	.	GN=ABL1;VT=R351W;CSQ=T|missense_variant|ABL1|25|transcript|ENST00000372348.2|ENST00000372348.2:c.1051C>T||R351W|1656|RS779478267&ARG351TRP&R332W|NP\x5F009297\x2E2\x3Ap\x2EArg351Trp&NM\x5F007313\x2E2\x3Ac\x2E1051C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748333C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1051C\x3ET|CA5285359|NONE_FOUND|9.0|evidence|6376|https://civicdb.org/links/evidence/6376|26758680_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Imatinib_(NCIt_ID_C62035)|||D|5|||||,T|missense_variant|ABL1|25|transcript|ENST00000372348.2|ENST00000372348.2:c.1051C>T||R351W|1656|RS779478267&ARG351TRP&R332W|NP\x5F009297\x2E2\x3Ap\x2EArg351Trp&NM\x5F007313\x2E2\x3Ac\x2E1051C\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133748333C\x3ET&ENST00000372348\x2E2\x3Ac\x2E1051C\x3ET|CA5285359|NONE_FOUND|9.0|evidence|4787|https://civicdb.org/links/evidence/4787|26758680_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dasatinib_(NCIt_ID_C38713)|||D|4|||||
9	133748346	1640	A	G	.	.	GN=ABL1;VT=BCR-ABL_N336S;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1007A>G||BCR-ABL_N336S|1640|BCR\x2DABL1\x20N336S&BCR\x2DABL\x20N336S&BCR\x2DABL1\x20ASN336SER&N355S|NP\x5F005148\x2E2\x3Ap\x2EAsn336Ser&NM\x5F005157\x2E5\x3Ac\x2E1007A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748346A\x3EG&ENST00000318560\x2E5\x3Ac\x2E1007A\x3EG|CA375249553|NONE_FOUND|5.0|evidence|6979|https://civicdb.org/links/evidence/6979|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1007A>G||BCR-ABL_N336S|1640|BCR\x2DABL1\x20N336S&BCR\x2DABL\x20N336S&BCR\x2DABL1\x20ASN336SER&N355S|NP\x5F005148\x2E2\x3Ap\x2EAsn336Ser&NM\x5F005157\x2E5\x3Ac\x2E1007A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748346A\x3EG&ENST00000318560\x2E5\x3Ac\x2E1007A\x3EG|CA375249553|NONE_FOUND|5.0|evidence|4769|https://civicdb.org/links/evidence/4769|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133748367	1524	T	C	.	.	GN=ABL1;VT=BCR-ABL_M343T;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1028T>C||BCR-ABL_M343T|1524|BCR\x2DABL1\x20MET343THR&BCR\x2DABL1\x20M343T&BCR\x2DABL\x20MET343THR&M362T|NP\x5F005148\x2E2\x3Ap\x2EMet343Thr&NM\x5F005157\x2E5\x3Ac\x2E1028T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748367T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1028T\x3EC|CA375249596|NONE_FOUND|2.0|evidence|4534|https://civicdb.org/links/evidence/4534|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||
9	133748391	1029	T	C	.	.	GN=ABL1;VT=BCR-ABL_M351T;CSQ=C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|2682|https://civicdb.org/links/evidence/2682|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|3|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|2683|https://civicdb.org/links/evidence/2683|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|4|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|2684|https://civicdb.org/links/evidence/2684|15930265_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|4394|https://civicdb.org/links/evidence/4394|22371878_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|4396|https://civicdb.org/links/evidence/4396|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|4|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|4397|https://civicdb.org/links/evidence/4397|17264298_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|4398|https://civicdb.org/links/evidence/4398|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|2685|https://civicdb.org/links/evidence/2685|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|3|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|6254|https://civicdb.org/links/evidence/6254|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|6989|https://civicdb.org/links/evidence/6989|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|7037|https://civicdb.org/links/evidence/7037|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,C|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||BCR-ABL_M351T|1029|BCR\x2DABL1\x20M351T&MET370THR&MET351THR&M370T&RS121913457|ENST00000318560\x2E5\x3Ac\x2E1052T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133748391T\x3EC&NP\x5F005148\x2E2\x3Ap\x2EMet351Thr&NM\x5F005157\x2E5\x3Ac\x2E1052T\x3EC|CA122590|12629|50.0|evidence|7769|https://civicdb.org/links/evidence/7769|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||
9	133748403	1487	A	G	.	.	GN=ABL1;VT=BCR-ABL_E355G;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|2664|https://civicdb.org/links/evidence/2664|12623848_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|8090|https://civicdb.org/links/evidence/8090|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|4402|https://civicdb.org/links/evidence/4402|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|4404|https://civicdb.org/links/evidence/4404|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|7036|https://civicdb.org/links/evidence/7036|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|4400|https://civicdb.org/links/evidence/4400|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|6255|https://civicdb.org/links/evidence/6255|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||BCR-ABL_E355G|1487|BCR\x2DABL1\x20GLU355GLY&BCR\x2DABL1\x20E355G&BCR\x2DABL\x20GLU355GLY&RS121913450|ENST00000318560\x2E5\x3Ac\x2E1064A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748403A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EGlu355Gly&NM\x5F005157\x2E5\x3Ac\x2E1064A\x3EG|CA16602556|376095|34.5|evidence|4403|https://civicdb.org/links/evidence/4403|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|2|||||
9	133748414	892	T	G	.	.	GN=ABL1;VT=BCR-ABL_F359V;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|3815|https://civicdb.org/links/evidence/3815|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|3816|https://civicdb.org/links/evidence/3816|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|3817|https://civicdb.org/links/evidence/3817|17264298_(PubMed)|Somatic|accepted|Reduced_Sensitivity|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|3819|https://civicdb.org/links/evidence/3819|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|3820|https://civicdb.org/links/evidence/3820|16775234_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|3822|https://civicdb.org/links/evidence/3822|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|2167|https://civicdb.org/links/evidence/2167|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|2168|https://civicdb.org/links/evidence/2168|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|2169|https://civicdb.org/links/evidence/2169|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|2170|https://civicdb.org/links/evidence/2170|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|6256|https://civicdb.org/links/evidence/6256|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|6970|https://civicdb.org/links/evidence/6970|19652056_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Substitutes||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|6995|https://civicdb.org/links/evidence/6995|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|7043|https://civicdb.org/links/evidence/7043|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>G||BCR-ABL_F359V|892|BCR\x2DABL1\x20PHE359VAL&BCR\x2DABL1\x20F359V&BCR\x2DABL\x20PHE359VAL&BCR\x2DABL\x20F378V&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Val&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EG|CA16602557|376096|54.0|evidence|8002|https://civicdb.org/links/evidence/8002|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||
9	133748414	1523	T	A	.	.	GN=ABL1;VT=BCR-ABL_F359I;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||BCR-ABL_F359I|1523|BCR\x2DABL1\x20PHE359ILE&BCR\x2DABL1\x20F359I&BCR\x2DABL\x20PHE359ILE&F378I&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe359Ile&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EA|CA16602580|376122|29.5|evidence|4533|https://civicdb.org/links/evidence/4533|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||BCR-ABL_F359I|1523|BCR\x2DABL1\x20PHE359ILE&BCR\x2DABL1\x20F359I&BCR\x2DABL\x20PHE359ILE&F378I&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe359Ile&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EA|CA16602580|376122|29.5|evidence|4529|https://civicdb.org/links/evidence/4529|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||BCR-ABL_F359I|1523|BCR\x2DABL1\x20PHE359ILE&BCR\x2DABL1\x20F359I&BCR\x2DABL\x20PHE359ILE&F378I&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe359Ile&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EA|CA16602580|376122|29.5|evidence|6984|https://civicdb.org/links/evidence/6984|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||BCR-ABL_F359I|1523|BCR\x2DABL1\x20PHE359ILE&BCR\x2DABL1\x20F359I&BCR\x2DABL\x20PHE359ILE&F378I&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe359Ile&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EA|CA16602580|376122|29.5|evidence|4532|https://civicdb.org/links/evidence/4532|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||BCR-ABL_F359I|1523|BCR\x2DABL1\x20PHE359ILE&BCR\x2DABL1\x20F359I&BCR\x2DABL\x20PHE359ILE&F378I&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe359Ile&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EA|CA16602580|376122|29.5|evidence|4530|https://civicdb.org/links/evidence/4530|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||BCR-ABL_F359I|1523|BCR\x2DABL1\x20PHE359ILE&BCR\x2DABL1\x20F359I&BCR\x2DABL\x20PHE359ILE&F378I&RS121913452|ENST00000318560\x2E5\x3Ac\x2E1075T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133748414T\x3EA&NP\x5F005148\x2E2\x3Ap\x2EPhe359Ile&NM\x5F005157\x2E5\x3Ac\x2E1075T\x3EA|CA16602580|376122|29.5|evidence|4531|https://civicdb.org/links/evidence/4531|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||
9	133748415	1184	T	G	.	.	GN=ABL1;VT=BCR-ABL_F359C;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|4481|https://civicdb.org/links/evidence/4481|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|6239|https://civicdb.org/links/evidence/6239|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Combination||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|7035|https://civicdb.org/links/evidence/7035|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|4480|https://civicdb.org/links/evidence/4480|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|4483|https://civicdb.org/links/evidence/4483|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|4|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|2854|https://civicdb.org/links/evidence/2854|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Substitutes||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|4482|https://civicdb.org/links/evidence/4482|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|6985|https://civicdb.org/links/evidence/6985|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||BCR-ABL_F359C|1184|BCR\x2DABL1\x20PHE359CYS&BCR\x2DABL1\x20F359C&BCR\x2DABL\x20PHE359CYS&RS1057519775&F378C|ENST00000318560\x2E5\x3Ac\x2E1076T\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133748415T\x3EG&NP\x5F005148\x2E2\x3Ap\x2EPhe359Cys&NM\x5F005157\x2E5\x3Ac\x2E1076T\x3EG|CA16602582|376124|41.5|evidence|6233|https://civicdb.org/links/evidence/6233|19652056_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Substitutes||C|3|||||
9	133750260	1530	T	C	.	.	GN=ABL1;VT=BCR-ABL_L364P;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1091T>C||BCR-ABL_L364P|1530|BCR\x2DABL1\x20LEU364PRO&BCR\x2DABL1\x20L364P&BCR\x2DABL\x20LEU364PRO&L383P|NP\x5F005148\x2E2\x3Ap\x2ELeu364Pro&NM\x5F005157\x2E5\x3Ac\x2E1091T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750260T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1091T\x3EC|CA375249757|NONE_FOUND|2.5|evidence|4551|https://civicdb.org/links/evidence/4551|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133750304	1609	G	A	.	.	GN=ABL1;VT=BCR-ABL_V379I;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||BCR-ABL_V379I|1609|BCR\x2DABL1\x20VAL379ILE&BCR\x2DABL1\x20V379I&BCR\x2DABL\x20VAL379ILE&V398I|NP\x5F005148\x2E2\x3Ap\x2EVal379Ile&NM\x5F005157\x2E5\x3Ac\x2E1135G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750304G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1135G\x3EA|CA375249852|NONE_FOUND|7.0|evidence|4702|https://civicdb.org/links/evidence/4702|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||BCR-ABL_V379I|1609|BCR\x2DABL1\x20VAL379ILE&BCR\x2DABL1\x20V379I&BCR\x2DABL\x20VAL379ILE&V398I|NP\x5F005148\x2E2\x3Ap\x2EVal379Ile&NM\x5F005157\x2E5\x3Ac\x2E1135G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750304G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1135G\x3EA|CA375249852|NONE_FOUND|7.0|evidence|4704|https://civicdb.org/links/evidence/4704|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||BCR-ABL_V379I|1609|BCR\x2DABL1\x20VAL379ILE&BCR\x2DABL1\x20V379I&BCR\x2DABL\x20VAL379ILE&V398I|NP\x5F005148\x2E2\x3Ap\x2EVal379Ile&NM\x5F005157\x2E5\x3Ac\x2E1135G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750304G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1135G\x3EA|CA375249852|NONE_FOUND|7.0|evidence|7033|https://civicdb.org/links/evidence/7033|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||BCR-ABL_V379I|1609|BCR\x2DABL1\x20VAL379ILE&BCR\x2DABL1\x20V379I&BCR\x2DABL\x20VAL379ILE&V398I|NP\x5F005148\x2E2\x3Ap\x2EVal379Ile&NM\x5F005157\x2E5\x3Ac\x2E1135G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750304G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1135G\x3EA|CA375249852|NONE_FOUND|7.0|evidence|6257|https://civicdb.org/links/evidence/6257|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||
9	133750319	1230	C	A	.	.	GN=ABL1;VT=BCR-ABL_L384M;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1150C>A||BCR-ABL_L384M|1230|BCR\x2DABL1\x20LEU384MET&BCR\x2DABL1\x20L384M&LEU384MET&LEU403MET&L403M|NP\x5F005148\x2E2\x3Ap\x2ELeu384Met&NM\x5F005157\x2E5\x3Ac\x2E1150C\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750319C\x3EA&ENST00000318560\x2E5\x3Ac\x2E1150C\x3EA|CA375249885|NONE_FOUND|5.5|evidence|4525|https://civicdb.org/links/evidence/4525|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1150C>A||BCR-ABL_L384M|1230|BCR\x2DABL1\x20LEU384MET&BCR\x2DABL1\x20L384M&LEU384MET&LEU403MET&L403M|NP\x5F005148\x2E2\x3Ap\x2ELeu384Met&NM\x5F005157\x2E5\x3Ac\x2E1150C\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750319C\x3EA&ENST00000318560\x2E5\x3Ac\x2E1150C\x3EA|CA375249885|NONE_FOUND|5.5|evidence|4527|https://civicdb.org/links/evidence/4527|19779040_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1150C>A||BCR-ABL_L384M|1230|BCR\x2DABL1\x20LEU384MET&BCR\x2DABL1\x20L384M&LEU384MET&LEU403MET&L403M|NP\x5F005148\x2E2\x3Ap\x2ELeu384Met&NM\x5F005157\x2E5\x3Ac\x2E1150C\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750319C\x3EA&ENST00000318560\x2E5\x3Ac\x2E1150C\x3EA|CA375249885|NONE_FOUND|5.5|evidence|2861|https://civicdb.org/links/evidence/2861|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)&Nilotinib_(NCIt_ID_C48375)|Substitutes||D|1|||||
9	133750328	1488	T	A	.	.	GN=ABL1;VT=BCR-ABL_L387M;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1159T>A||BCR-ABL_L387M|1488|BCR\x2DABL1\x20LEU387MET&BCR\x2DABL1\x20L387M&BCR\x2DABL\x20LEU387MET|NP\x5F005148\x2E2\x3Ap\x2ELeu387Met&NM\x5F005157\x2E5\x3Ac\x2E1159T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750328T\x3EA&ENST00000318560\x2E5\x3Ac\x2E1159T\x3EA|CA375249905|NONE_FOUND|7.5|evidence|4407|https://civicdb.org/links/evidence/4407|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1159T>A||BCR-ABL_L387M|1488|BCR\x2DABL1\x20LEU387MET&BCR\x2DABL1\x20L387M&BCR\x2DABL\x20LEU387MET|NP\x5F005148\x2E2\x3Ap\x2ELeu387Met&NM\x5F005157\x2E5\x3Ac\x2E1159T\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750328T\x3EA&ENST00000318560\x2E5\x3Ac\x2E1159T\x3EA|CA375249905|NONE_FOUND|7.5|evidence|4406|https://civicdb.org/links/evidence/4406|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||
9	133750330	1232	G	C	.	.	GN=ABL1;VT=BCR-ABL_L387F;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1161G>C||BCR-ABL_L387F|1232|BCR\x2DABL1\x20LEU387PHE&BCR\x2DABL1\x20L387F&LEU387PHE&LEU406PHE&L406F|NP\x5F005148\x2E2\x3Ap\x2ELeu387Phe&NM\x5F005157\x2E5\x3Ac\x2E1161G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750330G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1161G\x3EC|CA375249910|NONE_FOUND|7.0|evidence|6981|https://civicdb.org/links/evidence/6981|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1161G>C||BCR-ABL_L387F|1232|BCR\x2DABL1\x20LEU387PHE&BCR\x2DABL1\x20L387F&LEU387PHE&LEU406PHE&L406F|NP\x5F005148\x2E2\x3Ap\x2ELeu387Phe&NM\x5F005157\x2E5\x3Ac\x2E1161G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750330G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1161G\x3EC|CA375249910|NONE_FOUND|7.0|evidence|4552|https://civicdb.org/links/evidence/4552|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1161G>C||BCR-ABL_L387F|1232|BCR\x2DABL1\x20LEU387PHE&BCR\x2DABL1\x20L387F&LEU387PHE&LEU406PHE&L406F|NP\x5F005148\x2E2\x3Ap\x2ELeu387Phe&NM\x5F005157\x2E5\x3Ac\x2E1161G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750330G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1161G\x3EC|CA375249910|NONE_FOUND|7.0|evidence|2863|https://civicdb.org/links/evidence/2863|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|2|||||
9	133750356	1531	A	C	.	.	GN=ABL1;VT=BCR-ABL_H396P;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||BCR-ABL_H396P|1531|BCR\x2DABL1\x20HIS396PRO&BCR\x2DABL1\x20H396P&BCR\x2DABL\x20HIS396PRO|NP\x5F005148\x2E2\x3Ap\x2EHis396Pro&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EC&ENST00000318560\x2E5\x3Ac\x2E1187A\x3EC|CA375249969|NONE_FOUND|9.0|evidence|7770|https://civicdb.org/links/evidence/7770|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||BCR-ABL_H396P|1531|BCR\x2DABL1\x20HIS396PRO&BCR\x2DABL1\x20H396P&BCR\x2DABL\x20HIS396PRO|NP\x5F005148\x2E2\x3Ap\x2EHis396Pro&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EC&ENST00000318560\x2E5\x3Ac\x2E1187A\x3EC|CA375249969|NONE_FOUND|9.0|evidence|6240|https://civicdb.org/links/evidence/6240|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)&Imatinib_Mesylate_(NCIt_ID_C1687)|Combination||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||BCR-ABL_H396P|1531|BCR\x2DABL1\x20HIS396PRO&BCR\x2DABL1\x20H396P&BCR\x2DABL\x20HIS396PRO|NP\x5F005148\x2E2\x3Ap\x2EHis396Pro&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EC&ENST00000318560\x2E5\x3Ac\x2E1187A\x3EC|CA375249969|NONE_FOUND|9.0|evidence|4554|https://civicdb.org/links/evidence/4554|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||
9	133750356	1030	A	G	.	.	GN=ABL1;VT=BCR-ABL_H396R;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|6988|https://civicdb.org/links/evidence/6988|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|4411|https://civicdb.org/links/evidence/4411|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|4413|https://civicdb.org/links/evidence/4413|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|2687|https://civicdb.org/links/evidence/2687|19075254_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|4417|https://civicdb.org/links/evidence/4417|25686603_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|2688|https://civicdb.org/links/evidence/2688|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|6258|https://civicdb.org/links/evidence/6258|16772610_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||D|2|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|2689|https://civicdb.org/links/evidence/2689|15930265_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|None|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|7823|https://civicdb.org/links/evidence/7823|16775234_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|3|||||,G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||BCR-ABL_H396R|1030|BCR\x2DABL1\x20HIS396ARG&BCR\x2DABL1\x20H396R&BCR\x2DABL\x20H415R&BCR\x2DABL\x20HIS396ARG&BCR\x2DABL\x20HIS415ARG&RS121913454|ENST00000318560\x2E5\x3Ac\x2E1187A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750356A\x3EG&NP\x5F005148\x2E2\x3Ap\x2EHis396Arg&NM\x5F005157\x2E5\x3Ac\x2E1187A\x3EG|CA16602558|376097|36.0|evidence|4410|https://civicdb.org/links/evidence/4410|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133750358	1612	G	C	.	.	GN=ABL1;VT=BCR-ABL_A397P;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1189G>C||BCR-ABL_A397P|1612|BCR\x2DABL1\x20A397P&ALA397PRO&A416P|NP\x5F005148\x2E2\x3Ap\x2EAla397Pro&NM\x5F005157\x2E5\x3Ac\x2E1189G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750358G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1189G\x3EC|CA375249974|NONE_FOUND|5.0|evidence|4710|https://civicdb.org/links/evidence/4710|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1189G>C||BCR-ABL_A397P|1612|BCR\x2DABL1\x20A397P&ALA397PRO&A416P|NP\x5F005148\x2E2\x3Ap\x2EAla397Pro&NM\x5F005157\x2E5\x3Ac\x2E1189G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750358G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1189G\x3EC|CA375249974|NONE_FOUND|5.0|evidence|7034|https://civicdb.org/links/evidence/7034|17264298_(PubMed)|None|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||
9	133750361	1233	G	C	.	.	GN=ABL1;VT=BCR-ABL_G398R;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1192G>C||BCR-ABL_G398R|1233|BCR\x2DABL1\x20GLY398ARG&BCR\x2DABL1\x20G398R&BCR\x2DABL\x20GLY398ARG&BCR\x2DABL\x20GLY417ARG&BCR\x2DABL\x20G417R|NP\x5F005148\x2E2\x3Ap\x2EGly398Arg&NM\x5F005157\x2E5\x3Ac\x2E1192G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750361G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1192G\x3EC|CA375249980|NONE_FOUND|5.0|evidence|4561|https://civicdb.org/links/evidence/4561|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1192G>C||BCR-ABL_G398R|1233|BCR\x2DABL1\x20GLY398ARG&BCR\x2DABL1\x20G398R&BCR\x2DABL\x20GLY398ARG&BCR\x2DABL\x20GLY417ARG&BCR\x2DABL\x20G417R|NP\x5F005148\x2E2\x3Ap\x2EGly398Arg&NM\x5F005157\x2E5\x3Ac\x2E1192G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133750361G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1192G\x3EC|CA375249980|NONE_FOUND|5.0|evidence|2864|https://civicdb.org/links/evidence/2864|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|3|||||
9	133750419	1613	C	A	.	.	GN=ABL1;VT=S417Y;CSQ=A|missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1250C>A||S417Y|1613|SER417TYR&S436Y|NP\x5F005148\x2E2\x3Ap\x2ESer417Tyr&NM\x5F005157\x2E5\x3Ac\x2E1250C\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133750419C\x3EA&ENST00000318560\x2E5\x3Ac\x2E1250C\x3EA|CA375250115|NONE_FOUND|0.0|evidence|2679|https://civicdb.org/links/evidence/2679|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||
9	133750431	1532	A	G	.	.	GN=ABL1;VT=BCR-ABL_D421G;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1262A>G||BCR-ABL_D421G|1532|BCR\x2DABL1\x20ASP421GLY&BCR\x2DABL\x20ASP421GLY&BCR\x2DABL1\x20D421G|NP\x5F005148\x2E2\x3Ap\x2EAsp421Gly&NM\x5F005157\x2E5\x3Ac\x2E1262A\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133750431A\x3EG&ENST00000318560\x2E5\x3Ac\x2E1262A\x3EG|CA375250143|NONE_FOUND|2.5|evidence|4559|https://civicdb.org/links/evidence/4559|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133753880	1534	A	T	.	.	GN=ABL1;VT=BCR-ABL_E450V;CSQ=T|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1349A>T||BCR-ABL_E450V|1534|BCR\x2DABL1\x20E450V&BCR\x2DABL1\x20GLU450VAL&BCR\x2DABL\x20GLU450VAL&E469V|NP\x5F005148\x2E2\x3Ap\x2EGlu450Val&NM\x5F005157\x2E5\x3Ac\x2E1349A\x3ET&NC\x5F000009\x2E11\x3Ag\x2E133753880A\x3ET&ENST00000318560\x2E5\x3Ac\x2E1349A\x3ET|CA375251155|NONE_FOUND|5.0|evidence|4563|https://civicdb.org/links/evidence/4563|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||
9	133753888	1509	G	C	.	.	GN=ABL1;VT=BCR-ABL_E453Q;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1357G>C||BCR-ABL_E453Q|1509|BCR\x2DABL1\x20GLU453GLN&BCR\x2DABL1\x20E453Q&BCR\x2DABL\x20GLU453GLN&E472Q|NP\x5F005148\x2E2\x3Ap\x2EGlu453Gln&NM\x5F005157\x2E5\x3Ac\x2E1357G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133753888G\x3EC&ENST00000318560\x2E5\x3Ac\x2E1357G\x3EC|CA375251170|NONE_FOUND|5.0|evidence|4486|https://civicdb.org/links/evidence/4486|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|2|||||
9	133753888	1535	G	A	.	.	GN=ABL1;VT=BCR-ABL_E453K;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1357G>A||BCR-ABL_E453K|1535|BCR\x2DABL1\x20GLU453LYS&BCR\x2DABL1\x20E453K&BCR\x2DABL\x20GLU453LYS&E472K|NP\x5F005148\x2E2\x3Ap\x2EGlu453Lys&NM\x5F005157\x2E5\x3Ac\x2E1357G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133753888G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1357G\x3EA|CA375251169|NONE_FOUND|2.5|evidence|4565|https://civicdb.org/links/evidence/4565|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133753889	1536	A	C	.	.	GN=ABL1;VT=BCR-ABL_E453A;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1358A>C||BCR-ABL_E453A|1536|BCR\x2DABL1\x20GLU453ALA&BCR\x2DABL1\x20E453A&GLU453ALA&E472A|NP\x5F005148\x2E2\x3Ap\x2EGlu453Ala&NM\x5F005157\x2E5\x3Ac\x2E1358A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133753889A\x3EC&ENST00000318560\x2E5\x3Ac\x2E1358A\x3EC|CA375251172|NONE_FOUND|5.0|evidence|6980|https://civicdb.org/links/evidence/6980|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1358A>C||BCR-ABL_E453A|1536|BCR\x2DABL1\x20GLU453ALA&BCR\x2DABL1\x20E453A&GLU453ALA&E472A|NP\x5F005148\x2E2\x3Ap\x2EGlu453Ala&NM\x5F005157\x2E5\x3Ac\x2E1358A\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133753889A\x3EC&ENST00000318560\x2E5\x3Ac\x2E1358A\x3EC|CA375251172|NONE_FOUND|5.0|evidence|4567|https://civicdb.org/links/evidence/4567|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133753906	2370	G	A	.	.	GN=ABL1;VT=BCR-ABL_E459K;CSQ=A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||BCR-ABL_E459K|2370|BCR\x2DABL1\x20GLU459LYS&BCR\x2DABL1\x20E459K&RS1064156&BCR\x2DABL\x20GLU459LYS|NP\x5F005148\x2E2\x3Ap\x2EGlu459Lys&NM\x5F005157\x2E5\x3Ac\x2E1375G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133753906G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1375G\x3EA|CA200648598|NONE_FOUND|20.0|evidence|8092|https://civicdb.org/links/evidence/8092|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||BCR-ABL_E459K|2370|BCR\x2DABL1\x20GLU459LYS&BCR\x2DABL1\x20E459K&RS1064156&BCR\x2DABL\x20GLU459LYS|NP\x5F005148\x2E2\x3Ap\x2EGlu459Lys&NM\x5F005157\x2E5\x3Ac\x2E1375G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133753906G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1375G\x3EA|CA200648598|NONE_FOUND|20.0|evidence|7031|https://civicdb.org/links/evidence/7031|17264298_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||BCR-ABL_E459K|2370|BCR\x2DABL1\x20GLU459LYS&BCR\x2DABL1\x20E459K&RS1064156&BCR\x2DABL\x20GLU459LYS|NP\x5F005148\x2E2\x3Ap\x2EGlu459Lys&NM\x5F005157\x2E5\x3Ac\x2E1375G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133753906G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1375G\x3EA|CA200648598|NONE_FOUND|20.0|evidence|7046|https://civicdb.org/links/evidence/7046|17264298_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,A|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||BCR-ABL_E459K|2370|BCR\x2DABL1\x20GLU459LYS&BCR\x2DABL1\x20E459K&RS1064156&BCR\x2DABL\x20GLU459LYS|NP\x5F005148\x2E2\x3Ap\x2EGlu459Lys&NM\x5F005157\x2E5\x3Ac\x2E1375G\x3EA&NC\x5F000009\x2E11\x3Ag\x2E133753906G\x3EA&ENST00000318560\x2E5\x3Ac\x2E1375G\x3EA|CA200648598|NONE_FOUND|20.0|evidence|6310|https://civicdb.org/links/evidence/6310|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||
9	133753954	1639	TG	GT	.	.	GN=ABL1;VT=C475V;CSQ=GT|splice_donor_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1423_1424delinsGT||C475V|1639|CYS475VAL|NM\x5F005157\x2E6\x3Ac\x2E1423\x5F1424delinsGT&NC\x5F000009\x2E11\x3Ag\x2E133753954\x5F133755455delinsGT&ENST00000318560\x2E5\x3Ac\x2E1423\x5F1424delinsGT|CA913189156|NONE_FOUND|5.0|evidence|6977|https://civicdb.org/links/evidence/6977|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,GT|splice_donor_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1423_1424delinsGT||C475V|1639|CYS475VAL|NM\x5F005157\x2E6\x3Ac\x2E1423\x5F1424delinsGT&NC\x5F000009\x2E11\x3Ag\x2E133753954\x5F133755455delinsGT&ENST00000318560\x2E5\x3Ac\x2E1423\x5F1424delinsGT|CA913189156|NONE_FOUND|5.0|evidence|4768|https://civicdb.org/links/evidence/4768|22371878_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133755469	1537	C	G	.	.	GN=ABL1;VT=BCR-ABL_P480A;CSQ=G|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1438C>G||BCR-ABL_P480A|1537|BCR\x2DABL1\x20PRO480ALA&BCR\x2DABL1\x20P480A&BCR\x2DABL\x20PRO480ALA&P499A|NP\x5F005148\x2E2\x3Ap\x2EPro480Ala&NM\x5F005157\x2E5\x3Ac\x2E1438C\x3EG&NC\x5F000009\x2E11\x3Ag\x2E133755469C\x3EG&ENST00000318560\x2E5\x3Ac\x2E1438C\x3EG|CA375251559|NONE_FOUND|2.5|evidence|4568|https://civicdb.org/links/evidence/4568|21865346_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||
9	133755488	1152	T	C	.	.	GN=ABL1;VT=BCR-ABL_F486S;CSQ=C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1457T>C||BCR-ABL_F486S|1152|BCR\x2DABL1\x20F486S&BCR\x2DABL1\x20PHE486SER&BCR\x2DABL\x20PHE486SER&BCR\x2DABL\x20F505S|NP\x5F005148\x2E2\x3Ap\x2EPhe486Ser&NM\x5F005157\x2E5\x3Ac\x2E1457T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133755488T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1457T\x3EC|CA375251598|NONE_FOUND|25.0|evidence|8091|https://civicdb.org/links/evidence/8091|12623848_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_(NCIt_ID_C62035)|||C|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1457T>C||BCR-ABL_F486S|1152|BCR\x2DABL1\x20F486S&BCR\x2DABL1\x20PHE486SER&BCR\x2DABL\x20PHE486SER&BCR\x2DABL\x20F505S|NP\x5F005148\x2E2\x3Ap\x2EPhe486Ser&NM\x5F005157\x2E5\x3Ac\x2E1457T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133755488T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1457T\x3EC|CA375251598|NONE_FOUND|25.0|evidence|4438|https://civicdb.org/links/evidence/4438|25686603_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Axitinib_(NCIt_ID_C38718)|||D|2|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1457T>C||BCR-ABL_F486S|1152|BCR\x2DABL1\x20F486S&BCR\x2DABL1\x20PHE486SER&BCR\x2DABL\x20PHE486SER&BCR\x2DABL\x20F505S|NP\x5F005148\x2E2\x3Ap\x2EPhe486Ser&NM\x5F005157\x2E5\x3Ac\x2E1457T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133755488T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1457T\x3EC|CA375251598|NONE_FOUND|25.0|evidence|6987|https://civicdb.org/links/evidence/6987|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Imatinib_Mesylate_(NCIt_ID_C1687)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1457T>C||BCR-ABL_F486S|1152|BCR\x2DABL1\x20F486S&BCR\x2DABL1\x20PHE486SER&BCR\x2DABL\x20PHE486SER&BCR\x2DABL\x20F505S|NP\x5F005148\x2E2\x3Ap\x2EPhe486Ser&NM\x5F005157\x2E5\x3Ac\x2E1457T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133755488T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1457T\x3EC|CA375251598|NONE_FOUND|25.0|evidence|4571|https://civicdb.org/links/evidence/4571|19779040_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Myeloid_Leukemia_(DOID_8552)|Dasatinib_(NCIt_ID_C38713)|||B|3|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1457T>C||BCR-ABL_F486S|1152|BCR\x2DABL1\x20F486S&BCR\x2DABL1\x20PHE486SER&BCR\x2DABL\x20PHE486SER&BCR\x2DABL\x20F505S|NP\x5F005148\x2E2\x3Ap\x2EPhe486Ser&NM\x5F005157\x2E5\x3Ac\x2E1457T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133755488T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1457T\x3EC|CA375251598|NONE_FOUND|25.0|evidence|4440|https://civicdb.org/links/evidence/4440|22371878_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Bosutinib_(NCIt_ID_C60809)|||C|1|||||,C|transcript_fusion&missense_variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1457T>C||BCR-ABL_F486S|1152|BCR\x2DABL1\x20F486S&BCR\x2DABL1\x20PHE486SER&BCR\x2DABL\x20PHE486SER&BCR\x2DABL\x20F505S|NP\x5F005148\x2E2\x3Ap\x2EPhe486Ser&NM\x5F005157\x2E5\x3Ac\x2E1457T\x3EC&NC\x5F000009\x2E11\x3Ag\x2E133755488T\x3EC&ENST00000318560\x2E5\x3Ac\x2E1457T\x3EC|CA375251598|NONE_FOUND|25.0|evidence|2829|https://civicdb.org/links/evidence/2829|19075254_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)|Nilotinib_(NCIt_ID_C48375)|||D|3|||||
9	135771933	714	G	A	.	.	GN=TSC1;VT=R1062W;CSQ=A|missense_variant|TSC1|7248|transcript|ENST00000298552.3|ENST00000298552.3:c.3184C>T||R1062W|714|ARG1062TRP|NC\x5F000009\x2E11\x3Ag\x2E135771933G\x3EA&ENST00000298552\x2E3\x3Ac\x2E3184C\x3ET&NP\x5F000359\x2E1\x3Ap\x2EArg1062Trp&NM\x5F000368\x2E3\x3Ac\x2E3184C\x3ET|CA007223|49015|8.0|evidence|1921|https://civicdb.org/links/evidence/1921|21309039_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Tuberous_Sclerosis_(DOID_13515)||||D|3|||||,A|missense_variant|TSC1|7248|transcript|ENST00000298552.3|ENST00000298552.3:c.3184C>T||R1062W|714|ARG1062TRP|NC\x5F000009\x2E11\x3Ag\x2E135771933G\x3EA&ENST00000298552\x2E3\x3Ac\x2E3184C\x3ET&NP\x5F000359\x2E1\x3Ap\x2EArg1062Trp&NM\x5F000368\x2E3\x3Ac\x2E3184C\x3ET|CA007223|49015|8.0|evidence|1768|https://civicdb.org/links/evidence/1768|20165957_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Tuberous_Sclerosis_(DOID_13515)||||C|2|||||
9	139390861	137	GG	GTGT	.	.	GN=NOTCH1;VT=V2444FS;CSQ=TGT|frameshift_variant|NOTCH1|4851|transcript|ENST00000277541.6|ENST00000277541.6:c.7330delinsACA||V2444FS|137|VAL2444FS|ENST00000277541\x2E6\x3Ac\x2E7330delinsACA|None|NONE_FOUND|20.0|evidence|383|https://civicdb.org/links/evidence/383|20007775_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||
9	139391212	136	G	A	.	.	GN=NOTCH1;VT=R2327W;CSQ=A|missense_variant|NOTCH1|4851|transcript|ENST00000277541.6|||R2327W|136|ARG2327TRP|NC\x5F000009\x2E11\x3Ag\x2E139391212G\x3EA&NP\x5F060087\x2E3\x3Ap\x2EArg2327Trp&NM\x5F017617\x2E4\x3Ac\x2E6979C\x3ET|CA5339772|376346|20.0|evidence|381|https://civicdb.org/links/evidence/381|20007775_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||
9	139391369	138	G	GA	.	.	GN=NOTCH1;VT=S2275FS;CSQ=A|plus_1_frameshift_variant|NOTCH1|4851|transcript|ENST00000277541.6|ENST00000277541.6:c.6821_6822insT||S2275FS|138||NC\x5F000009\x2E11\x3Ag\x2E139391369\x5F139391370insA&ENST00000277541\x2E6\x3Ac\x2E6821\x5F6822insT|CA645544343|NONE_FOUND|20.0|evidence|382|https://civicdb.org/links/evidence/382|20007775_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||
9	139399219	135	C	G	.	.	GN=NOTCH1;VT=D1642H;CSQ=G|missense_variant|NOTCH1|4851|transcript|ENST00000277541.6|ENST00000277541.6:c.4924G>C||D1642H|135|ASP1642HIS|NP\x5F060087\x2E3\x3Ap\x2EAsp1642His&NM\x5F017617\x2E4\x3Ac\x2E4924G\x3EC&ENST00000277541\x2E6\x3Ac\x2E4924G\x3EC&NC\x5F000009\x2E11\x3Ag\x2E139399219C\x3EG|CA16602788|376345|20.0|evidence|380|https://civicdb.org/links/evidence/380|20007775_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||
10	43609070	1260	G	A	.	.	GN=RET;VT=C609Y;CSQ=A|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.1826G>A||C609Y|1260|CYS609TYR|ENST00000355710\x2E3\x3Ac\x2E1826G\x3EA&NP\x5F065681\x2E1\x3Ap\x2ECys609Tyr&NC\x5F000010\x2E10\x3Ag\x2E43609070G\x3EA&NM\x5F020630\x2E4\x3Ac\x2E1826G\x3EA|CA007824|13933|20.0|evidence|2913|https://civicdb.org/links/evidence/2913|19472011_(PubMed)|Rare_Germline|accepted|Pathogenic|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)||||B|4|||||
10	43609950	112	C	G	.	.	GN=RET;VT=C634W;CSQ=G|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.1902C>G||C634W|112|CYS634TRP|NC\x5F000010\x2E10\x3Ag\x2E43609950C\x3EG&ENST00000355710\x2E3\x3Ac\x2E1902C\x3EG&NP\x5F065681\x2E1\x3Ap\x2ECys634Trp&NM\x5F020975\x2E4\x3Ac\x2E1902C\x3EG|CA008378|13918|3.0|evidence|75|https://civicdb.org/links/evidence/75|21422803_(PubMed)|Somatic|accepted|Resistance|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)|Motesanib_(NCIt_ID_C71896)|||D|3|||||
10	43617416	113	T	C	.	.	GN=RET;VT=M918T;CSQ=C|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|RS74799832&MET918THR|NC\x5F000010\x2E10\x3Ag\x2E43617416T\x3EC&ENST00000355710\x2E3\x3Ac\x2E2753T\x3EC&NP\x5F065681\x2E1\x3Ap\x2EMet918Thr&NM\x5F020975\x2E4\x3Ac\x2E2753T\x3EC|CA009082|13919|86.0|evidence|7710|https://civicdb.org/links/evidence/7710|27525386_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)|Cabozantinib_(NCIt_ID_C52200)|||B|4|||||,C|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|RS74799832&MET918THR|NC\x5F000010\x2E10\x3Ag\x2E43617416T\x3EC&ENST00000355710\x2E3\x3Ac\x2E2753T\x3EC&NP\x5F065681\x2E1\x3Ap\x2EMet918Thr&NM\x5F020975\x2E4\x3Ac\x2E2753T\x3EC|CA009082|13919|86.0|evidence|74|https://civicdb.org/links/evidence/74|18073307_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)||||B|5|||||,C|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|RS74799832&MET918THR|NC\x5F000010\x2E10\x3Ag\x2E43617416T\x3EC&ENST00000355710\x2E3\x3Ac\x2E2753T\x3EC&NP\x5F065681\x2E1\x3Ap\x2EMet918Thr&NM\x5F020975\x2E4\x3Ac\x2E2753T\x3EC|CA009082|13919|86.0|evidence|1365|https://civicdb.org/links/evidence/1365|20368568_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)|Sorafenib_(NCIt_ID_C61948)|||B|3|||||,C|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|RS74799832&MET918THR|NC\x5F000010\x2E10\x3Ag\x2E43617416T\x3EC&ENST00000355710\x2E3\x3Ac\x2E2753T\x3EC&NP\x5F065681\x2E1\x3Ap\x2EMet918Thr&NM\x5F020975\x2E4\x3Ac\x2E2753T\x3EC|CA009082|13919|86.0|evidence|76|https://civicdb.org/links/evidence/76|21422803_(PubMed)|Somatic|accepted|Resistance|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)|Motesanib_(NCIt_ID_C71896)|||D|3|||||,C|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|RS74799832&MET918THR|NC\x5F000010\x2E10\x3Ag\x2E43617416T\x3EC&ENST00000355710\x2E3\x3Ac\x2E2753T\x3EC&NP\x5F065681\x2E1\x3Ap\x2EMet918Thr&NM\x5F020975\x2E4\x3Ac\x2E2753T\x3EC|CA009082|13919|86.0|evidence|78|https://civicdb.org/links/evidence/78|9839497_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)||||B|4|||||,C|missense_variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|RS74799832&MET918THR|NC\x5F000010\x2E10\x3Ag\x2E43617416T\x3EC&ENST00000355710\x2E3\x3Ac\x2E2753T\x3EC&NP\x5F065681\x2E1\x3Ap\x2EMet918Thr&NM\x5F020975\x2E4\x3Ac\x2E2753T\x3EC|CA009082|13919|86.0|evidence|77|https://civicdb.org/links/evidence/77|23056499_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Medullary_Carcinoma_(DOID_3973)|JAK2_Inhibitor_AZD1480_(NCIt_ID_C91394)|||D|3|||||
10	89692904	636	C	T	.	.	GN=PTEN;VT=R130*;CSQ=T|stop_gained|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.388C>T||R130*|636|RS121909224&ARG130TER&R130X|NC\x5F000010\x2E10\x3Ag\x2E89692904C\x3ET&ENST00000371953\x2E3\x3Ac\x2E388C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg130Ter&NM\x5F000314\x2E6\x3Ac\x2E388C\x3ET|CA000433|7819|2.0|evidence|1627|https://civicdb.org/links/evidence/1627|19706758_(PubMed)|N/A|accepted|Sensitivity/Response|Supports|Thyroid_Cancer_(DOID_1781)|Temsirolimus_(NCIt_ID_C1844)&Perifosine_(NCIt_ID_C1727)|Substitutes||D|2|||||
10	89711899	838	C	T	.	.	GN=PTEN;VT=R173C;CSQ=T|missense_variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.517C>T||R173C|838|RS121913293&ARG173CYS|NC\x5F000010\x2E10\x3Ag\x2E89711899C\x3ET&ENST00000371953\x2E3\x3Ac\x2E517C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg173Cys&NM\x5F000314\x2E6\x3Ac\x2E517C\x3ET|CA000498|189500|10.75|evidence|1935|https://civicdb.org/links/evidence/1935|22628360_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|PTEN_Hamartoma_Tumor_Syndrome_(DOID_0080191)||||C|3|||||,T|missense_variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.517C>T||R173C|838|RS121913293&ARG173CYS|NC\x5F000010\x2E10\x3Ag\x2E89711899C\x3ET&ENST00000371953\x2E3\x3Ac\x2E517C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg173Cys&NM\x5F000314\x2E6\x3Ac\x2E517C\x3ET|CA000498|189500|10.75|evidence|1934|https://civicdb.org/links/evidence/1934|9635567_(PubMed)|Somatic|accepted|Uncertain_Significance|Supports|Endometrial_Hyperplasia_(DOID_0080365)||||E|1|||||,T|missense_variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.517C>T||R173C|838|RS121913293&ARG173CYS|NC\x5F000010\x2E10\x3Ag\x2E89711899C\x3ET&ENST00000371953\x2E3\x3Ac\x2E517C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg173Cys&NM\x5F000314\x2E6\x3Ac\x2E517C\x3ET|CA000498|189500|10.75|evidence|1930|https://civicdb.org/links/evidence/1930|10866302_(PubMed)|N/A|accepted|Uncertain_Significance|Supports|Cancer_(DOID_162)||||D|3|||||
10	89717672	110	C	T	.	.	GN=PTEN;VT=R233*;CSQ=T|loss_of_function_variant&stop_gained|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.697C>T||R233*|110|RS121909219&ARG233TER&R233X|NC\x5F000010\x2E10\x3Ag\x2E89717672C\x3ET&ENST00000371953\x2E3\x3Ac\x2E697C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg233Ter&NM\x5F000314\x2E6\x3Ac\x2E697C\x3ET|CA000549|7813|19.0|evidence|343|https://civicdb.org/links/evidence/343|22479427_(PubMed)|Somatic|accepted|Poor_Outcome|Does_Not_Support|Glioblastoma_Multiforme_(DOID_3068)||||B|3|||||,T|loss_of_function_variant&stop_gained|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.697C>T||R233*|110|RS121909219&ARG233TER&R233X|NC\x5F000010\x2E10\x3Ag\x2E89717672C\x3ET&ENST00000371953\x2E3\x3Ac\x2E697C\x3ET&NP\x5F000305\x2E3\x3Ap\x2EArg233Ter&NM\x5F000314\x2E6\x3Ac\x2E697C\x3ET|CA000549|7813|19.0|evidence|317|https://civicdb.org/links/evidence/317|20085938_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|MTOR_Inhibitor_(NCIt_ID_C2201)|||D|4|||||
10	89720798	605	GTACT	G	.	.	GN=PTEN;VT=V317FS;CSQ=-|frameshift_variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.950_953delTACT||V317FS|605|VAL317FS|NC\x5F000010\x2E10\x3Ag\x2E89720799\x5F89720802del&ENST00000371953\x2E3\x3Ac\x2E950\x5F953delTACT|CA000646|NONE_FOUND|3.0|evidence|1534|https://civicdb.org/links/evidence/1534|24504448_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|MEK_Inhibitor_CI-1040_(NCIt_ID_C2670)&Akt_Inhibitor_MK2206_(NCIt_ID_C90581)|Combination||D|3|||||
10	104850483	2897	G	A	.	.	GN=NT5C2;VT=S445F;CSQ=A|sequence_variant_causing_missense_codon_change_in_transcript&gain_of_function_variant|NT5C2|22978|transcript|ENST00000343289.5|||S445F|2897|||CA377969059|NONE_FOUND|9.0|evidence|7817|https://civicdb.org/links/evidence/7817|23377183_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Prednisolone_(NCIt_ID_C769)&Doxorubicin_(NCIt_ID_C456)&Gemcitabine_(NCIt_ID_C66876)&Cytarabine_(NCIt_ID_C408)|Substitutes||D|4|||||,A|sequence_variant_causing_missense_codon_change_in_transcript&gain_of_function_variant|NT5C2|22978|transcript|ENST00000343289.5|||S445F|2897|||CA377969059|NONE_FOUND|9.0|evidence|7814|https://civicdb.org/links/evidence/7814|23377183_(PubMed)|Somatic|accepted|Resistance|Supports|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Mercaptopurine_(NCIt_ID_C195)&Thioguanine_(NCIt_ID_C876)|Substitutes||D|4|||||,A|sequence_variant_causing_missense_codon_change_in_transcript&gain_of_function_variant|NT5C2|22978|transcript|ENST00000343289.5|||S445F|2897|||CA377969059|NONE_FOUND|9.0|evidence|7864|https://civicdb.org/links/evidence/7864|23377183_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)||||C|2|||||
10	104850745	240	T	G	.	.	GN=NT5C2;VT=D407A;CSQ=G|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1220A>C||D407A|240|ASP407ALA|ENST00000343289\x2E5\x3Ac\x2E1220A\x3EC&NP\x5F036361\x2E1\x3Ap\x2EAsp407Ala&NM\x5F012229\x2E4\x3Ac\x2E1220A\x3EC&NC\x5F000010\x2E10\x3Ag\x2E104850745T\x3EG|CA16602793|376351|8.0|evidence|635|https://civicdb.org/links/evidence/635|23377281_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Arabinosylguanine&Nelarabine_(NCIt_ID_C1704)|Substitutes||D|4|||||,G|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1220A>C||D407A|240|ASP407ALA|ENST00000343289\x2E5\x3Ac\x2E1220A\x3EC&NP\x5F036361\x2E1\x3Ap\x2EAsp407Ala&NM\x5F012229\x2E4\x3Ac\x2E1220A\x3EC&NC\x5F000010\x2E10\x3Ag\x2E104850745T\x3EG|CA16602793|376351|8.0|evidence|632|https://civicdb.org/links/evidence/632|23377281_(PubMed)|Somatic|accepted|Resistance|Supports|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Thioguanine_(NCIt_ID_C876)&Mercaptopurine_(NCIt_ID_C195)|Substitutes||D|4|||||
10	104852955	238	C	T	.	.	GN=NT5C2;VT=R367Q;CSQ=T|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|NC\x5F000010\x2E10\x3Ag\x2E104852955C\x3ET|CA16602791|376349|17.0|evidence|7815|https://civicdb.org/links/evidence/7815|23377183_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Doxorubicin_(NCIt_ID_C456)&Prednisolone_(NCIt_ID_C769)&Gemcitabine_(NCIt_ID_C66876)&Cytarabine_(NCIt_ID_C408)|Substitutes||D|4|||||,T|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|NC\x5F000010\x2E10\x3Ag\x2E104852955C\x3ET|CA16602791|376349|17.0|evidence|7862|https://civicdb.org/links/evidence/7862|23377183_(PubMed)|Somatic|accepted|Resistance|Supports|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Mercaptopurine_(NCIt_ID_C195)&Thioguanine_(NCIt_ID_C876)|Substitutes||D|4|||||,T|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|NC\x5F000010\x2E10\x3Ag\x2E104852955C\x3ET|CA16602791|376349|17.0|evidence|7812|https://civicdb.org/links/evidence/7812|23377183_(PubMed)|Somatic|accepted|Resistance|Supports|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Mercaptopurine_(NCIt_ID_C195)&Thioguanine_(NCIt_ID_C876)|Substitutes||C|2|||||,T|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|NC\x5F000010\x2E10\x3Ag\x2E104852955C\x3ET|CA16602791|376349|17.0|evidence|633|https://civicdb.org/links/evidence/633|23377281_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Arabinosylguanine&Nelarabine_(NCIt_ID_C1704)|Substitutes||D|4|||||,T|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|NC\x5F000010\x2E10\x3Ag\x2E104852955C\x3ET|CA16602791|376349|17.0|evidence|630|https://civicdb.org/links/evidence/630|23377281_(PubMed)|Somatic|accepted|Resistance|Supports|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Thioguanine_(NCIt_ID_C876)&Mercaptopurine_(NCIt_ID_C195)|Substitutes||D|4|||||
10	104852980	239	T	G	.	.	GN=NT5C2;VT=K359Q;CSQ=G|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1075A>C||K359Q|239|LYS359GLN|ENST00000343289\x2E5\x3Ac\x2E1075A\x3EC&NP\x5F036361\x2E1\x3Ap\x2ELys359Gln&NM\x5F012229\x2E4\x3Ac\x2E1075A\x3EC&NC\x5F000010\x2E10\x3Ag\x2E104852980T\x3EG|CA16602792|376350|28.0|evidence|636|https://civicdb.org/links/evidence/636|23377281_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Nelarabine_(NCIt_ID_C1704)&Arabinosylguanine|Substitutes||D|4|||||,G|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1075A>C||K359Q|239|LYS359GLN|ENST00000343289\x2E5\x3Ac\x2E1075A\x3EC&NP\x5F036361\x2E1\x3Ap\x2ELys359Gln&NM\x5F012229\x2E4\x3Ac\x2E1075A\x3EC&NC\x5F000010\x2E10\x3Ag\x2E104852980T\x3EG|CA16602792|376350|28.0|evidence|667|https://civicdb.org/links/evidence/667|23377281_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Lymphoblastic_Leukemia_(DOID_9952)||||B|4|||||,G|missense_variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1075A>C||K359Q|239|LYS359GLN|ENST00000343289\x2E5\x3Ac\x2E1075A\x3EC&NP\x5F036361\x2E1\x3Ap\x2ELys359Gln&NM\x5F012229\x2E4\x3Ac\x2E1075A\x3EC&NC\x5F000010\x2E10\x3Ag\x2E104852980T\x3EG|CA16602792|376350|28.0|evidence|631|https://civicdb.org/links/evidence/631|23377281_(PubMed)|Somatic|accepted|Resistance|Supports|T-cell_Acute_Lymphoblastic_Leukemia_(DOID_5603)|Thioguanine_(NCIt_ID_C876)&Mercaptopurine_(NCIt_ID_C195)|Substitutes||D|4|||||
10	104857107	2896	G	A	.	.	GN=NT5C2;VT=R238W;CSQ=A||NT5C2|22978|transcript|ENST00000343289.5|||R238W|2896|||CA377975023||9.0|evidence|7816|https://civicdb.org/links/evidence/7816|23377183_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Prednisolone_(NCIt_ID_C769)&Doxorubicin_(NCIt_ID_C456)&Gemcitabine_(NCIt_ID_C66876)&Cytarabine_(NCIt_ID_C408)|Substitutes||D|4|||||,A||NT5C2|22978|transcript|ENST00000343289.5|||R238W|2896|||CA377975023||9.0|evidence|7813|https://civicdb.org/links/evidence/7813|23377183_(PubMed)|Somatic|accepted|Resistance|Supports|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)|Mercaptopurine_(NCIt_ID_C195)&Thioguanine_(NCIt_ID_C876)|Substitutes||D|4|||||,A||NT5C2|22978|transcript|ENST00000343289.5|||R238W|2896|||CA377975023||9.0|evidence|7863|https://civicdb.org/links/evidence/7863|23377183_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Childhood_Acute_Lymphocytic_Leukemia_(DOID_0080144)||||C|2|||||
10	123258034	545	A	T	.	.	GN=FGFR2;VT=N550K;CSQ=T|gain_of_function_variant&missense_variant|FGFR2|2263|transcript|ENST00000457416.2|ENST00000457416.2:c.1650T>A||N550K|545|RS121913476&N549K&ASN550LYS|ENST00000457416\x2E2\x3Ac\x2E1650T\x3EA&NP\x5F075259\x2E4\x3Ap\x2EAsn550Lys&NM\x5F022970\x2E3\x3Ac\x2E1650T\x3EA&NC\x5F000010\x2E10\x3Ag\x2E123258034A\x3ET|CA16602614|376157|3.0|evidence|1322|https://civicdb.org/links/evidence/1322|18757403_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Endometrial_Cancer_(DOID_1380)|PD173074|||D|3|||||
10	131265545	338	C	T	.	.	GN=MGMT;VT=RS16906252;CSQ=T|synonymous_variant|MGMT|4255|transcript|ENST00000306010.7|||RS16906252|338||NC\x5F000010\x2E10\x3Ag\x2E131265545C\x3ET|CA5747879||15.0|evidence|822|https://civicdb.org/links/evidence/822|25910840_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Glioblastoma_Multiforme_(DOID_3068)|Temozolomide_(NCIt_ID_C1244)|||B|3|||||
11	534285	274	C	T	.	.	GN=HRAS;VT=G13D;CSQ=T|missense_variant|HRAS|3265|transcript|ENST00000451590.1|ENST00000451590.1:c.38G>A||G13D|274|RS104894226&GLY13ASP|ENST00000451590\x2E1\x3Ac\x2E38G\x3EA&NM\x5F005343\x2E3\x3Ac\x2E38G\x3EA&NP\x5F005334\x2E1\x3Ap\x2EGly13Asp&NC\x5F000011\x2E9\x3Ag\x2E534285C\x3ET|CA256488|12604|7.5|evidence|3851|https://civicdb.org/links/evidence/3851|22256804_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Squamous_Cell_Carcinoma_(DOID_3151)|Vemurafenib_(NCIt_ID_C64768)|||C|None|||||,T|missense_variant|HRAS|3265|transcript|ENST00000451590.1|ENST00000451590.1:c.38G>A||G13D|274|RS104894226&GLY13ASP|ENST00000451590\x2E1\x3Ac\x2E38G\x3EA&NM\x5F005343\x2E3\x3Ac\x2E38G\x3EA&NP\x5F005334\x2E1\x3Ap\x2EGly13Asp&NC\x5F000011\x2E9\x3Ag\x2E534285C\x3ET|CA256488|12604|7.5|evidence|3852|https://civicdb.org/links/evidence/3852|26561417_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,T|missense_variant|HRAS|3265|transcript|ENST00000451590.1|ENST00000451590.1:c.38G>A||G13D|274|RS104894226&GLY13ASP|ENST00000451590\x2E1\x3Ac\x2E38G\x3EA&NM\x5F005343\x2E3\x3Ac\x2E38G\x3EA&NP\x5F005334\x2E1\x3Ap\x2EGly13Asp&NC\x5F000011\x2E9\x3Ag\x2E534285C\x3ET|CA256488|12604|7.5|evidence|699|https://civicdb.org/links/evidence/699|26561417_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Epidermal_Growth_Factor_Receptor_Tyrosine_Kinase_Inhibitor_(NCIt_ID_C2167)|||C|3|||||
11	9599943	331	A	G	.	.	GN=WEE1;VT=RS3910384;CSQ=G|polymorphic_sequence_variant&intron_variant|WEE1|7465|transcript|ENST00000450114.2|ENST00000450114.2:c.1141+1133A>G||RS3910384|331|INTRON\x20POLYMORPHISM|ENST00000450114\x2E2\x3Ac\x2E1141\x2B1133A\x3EG&NC\x5F000011\x2E9\x3Ag\x2E9599943A\x3EG|CA15681425|NONE_FOUND|15.0|evidence|814|https://civicdb.org/links/evidence/814|26057002_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Gemcitabine_(NCIt_ID_C66876)&Platinum_Compound_(NCIt_ID_C1450)|Combination||B|3|||||
11	64572091	667	CC	C	.	.	GN=MEN1;VT=FRAMESHIFT_TRUNCATION;CSQ=-|frameshift_truncation|MEN1|4221|transcript|ENST00000337652.1|||FRAMESHIFT_TRUNCATION|667||NC\x5F000011\x2E9\x3Ag\x2E64572092del|CA16044439||5.0|evidence|1695|https://civicdb.org/links/evidence/1695|25625803_(PubMed)|Somatic|accepted|Positive|Supports|Thyroid_Hurthle_Cell_Carcinoma_(DOID_8161)||||C|2|||||
11	67352689	259	A	G	.	.	GN=GSTP1;VT=I105V;CSQ=G|missense_variant|GSTP1|2950|transcript|ENST00000398606.3|ENST00000398606.3:c.313A>G||I105V|259|ILE105VAL|NC\x5F000011\x2E9\x3Ag\x2E67352689A\x3EG&ENST00000398606\x2E3\x3Ac\x2E313A\x3EG&NP\x5F000843\x2E1\x3Ap\x2EIle105Val&NM\x5F000852\x2E3\x3Ac\x2E313A\x3EG|CA6142790|37340|20.0|evidence|670|https://civicdb.org/links/evidence/670|19922504_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|FOLFOX_Regimen_(NCIt_ID_C11197)|||B|4|||||
11	108115729	1155	A	T	.	.	GN=ATM;VT=K293*;CSQ=T|stop_gained|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.877A>T||K293*|1155|RS1057516442&LYS293TER&K293X|NC\x5F000011\x2E9\x3Ag\x2E108115729A\x3ET&NP\x5F000042\x2E3\x3Ap\x2ELys293Ter&NM\x5F000051\x2E3\x3Ac\x2E877A\x3ET&ENST00000278616\x2E4\x3Ac\x2E877A\x3ET|CA16041383|370378|3.0|evidence|2832|https://civicdb.org/links/evidence/2832|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108121593	1166	CAA	C	.	.	GN=ATM;VT=K468FS;CSQ=-|frameshift_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.1402_1403delAA||K468FS|1166|LYS468GLUFS|NC\x5F000011\x2E9\x3Ag\x2E108121594\x5F108121595del&ENST00000278616\x2E4\x3Ac\x2E1402\x5F1403delAA&NC\x5F000011\x2E9\x3Ag\x2E108121594\x5F108121595delAA&NP\x5F000042\x2E3\x3Ap\x2ELys468Glufs&NM\x5F000051\x2E3\x3Ac\x2E1402\x5F1403delAA|CA163840|140889|2.0|evidence|2843|https://civicdb.org/links/evidence/2843|23585524_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|2|||||
11	108142131	1158	T	G	.	.	GN=ATM;VT=F1025L;CSQ=G|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.3075T>G||F1025L|1158|PHE1025LEU|NP\x5F000042\x2E3\x3Ap\x2EPhe1025Leu&NM\x5F000051\x2E3\x3Ac\x2E3075T\x3EG&NC\x5F000011\x2E9\x3Ag\x2E108142131T\x3EG&ENST00000278616\x2E4\x3Ac\x2E3075T\x3EG|CA382547708|NONE_FOUND|3.0|evidence|2835|https://civicdb.org/links/evidence/2835|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108170479	1168	G	C	.	.	GN=ATM;VT=D1682H;CSQ=C|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.5044G>C||D1682H|1168|ASP1682HIS&RS121434217|ENST00000278616\x2E4\x3Ac\x2E5044G\x3EC&NC\x5F000011\x2E9\x3Ag\x2E108170479G\x3EC&NP\x5F000042\x2E3\x3Ap\x2EAsp1682His&NM\x5F000051\x2E3\x3Ac\x2E5044G\x3EC|CA115932|3026|3.0|evidence|2845|https://civicdb.org/links/evidence/2845|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108180913	1160	A	T	.	.	GN=ATM;VT=D1930V;CSQ=T|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.5789A>T||D1930V|1160|MET72LEU&ASP1930VAL&M72L|NP\x5F000042\x2E3\x3Ap\x2EAsp1930Val&NM\x5F000051\x2E3\x3Ac\x2E5789A\x3ET&NC\x5F000011\x2E9\x3Ag\x2E108180913A\x3ET&ENST00000278616\x2E4\x3Ac\x2E5789A\x3ET|CA382548326|NONE_FOUND|2.0|evidence|2837|https://civicdb.org/links/evidence/2837|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|2|||||
11	108186827	1169	C	T	.	.	GN=ATM;VT=A2062V;CSQ=T|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.6185C>T||A2062V|1169|ALA2062VAL|NP\x5F000042\x2E3\x3Ap\x2EAla2062Val&NM\x5F000051\x2E3\x3Ac\x2E6185C\x3ET&NC\x5F000011\x2E9\x3Ag\x2E108186827C\x3ET&ENST00000278616\x2E4\x3Ac\x2E6185C\x3ET|CA382550752|NONE_FOUND|3.0|evidence|2846|https://civicdb.org/links/evidence/2846|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108192134	1162	G	T	.	.	GN=ATM;VT=E2187*;CSQ=T|stop_gained|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.6559G>T||E2187*|1162|GLU2187TER&E2187X|NP\x5F000042\x2E3\x3Ap\x2EGlu2187Ter&NM\x5F000051\x2E3\x3Ac\x2E6559G\x3ET&NC\x5F000011\x2E9\x3Ag\x2E108192134G\x3ET&ENST00000278616\x2E4\x3Ac\x2E6559G\x3ET|CA382554382|NONE_FOUND|3.0|evidence|2839|https://civicdb.org/links/evidence/2839|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108196839	243	GTC	G	.	.	GN=ATM;VT=V2288FS*1;CSQ=-|frameshift_truncation|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.6863_6864delTC||V2288FS*1|243||ENST00000278616\x2E4\x3Ac\x2E6863\x5F6864delTC|CA10588507|NONE_FOUND|7.5|evidence|647|https://civicdb.org/links/evidence/647|26510020_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Prostate_Cancer_(DOID_10283)|Olaparib_(NCIt_ID_C71721)|||C|3|||||
11	108199938	1163	T	C	.	.	GN=ATM;VT=L2427P;CSQ=C|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.7280T>C||L2427P|1163|LEU2427PRO|NP\x5F000042\x2E3\x3Ap\x2ELeu2427Pro&NM\x5F000051\x2E3\x3Ac\x2E7280T\x3EC&NC\x5F000011\x2E9\x3Ag\x2E108199938T\x3EC&ENST00000278616\x2E4\x3Ac\x2E7280T\x3EC|CA382559785|NONE_FOUND|3.0|evidence|2840|https://civicdb.org/links/evidence/2840|23585524_(PubMed)|Unknown|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108201096	1172	G	A	.	.	GN=ATM;VT=C2488Y;CSQ=A|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.7463G>A||C2488Y|1172|RS774281788&CYS2488TYR|ENST00000278616\x2E4\x3Ac\x2E7463G\x3EA&NC\x5F000011\x2E9\x3Ag\x2E108201096G\x3EA&NP\x5F000042\x2E3\x3Ap\x2ECys2488Tyr&NM\x5F000051\x2E3\x3Ac\x2E7463G\x3EA|CA196568|187037|3.0|evidence|2849|https://civicdb.org/links/evidence/2849|23585524_(PubMed)|Rare_Germline|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108204681	901	A	G	.	.	GN=ATM;VT=T2666A;CSQ=G|missense_variant|ATM|472|transcript|ENST00000278616.4|||T2666A|901||NC\x5F000011\x2E9\x3Ag\x2E108204681A\x3EG|CA349494|219594|3.0|evidence|2221|https://civicdb.org/links/evidence/2221|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108206614	1164	T	G	.	.	GN=ATM;VT=F2732V;CSQ=G|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.8194T>G||F2732V|1164|RS876659619&PHE2732VAL|NP\x5F000042\x2E3\x3Ap\x2EPhe2732Val&NM\x5F000051\x2E3\x3Ac\x2E8194T\x3EG&NC\x5F000011\x2E9\x3Ag\x2E108206614T\x3EG&ENST00000278616\x2E4\x3Ac\x2E8194T\x3EG|CA16619250|422531|3.0|evidence|2841|https://civicdb.org/links/evidence/2841|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
11	108218044	244	A	C	.	.	GN=ATM;VT=N2875H;CSQ=C|missense_variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.8623A>C||N2875H|244|RS1057519869&ASN2875HIS|NP\x5F000042\x2E3\x3Ap\x2EAsn2875His&NM\x5F000051\x2E3\x3Ac\x2E8623A\x3EC&NC\x5F000011\x2E9\x3Ag\x2E108218044A\x3EC&ENST00000278616\x2E4\x3Ac\x2E8623A\x3EC|CA16602795|376353|7.5|evidence|648|https://civicdb.org/links/evidence/648|26510020_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Prostate_Cancer_(DOID_10283)|Olaparib_(NCIt_ID_C71721)|||C|3|||||
11	108236086	903	C	T	.	.	GN=ATM;VT=R3008C;CSQ=T|missense_variant|ATM|472|transcript|ENST00000278616.4|||R3008C|903||NC\x5F000011\x2E9\x3Ag\x2E108236086C\x3ET|CA294307||3.0|evidence|2223|https://civicdb.org/links/evidence/2223|23585524_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||
12	21329738	778	A	G	.	.	GN=SLCO1B1;VT=N130D;CSQ=G|missense_variant|SLCO1B1|10599|transcript|ENST00000256958.2|||N130D|778|RS2306283&ASN130ASP|NC\x5F000012\x2E11\x3Ag\x2E21329738A\x3EG|CA6476674|259983|15.0|evidence|1842|https://civicdb.org/links/evidence/1842|23652803_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Methotrexate_(NCIt_ID_C642)|||B|3|||||
12	21331549	777	T	C	.	.	GN=SLCO1B1;VT=RS4149056;CSQ=C|polymorphic_sequence_variant&missense_variant|SLCO1B1|10599|transcript|ENST00000256958.2|||RS4149056|777|V174A&VAL174ALA|NC\x5F000012\x2E11\x3Ag\x2E21331549T\x3EC|CA6476722|37346|15.0|evidence|1841|https://civicdb.org/links/evidence/1841|23652803_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Cancer_(DOID_162)|Methotrexate_(NCIt_ID_C642)|||B|3|||||
12	25360224	254	A	C	.	.	GN=KRAS;VT=RS61764370;CSQ=C|3_prime_UTR_variant|KRAS|3845|transcript|ENST00000311936.3|ENST00000311936.3:c.*2505T>G||RS61764370|254||ENST00000311936\x2E3\x3Ac\x2E\x2A2505T\x3EG&NM\x5F004985\x2E4\x3Ac\x2E\x2A2505T\x3EG&NC\x5F000012\x2E11\x3Ag\x2E25360224A\x3EC|CA10637079|308084|30.0|evidence|872|https://civicdb.org/links/evidence/872|25081901_(PubMed)|Common_Germline|accepted|Resistance|Supports|Head_And_Neck_Squamous_Cell_Carcinoma_(DOID_5520)|Cisplatin_(NCIt_ID_C376)|||B|3|||||,C|3_prime_UTR_variant|KRAS|3845|transcript|ENST00000311936.3|ENST00000311936.3:c.*2505T>G||RS61764370|254||ENST00000311936\x2E3\x3Ac\x2E\x2A2505T\x3EG&NM\x5F004985\x2E4\x3Ac\x2E\x2A2505T\x3EG&NC\x5F000012\x2E11\x3Ag\x2E25360224A\x3EC|CA10637079|308084|30.0|evidence|664|https://civicdb.org/links/evidence/664|22139083_(PubMed)|Common_Germline|accepted|Resistance|Supports|Epithelial_Ovarian_Cancer_(DOID_2152)|Paclitaxel_(NCIt_ID_C1411)&Carboplatin_(NCIt_ID_C1282)|Substitutes||B|3|||||
12	25378561	322	G	A	.	.	GN=KRAS;VT=A146V;CSQ=A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.437C>T||A146V|322|RS1057519725&ALA146VAL|NM\x5F004985\x2E4\x3Ac\x2E437C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EAla146Val&NC\x5F000012\x2E11\x3Ag\x2E25378561G\x3EA&ENST00000256078\x2E4\x3Ac\x2E437C\x3ET|CA16602440|375962|8.0|evidence|2209|https://civicdb.org/links/evidence/2209|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Selumetinib_(NCIt_ID_C66939)&Dactolisib_(NCIt_ID_C74072)|Combination||D|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.437C>T||A146V|322|RS1057519725&ALA146VAL|NM\x5F004985\x2E4\x3Ac\x2E437C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EAla146Val&NC\x5F000012\x2E11\x3Ag\x2E25378561G\x3EA&ENST00000256078\x2E4\x3Ac\x2E437C\x3ET|CA16602440|375962|8.0|evidence|794|https://civicdb.org/links/evidence/794|24836576_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Abemaciclib_(NCIt_ID_C97660)|||C|2|||||
12	25378562	905	C	G	.	.	GN=KRAS;VT=A146P;CSQ=G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>C||A146P|905|ALA146PRO&RS121913527|ENST00000256078\x2E4\x3Ac\x2E436G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25378562C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EAla146Pro&NM\x5F004985\x2E4\x3Ac\x2E436G\x3EC|CA16602441|375963|15.0|evidence|2225|https://civicdb.org/links/evidence/2225|19603018_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|3|||||
12	25378562	906	C	T	.	.	GN=KRAS;VT=A146T;CSQ=T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>A||A146T|906|ALA146THR&RS121913527|ENST00000256078\x2E4\x3Ac\x2E436G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25378562C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EAla146Thr&NM\x5F004985\x2E4\x3Ac\x2E436G\x3EA|CA245262|197243|21.0|evidence|3858|https://civicdb.org/links/evidence/3858|25666295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|FOLFOX-4_Regimen_(NCIt_ID_C63590)&Cetuximab_(NCIt_ID_C1723)|Combination||B|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>A||A146T|906|ALA146THR&RS121913527|ENST00000256078\x2E4\x3Ac\x2E436G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25378562C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EAla146Thr&NM\x5F004985\x2E4\x3Ac\x2E436G\x3EA|CA245262|197243|21.0|evidence|2206|https://civicdb.org/links/evidence/2206|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Selumetinib_(NCIt_ID_C66939)&Dactolisib_(NCIt_ID_C74072)|Combination||D|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>A||A146T|906|ALA146THR&RS121913527|ENST00000256078\x2E4\x3Ac\x2E436G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25378562C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EAla146Thr&NM\x5F004985\x2E4\x3Ac\x2E436G\x3EA|CA245262|197243|21.0|evidence|2943|https://civicdb.org/links/evidence/2943|20570890_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|3|||||
12	25380275	907	T	G	.	.	GN=KRAS;VT=Q61H;CSQ=G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.183A>C||Q61H|907|GLN61HIS&RS17851045|ENST00000256078\x2E4\x3Ac\x2E183A\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25380275T\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGln61His&NM\x5F004985\x2E4\x3Ac\x2E183A\x3EC|CA180922|177881|0.0|evidence|3861|https://civicdb.org/links/evidence/3861|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Chemotherapy_(NCIt_ID_C15632)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.183A>C||Q61H|907|GLN61HIS&RS17851045|ENST00000256078\x2E4\x3Ac\x2E183A\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25380275T\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGln61His&NM\x5F004985\x2E4\x3Ac\x2E183A\x3EC|CA180922|177881|0.0|evidence|3862|https://civicdb.org/links/evidence/3862|22722830_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||C|None|||||
12	25380276	908	T	A	.	.	GN=KRAS;VT=Q61L;CSQ=A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.182A>T||Q61L|908|GLN61LEU&RS121913240|ENST00000256078\x2E4\x3Ac\x2E182A\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25380276T\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGln61Leu&NM\x5F004985\x2E4\x3Ac\x2E182A\x3ET|CA210876|45116|7.5|evidence|3867|https://civicdb.org/links/evidence/3867|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Chemotherapy_(NCIt_ID_C15632)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
12	25380276	909	T	C	.	.	GN=KRAS;VT=Q61R;CSQ=C|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.182A>G||Q61R|909|GLN61ARG&RS121913240|ENST00000256078\x2E4\x3Ac\x2E182A\x3EG&NC\x5F000012\x2E11\x3Ag\x2E25380276T\x3EC&NP\x5F004976\x2E2\x3Ap\x2EGln61Arg&NM\x5F004985\x2E4\x3Ac\x2E182A\x3EG|CA261702|45115|7.5|evidence|3870|https://civicdb.org/links/evidence/3870|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
12	25380277	910	G	T	.	.	GN=KRAS;VT=Q61K;CSQ=T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.181C>A||Q61K|910|GLN61LYS&RS121913238|ENST00000256078\x2E4\x3Ac\x2E181C\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25380277G\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGln61Lys&NM\x5F004985\x2E4\x3Ac\x2E181C\x3EA|CA180750|177777|7.5|evidence|3872|https://civicdb.org/links/evidence/3872|20619739_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Chemotherapy_(NCIt_ID_C15632)&Cetuximab_(NCIt_ID_C1723)|Combination||C|3|||||
12	25398255	479	G	A	.	.	GN=KRAS;VT=Q22*;CSQ=A|stop_gained|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.64C>T||Q22*|479|GLN22TER&Q22X|NP\x5F004976\x2E2\x3Ap\x2EGln22Ter&NM\x5F004985\x2E4\x3Ac\x2E64C\x3ET&ENST00000256078\x2E4\x3Ac\x2E64C\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398255G\x3EA|CA384157370|NONE_FOUND|5.0|evidence|1131|https://civicdb.org/links/evidence/1131|19661358_(PubMed)|Somatic|accepted|Resistance|Supports|Colon_Mucinous_Adenocarcinoma_(DOID_3029)|Panitumumab_(NCIt_ID_C1857)|||C|2|||||
12	25398280	1517	GC	AA	.	.	GN=KRAS;VT=G13V;CSQ=AA|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38_39delinsTT||G13V|1517|GLY13VAL&RS397517040|NP\x5F004976\x2E2\x3Ap\x2EGly13Val&NM\x5F004985\x2E4\x3Ac\x2E38\x5F39delinsTT&ENST00000256078\x2E4\x3Ac\x2E38\x5F39delinsTT&NC\x5F000012\x2E11\x3Ag\x2E25398280\x5F25398281delinsAA|CA645572107|45124|5.0|evidence|6312|https://civicdb.org/links/evidence/6312|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||C|2|||||
12	25398281	81	C	T	.	.	GN=KRAS;VT=G13D;CSQ=T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|1181|https://civicdb.org/links/evidence/1181|26812186_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|4|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|145|https://civicdb.org/links/evidence/145|20978259_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|4|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|306|https://civicdb.org/links/evidence/306|20978259_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|4|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|806|https://civicdb.org/links/evidence/806|26623049_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|1180|https://civicdb.org/links/evidence/1180|26371285_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|3878|https://civicdb.org/links/evidence/3878|22722830_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|3882|https://civicdb.org/links/evidence/3882|25666295_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||B|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|2231|https://civicdb.org/links/evidence/2231|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|6320|https://civicdb.org/links/evidence/6320|19223544_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||C|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|6322|https://civicdb.org/links/evidence/6322|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||C|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|RS112445441&GLY13ASP|ENST00000256078\x2E4\x3Ac\x2E38G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398281C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly13Asp&NM\x5F033360\x2E3\x3Ac\x2E38G\x3EA|CA122534|12580|81.0|evidence|2183|https://civicdb.org/links/evidence/2183|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|2|||||
12	25398284	79	C	T	.	.	GN=KRAS;VT=G12D;CSQ=T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|305|https://civicdb.org/links/evidence/305|19029981_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Selumetinib_(NCIt_ID_C66939)&Dactolisib_(NCIt_ID_C74072)|Combination||D|4|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|937|https://civicdb.org/links/evidence/937|22025163_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Pancreatic_Carcinoma_(DOID_4905)|Akt_Inhibitor_MK2206_(NCIt_ID_C90581)|||C|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|1580|https://civicdb.org/links/evidence/1580|26352686_(PubMed)|Somatic|accepted|Resistance|Supports|Hairy_Cell_Leukemia_(DOID_285)|Vemurafenib_(NCIt_ID_C64768)|||C|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|3946|https://civicdb.org/links/evidence/3946|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|3957|https://civicdb.org/links/evidence/3957|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|3958|https://civicdb.org/links/evidence/3958|22246397_(PubMed)|Somatic|accepted|Resistance|Supports|Ovarian_Cancer_(DOID_2394)|Cetuximab_(NCIt_ID_C1723)|||D|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2236|https://civicdb.org/links/evidence/2236|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2240|https://civicdb.org/links/evidence/2240|17409929_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)|||B|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2247|https://civicdb.org/links/evidence/2247|19284554_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2250|https://civicdb.org/links/evidence/2250|11050000_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2251|https://civicdb.org/links/evidence/2251|12483530_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2252|https://civicdb.org/links/evidence/2252|16497971_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|6316|https://civicdb.org/links/evidence/6316|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||C|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|2218|https://civicdb.org/links/evidence/2218|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|1898|https://civicdb.org/links/evidence/1898|27959684_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Therapeutic_Tumor_Infiltrating_Lymphocytes_(NCIt_ID_C28699)|||C|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|1732|https://civicdb.org/links/evidence/1732|27010960_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Pancreatic_Ductal_Carcinoma_(DOID_3587)||||B|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|228|https://civicdb.org/links/evidence/228|23014527_(PubMed)|Somatic|accepted|Positive|Supports|Lung_Cancer_(DOID_1324)||||B|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|1215|https://civicdb.org/links/evidence/1215|22948721_(PubMed)|Somatic|accepted|Positive|Supports|Colorectal_Cancer_(DOID_9256)||||B|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|1311|https://civicdb.org/links/evidence/1311|23565280_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Tumor_Of_Exocrine_Pancreas_(DOID_1795)||||B|3|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|RS121913529&GLY12ASP|ENST00000256078\x2E4\x3Ac\x2E35G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Asp&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EA|CA122538|12582|135.5|evidence|1300|https://civicdb.org/links/evidence/1300|27010960_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Pancreatic_Cancer_(DOID_1793)||||B|4|||||
12	25398284	425	C	A	.	.	GN=KRAS;VT=G12V;CSQ=A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|136|https://civicdb.org/links/evidence/136|20978259_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|4|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|1143|https://civicdb.org/links/evidence/1143|26125448_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Docetaxel_(NCIt_ID_C1526)&Selumetinib_(NCIt_ID_C66939)|Combination||B|1|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|3924|https://civicdb.org/links/evidence/3924|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|1715|https://civicdb.org/links/evidence/1715|25232318_(PubMed)|Somatic|accepted|Resistance|Does_Not_Support|Cancer_(DOID_162)|Crizotinib_(NCIt_ID_C74061)|||C|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|2232|https://civicdb.org/links/evidence/2232|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|2268|https://civicdb.org/links/evidence/2268|17409929_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)|||C|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|6323|https://civicdb.org/links/evidence/6323|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)&Cetuximab_(NCIt_ID_C1723)|Substitutes||C|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|2001|https://civicdb.org/links/evidence/2001|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|795|https://civicdb.org/links/evidence/795|20609353_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Palbociclib_(NCIt_ID_C49176)|||D|1|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|RS121913529&GLY12VAL|ENST00000256078\x2E4\x3Ac\x2E35G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Val&NM\x5F004985\x2E4\x3Ac\x2E35G\x3ET|CA122540|12583|43.0|evidence|987|https://civicdb.org/links/evidence/987|26372703_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|3|||||
12	25398284	148	C	G	.	.	GN=KRAS;VT=G12A;CSQ=G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|3710|https://civicdb.org/links/evidence/3710|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|2|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|251|https://civicdb.org/links/evidence/251|19794967_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Adenocarcinoma_(DOID_3910)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||B|3|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|2004|https://civicdb.org/links/evidence/2004|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|2008|https://civicdb.org/links/evidence/2008|17409929_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)|||B|2|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|2009|https://civicdb.org/links/evidence/2009|19284554_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|2|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|2012|https://civicdb.org/links/evidence/2012|11050000_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|2013|https://civicdb.org/links/evidence/2013|12483530_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|2014|https://civicdb.org/links/evidence/2014|16497971_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|RS121913529&GLY12ALA|ENST00000256078\x2E4\x3Ac\x2E35G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398284C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Ala&NM\x5F004985\x2E4\x3Ac\x2E35G\x3EC|CA135567|45122|48.0|evidence|6319|https://civicdb.org/links/evidence/6319|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||C|2|||||
12	25398285	78	C	A	.	.	GN=KRAS;VT=G12C;CSQ=A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|1142|https://civicdb.org/links/evidence/1142|26125448_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Docetaxel_(NCIt_ID_C1526)&Selumetinib_(NCIt_ID_C66939)|Combination||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|1173|https://civicdb.org/links/evidence/1173|26739882_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|ARS-853&Epidermal_Growth_Factor_Receptor_Tyrosine_Kinase_Inhibitor_(NCIt_ID_C2167)|Combination||D|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|1216|https://civicdb.org/links/evidence/1216|23313110_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Gefitinib_(NCIt_ID_C1855)&Erlotinib_(NCIt_ID_C65530)|Substitutes||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|3973|https://civicdb.org/links/evidence/3973|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2253|https://civicdb.org/links/evidence/2253|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2257|https://civicdb.org/links/evidence/2257|17409929_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)|||B|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2258|https://civicdb.org/links/evidence/2258|19284554_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2261|https://civicdb.org/links/evidence/2261|11050000_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2262|https://civicdb.org/links/evidence/2262|12483530_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|None|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2263|https://civicdb.org/links/evidence/2263|16497971_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|2212|https://civicdb.org/links/evidence/2212|22392911_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|Dactolisib_(NCIt_ID_C74072)&Selumetinib_(NCIt_ID_C66939)|Combination||D|2|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|1217|https://civicdb.org/links/evidence/1217|22247021_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|3|||||,A|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|RS121913530&GLY12CYS|ENST00000256078\x2E4\x3Ac\x2E34G\x3ET&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EA&NP\x5F004976\x2E2\x3Ap\x2EGly12Cys&NM\x5F004985\x2E4\x3Ac\x2E34G\x3ET|CA122528|12578|74.0|evidence|227|https://civicdb.org/links/evidence/227|23014527_(PubMed)|Somatic|accepted|Positive|Supports|Lung_Cancer_(DOID_1324)||||B|2|||||
12	25398285	530	C	G	.	.	GN=KRAS;VT=G12R;CSQ=G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|RS121913530&GLY12ARG|ENST00000256078\x2E4\x3Ac\x2E34G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Arg&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EC|CA122531|12579|24.0|evidence|3989|https://civicdb.org/links/evidence/3989|22722830_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)|||D|4|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|RS121913530&GLY12ARG|ENST00000256078\x2E4\x3Ac\x2E34G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Arg&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EC|CA122531|12579|24.0|evidence|3991|https://civicdb.org/links/evidence/3991|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|None|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|RS121913530&GLY12ARG|ENST00000256078\x2E4\x3Ac\x2E34G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Arg&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EC|CA122531|12579|24.0|evidence|2264|https://civicdb.org/links/evidence/2264|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,G|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|RS121913530&GLY12ARG|ENST00000256078\x2E4\x3Ac\x2E34G\x3EC&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3EG&NP\x5F004976\x2E2\x3Ap\x2EGly12Arg&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EC|CA122531|12579|24.0|evidence|1298|https://civicdb.org/links/evidence/1298|22983505_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Pancreatic_Cancer_(DOID_1793)||||B|4|||||
12	25398285	913	C	T	.	.	GN=KRAS;VT=G12S;CSQ=T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|4012|https://civicdb.org/links/evidence/4012|26161928_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Regorafenib_(NCIt_ID_C78204)|||D|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|2269|https://civicdb.org/links/evidence/2269|18316791_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Panitumumab_(NCIt_ID_C1857)|||C|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|2273|https://civicdb.org/links/evidence/2273|17409929_(PubMed)|Somatic|accepted|Resistance|Supports|Lung_Cancer_(DOID_1324)|Gefitinib_(NCIt_ID_C1855)|||B|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|2274|https://civicdb.org/links/evidence/2274|19284554_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||B|None|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|2277|https://civicdb.org/links/evidence/2277|11050000_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|2278|https://civicdb.org/links/evidence/2278|12483530_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|2279|https://civicdb.org/links/evidence/2279|16497971_(PubMed)|Somatic|accepted|Resistance|Supports|Multiple_Myeloma_(DOID_9538)|Melphalan_(NCIt_ID_C633)|||D|2|||||,T|missense_variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|GLY12SER&RS121913530|ENST00000256078\x2E4\x3Ac\x2E34G\x3EA&NC\x5F000012\x2E11\x3Ag\x2E25398285C\x3ET&NP\x5F004976\x2E2\x3Ap\x2EGly12Ser&NM\x5F004985\x2E4\x3Ac\x2E34G\x3EA|CA135565|12584|23.5|evidence|6314|https://civicdb.org/links/evidence/6314|19223544_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Cetuximab_(NCIt_ID_C1723)&Panitumumab_(NCIt_ID_C1857)|Substitutes||C|2|||||
12	56478851	702	C	G	.	.	GN=ERBB3;VT=R103G;CSQ=G|missense_variant|ERBB3|2065|transcript|ENST00000267101.3|||R103G|702|ARG103GLY|NC\x5F000012\x2E11\x3Ag\x2E56478851C\x3EG|CA385279657|NONE_FOUND|15.0|evidence|1747|https://civicdb.org/links/evidence/1747|27044931_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Urothelial_Carcinoma_(DOID_2671)|Afatinib_(NCIt_ID_C66940)|||B|3|||||
12	56478854	701	G	A	.	.	GN=ERBB3;VT=V104M;CSQ=A|missense_variant|ERBB3|2065|transcript|ENST00000267101.3|||V104M|701|VAL104MET|NC\x5F000012\x2E11\x3Ag\x2E56478854G\x3EA|CA16602847|376410|15.0|evidence|1746|https://civicdb.org/links/evidence/1746|27044931_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Urothelial_Carcinoma_(DOID_2671)|Afatinib_(NCIt_ID_C66940)|||B|3|||||
12	56481922	703	G	A	.	.	GN=ERBB3;VT=G284R;CSQ=A|missense_variant|ERBB3|2065|transcript|ENST00000267101.3|||G284R|703|GLY284ARG|NC\x5F000012\x2E11\x3Ag\x2E56481922G\x3EA|CA16602624|376167|15.0|evidence|1748|https://civicdb.org/links/evidence/1748|27044931_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Urothelial_Carcinoma_(DOID_2671)|Afatinib_(NCIt_ID_C66940)|||B|3|||||
12	56491672	781	T	C	.	.	GN=ERBB3;VT=V855A;CSQ=C|missense_variant|ERBB3|2065|transcript|ENST00000267101.3|||V855A|781|VAL855ALA|NC\x5F000012\x2E11\x3Ag\x2E56491672T\x3EC|CA385313732|NONE_FOUND|2.0|evidence|1845|https://civicdb.org/links/evidence/1845|26689995_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Pertuzumab_(NCIt_ID_C38692)&Afatinib_(NCIt_ID_C66940)|Substitutes||D|2|||||
12	58145431	556	G	A	.	.	GN=CDK4;VT=R24C;CSQ=A|missense_variant|CDK4|1019|transcript|ENST00000257904.6|ENST00000257904.6:c.70C>T||R24C|556|RS11547328&ARG24CYS|NC\x5F000012\x2E11\x3Ag\x2E58145431G\x3EA&ENST00000257904\x2E6\x3Ac\x2E70C\x3ET&NP\x5F000066\x2E1\x3Ap\x2EArg24Cys&NM\x5F000075\x2E3\x3Ac\x2E70C\x3ET|CA126982|16928|1.0|evidence|1376|https://civicdb.org/links/evidence/1376|24495407_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Skin_Melanoma_(DOID_8923)|Palbociclib_(NCIt_ID_C49176)|||D|1|||||
12	69202580	495	T	G	.	.	GN=MDM2;VT=SNP309;CSQ=G|coding_transcript_intron_variant|MDM2|4193|transcript|ENST00000462284.1|||SNP309|495||NC\x5F000012\x2E11\x3Ag\x2E69202580T\x3EG|CA123622|13904|10.0|evidence|1169|https://civicdb.org/links/evidence/1169|26916894_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Head_And_Neck_Cancer_(DOID_11934)||||B|2|||||
12	69234987	642	TA	T	.	.	GN=MDM2;VT=RS34886328;CSQ=-|3_prime_UTR_truncation|MDM2|4193|transcript|ENST00000462284.1|||RS34886328|642|||CA238461468||10.0|evidence|1636|https://civicdb.org/links/evidence/1636|27414035_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Esophagus_Squamous_Cell_Carcinoma_(DOID_3748)||||B|2|||||
12	111884608	699	T	C	.	.	GN=SH2B3;VT=RS3184504;CSQ=C|polymorphic_sequence_variant&missense_variant|SH2B3|10019|transcript|ENST00000341259.2|||RS3184504|699|TRP262ARG&R262W&ARG262TRP|NC\x5F000012\x2E11\x3Ag\x2E111884608T\x3EC|CA6789733||10.0|evidence|1744|https://civicdb.org/links/evidence/1744|26621817_(PubMed)|Common_Germline|accepted|Positive|Supports|Colorectal_Cancer_(DOID_9256)||||B|2|||||
13	28592641	1302	T	A	.	.	GN=FLT3;VT=D835V;CSQ=A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|3010|https://civicdb.org/links/evidence/3010|15304385_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sunitinib_(NCIt_ID_C71622)&Daunorubicin_(NCIt_ID_C62091)|Combination||D|2|||||,A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|4022|https://civicdb.org/links/evidence/4022|15459012_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sunitinib_(NCIt_ID_C71622)|||C|None|||||,A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|3012|https://civicdb.org/links/evidence/3012|23497317_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)|Quizartinib_(NCIt_ID_C68936)|||D|5|||||,A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|3034|https://civicdb.org/links/evidence/3034|17330097_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Tyrphostin_AG_1296_(NCIt_ID_C1731)&AS602868|Substitutes||D|3|||||,A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|3008|https://civicdb.org/links/evidence/3008|15304385_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)|Sunitinib_(NCIt_ID_C71622)|||D|3|||||,A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|3009|https://civicdb.org/links/evidence/3009|15304385_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sunitinib_(NCIt_ID_C71622)&Cytarabine_(NCIt_ID_C408)|Combination||D|2|||||,A|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|ASP835VAL&RS121909646|NC\x5F000013\x2E10\x3Ag\x2E28592641T\x3EA&NP\x5F004110\x2E2\x3Ap\x2EAsp835Val&NM\x5F004119\x2E2\x3Ac\x2E2504A\x3ET&ENST00000241453\x2E7\x3Ac\x2E2504A\x3ET|CA126344|16272|18.0|evidence|3007|https://civicdb.org/links/evidence/3007|15256420_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Tandutinib_(NCIt_ID_C48404)|||D|3|||||
13	28592642	612	C	G	.	.	GN=FLT3;VT=D835H;CSQ=G|missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2503G>C||D835H|612|RS121913488&ASP835HIS|NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EG&ENST00000241453\x2E7\x3Ac\x2E2503G\x3EC&NP\x5F004110\x2E2\x3Ap\x2EAsp835His&NM\x5F004119\x2E2\x3Ac\x2E2503G\x3EC|CA280208|16273|7.5|evidence|1556|https://civicdb.org/links/evidence/1556|23969938_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sorafenib_(NCIt_ID_C61948)|||C|3|||||
13	28592642	437	C	A	.	.	GN=FLT3;VT=D835;CSQ=A|protein_altering_variant|FLT3|2322|transcript|ENST00000241453.7|||D835|437||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|46.0|evidence|1038|https://civicdb.org/links/evidence/1038|22504184_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Quizartinib_(NCIt_ID_C68936)&Sorafenib_(NCIt_ID_C61948)|Substitutes||B|4|||||,A|protein_altering_variant|FLT3|2322|transcript|ENST00000241453.7|||D835|437||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|46.0|evidence|1039|https://civicdb.org/links/evidence/1039|22368270_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sorafenib_(NCIt_ID_C61948)|||B|4|||||,A|protein_altering_variant|FLT3|2322|transcript|ENST00000241453.7|||D835|437||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|46.0|evidence|1036|https://civicdb.org/links/evidence/1036|23430109_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Quizartinib_(NCIt_ID_C68936)&Ponatinib_(NCIt_ID_C95777)|Substitutes||D|3|||||,A|protein_altering_variant|FLT3|2322|transcript|ENST00000241453.7|||D835|437||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|46.0|evidence|1037|https://civicdb.org/links/evidence/1037|19318574_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|SU5614|||D|3|||||
13	28592642	56	C	A	.	.	GN=FLT3;VT=TKD_MUTATION;CSQ=A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|1295|https://civicdb.org/links/evidence/1295|20733134_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Midostaurin_(NCIt_ID_C1872)|||B|3|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|373|https://civicdb.org/links/evidence/373|17940205_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|4|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|322|https://civicdb.org/links/evidence/322|11290608_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|248|https://civicdb.org/links/evidence/248|18230792_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sorafenib_(NCIt_ID_C61948)|||B|4|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|247|https://civicdb.org/links/evidence/247|22368270_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)|Sorafenib_(NCIt_ID_C61948)|||B|4|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|214|https://civicdb.org/links/evidence/214|11290608_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,A|nonsynonymous_variant|FLT3|2322|transcript|ENST00000241453.7|||TKD_MUTATION|56||NC\x5F000013\x2E10\x3Ag\x2E28592642C\x3EA|CA126347|16276|120.0|evidence|171|https://civicdb.org/links/evidence/171|17965322_(PubMed)|Somatic|accepted|Better_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||
13	28624294	540	G	A	.	.	GN=FLT3;VT=T227M;CSQ=A|SNP&missense_variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.680C>T||T227M|540|THR227MET&RS1933437|NC\x5F000013\x2E10\x3Ag\x2E28624294G\x3EA&ENST00000241453\x2E7\x3Ac\x2E680C\x3ET&NP\x5F004110\x2E2\x3Ap\x2EThr227Met&NM\x5F004119\x2E2\x3Ac\x2E680C\x3ET|CA159846|134447|15.0|evidence|1317|https://civicdb.org/links/evidence/1317|19667267_(PubMed)|Common_Germline|accepted|Adverse_Response|Supports|Renal_Cell_Carcinoma_(DOID_4450)|Sunitinib_(NCIt_ID_C71622)|||B|3|||||
13	32890599	1247	T	G	.	.	GN=BRCA2;VT=M1R;CSQ=G|missense_variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.2T>G||M1R|1247|RS80358547&MET1ARG|ENST00000544455\x2E1\x3Ac\x2E2T\x3EG&NP\x5F000050\x2E2\x3Ap\x2EMet1Arg&NC\x5F000013\x2E10\x3Ag\x2E32890599T\x3EG&NM\x5F000059\x2E3\x3Ac\x2E2T\x3EG|CA017013|51385|0.0|evidence|2879|https://civicdb.org/links/evidence/2879|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32890600	1248	G	T	.	.	GN=BRCA2;VT=M1I;CSQ=T|missense_variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.3G>T||M1I|1248|RS80358650&MET1ILE|ENST00000544455\x2E1\x3Ac\x2E3G\x3ET&NP\x5F000050\x2E2\x3Ap\x2EMet1Ile&NM\x5F000059\x2E3\x3Ac\x2E3G\x3ET&NC\x5F000013\x2E10\x3Ag\x2E32890600G\x3ET|CA019369|37871|0.0|evidence|2880|https://civicdb.org/links/evidence/2880|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32900287	1249	G	A	.	.	GN=BRCA2;VT=V159M;CSQ=A|missense_variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.475G>A||V159M|1249|RS80358702&VAL159MET|NC\x5F000013\x2E10\x3Ag\x2E32900287G\x3EA&NP\x5F000050\x2E2\x3Ap\x2EVal159Met&NM\x5F000059\x2E3\x3Ac\x2E475G\x3EA&ENST00000544455\x2E1\x3Ac\x2E475G\x3EA|CA020781|51711|0.0|evidence|2881|https://civicdb.org/links/evidence/2881|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32900751	1250	G	C	.	.	GN=BRCA2;VT=V211L;CSQ=C|missense_variant|BRCA2|675|transcript|None|||V211L|1250||NC\x5F000013\x2E10\x3Ag\x2E32900751G\x3EC|CA16619647||0.0|evidence|2882|https://civicdb.org/links/evidence/2882|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32900751	1251	G	A	.	.	GN=BRCA2;VT=V211I;CSQ=A|missense_variant|BRCA2|675|transcript|None|||V211I|1251||NC\x5F000013\x2E10\x3Ag\x2E32900751G\x3EA|CA023848||0.0|evidence|2883|https://civicdb.org/links/evidence/2883|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32921033	1252	G	C	.	.	GN=BRCA2;VT=R2336P;CSQ=C|missense_variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.7007G>C||R2336P|1252|RS28897743&ARG2336PRO|ENST00000544455\x2E1\x3Ac\x2E7007G\x3EC&NC\x5F000013\x2E10\x3Ag\x2E32921033G\x3EC&NP\x5F000050\x2E2\x3Ap\x2EArg2336Pro&NM\x5F000059\x2E3\x3Ac\x2E7007G\x3EC|CA024716|52241|0.0|evidence|2884|https://civicdb.org/links/evidence/2884|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32921033	1253	G	A	.	.	GN=BRCA2;VT=R2336H;CSQ=A|missense_variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.7007G>A||R2336H|1253|ARG2336HIS&RS28897743|NC\x5F000013\x2E10\x3Ag\x2E32921033G\x3EA&ENST00000544455\x2E1\x3Ac\x2E7007G\x3EA&NP\x5F000050\x2E2\x3Ap\x2EArg2336His&NM\x5F000059\x2E3\x3Ac\x2E7007G\x3EA|CA024713|38077|0.0|evidence|2885|https://civicdb.org/links/evidence/2885|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
13	32968854	661	C	A	.	.	GN=BRCA2;VT=D3095E;CSQ=A|missense_variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.9285C>A||D3095E|661|RS80359198&ASP3095GLU|NC\x5F000013\x2E10\x3Ag\x2E32968854C\x3EA&ENST00000544455\x2E1\x3Ac\x2E9285C\x3EA&NP\x5F000050\x2E2\x3Ap\x2EAsp3095Glu&NM\x5F000059\x2E3\x3Ac\x2E9285C\x3EA|CA10586089|252859|2.5|evidence|1679|https://civicdb.org/links/evidence/1679|18951446_(PubMed)|Rare_Germline|accepted|Positive|Supports|Breast_Cancer_(DOID_1612)||||C|1|||||
13	49033946	638	A	AA	.	.	GN=RB1;VT=M695FS*26;CSQ=A|frameshift_truncation|RB1|5925|transcript|ENST00000267163.4|ENST00000267163.4:c.2083_2084insA||M695FS*26|638||NC\x5F000013\x2E10\x3Ag\x2E49033946\x5F49033947insA&ENST00000267163\x2E4\x3Ac\x2E2083\x5F2084insA|CA913189236|NONE_FOUND|2.0|evidence|1630|https://civicdb.org/links/evidence/1630|27020857_(PubMed)|Somatic|accepted|Resistance|Supports|Estrogen-receptor_Positive_Breast_Cancer_(DOID_0060075)|Palbociclib_(NCIt_ID_C49176)|||D|2|||||
13	103498198	255	A	G	.	.	GN=ERCC5;VT=RS751402;CSQ=G|SNP&5_prime_UTR_variant|ERCC5|2073|transcript|ENST00000355739.4|||RS751402|255||NC\x5F000013\x2E10\x3Ag\x2E103498198A\x3EG|CA10642711|310903|15.0|evidence|665|https://civicdb.org/links/evidence/665|26338418_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Parietal_Lobe_Ependymoma_(DOID_0050903)||||B|3|||||
14	62213848	433	T	C	.	.	GN=HIF1A;VT=3'_UTR_Polymorphism;CSQ=C|SNP&3_prime_UTR_variant|HIF1A|3091|transcript|ENST00000394997.1|||3'_UTR_Polymorphism|433||NC\x5F000014\x2E8\x3Ag\x2E62213848T\x3EC|CA7216212||10.0|evidence|1031|https://civicdb.org/links/evidence/1031|26872370_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Pancreatic_Adenocarcinoma_(DOID_4074)||||B|2|||||
14	65453063	332	G	C	.	.	GN=FNTB;VT=RS11623866;CSQ=C|regulatory_region_variant|FNTB|2342|transcript|ENST00000246166.2|||RS11623866|332||NC\x5F000014\x2E8\x3Ag\x2E65453063G\x3EC|CA13941207||10.0|evidence|815|https://civicdb.org/links/evidence/815|26033044_(PubMed)|Common_Germline|accepted|Resistance|Supports|Ovarian_Cancer_(DOID_2394)|Lonafarnib_(NCIt_ID_C1829)|||B|2|||||
14	95557630	2052	C	G	.	.	GN=DICER1;VT=E1813Q;CSQ=G|missense_variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5437G>C||E1813Q|2052|GLU1813GLN|ENST00000526495\x2E1\x3Ac\x2E5437G\x3EC|CA390864655|NONE_FOUND|25.0|evidence|5535|https://civicdb.org/links/evidence/5535|26428316_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Malignant_Sertoli-Leydig_Cell_Tumor_(DOID_0050618)||||B|4|||||,G|missense_variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5437G>C||E1813Q|2052|GLU1813GLN|ENST00000526495\x2E1\x3Ac\x2E5437G\x3EC|CA390864655|NONE_FOUND|25.0|evidence|5892|https://civicdb.org/links/evidence/5892|22187960_(PubMed)|Rare_Germline|accepted|Likely_Pathogenic|Supports|Malignant_Sertoli-Leydig_Cell_Tumor_(DOID_0050618)||||C|2|||||
14	95560476	2050	C	T	.	.	GN=DICER1;VT=E1705K;CSQ=T|missense_variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5113G>A||E1705K|2050|GLU1705LYS|ENST00000526495\x2E1\x3Ac\x2E5113G\x3EA|CA390865421|NONE_FOUND|20.0|evidence|5533|https://civicdb.org/links/evidence/5533|26428316_(PubMed)|Somatic|accepted|Positive|Supports|Malignant_Sertoli-Leydig_Cell_Tumor_(DOID_0050618)||||B|4|||||
14	105243048	169	G	T	.	.	GN=AKT1;VT=Q79K;CSQ=T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.235C>A||Q79K|169|GLN79LYS&Q17K|ENST00000407796\x2E2\x3Ac\x2E235C\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGln79Lys&NM\x5F001014432\x2E1\x3Ac\x2E235C\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105243048G\x3ET|CA16602625|376168|14.0|evidence|6260|https://civicdb.org/links/evidence/6260|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Dabrafenib_(NCIt_ID_C82386)|||C|4|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.235C>A||Q79K|169|GLN79LYS&Q17K|ENST00000407796\x2E2\x3Ac\x2E235C\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGln79Lys&NM\x5F001014432\x2E1\x3Ac\x2E235C\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105243048G\x3ET|CA16602625|376168|14.0|evidence|4498|https://civicdb.org/links/evidence/4498|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.235C>A||Q79K|169|GLN79LYS&Q17K|ENST00000407796\x2E2\x3Ac\x2E235C\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGln79Lys&NM\x5F001014432\x2E1\x3Ac\x2E235C\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105243048G\x3ET|CA16602625|376168|14.0|evidence|439|https://civicdb.org/links/evidence/439|24265152_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|4|||||
14	105246551	4	C	T	.	.	GN=AKT1;VT=E17K;CSQ=T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|RS34409589&GLU17LYS|ENST00000407796\x2E2\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET|CA123660|13983|32.5|evidence|4029|https://civicdb.org/links/evidence/4029|24265155_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||D|None|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|RS34409589&GLU17LYS|ENST00000407796\x2E2\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET|CA123660|13983|32.5|evidence|3039|https://civicdb.org/links/evidence/3039|28489509_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Cancer_(DOID_162)|Capivasertib_(NCIt_ID_C102564)|||B|4|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|RS34409589&GLU17LYS|ENST00000407796\x2E2\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET|CA123660|13983|32.5|evidence|709|https://civicdb.org/links/evidence/709|26351323_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Capivasertib_(NCIt_ID_C102564)|||C|3|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|RS34409589&GLU17LYS|ENST00000407796\x2E2\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET|CA123660|13983|32.5|evidence|707|https://civicdb.org/links/evidence/707|24735930_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Melanoma_(DOID_1909)|Uprosertib_(NCIt_ID_C84870)|||D|2|||||,T|missense_variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|RS34409589&GLU17LYS|ENST00000407796\x2E2\x3Ac\x2E49G\x3EA&NP\x5F001014432\x2E1\x3Ap\x2EGlu17Lys&NM\x5F001014432\x2E1\x3Ac\x2E49G\x3EA&NC\x5F000014\x2E8\x3Ag\x2E105246551C\x3ET|CA123660|13983|32.5|evidence|231|https://civicdb.org/links/evidence/231|23888070_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Breast_Cancer_(DOID_1612)|Akt_Inhibitor_MK2206_(NCIt_ID_C90581)|||D|3|||||
15	45003785	616	CTCTT	C	.	.	GN=B2M;VT=S14FS;CSQ=-|frameshift_truncation|B2M|567|transcript|ENST00000558401.1|ENST00000558401.1:c.42_45delTCTT||S14FS|616||NC\x5F000015\x2E9\x3Ag\x2E45003786\x5F45003789del&ENST00000558401\x2E1\x3Ac\x2E42\x5F45delTCTT|CA645576720||7.5|evidence|1569|https://civicdb.org/links/evidence/1569|27433843_(PubMed)|Somatic|accepted|Resistance|Supports|Skin_Melanoma_(DOID_8923)|Pembrolizumab_(NCIt_ID_C106432)|||C|3|||||
15	66727448	655	CCCAGAAGCAGAAGGT	C	.	.	GN=MAP2K1;VT=Q56_V60del;CSQ=-|inframe_deletion|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.165_179del||Q56_V60del|655||NC\x5F000015\x2E9\x3Ag\x2E66727449\x5F66727463del&ENST00000307102\x2E5\x3Ac\x2E165\x5F179del|CA912992484|NONE_FOUND|10.0|evidence|1661|https://civicdb.org/links/evidence/1661|26324360_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Serous_Carcinoma_(DOID_0050933)|Selumetinib_(NCIt_ID_C66939)|||C|4|||||
15	66727451	83	A	C	.	.	GN=MAP2K1;VT=Q56P;CSQ=C|missense_variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.167A>C||Q56P|83|GLN56PRO|NP\x5F002746\x2E1\x3Ap\x2EGln56Pro&NM\x5F002755\x2E3\x3Ac\x2E167A\x3EC&NC\x5F000015\x2E9\x3Ag\x2E66727451A\x3EC&ENST00000307102\x2E5\x3Ac\x2E167A\x3EC|CA16602453|375978|3.0|evidence|13|https://civicdb.org/links/evidence/13|19915144_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Selumetinib_(NCIt_ID_C66939)|||D|3|||||
15	66727455	1272	G	T	.	.	GN=MAP2K1;VT=K57N;CSQ=T|missense_variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.171G>T||K57N|1272|RS869025608&LYS57ASN|ENST00000307102\x2E5\x3Ac\x2E171G\x3ET&NC\x5F000015\x2E9\x3Ag\x2E66727455G\x3ET&NG\x5F008305\x2E1\x3Ag\x2E53245G\x3ET&NP\x5F002746\x2E1\x3Ap\x2ELys57Asn&NM\x5F002755\x2E3\x3Ac\x2E171G\x3ET|CA356995|223140|9.5|evidence|2936|https://civicdb.org/links/evidence/2936|18632602_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Selumetinib_(NCIt_ID_C66939)|||D|2|||||,T|missense_variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.171G>T||K57N|1272|RS869025608&LYS57ASN|ENST00000307102\x2E5\x3Ac\x2E171G\x3ET&NC\x5F000015\x2E9\x3Ag\x2E66727455G\x3ET&NG\x5F008305\x2E1\x3Ag\x2E53245G\x3ET&NP\x5F002746\x2E1\x3Ap\x2ELys57Asn&NM\x5F002755\x2E3\x3Ac\x2E171G\x3ET|CA356995|223140|9.5|evidence|2935|https://civicdb.org/links/evidence/2935|25351745_(PubMed)|Somatic|accepted|Positive|Supports|Lung_Adenocarcinoma_(DOID_3910)||||C|3|||||
15	66729154	627	G	C	.	.	GN=MAP2K1;VT=C121S;CSQ=C|missense_variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.362G>C||C121S|627|CYS121SER|NP\x5F002746\x2E1\x3Ap\x2ECys121Ser&NM\x5F002755\x2E3\x3Ac\x2E362G\x3EC&NC\x5F000015\x2E9\x3Ag\x2E66729154G\x3EC&ENST00000307102\x2E5\x3Ac\x2E362G\x3EC|CA16602455|375980|10.0|evidence|1602|https://civicdb.org/links/evidence/1602|21383288_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Vemurafenib_(NCIt_ID_C64768)|||C|4|||||
15	66729162	82	C	T	.	.	GN=MAP2K1;VT=P124S;CSQ=T|missense_variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.370C>T||P124S|82|PRO124SER|NP\x5F002746\x2E1\x3Ap\x2EPro124Ser&NM\x5F002755\x2E3\x3Ac\x2E370C\x3ET&NC\x5F000015\x2E9\x3Ag\x2E66729162C\x3ET&ENST00000307102\x2E5\x3Ac\x2E370C\x3ET|CA16602456|375981|3.0|evidence|12|https://civicdb.org/links/evidence/12|19915144_(PubMed)|Somatic|accepted|Resistance|Supports|Melanoma_(DOID_1909)|Selumetinib_(NCIt_ID_C66939)|||D|3|||||
15	74315213	462	C	T	.	.	GN=PML;VT=PML-RARA_A216V;CSQ=T|missense_variant|PML|5371|transcript|ENST00000268058.3|||PML-RARA_A216V|462||NC\x5F000015\x2E9\x3Ag\x2E74315213C\x3ET|CA393121894|NONE_FOUND|30.0|evidence|8177|https://civicdb.org/links/evidence/8177|26537301_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Promyelocytic_Leukemia_(DOID_0060318)|Arsenic_Trioxide_(NCIt_ID_C1005)|||B|4|||||,T|missense_variant|PML|5371|transcript|ENST00000268058.3|||PML-RARA_A216V|462||NC\x5F000015\x2E9\x3Ag\x2E74315213C\x3ET|CA393121894|NONE_FOUND|30.0|evidence|1093|https://civicdb.org/links/evidence/1093|21613260_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Promyelocytic_Leukemia_(DOID_0060318)|Tretinoin_(NCIt_ID_C900)|||C|4|||||
15	74315219	463	T	C	.	.	GN=PML;VT=PML-RARA_L218P;CSQ=C|missense_variant|PML|5371|transcript|ENST00000268058.3|||PML-RARA_L218P|463||NC\x5F000015\x2E9\x3Ag\x2E74315219T\x3EC|CA393121927|NONE_FOUND|7.5|evidence|1094|https://civicdb.org/links/evidence/1094|21613260_(PubMed)|Somatic|accepted|Resistance|Supports|Acute_Promyelocytic_Leukemia_(DOID_0060318)|Tretinoin_(NCIt_ID_C900)|||C|3|||||
15	88476265	805	C	T	.	.	GN=NTRK3;VT=ETV6-NTRK3_G623R;CSQ=T|transcript_fusion&missense_variant|NTRK3|4916|transcript|ENST00000394480.2|ENST00000394480.2:c.1867G>A||ETV6-NTRK3_G623R|805|GLY623ARG|ENST00000394480\x2E2\x3Ac\x2E1867G\x3EA&NC\x5F000015\x2E9\x3Ag\x2E88476265C\x3ET|CA393914380|NONE_FOUND|10.0|evidence|1874|https://civicdb.org/links/evidence/1874|26884591_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Entrectinib_(NCIt_ID_C114984)|||C|4|||||
15	90631838	63	C	T	.	.	GN=IDH2;VT=R172K;CSQ=T|missense_variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|RS121913503&R120K&ARG172LYS|ENST00000330062\x2E3\x3Ac\x2E515G\x3EA&NP\x5F002159\x2E2\x3Ap\x2EArg172Lys&NM\x5F002168\x2E3\x3Ac\x2E515G\x3EA&NC\x5F000015\x2E9\x3Ag\x2E90631838C\x3ET|CA16602462|375987|35.0|evidence|375|https://civicdb.org/links/evidence/375|21596855_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,T|missense_variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|RS121913503&R120K&ARG172LYS|ENST00000330062\x2E3\x3Ac\x2E515G\x3EA&NP\x5F002159\x2E2\x3Ap\x2EArg172Lys&NM\x5F002168\x2E3\x3Ac\x2E515G\x3EA&NC\x5F000015\x2E9\x3Ag\x2E90631838C\x3ET|CA16602462|375987|35.0|evidence|332|https://civicdb.org/links/evidence/332|21997850_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Myelodysplastic_Syndrome_(DOID_0050908)||||B|2|||||,T|missense_variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|RS121913503&R120K&ARG172LYS|ENST00000330062\x2E3\x3Ac\x2E515G\x3EA&NP\x5F002159\x2E2\x3Ap\x2EArg172Lys&NM\x5F002168\x2E3\x3Ac\x2E515G\x3EA&NC\x5F000015\x2E9\x3Ag\x2E90631838C\x3ET|CA16602462|375987|35.0|evidence|331|https://civicdb.org/links/evidence/331|22616558_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|2|||||
16	2130300	469	C	T	.	.	GN=TSC2;VT=Q1178*;CSQ=T|stop_gained|TSC2|7249|transcript|ENST00000219476.3|ENST00000219476.3:c.3532C>T||Q1178*|469|RS45517297&GLN1178TER&Q1178X|NC\x5F000016\x2E9\x3Ag\x2E2130300C\x3ET&ENST00000219476\x2E3\x3Ac\x2E3532C\x3ET&NP\x5F000539\x2E2\x3Ap\x2EGln1178Ter&NM\x5F000548\x2E4\x3Ac\x2E3532C\x3ET|CA019253|49263|12.5|evidence|1108|https://civicdb.org/links/evidence/1108|25295501_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Thyroid_Gland_Carcinoma_(DOID_3963)|Everolimus_(NCIt_ID_C48387)|||C|5|||||
16	69745145	402	G	A	.	.	GN=NQO1;VT=P187S;CSQ=A|missense_variant|NQO1|1728|transcript|ENST00000320623.5|||P187S|402|PRO187SER|NC\x5F000016\x2E9\x3Ag\x2E69745145G\x3EA&NP\x5F000894\x2E1\x3Ap\x2EPro187Ser&NM\x5F000903\x2E2\x3Ac\x2E559C\x3ET|CA126904|16809|2.0|evidence|941|https://civicdb.org/links/evidence/941|21964527_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Lung_Cancer_(DOID_1324)|Amrubicin_(NCIt_ID_C80089)|||D|2|||||
17	7577093	1108	C	A	.	.	GN=TP53;VT=R282L;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.845G>T||R282L|1108|RS730882008&R243L&R150L&ARG282LEU|ENST00000269305\x2E4\x3Ac\x2E845G\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577093C\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg282Leu&NM\x5F000546\x2E5\x3Ac\x2E845G\x3ET|CA000456|182938|0.0|evidence|2818|https://civicdb.org/links/evidence/2818|14514923_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Stomach_Carcinoma_(DOID_5517)|EAP_Protocol|||C|None|||||
17	7577120	918	C	A	.	.	GN=TP53;VT=R273L;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>T||R273L|918|ARG273LEU&RS28934576|ENST00000269305\x2E4\x3Ac\x2E818G\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577120C\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg273Leu&NM\x5F000546\x2E5\x3Ac\x2E818G\x3ET|CA001530|376655|0.0|evidence|2286|https://civicdb.org/links/evidence/2286|11595686_(PubMed)|Somatic|accepted|Resistance|Supports|Ovarian_Cancer_(DOID_2394)|Cisplatin_(NCIt_ID_C376)&Carboplatin_(NCIt_ID_C1282)|Substitutes||C|None|||||
17	7577120	122	C	T	.	.	GN=TP53;VT=R273H;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|RS28934576&ARG273HIS|ENST00000269305\x2E4\x3Ac\x2E818G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577120C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg273His&NM\x5F000546\x2E5\x3Ac\x2E818G\x3EA|CA000434|12366|41.0|evidence|397|https://civicdb.org/links/evidence/397|16489069_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|RS28934576&ARG273HIS|ENST00000269305\x2E4\x3Ac\x2E818G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577120C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg273His&NM\x5F000546\x2E5\x3Ac\x2E818G\x3EA|CA000434|12366|41.0|evidence|7530|https://civicdb.org/links/evidence/7530|31395785_(PubMed)|Unknown|accepted|Neomorphic|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|RS28934576&ARG273HIS|ENST00000269305\x2E4\x3Ac\x2E818G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577120C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg273His&NM\x5F000546\x2E5\x3Ac\x2E818G\x3EA|CA000434|12366|41.0|evidence|7430|https://civicdb.org/links/evidence/7430|17363498_(PubMed)|Somatic|accepted|Resistance|Supports|Osteosarcoma_(DOID_3347)|Methotrexate_(NCIt_ID_C642)&Doxorubicin_(NCIt_ID_C456)|Substitutes||D|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|RS28934576&ARG273HIS|ENST00000269305\x2E4\x3Ac\x2E818G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577120C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg273His&NM\x5F000546\x2E5\x3Ac\x2E818G\x3EA|CA000434|12366|41.0|evidence|398|https://civicdb.org/links/evidence/398|9569050_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|RS28934576&ARG273HIS|ENST00000269305\x2E4\x3Ac\x2E818G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577120C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg273His&NM\x5F000546\x2E5\x3Ac\x2E818G\x3EA|CA000434|12366|41.0|evidence|4882|https://civicdb.org/links/evidence/4882|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7577121	121	G	A	.	.	GN=TP53;VT=R273C;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|RS121913343&ARG273CYS|ENST00000269305\x2E4\x3Ac\x2E817C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577121G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg273Cys&NM\x5F000546\x2E5\x3Ac\x2E817C\x3ET|CA000432|43594|41.5|evidence|4881|https://civicdb.org/links/evidence/4881|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||,A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|RS121913343&ARG273CYS|ENST00000269305\x2E4\x3Ac\x2E817C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577121G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg273Cys&NM\x5F000546\x2E5\x3Ac\x2E817C\x3ET|CA000432|43594|41.5|evidence|2292|https://civicdb.org/links/evidence/2292|14514923_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Stomach_Carcinoma_(DOID_5517)|Mitomycin_(NCIt_ID_C1820)&Etoposide_(NCIt_ID_C491)&Cisplatin_(NCIt_ID_C376)|Combination||C|3|||||,A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|RS121913343&ARG273CYS|ENST00000269305\x2E4\x3Ac\x2E817C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577121G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg273Cys&NM\x5F000546\x2E5\x3Ac\x2E817C\x3ET|CA000432|43594|41.5|evidence|396|https://civicdb.org/links/evidence/396|9569050_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||,A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|RS121913343&ARG273CYS|ENST00000269305\x2E4\x3Ac\x2E817C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577121G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg273Cys&NM\x5F000546\x2E5\x3Ac\x2E817C\x3ET|CA000432|43594|41.5|evidence|395|https://civicdb.org/links/evidence/395|16489069_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||
17	7577535	119	C	G	.	.	GN=TP53;VT=R249;CSQ=G|protein_altering_variant|TP53|7157|transcript|ENST00000269305.4|||R249|119|ARG249|NC\x5F000017\x2E10\x3Ag\x2E7577535C\x3EG|CA16602484|376015|30.0|evidence|399|https://civicdb.org/links/evidence/399|9569050_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Doxorubicin_(NCIt_ID_C456)|||B|3|||||,G|protein_altering_variant|TP53|7157|transcript|ENST00000269305.4|||R249|119|ARG249|NC\x5F000017\x2E10\x3Ag\x2E7577535C\x3EG|CA16602484|376015|30.0|evidence|393|https://civicdb.org/links/evidence/393|9569050_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||
17	7577538	117	C	T	.	.	GN=TP53;VT=R248Q;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|RS11540652&ARG248GLN|ENST00000269305\x2E4\x3Ac\x2E743G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577538C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg248Gln&NM\x5F000546\x2E5\x3Ac\x2E743G\x3EA|CA000387|12356|46.0|evidence|391|https://civicdb.org/links/evidence/391|9569050_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|RS11540652&ARG248GLN|ENST00000269305\x2E4\x3Ac\x2E743G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577538C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg248Gln&NM\x5F000546\x2E5\x3Ac\x2E743G\x3EA|CA000387|12356|46.0|evidence|7161|https://civicdb.org/links/evidence/7161|23538418_(PubMed)|Rare_Germline|accepted|Likely_Pathogenic|Supports|Lymphoma_(DOID_0060058)||||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|RS11540652&ARG248GLN|ENST00000269305\x2E4\x3Ac\x2E743G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577538C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg248Gln&NM\x5F000546\x2E5\x3Ac\x2E743G\x3EA|CA000387|12356|46.0|evidence|3042|https://civicdb.org/links/evidence/3042|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|RS11540652&ARG248GLN|ENST00000269305\x2E4\x3Ac\x2E743G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577538C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg248Gln&NM\x5F000546\x2E5\x3Ac\x2E743G\x3EA|CA000387|12356|46.0|evidence|7529|https://civicdb.org/links/evidence/7529|31395785_(PubMed)|Unknown|accepted|Neomorphic|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|RS11540652&ARG248GLN|ENST00000269305\x2E4\x3Ac\x2E743G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577538C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg248Gln&NM\x5F000546\x2E5\x3Ac\x2E743G\x3EA|CA000387|12356|46.0|evidence|390|https://civicdb.org/links/evidence/390|16489069_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|RS11540652&ARG248GLN|ENST00000269305\x2E4\x3Ac\x2E743G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577538C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg248Gln&NM\x5F000546\x2E5\x3Ac\x2E743G\x3EA|CA000387|12356|46.0|evidence|7525|https://civicdb.org/links/evidence/7525|31395785_(PubMed)|Unknown|accepted|Dominant_Negative|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||D|4|||||
17	7577539	118	G	A	.	.	GN=TP53;VT=R248W;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.742C>T||R248W|118|RS121912651&ARG248TRP|ENST00000269305\x2E4\x3Ac\x2E742C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577539G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg248Trp&NM\x5F000546\x2E5\x3Ac\x2E742C\x3ET|CA000382|12347|19.0|evidence|4879|https://civicdb.org/links/evidence/4879|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||,A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.742C>T||R248W|118|RS121912651&ARG248TRP|ENST00000269305\x2E4\x3Ac\x2E742C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7577539G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EArg248Trp&NM\x5F000546\x2E5\x3Ac\x2E742C\x3ET|CA000382|12347|19.0|evidence|392|https://civicdb.org/links/evidence/392|16489069_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||
17	7577548	879	C	T	.	.	GN=TP53;VT=G245S;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.733G>A||G245S|879|RS28934575|ENST00000269305\x2E4\x3Ac\x2E733G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EGly245Ser&NM\x5F000546\x2E5\x3Ac\x2E733G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577548C\x3ET|CA000367|12365|4.0|evidence|4883|https://civicdb.org/links/evidence/4883|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7577568	2648	C	T	.	.	GN=TP53;VT=C238Y;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.713G>A||C238Y|2648|CYS238TYR|ENST00000269305\x2E4\x3Ac\x2E713G\x3EA&NP\x5F000537\x2E3\x3Ap\x2ECys238Tyr&NM\x5F000546\x2E5\x3Ac\x2E713G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7577568C\x3ET|CA000351|181000|0.0|evidence|7173|https://civicdb.org/links/evidence/7173|11051239_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||E|3|||||
17	7577570	1066	C	A	.	.	GN=TP53;VT=M237I;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.711G>T||M237I|1066|MET237ILE|ENST00000269305\x2E4\x3Ac\x2E711G\x3ET|CA287488024|NONE_FOUND|4.0|evidence|7528|https://civicdb.org/links/evidence/7528|31395785_(PubMed)|Unknown|accepted|Neomorphic|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||D|4|||||,A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.711G>T||M237I|1066|MET237ILE|ENST00000269305\x2E4\x3Ac\x2E711G\x3ET|CA287488024|NONE_FOUND|4.0|evidence|4885|https://civicdb.org/links/evidence/4885|25730903_(PubMed)|None|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7577580	1068	T	C	.	.	GN=TP53;VT=Y234C;CSQ=C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.701A>G||Y234C|1068|RS587780073&Y195C&Y102C&TYR234CYS|ENST00000269305\x2E4\x3Ac\x2E701A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7577580T\x3EC&NP\x5F000537\x2E3\x3Ap\x2ETyr234Cys&NM\x5F000546\x2E5\x3Ac\x2E701A\x3EG|CA000337|127820|0.0|evidence|2745|https://civicdb.org/links/evidence/2745|11595686_(PubMed)|Somatic|accepted|Resistance|Supports|Ovarian_Cancer_(DOID_2394)|Cisplatin_(NCIt_ID_C376)&Carboplatin_(NCIt_ID_C1282)|Substitutes||C|None|||||
17	7578190	922	T	C	.	.	GN=TP53;VT=Y220C;CSQ=C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.659A>G||Y220C|922|TYR220CYS&RS121912666|ENST00000269305\x2E4\x3Ac\x2E659A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7578190T\x3EC&NP\x5F000537\x2E3\x3Ap\x2ETyr220Cys&NM\x5F000546\x2E5\x3Ac\x2E659A\x3EG|CA000315|127819|15.5|evidence|7527|https://civicdb.org/links/evidence/7527|31395785_(PubMed)|Unknown|accepted|Neomorphic|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||D|4|||||,C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.659A>G||Y220C|922|TYR220CYS&RS121912666|ENST00000269305\x2E4\x3Ac\x2E659A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7578190T\x3EC&NP\x5F000537\x2E3\x3Ap\x2ETyr220Cys&NM\x5F000546\x2E5\x3Ac\x2E659A\x3EG|CA000315|127819|15.5|evidence|2306|https://civicdb.org/links/evidence/2306|14514923_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Stomach_Carcinoma_(DOID_5517)|Mitomycin_(NCIt_ID_C1820)&Etoposide_(NCIt_ID_C491)&Cisplatin_(NCIt_ID_C376)|Combination||C|3|||||,C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.659A>G||Y220C|922|TYR220CYS&RS121912666|ENST00000269305\x2E4\x3Ac\x2E659A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7578190T\x3EC&NP\x5F000537\x2E3\x3Ap\x2ETyr220Cys&NM\x5F000546\x2E5\x3Ac\x2E659A\x3EG|CA000315|127819|15.5|evidence|4884|https://civicdb.org/links/evidence/4884|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7578211	1109	C	G	.	.	GN=TP53;VT=R213P;CSQ=G|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.638G>C||R213P|1109|RS587778720&R81P&R174P&ARG213PRO|ENST00000269305\x2E4\x3Ac\x2E638G\x3EC&NC\x5F000017\x2E10\x3Ag\x2E7578211C\x3EG&NP\x5F000537\x2E3\x3Ap\x2EArg213Pro&NM\x5F000546\x2E5\x3Ac\x2E638G\x3EC|CA10580932|231214|0.0|evidence|2819|https://civicdb.org/links/evidence/2819|14514923_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Stomach_Carcinoma_(DOID_5517)|EAP_Protocol|||C|None|||||
17	7578406	116	C	T	.	.	GN=TP53;VT=R175H;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|ENST00000269305\x2E4\x3Ac\x2E524G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|319|https://civicdb.org/links/evidence/319|22698404_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Doxorubicin_(NCIt_ID_C456)|||D|3|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|ENST00000269305\x2E4\x3Ac\x2E524G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|4880|https://civicdb.org/links/evidence/4880|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|ENST00000269305\x2E4\x3Ac\x2E524G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|2310|https://civicdb.org/links/evidence/2310|14514923_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Stomach_Carcinoma_(DOID_5517)|EAP_Protocol|||C|None|||||,T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|R136H&R43H&RS28934578&ARG175HIS|ENST00000269305\x2E4\x3Ac\x2E524G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E7578406C\x3ET&NP\x5F000537\x2E3\x3Ap\x2EArg175His&NM\x5F000546\x2E5\x3Ac\x2E524G\x3EA|CA000251|12374|22.0|evidence|389|https://civicdb.org/links/evidence/389|16489069_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Breast_Cancer_(DOID_1612)||||B|3|||||
17	7578457	1695	C	T	.	.	GN=TP53;VT=R158H;CSQ=T|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.473G>A||R158H|1695|ARG158HIS|ENST00000269305\x2E4\x3Ac\x2E473G\x3EA|CA000227|NONE_FOUND|4.0|evidence|4886|https://civicdb.org/links/evidence/4886|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7578457	1699	C	A	.	.	GN=TP53;VT=R158L;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.473G>T||R158L|1699|ARG158LEU|ENST00000269305\x2E4\x3Ac\x2E473G\x3ET|CA397842028|NONE_FOUND|4.0|evidence|4891|https://civicdb.org/links/evidence/4891|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7578461	1092	C	A	.	.	GN=TP53;VT=V157F;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.469G>T||V157F|1092|VAL157PHE&RS121912654|ENST00000269305\x2E4\x3Ac\x2E469G\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7578461C\x3EA&NP\x5F000537\x2E3\x3Ap\x2EVal157Phe&NM\x5F000546\x2E5\x3Ac\x2E469G\x3ET|CA000222|12353|4.0|evidence|4887|https://civicdb.org/links/evidence/4887|25730903_(PubMed)|Somatic|accepted|Resistance|Supports|Cancer_(DOID_162)|AMGMDS3|||D|4|||||
17	7579472	531	G	C	.	.	GN=TP53;VT=P72R;CSQ=C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.215C>G||P72R|531|RS1042522&P33R&PRO72ARG|ENST00000269305\x2E4\x3Ac\x2E215C\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7579472G\x3EC&NP\x5F000537\x2E3\x3Ap\x2EPro72Arg&NM\x5F000546\x2E5\x3Ac\x2E215C\x3EG|CA000072|12351|45.0|evidence|1302|https://civicdb.org/links/evidence/1302|17909070_(PubMed)|Common_Germline|accepted|Positive|Does_Not_Support|Breast_Cancer_(DOID_1612)||||B|4|||||,C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.215C>G||P72R|531|RS1042522&P33R&PRO72ARG|ENST00000269305\x2E4\x3Ac\x2E215C\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7579472G\x3EC&NP\x5F000537\x2E3\x3Ap\x2EPro72Arg&NM\x5F000546\x2E5\x3Ac\x2E215C\x3EG|CA000072|12351|45.0|evidence|1304|https://civicdb.org/links/evidence/1304|11535556_(PubMed)|Common_Germline|accepted|Poor_Outcome|Does_Not_Support|Cervical_Cancer_(DOID_4362)||||B|2|||||,C|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.215C>G||P72R|531|RS1042522&P33R&PRO72ARG|ENST00000269305\x2E4\x3Ac\x2E215C\x3EG&NC\x5F000017\x2E10\x3Ag\x2E7579472G\x3EC&NP\x5F000537\x2E3\x3Ap\x2EPro72Arg&NM\x5F000546\x2E5\x3Ac\x2E215C\x3EG|CA000072|12351|45.0|evidence|1303|https://civicdb.org/links/evidence/1303|12840112_(PubMed)|Common_Germline|accepted|Poor_Outcome|Does_Not_Support|Lung_Carcinoma_(DOID_3905)||||B|3|||||
17	7579548	504	G	A	.	.	GN=TP53;VT=P47S;CSQ=A|missense_variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.139C>T||P47S|504|RS1800371&PRO47SER|ENST00000269305\x2E4\x3Ac\x2E139C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E7579548G\x3EA&NP\x5F000537\x2E3\x3Ap\x2EPro47Ser&NM\x5F000546\x2E5\x3Ac\x2E139C\x3ET|CA000053|43588|0.5|evidence|1209|https://civicdb.org/links/evidence/1209|27034505_(PubMed)|Common_Germline|accepted|Resistance|Supports|Cancer_(DOID_162)|Cisplatin_(NCIt_ID_C376)|||E|2|||||
17	33433425	471	G	A	.	.	GN=RAD51D;VT=R186*;CSQ=A|stop_gained|RAD51D|5892|transcript|ENST00000345365.6|||R186*|471|RS387906843&ARG186TER&R186X|NC\x5F000017\x2E10\x3Ag\x2E33433425G\x3EA|CA129082|30285|5.0|evidence|1111|https://civicdb.org/links/evidence/1111|25445424_(PubMed)|Rare_Germline|accepted||Supports|Breast_Cancer_(DOID_1612)||||C|2|||||
17	37868205	38	G	C	.	.	GN=ERBB2;VT=G309A;CSQ=C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.926G>C||G309A|38|RS1057519787&G279A&G294A&GLY294ALA&GLY279ALA&GLY309ALA|NP\x5F004439\x2E2\x3Ap\x2EGly309Ala&NM\x5F004448\x2E3\x3Ac\x2E926G\x3EC&NC\x5F000017\x2E10\x3Ag\x2E37868205G\x3EC&ENST00000269571\x2E5\x3Ac\x2E926G\x3EC|CA16602660|376205|5.0|evidence|282|https://civicdb.org/links/evidence/282|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||
17	37879658	42	G	A	.	.	GN=ERBB2;VT=R678Q;CSQ=A|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2033G>A||R678Q|42|RS1057519862&R663Q&R648Q&ARG678GLN|NP\x5F004439\x2E2\x3Ap\x2EArg678Gln&NM\x5F004448\x2E3\x3Ac\x2E2033G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E37879658G\x3EA&ENST00000269571\x2E5\x3Ac\x2E2033G\x3EA|CA16602787|376344|5.0|evidence|286|https://civicdb.org/links/evidence/286|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Lapatinib_(NCIt_ID_C26653)&Neratinib_(NCIt_ID_C49094)|Substitutes||D|5|||||
17	37880218	37	GTTGAGGGAAAACACA	G	.	.	GN=ERBB2;VT=L755_T759del;CSQ=-|inframe_deletion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2263_2277del||L755_T759del|37|LEU755\x5FTHR759DEL&RS1131692241|NM\x5F004448\x2E3\x3Ac\x2E2263\x5F2277delTTGAGGGAAAACACA&NP\x5F004439\x2E2\x3Ap\x2ELeu755\x5FThr759del&NC\x5F000017\x2E10\x3Ag\x2E37880219\x5F37880233del&ENST00000269571\x2E5\x3Ac\x2E2263\x5F2277del|CA645372623|375990|5.0|evidence|281|https://civicdb.org/links/evidence/281|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Lapatinib_(NCIt_ID_C26653)&Neratinib_(NCIt_ID_C49094)|Substitutes||D|5|||||
17	37880220	39	T	C	.	.	GN=ERBB2;VT=L755S;CSQ=C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|L740S&L725S&LEU755SER|NP\x5F004439\x2E2\x3Ap\x2ELeu755Ser&NM\x5F004448\x2E3\x3Ac\x2E2264T\x3EC&ENST00000269571\x2E5\x3Ac\x2E2264T\x3EC&NC\x5F000017\x2E10\x3Ag\x2E37880220T\x3EC|CA16602502|376035|21.5|evidence|4955|https://civicdb.org/links/evidence/4955|27626067_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Colorectal_Adenocarcinoma_(DOID_0050861)|Fluorouracil_(NCIt_ID_C505)&Leucovorin_(NCIt_ID_C71631)&Trastuzumab_(NCIt_ID_C1647)|Combination||C|3|||||,C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|L740S&L725S&LEU755SER|NP\x5F004439\x2E2\x3Ap\x2ELeu755Ser&NM\x5F004448\x2E3\x3Ac\x2E2264T\x3EC&ENST00000269571\x2E5\x3Ac\x2E2264T\x3EC&NC\x5F000017\x2E10\x3Ag\x2E37880220T\x3EC|CA16602502|376035|21.5|evidence|1176|https://civicdb.org/links/evidence/1176|26243863_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colon_Cancer_(DOID_219)|Lapatinib_(NCIt_ID_C26653)&Neratinib_(NCIt_ID_C49094)&Trastuzumab_(NCIt_ID_C1647)|Combination||D|4|||||,C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|L740S&L725S&LEU755SER|NP\x5F004439\x2E2\x3Ap\x2ELeu755Ser&NM\x5F004448\x2E3\x3Ac\x2E2264T\x3EC&ENST00000269571\x2E5\x3Ac\x2E2264T\x3EC&NC\x5F000017\x2E10\x3Ag\x2E37880220T\x3EC|CA16602502|376035|21.5|evidence|283|https://civicdb.org/links/evidence/283|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||,C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|L740S&L725S&LEU755SER|NP\x5F004439\x2E2\x3Ap\x2ELeu755Ser&NM\x5F004448\x2E3\x3Ac\x2E2264T\x3EC&ENST00000269571\x2E5\x3Ac\x2E2264T\x3EC&NC\x5F000017\x2E10\x3Ag\x2E37880220T\x3EC|CA16602502|376035|21.5|evidence|241|https://civicdb.org/links/evidence/241|23220880_(PubMed)|Somatic|accepted|Resistance|Supports|Breast_Cancer_(DOID_1612)|Lapatinib_(NCIt_ID_C26653)|||D|5|||||
17	37880220	40	T	G	.	.	GN=ERBB2;VT=L755W;CSQ=G|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>G||L755W|40|RS121913470&L740W&L725W&LEU755TRP|NP\x5F004439\x2E2\x3Ap\x2ELeu755Trp&NM\x5F004448\x2E3\x3Ac\x2E2264T\x3EG&NC\x5F000017\x2E10\x3Ag\x2E37880220T\x3EG&ENST00000269571\x2E5\x3Ac\x2E2264T\x3EG|CA16602786|376343|5.0|evidence|284|https://civicdb.org/links/evidence/284|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||
17	37880261	36	G	T	.	.	GN=ERBB2;VT=D769Y;CSQ=T|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2305G>T||D769Y|36|ASP739TYR&ASP754TYR&D769Y&ASP769TYR&RS121913468&D754Y&D739Y|NP\x5F004439\x2E2\x3Ap\x2EAsp769Tyr&NM\x5F004448\x2E3\x3Ac\x2E2305G\x3ET&NC\x5F000017\x2E10\x3Ag\x2E37880261G\x3ET&ENST00000269571\x2E5\x3Ac\x2E2305G\x3ET|CA16602466|375992|4.0|evidence|280|https://civicdb.org/links/evidence/280|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|4|||||
17	37880261	35	G	C	.	.	GN=ERBB2;VT=D769H;CSQ=C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2305G>C||D769H|35|RS121913468&D769H&ASP754HIS&ASP739HIS&D754H&D739H&ASP769HIS|NC\x5F000017\x2E10\x3Ag\x2E37880261G\x3EC&ENST00000269571\x2E5\x3Ac\x2E2305G\x3EC&NP\x5F001276866\x2E1\x3Ap\x2EAsp769His&NM\x5F001289937\x2E1\x3Ac\x2E2305G\x3EC|CA16602465|375991|4.0|evidence|279|https://civicdb.org/links/evidence/279|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Lapatinib_(NCIt_ID_C26653)&Neratinib_(NCIt_ID_C49094)|Substitutes||D|4|||||
17	37880989	872	T	C	.	.	GN=ERBB2;VT=V773A;CSQ=C|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2318T>C||V773A|872|VAL773ALA|NP\x5F004439\x2E2\x3Ap\x2EVal773Ala&NM\x5F004448\x2E3\x3Ac\x2E2318T\x3EC&NC\x5F000017\x2E10\x3Ag\x2E37880989T\x3EC&ENST00000269571\x2E5\x3Ac\x2E2318T\x3EC|CA399302815|NONE_FOUND|3.0|evidence|1987|https://civicdb.org/links/evidence/1987|22046346_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Squamous_Cell_Carcinoma_(DOID_5520)|Lapatinib_(NCIt_ID_C26653)|||D|3|||||
17	37880991	818	AA	ATGGCTGG	.	.	GN=ERBB2;VT=M774DELINSWLV;CSQ=TGGCTGG|inframe_indel|ERBB2|2064|transcript|ENST00000269571.5|||M774DELINSWLV|818|||None|NONE_FOUND|7.5|evidence|1894|https://civicdb.org/links/evidence/1894|25899785_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||C|3|||||
17	37880996	414	T	TTACGTGATGGCT	.	.	GN=ERBB2;VT=Y772_A775DUP;CSQ=TACGTGATGGCT|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|M774INSAYVM&A775\x5FG776INSYVMA&TYR772\x5FALA775DUP&P\x2EE770\x5FA771INSAYVM&P\x2EA775\x5FG776INSYVMA&A775INSYVMA|NC\x5F000017\x2E10\x3Ag\x2E37880985\x5F37880996dupTACGTGATGGCT&ENST00000269571\x2E5\x3Ac\x2E2314\x5F2325dupTACGTGATGGCT&NM\x5F001005862\x2E2\x3Ac\x2E2224\x5F2235dupTACGTGATGGCT&NC\x5F000017\x2E10\x3Ag\x2E37880993\x5F37880994insGCTTACGTGATG|CA135369|44985|36.0|evidence|1888|https://civicdb.org/links/evidence/1888|22325357_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||C|3|||||,TACGTGATGGCT|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|M774INSAYVM&A775\x5FG776INSYVMA&TYR772\x5FALA775DUP&P\x2EE770\x5FA771INSAYVM&P\x2EA775\x5FG776INSYVMA&A775INSYVMA|NC\x5F000017\x2E10\x3Ag\x2E37880985\x5F37880996dupTACGTGATGGCT&ENST00000269571\x2E5\x3Ac\x2E2314\x5F2325dupTACGTGATGGCT&NM\x5F001005862\x2E2\x3Ac\x2E2224\x5F2235dupTACGTGATGGCT&NC\x5F000017\x2E10\x3Ag\x2E37880993\x5F37880994insGCTTACGTGATG|CA135369|44985|36.0|evidence|1893|https://civicdb.org/links/evidence/1893|25899785_(PubMed)|Somatic|accepted|Sensitivity/Response|Does_Not_Support|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||B|2|||||,TACGTGATGGCT|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|M774INSAYVM&A775\x5FG776INSYVMA&TYR772\x5FALA775DUP&P\x2EE770\x5FA771INSAYVM&P\x2EA775\x5FG776INSYVMA&A775INSYVMA|NC\x5F000017\x2E10\x3Ag\x2E37880985\x5F37880996dupTACGTGATGGCT&ENST00000269571\x2E5\x3Ac\x2E2314\x5F2325dupTACGTGATGGCT&NM\x5F001005862\x2E2\x3Ac\x2E2224\x5F2235dupTACGTGATGGCT&NC\x5F000017\x2E10\x3Ag\x2E37880993\x5F37880994insGCTTACGTGATG|CA135369|44985|36.0|evidence|1125|https://civicdb.org/links/evidence/1125|25789838_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Trastuzumab_Emtansine_(NCIt_ID_C82492)|||C|3|||||,TACGTGATGGCT|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|M774INSAYVM&A775\x5FG776INSYVMA&TYR772\x5FALA775DUP&P\x2EE770\x5FA771INSAYVM&P\x2EA775\x5FG776INSYVMA&A775INSYVMA|NC\x5F000017\x2E10\x3Ag\x2E37880985\x5F37880996dupTACGTGATGGCT&ENST00000269571\x2E5\x3Ac\x2E2314\x5F2325dupTACGTGATGGCT&NM\x5F001005862\x2E2\x3Ac\x2E2224\x5F2235dupTACGTGATGGCT&NC\x5F000017\x2E10\x3Ag\x2E37880993\x5F37880994insGCTTACGTGATG|CA135369|44985|36.0|evidence|1047|https://civicdb.org/links/evidence/1047|19122144_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Carcinoma_(DOID_3905)|Afatinib_(NCIt_ID_C66940)|||D|4|||||,TACGTGATGGCT|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|M774INSAYVM&A775\x5FG776INSYVMA&TYR772\x5FALA775DUP&P\x2EE770\x5FA771INSAYVM&P\x2EA775\x5FG776INSYVMA&A775INSYVMA|NC\x5F000017\x2E10\x3Ag\x2E37880985\x5F37880996dupTACGTGATGGCT&ENST00000269571\x2E5\x3Ac\x2E2314\x5F2325dupTACGTGATGGCT&NM\x5F001005862\x2E2\x3Ac\x2E2224\x5F2235dupTACGTGATGGCT&NC\x5F000017\x2E10\x3Ag\x2E37880993\x5F37880994insGCTTACGTGATG|CA135369|44985|36.0|evidence|1045|https://civicdb.org/links/evidence/1045|26559459_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||C|4|||||,TACGTGATGGCT|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|M774INSAYVM&A775\x5FG776INSYVMA&TYR772\x5FALA775DUP&P\x2EE770\x5FA771INSAYVM&P\x2EA775\x5FG776INSYVMA&A775INSYVMA|NC\x5F000017\x2E10\x3Ag\x2E37880985\x5F37880996dupTACGTGATGGCT&ENST00000269571\x2E5\x3Ac\x2E2314\x5F2325dupTACGTGATGGCT&NM\x5F001005862\x2E2\x3Ac\x2E2224\x5F2235dupTACGTGATGGCT&NC\x5F000017\x2E10\x3Ag\x2E37880993\x5F37880994insGCTTACGTGATG|CA135369|44985|36.0|evidence|960|https://civicdb.org/links/evidence/960|19122144_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sirolimus_(NCIt_ID_C1212)&Afatinib_(NCIt_ID_C66940)|Combination||D|3|||||
17	37880997	816	GG	CT	.	.	GN=ERBB2;VT=G776L;CSQ=CT|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2326_2327delinsCT||G776L|816|GLY776LEU|NM\x5F001289937\x2E1\x3Ac\x2E2326\x5F2327delinsCT&NP\x5F001276866\x2E1\x3Ap\x2EGly776Leu&NC\x5F000017\x2E10\x3Ag\x2E37880997\x5F37880998delinsCT&ENST00000269571\x2E5\x3Ac\x2E2326\x5F2327delinsCT|CA913189238|NONE_FOUND|7.5|evidence|1889|https://civicdb.org/links/evidence/1889|22325357_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||C|3|||||
17	37881000	44	G	T	.	.	GN=ERBB2;VT=V777L;CSQ=T|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2329G>T||V777L|44|RS121913471&VAL777LEU&V762L&V747L|NC\x5F000017\x2E10\x3Ag\x2E37881000G\x3ET&ENST00000269571\x2E5\x3Ac\x2E2329G\x3ET&NP\x5F004439\x2E2\x3Ap\x2EVal777Leu&NM\x5F004448\x2E3\x3Ac\x2E2329G\x3ET|CA135387|44991|9.0|evidence|1177|https://civicdb.org/links/evidence/1177|26243863_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colon_Cancer_(DOID_219)|Lapatinib_(NCIt_ID_C26653)&Neratinib_(NCIt_ID_C49094)&Trastuzumab_(NCIt_ID_C1647)|Combination||D|4|||||,T|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2329G>T||V777L|44|RS121913471&VAL777LEU&V762L&V747L|NC\x5F000017\x2E10\x3Ag\x2E37881000G\x3ET&ENST00000269571\x2E5\x3Ac\x2E2329G\x3ET&NP\x5F004439\x2E2\x3Ap\x2EVal777Leu&NM\x5F004448\x2E3\x3Ac\x2E2329G\x3ET|CA135387|44991|9.0|evidence|288|https://civicdb.org/links/evidence/288|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||
17	37881011	817	A	AGGCTCCCCA	.	.	GN=ERBB2;VT=G778_P780DUP;CSQ=GGCTCCCCA|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2332_2340dupGGCTCCCCA||G778_P780DUP|817|GLY778\x5FPRO780DUP|ENST00000269571\x2E5\x3Ac\x2E2332\x5F2340dupGGCTCCCCA&NM\x5F004448\x2E3\x3Ac\x2E2332\x5F2340dupGGCTCCCCA|CA135401|44993|15.0|evidence|1890|https://civicdb.org/links/evidence/1890|22325357_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Afatinib_(NCIt_ID_C66940)|||C|3|||||,GGCTCCCCA|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2332_2340dupGGCTCCCCA||G778_P780DUP|817|GLY778\x5FPRO780DUP|ENST00000269571\x2E5\x3Ac\x2E2332\x5F2340dupGGCTCCCCA&NM\x5F004448\x2E3\x3Ac\x2E2332\x5F2340dupGGCTCCCCA|CA135401|44993|15.0|evidence|1892|https://civicdb.org/links/evidence/1892|25899785_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Dacomitinib_(NCIt_ID_C53398)|||C|3|||||
17	37881011	41	A	AGGCTCCCCA	.	.	GN=ERBB2;VT=P780INS;CSQ=GGCTCCCCA|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2340_2341insGGCTCCCCA||P780INS|41|PRO780INS|NC\x5F000017\x2E10\x3Ag\x2E37881011\x5F37881012insGGCTCCCCA&ENST00000269571\x2E5\x3Ac\x2E2340\x5F2341insGGCTCCCCA|CA135401|NONE_FOUND|12.5|evidence|1048|https://civicdb.org/links/evidence/1048|25899785_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Adenocarcinoma_(DOID_3910)|Dacomitinib_(NCIt_ID_C53398)|||C|3|||||,GGCTCCCCA|inframe_insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2340_2341insGGCTCCCCA||P780INS|41|PRO780INS|NC\x5F000017\x2E10\x3Ag\x2E37881011\x5F37881012insGGCTCCCCA&ENST00000269571\x2E5\x3Ac\x2E2340\x5F2341insGGCTCCCCA|CA135401|NONE_FOUND|12.5|evidence|285|https://civicdb.org/links/evidence/285|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||
17	37881332	45	G	A	.	.	GN=ERBB2;VT=V842I;CSQ=A|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2524G>A||V842I|45|RS1057519738&VAL827ILE&VAL812ILE&V827I&V812I&VAL842ILE|NC\x5F000017\x2E10\x3Ag\x2E37881332G\x3EA&NP\x5F004439\x2E2\x3Ap\x2EVal842Ile&NM\x5F004448\x2E3\x3Ac\x2E2524G\x3EA&ENST00000269571\x2E5\x3Ac\x2E2524G\x3EA|CA16602468|375994|9.0|evidence|289|https://civicdb.org/links/evidence/289|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||,A|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2524G>A||V842I|45|RS1057519738&VAL827ILE&VAL812ILE&V827I&V812I&VAL842ILE|NC\x5F000017\x2E10\x3Ag\x2E37881332G\x3EA&NP\x5F004439\x2E2\x3Ap\x2EVal842Ile&NM\x5F004448\x2E3\x3Ac\x2E2524G\x3EA&ENST00000269571\x2E5\x3Ac\x2E2524G\x3EA|CA16602468|375994|9.0|evidence|1174|https://civicdb.org/links/evidence/1174|26243863_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colon_Cancer_(DOID_219)|Trastuzumab_(NCIt_ID_C1647)&Lapatinib_(NCIt_ID_C26653)&Neratinib_(NCIt_ID_C49094)|Combination||D|4|||||
17	37881378	873	A	G	.	.	GN=ERBB2;VT=N857S;CSQ=G|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2570A>G||N857S|873|RS28933370&N842S&N827S&ASN857SER|ENST00000269571\x2E5\x3Ac\x2E2570A\x3EG&NM\x5F004448\x2E3\x3Ac\x2E2570A\x3EG&NP\x5F004439\x2E2\x3Ap\x2EAsn857Ser&NC\x5F000017\x2E10\x3Ag\x2E37881378A\x3EG|CA123601|13880|3.0|evidence|1988|https://civicdb.org/links/evidence/1988|22046346_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Lapatinib_(NCIt_ID_C26653)|||D|3|||||
17	37881392	871	A	G	.	.	GN=ERBB2;VT=T862A;CSQ=G|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2584A>G||T862A|871|THR862ALA|NP\x5F001276866\x2E1\x3Ap\x2EThr862Ala&NM\x5F001289937\x2E1\x3Ac\x2E2584A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E37881392A\x3EG&ENST00000269571\x2E5\x3Ac\x2E2584A\x3EG|CA399304738|NONE_FOUND|3.0|evidence|1986|https://civicdb.org/links/evidence/1986|22046346_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Stomach_Carcinoma_(DOID_5517)|Lapatinib_(NCIt_ID_C26653)|||D|3|||||
17	37881404	496	C	A	.	.	GN=ERBB2;VT=L866M;CSQ=A|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2596C>A||L866M|496|LEU866MET|NP\x5F001276866\x2E1\x3Ap\x2ELeu866Met&NM\x5F001289937\x2E1\x3Ac\x2E2596C\x3EA&NC\x5F000017\x2E10\x3Ag\x2E37881404C\x3EA&ENST00000269571\x2E5\x3Ac\x2E2596C\x3EA|CA399304874|NONE_FOUND|4.0|evidence|1178|https://civicdb.org/links/evidence/1178|26243863_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Colon_Cancer_(DOID_219)|Neratinib_(NCIt_ID_C49094)&Lapatinib_(NCIt_ID_C26653)&Trastuzumab_(NCIt_ID_C1647)|Combination||D|4|||||
17	37881440	874	C	T	.	.	GN=ERBB2;VT=H878Y;CSQ=T|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2632C>T||H878Y|874|HIS878TYR|NP\x5F001276866\x2E1\x3Ap\x2EHis878Tyr&NM\x5F001289937\x2E1\x3Ac\x2E2632C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E37881440C\x3ET&ENST00000269571\x2E5\x3Ac\x2E2632C\x3ET|CA399305170|NONE_FOUND|3.0|evidence|1989|https://civicdb.org/links/evidence/1989|22046346_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Hepatocellular_Carcinoma_(DOID_684)|Lapatinib_(NCIt_ID_C26653)|||D|3|||||
17	37881616	43	C	T	.	.	GN=ERBB2;VT=R896C;CSQ=T|missense_variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2686C>T||R896C|43|RS758222990&R881C&R866C&ARG896CYS|NP\x5F004439\x2E2\x3Ap\x2EArg896Cys&NM\x5F004448\x2E3\x3Ac\x2E2686C\x3ET&ENST00000269571\x2E5\x3Ac\x2E2686C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E37881616C\x3ET|CA8534359|375995|5.0|evidence|287|https://civicdb.org/links/evidence/287|23220880_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Breast_Cancer_(DOID_1612)|Neratinib_(NCIt_ID_C49094)|||D|5|||||
17	41199682	1555	C	T	.	.	GN=BRCA1;VT=W1815X;CSQ=T|stop_gained|BRCA1|672|transcript|None|||W1815X|1555|W711X&W673X&W664X&W632X&W48X&W306X&W1836X&W1768X&W1576X&W1550X&W1519X&W125X||CA003600||0.0|evidence|4623|https://civicdb.org/links/evidence/4623|23415752_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Olaparib_(NCIt_ID_C71721)|||D|None|||||
17	41219625	1244	C	T	.	.	GN=BRCA1;VT=D1692N;CSQ=T|missense_variant|BRCA1|672|transcript|ENST00000357654.3|ENST00000357654.3:c.5074G>A||D1692N|1244|RS80187739&ASP1692ASN|ENST00000357654\x2E3\x3Ac\x2E5074G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E41219625C\x3ET&NP\x5F009225\x2E1\x3Ap\x2EAsp1692Asn&NM\x5F007294\x2E3\x3Ac\x2E5074G\x3EA|CA003201|37632|0.0|evidence|2876|https://civicdb.org/links/evidence/2876|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41226348	1243	C	T	.	.	GN=BRCA1;VT=E1559K;CSQ=T|missense_variant|BRCA1|672|transcript|ENST00000357654.3|ENST00000357654.3:c.4675G>A||E1559K|1243|RS80356988&GLU1559LYS|ENST00000357654\x2E3\x3Ac\x2E4675G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E41226348C\x3ET&NP\x5F009225\x2E1\x3Ap\x2EGlu1559Lys&NM\x5F007294\x2E3\x3Ac\x2E4675G\x3EA|CA002963|37604|0.0|evidence|2875|https://civicdb.org/links/evidence/2875|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41228505	1242	C	A	.	.	GN=BRCA1;VT=R1495M;CSQ=A|missense_variant|BRCA1|672|transcript|ENST00000357654.3|ENST00000357654.3:c.4484G>T||R1495M|1242|R1516M&ARG1495MET|NC\x5F000017\x2E10\x3Ag\x2E41228505C\x3EA&NP\x5F009225\x2E1\x3Ap\x2EArg1495Met&NM\x5F007294\x2E3\x3Ac\x2E4484G\x3ET&ENST00000357654\x2E3\x3Ac\x2E4484G\x3ET|CA002876|37598|0.0|evidence|2874|https://civicdb.org/links/evidence/2874|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41228590	1246	G	A	.	.	GN=BRCA1;VT=Q1467*;CSQ=A|stop_gained|BRCA1|672|transcript|ENST00000357654.3|ENST00000357654.3:c.4399C>T||Q1467*|1246|RS397509171&GLN1467TER&Q1467X|ENST00000357654\x2E3\x3Ac\x2E4399C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E41228590G\x3EA&NP\x5F009225\x2E1\x3Ap\x2EGln1467Ter&NM\x5F007294\x2E3\x3Ac\x2E4399C\x3ET|CA002821|55191|0.0|evidence|2878|https://civicdb.org/links/evidence/2878|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41234451	1245	G	A	.	.	GN=BRCA1;VT=R1443*;CSQ=A|stop_gained|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.4327C>T||R1443*|1245|RS41293455&ARG1443TER&R1443X|ENST00000471181\x2E2\x3Ac\x2E4327C\x3ET&NC\x5F000017\x2E10\x3Ag\x2E41234451G\x3EA&NP\x5F009225\x2E1\x3Ap\x2EArg1443Ter&NM\x5F007294\x2E3\x3Ac\x2E4327C\x3ET|CA002769|17675|0.0|evidence|2877|https://civicdb.org/links/evidence/2877|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41244645	477	G	GGA	.	.	GN=BRCA1;VT=P968FS;CSQ=GA|frameshift_truncation|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.2902_2903insTC||P968FS|477|RS398122670&PRO968LEUFS&3021INSTC|ENST00000471181\x2E2\x3Ac\x2E2902\x5F2903insTC&NC\x5F000017\x2E10\x3Ag\x2E41244645\x5F41244646insGA&NP\x5F009225\x2E1\x3Ap\x2EPro968Leufs&NM\x5F007294\x2E3\x3Ac\x2E2902\x5F2903insTC|CA001889|91602|20.0|evidence|1123|https://civicdb.org/links/evidence/1123|24137399_(PubMed)|Rare_Germline|accepted|Likely_Pathogenic|Supports|Breast_Cancer_(DOID_1612)||||C|4|||||,GA|frameshift_truncation|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.2902_2903insTC||P968FS|477|RS398122670&PRO968LEUFS&3021INSTC|ENST00000471181\x2E2\x3Ac\x2E2902\x5F2903insTC&NC\x5F000017\x2E10\x3Ag\x2E41244645\x5F41244646insGA&NP\x5F009225\x2E1\x3Ap\x2EPro968Leufs&NM\x5F007294\x2E3\x3Ac\x2E2902\x5F2903insTC|CA001889|91602|20.0|evidence|1124|https://civicdb.org/links/evidence/1124|24137399_(PubMed)|Rare_Germline|accepted|Pathogenic|Supports|Ovarian_Cancer_(DOID_2394)||||C|4|||||
17	41258473	1241	C	T	.	.	GN=BRCA1;VT=R71K;CSQ=T|missense_variant|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.212G>A||R71K|1241|RS80356913&ARG71LYS|ENST00000471181\x2E2\x3Ac\x2E212G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E41258473C\x3ET&NP\x5F009225\x2E1\x3Ap\x2EArg71Lys&NM\x5F007294\x2E3\x3Ac\x2E212G\x3EA|CA001420|54471|0.0|evidence|2873|https://civicdb.org/links/evidence/2873|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41258474	1240	T	C	.	.	GN=BRCA1;VT=R71G;CSQ=C|missense_variant|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.211A>G||R71G|1240|RS80357382&ARG71GLY|ENST00000471181\x2E2\x3Ac\x2E211A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E41258474T\x3EC&NP\x5F009225\x2E1\x3Ap\x2EArg71Gly&NM\x5F007294\x2E3\x3Ac\x2E211A\x3EG|CA001398|17693|0.0|evidence|2872|https://civicdb.org/links/evidence/2872|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41258494	1239	C	T	.	.	GN=BRCA1;VT=C64Y;CSQ=T|missense_variant|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.191G>A||C64Y|1239|RS55851803&CYS64TYR|ENST00000471181\x2E2\x3Ac\x2E191G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E41258494C\x3ET&NP\x5F009225\x2E1\x3Ap\x2ECys64Tyr&NM\x5F007294\x2E3\x3Ac\x2E191G\x3EA|CA001262|54400|0.0|evidence|2871|https://civicdb.org/links/evidence/2871|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41258504	1238	A	C	.	.	GN=BRCA1;VT=C61G;CSQ=C|missense_variant|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.181T>G||C61G|1238|RS28897672&CYS61GLY|ENST00000471181\x2E2\x3Ac\x2E181T\x3EG&NC\x5F000017\x2E10\x3Ag\x2E41258504A\x3EC&NP\x5F009225\x2E1\x3Ap\x2ECys61Gly&NM\x5F007294\x2E3\x3Ac\x2E181T\x3EG|CA001182|17661|0.0|evidence|2870|https://civicdb.org/links/evidence/2870|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41276111	1237	C	A	.	.	GN=BRCA1;VT=M1I;CSQ=A|start_lost|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.3G>T||M1I|1237|MET1ILE|ENST00000471181\x2E2\x3Ac\x2E3G\x3ET&NC\x5F000017\x2E10\x3Ag\x2E41276111C\x3EA&NP\x5F009225\x2E1\x3Ap\x2EMet1Ile&NM\x5F007294\x2E3\x3Ac\x2E3G\x3ET|CA002562|55072|0.0|evidence|2869|https://civicdb.org/links/evidence/2869|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	41276113	1236	T	C	.	.	GN=BRCA1;VT=M1V;CSQ=C|start_lost|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.1A>G||M1V|1236|RS80357287&MET1VAL|ENST00000471181\x2E2\x3Ac\x2E1A\x3EG&NC\x5F000017\x2E10\x3Ag\x2E41276113T\x3EC&NP\x5F009225\x2E1\x3Ap\x2EMet1Val&NM\x5F007294\x2E3\x3Ac\x2E1A\x3EG|CA001332|54432|0.0|evidence|2868|https://civicdb.org/links/evidence/2868|27908594_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Ovarian_Cancer_(DOID_2394)|Rucaparib_(NCIt_ID_C137800)|||C|None|||||
17	46805705	772	C	T	.	.	GN=HOXB13;VT=G84E;CSQ=T|missense_variant|HOXB13|10481|transcript|ENST00000290295.7|ENST00000290295.7:c.251G>A||G84E|772|GLY84GLU&RS138213197|ENST00000290295\x2E7\x3Ac\x2E251G\x3EA&NP\x5F006352\x2E2\x3Ap\x2EGly84Glu&NM\x5F006361\x2E5\x3Ac\x2E251G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E46805705C\x3ET|CA288225|128031|40.0|evidence|1760|https://civicdb.org/links/evidence/1760|26108461_(PubMed)|Common_Germline|accepted|Uncertain_Significance|Supports|Prostate_Cancer_(DOID_10283)||||B|4|||||,T|missense_variant|HOXB13|10481|transcript|ENST00000290295.7|ENST00000290295.7:c.251G>A||G84E|772|GLY84GLU&RS138213197|ENST00000290295\x2E7\x3Ac\x2E251G\x3EA&NP\x5F006352\x2E2\x3Ap\x2EGly84Glu&NM\x5F006361\x2E5\x3Ac\x2E251G\x3EA&NC\x5F000017\x2E10\x3Ag\x2E46805705C\x3ET|CA288225|128031|40.0|evidence|1836|https://civicdb.org/links/evidence/1836|27626483_(PubMed)|Rare_Germline|accepted|Positive|Supports|Prostate_Cancer_(DOID_10283)||||B|4|||||
18	42531913	351	G	A	.	.	GN=SETBP1;VT=G870S;CSQ=A|missense_variant|SETBP1|26040|transcript|ENST00000282030.5|ENST00000282030.5:c.2608G>A||G870S|351|RS267607040&GLY870SER|NC\x5F000018\x2E9\x3Ag\x2E42531913G\x3EA&ENST00000282030\x2E5\x3Ac\x2E2608G\x3EA&NP\x5F056374\x2E2\x3Ap\x2EGly870Ser&NM\x5F015559\x2E2\x3Ac\x2E2608G\x3EA|CA114719|1035|3.0|evidence|840|https://civicdb.org/links/evidence/840|23222956_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Chronic_Myeloid_Leukemia_(DOID_8552)||||D|3|||||
19	1220489	634	C	A	.	.	GN=STK11;VT=D194E;CSQ=A|loss_of_heterozygosity&missense_variant|STK11|6794|transcript|ENST00000326873.7|ENST00000326873.7:c.582C>A||D194E|634|RS786202134&ASP194GLU|ENST00000326873\x2E7\x3Ac\x2E582C\x3EA&NP\x5F000446\x2E1\x3Ap\x2EAsp194Glu&NM\x5F000455\x2E4\x3Ac\x2E582C\x3EA&NC\x5F000019\x2E9\x3Ag\x2E1220489C\x3EA|CA023096|185384|5.0|evidence|1617|https://civicdb.org/links/evidence/1617|21189378_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Pancreatic_Cancer_(DOID_1793)|Everolimus_(NCIt_ID_C48387)|||C|2|||||
19	7975157	566	G	A	.	.	GN=MAP2K7;VT=E116K;CSQ=A|missense_variant|MAP2K7|5609|transcript|ENST00000397979.3|||E116K|566|GLU116LYS|NC\x5F000019\x2E9\x3Ag\x2E7975157G\x3EA|CA304968685|NONE_FOUND|25.0|evidence|1420|https://civicdb.org/links/evidence/1420|27028764_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Lung_Cancer_(DOID_1324)||||B|5|||||
19	44055726	261	T	C	.	.	GN=XRCC1;VT=Q399R;CSQ=C|missense_variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.1196A>G||Q399R|261|RS25487&GLN399ARG|ENST00000262887\x2E5\x3Ac\x2E1196A\x3EG&NC\x5F000019\x2E9\x3Ag\x2E44055726T\x3EC&NP\x5F006288\x2E2\x3Ap\x2EGln399Arg&NM\x5F006297\x2E2\x3Ac\x2E1196A\x3EG|CA9488516|225976|40.0|evidence|673|https://civicdb.org/links/evidence/673|16875718_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Cervical_Cancer_(DOID_4362)|Cisplatin_(NCIt_ID_C376)&Carboplatin_(NCIt_ID_C1282)|Substitutes||B|4|||||,C|missense_variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.1196A>G||Q399R|261|RS25487&GLN399ARG|ENST00000262887\x2E5\x3Ac\x2E1196A\x3EG&NC\x5F000019\x2E9\x3Ag\x2E44055726T\x3EC&NP\x5F006288\x2E2\x3Ap\x2EGln399Arg&NM\x5F006297\x2E2\x3Ac\x2E1196A\x3EG|CA9488516|225976|40.0|evidence|672|https://civicdb.org/links/evidence/672|22551904_(PubMed)|Rare_Germline|accepted|Better_Outcome|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)||||B|4|||||
19	44057574	249	G	A	.	.	GN=XRCC1;VT=R194W;CSQ=A|missense_variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.580C>T||R194W|249|ARG194TRP&RS1799782|ENST00000262887\x2E5\x3Ac\x2E580C\x3ET&NP\x5F006288\x2E2\x3Ap\x2EArg194Trp&NM\x5F006297\x2E2\x3Ac\x2E580C\x3ET&NC\x5F000019\x2E9\x3Ag\x2E44057574G\x3EA|CA9488737|376355|20.0|evidence|659|https://civicdb.org/links/evidence/659|19157633_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Docetaxel_(NCIt_ID_C1526)&Vinorelbine_(NCIt_ID_C1275)&Gemcitabine_(NCIt_ID_C66876)|Substitutes||B|4|||||
19	45854919	264	T	G	.	.	GN=ERCC2;VT=K751Q;CSQ=G|missense_variant|ERCC2|2068|transcript|ENST00000391945.4|||K751Q|264|LYS751GLN|NC\x5F000019\x2E9\x3Ag\x2E45854919T\x3EG|CA158782|134105|35.0|evidence|677|https://civicdb.org/links/evidence/677|19470925_(PubMed)|Rare_Germline|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Carboplatin_(NCIt_ID_C1282)&Paclitaxel_(NCIt_ID_C1411)|Combination||B|3|||||,G|missense_variant|ERCC2|2068|transcript|ENST00000391945.4|||K751Q|264|LYS751GLN|NC\x5F000019\x2E9\x3Ag\x2E45854919T\x3EG|CA158782|134105|35.0|evidence|676|https://civicdb.org/links/evidence/676|19434073_(PubMed)|Rare_Germline|accepted|Resistance|Supports|Osteosarcoma_(DOID_3347)|Cisplatin_(NCIt_ID_C376)|||B|4|||||
19	49377242	548	G	C	.	.	GN=PPP1R15A;VT=RS557806;CSQ=C|polymorphic_sequence_variant&missense_variant|PPP1R15A|23645|transcript|ENST00000200453.5|ENST00000200453.5:c.752G>C||RS557806|548|R251P&ARG251PRO|NC\x5F000019\x2E9\x3Ag\x2E49377242G\x3EC&ENST00000200453\x2E5\x3Ac\x2E752G\x3EC&NP\x5F055145\x2E3\x3Ap\x2EArg251Pro&NM\x5F014330\x2E3\x3Ac\x2E752G\x3EC|CA9560103|NONE_FOUND|5.0|evidence|1325|https://civicdb.org/links/evidence/1325|27177629_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Colorectal_Cancer_(DOID_9256)|FOLFIRI_Regimen_(NCIt_ID_C63593)&Bevacizumab_(NCIt_ID_C2039)|Combination||B|1|||||
20	57428713	877	T	C	.	.	GN=GNAS;VT=T393C;CSQ=C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|1996|https://civicdb.org/links/evidence/1996|17356712_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Intrahepatic_Cholangiocarcinoma_(DOID_4928)||||B|3|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|1997|https://civicdb.org/links/evidence/1997|17186357_(PubMed)|Common_Germline|accepted|Poor_Outcome|Supports|Breast_Carcinoma_(DOID_3459)||||B|4|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|1995|https://civicdb.org/links/evidence/1995|24758907_(PubMed)|Common_Germline|accepted|Resistance|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Erlotinib_(NCIt_ID_C65530)&Gefitinib_(NCIt_ID_C1855)|Substitutes||B|2|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|2893|https://civicdb.org/links/evidence/2893|16033819_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Colorectal_Cancer_(DOID_9256)||||B|4|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|2897|https://civicdb.org/links/evidence/2897|17020971_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)||||B|4|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|2896|https://civicdb.org/links/evidence/2896|16467086_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Clear_Cell_Renal_Cell_Carcinoma_(DOID_4467)||||B|4|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|2898|https://civicdb.org/links/evidence/2898|21156401_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Melanoma_(DOID_1909)||||B|4|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|2895|https://civicdb.org/links/evidence/2895|19274060_(PubMed)|Common_Germline|accepted|Resistance|Supports|Esophageal_Cancer_(DOID_5041)|Fluorouracil_(NCIt_ID_C505)&Cisplatin_(NCIt_ID_C376)|Combination||B|4|||||,C|missense_variant|GNAS|2778|transcript|ENST00000371100|||T393C|877|||CA409455494||165.0|evidence|2892|https://civicdb.org/links/evidence/2892|15824158_(PubMed)|Common_Germline|accepted|Better_Outcome|Supports|Bladder_Urothelial_Carcinoma_(DOID_4006)||||B|4|||||
20	57484420	826	C	T	.	.	GN=GNAS;VT=R201C;CSQ=T|missense_variant|GNAS|2778|transcript|ENST00000371085.3|ENST00000371085.3:c.601C>T||R201C|826|RS11554273&R202C&ARG201CYS|ENST00000371085\x2E3\x3Ac\x2E601C\x3ET&NC\x5F000020\x2E10\x3Ag\x2E57484420C\x3ET&NP\x5F000507\x2E1\x3Ap\x2EArg201Cys&NM\x5F000516\x2E5\x3Ac\x2E601C\x3ET|CA126067|15933|5.0|evidence|1906|https://civicdb.org/links/evidence/1906|27729313_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|2|||||
21	36171704	803	G	T	.	.	GN=RUNX1;VT=Y260*;CSQ=T|stop_gained|RUNX1|861|transcript|ENST00000344691.4|ENST00000344691.4:c.780C>A||Y260*|803|RS121912499&TYR260TER&Y260X|ENST00000344691\x2E4\x3Ac\x2E780C\x3EA&NC\x5F000021\x2E8\x3Ag\x2E36171704G\x3ET&NP\x5F001001890\x2E1\x3Ap\x2ETyr260Ter&NM\x5F001001890\x2E2\x3Ac\x2E780C\x3EA|CA248619|14467|7.5|evidence|1872|https://civicdb.org/links/evidence/1872|11830488_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||C|3|||||
21	36231792	806	C	A	.	.	GN=RUNX1;VT=D198Y;CSQ=A|loss_of_function_variant&missense_variant|RUNX1|861|transcript|ENST00000300305.3|||D198Y|806|ASP198TYR|NC\x5F000021\x2E8\x3Ag\x2E36231792C\x3EA|CA410207975|NONE_FOUND|7.5|evidence|1875|https://civicdb.org/links/evidence/1875|11675361_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||C|3|||||
21	36252912	810	GGCTGCGGT	G	.	.	GN=RUNX1;VT=T148HFSX9;CSQ=-|frameshift_truncation|RUNX1|861|transcript|ENST00000300305.3|ENST00000300305.3:c.442_449delACCGCAGC||T148HFSX9|810|RS587776811&THR148HISFSX9&C\x2E442\x5F449DEL|ENST00000300305\x2E3\x3Ac\x2E442\x5F449delACCGCAGC&NC\x5F000021\x2E8\x3Ag\x2E36252913\x5F36252920del&NP\x5F001745\x2E2\x3Ap\x2EThr148Hisfs&NM\x5F001754\x2E4\x3Ac\x2E442\x5F449delACCGCAGC|CA248627|14470|5.0|evidence|1882|https://civicdb.org/links/evidence/1882|18478040_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||C|2|||||
21	36252962	807	C	G	.	.	GN=RUNX1;VT=A107P;CSQ=G|missense_variant|RUNX1|861|transcript|ENST00000344691.4|ENST00000344691.4:c.400G>C||A107P|807|RS74315451&ALA134PRO&A134P|ENST00000344691\x2E4\x3Ac\x2E400G\x3EC&NC\x5F000021\x2E8\x3Ag\x2E36252962C\x3EG&NP\x5F001745\x2E2\x3Ap\x2EAla134Pro&NM\x5F001754\x2E4\x3Ac\x2E400G\x3EC|CA248623|14468|12.5|evidence|1876|https://civicdb.org/links/evidence/1876|12060124_(PubMed)|Rare_Germline|accepted|Positive|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||C|5|||||
21	36259163	802	T	C	.	.	GN=RUNX1;VT=K83E;CSQ=C|missense_variant|RUNX1|861|transcript|ENST00000344691.4|ENST00000344691.4:c.247A>G||K83E|802|RS121912498&K110E&LYS83GLU|ENST00000344691\x2E4\x3Ac\x2E247A\x3EG&NM\x5F001001890\x2E2\x3Ac\x2E247A\x3EG&NP\x5F001001890\x2E1\x3Ap\x2ELys83Glu&NC\x5F000021\x2E8\x3Ag\x2E36259163T\x3EC|CA248613|14465|10.0|evidence|1871|https://civicdb.org/links/evidence/1871|11830488_(PubMed)|Rare_Germline|accepted|Likely_Pathogenic|Supports|Acute_Myeloid_Leukemia_(DOID_9119)||||C|4|||||
21	40191638	445	A	G	.	.	GN=ETS2;VT=RS461155;CSQ=G|synonymous_variant|ETS2|2114|transcript|ENST00000360214.3|||RS461155|445||NC\x5F000021\x2E8\x3Ag\x2E40191638A\x3EG|CA10025650||10.0|evidence|1060|https://civicdb.org/links/evidence/1060|26893365_(PubMed)|Common_Germline|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Cisplatin_(NCIt_ID_C376)&Paclitaxel_(NCIt_ID_C1411)|Combination||B|2|||||
21	44514777	127	T	G	.	.	GN=U2AF1;VT=Q157P/R;CSQ=G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|217|https://civicdb.org/links/evidence/217|23029227_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||,G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|338|https://civicdb.org/links/evidence/338|23029227_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|2|||||,G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|339|https://civicdb.org/links/evidence/339|23029227_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Myelodysplastic_Syndrome_(DOID_0050908)||||B|2|||||,G|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||NC\x5F000021\x2E8\x3Ag\x2E44514777T\x3EG|None||50.0|evidence|400|https://civicdb.org/links/evidence/400|23861105_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Myelodysplastic_Syndrome_(DOID_0050908)||||B|3|||||
21	44524456	128	G	A	.	.	GN=U2AF1;VT=S34Y/F;CSQ=A|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||S34Y/F|128||NC\x5F000021\x2E8\x3Ag\x2E44524456G\x3EA|None||40.0|evidence|401|https://civicdb.org/links/evidence/401|23861105_(PubMed)|Somatic|accepted|Poor_Outcome|Supports|Myelodysplastic_Syndrome_(DOID_0050908)||||B|3|||||,A|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||S34Y/F|128||NC\x5F000021\x2E8\x3Ag\x2E44524456G\x3EA|None||40.0|evidence|340|https://civicdb.org/links/evidence/340|23029227_(PubMed)|Somatic|accepted|N/A|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|2|||||,A|missense_variant|U2AF1|7307|transcript|ENST00000291552.4|||S34Y/F|128||NC\x5F000021\x2E8\x3Ag\x2E44524456G\x3EA|None||40.0|evidence|218|https://civicdb.org/links/evidence/218|23029227_(PubMed)|Somatic|accepted|Positive|Does_Not_Support|Acute_Myeloid_Leukemia_(DOID_9119)||||B|3|||||
22	22127164	320	C	T	.	.	GN=MAPK1;VT=E322K;CSQ=T|gain_of_function_variant&missense_variant|MAPK1|5594|transcript|ENST00000215832.6|ENST00000215832.6:c.964G>A||E322K|320|GLU322LYS|NM\x5F002745\x2E4\x3Ac\x2E964G\x3EA&NP\x5F002736\x2E3\x3Ap\x2EGlu322Lys&NC\x5F000002\x2E11\x3Ag\x2E22127164C\x3ET&ENST00000215832\x2E6\x3Ac\x2E964G\x3EA|CA16602885|376450|10.0|evidence|791|https://civicdb.org/links/evidence/791|26181029_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Head_And_Neck_Squamous_Cell_Carcinoma_(DOID_5520)|Erlotinib_(NCIt_ID_C65530)|||C|4|||||
22	29091856	785	AG	A	.	.	GN=CHEK2;VT=1100DELC;CSQ=-|frameshift_truncation|CHEK2|11200|transcript|ENST00000328354.6|ENST00000328354.6:c.1100delC||1100DELC|785|RS555607708&THR367METFS|NC\x5F000022\x2E10\x3Ag\x2E29091857del&ENST00000328354\x2E6\x3Ac\x2E1100delC&NP\x5F009125\x2E1\x3Ap\x2EThr367Metfs&NM\x5F007194\x2E3\x3Ac\x2E1100delC&NC\x5F000022\x2E10\x3Ag\x2E29091857delG|CA288251|128042|15.0|evidence|1850|https://civicdb.org/links/evidence/1850|26629066_(PubMed)|Rare_Germline|accepted|Positive|Supports|Prostate_Cancer_(DOID_10283)||||B|3|||||
22	29121087	787	A	G	.	.	GN=CHEK2;VT=I157T;CSQ=G|missense_variant|CHEK2|11200|transcript|ENST00000328354.6|ENST00000328354.6:c.470T>C||I157T|787|RS17879961&I200T&ILE157THR|NC\x5F000022\x2E10\x3Ag\x2E29121087A\x3EG&ENST00000328354\x2E6\x3Ac\x2E470T\x3EC&NP\x5F009125\x2E1\x3Ap\x2EIle157Thr&NM\x5F007194\x2E3\x3Ac\x2E470T\x3EC|CA117630|5591|15.0|evidence|1852|https://civicdb.org/links/evidence/1852|26629066_(PubMed)|Rare_Germline|accepted|Uncertain_Significance|Supports|Prostate_Cancer_(DOID_10283)||||B|3|||||
22	30051593	245	T	TT	.	.	GN=NF2;VT=Y177FS;CSQ=T|frameshift_elongation|NF2|4771|transcript|ENST00000338641.4|ENST00000338641.4:c.527_528insT||Y177FS|245|TYR177FS|NC\x5F000022\x2E10\x3Ag\x2E30051593\x5F30051594insT&ENST00000338641\x2E4\x3Ac\x2E527\x5F528insT|CA645601016|NONE_FOUND|7.5|evidence|649|https://civicdb.org/links/evidence/649|25798586_(PubMed)|Somatic|accepted|Resistance|Supports|Peritoneal_Mesothelioma_(DOID_1788)|Cisplatin_(NCIt_ID_C376)&Carboplatin_(NCIt_ID_C1282)|Substitutes||C|3|||||
X	47426121	10	C	G	.	.	GN=ARAF;VT=S214C;CSQ=G|missense_variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|RS1057519786&SER214CYS|ENST00000377045\x2E4\x3Ac\x2E641C\x3EG&NP\x5F001645\x2E1\x3Ap\x2ESer214Cys&NM\x5F001654\x2E4\x3Ac\x2E641C\x3EG&NC\x5F000023\x2E10\x3Ag\x2E47426121C\x3EG|CA16602595|376137|11.0|evidence|41|https://civicdb.org/links/evidence/41|24569458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Trametinib_(NCIt_ID_C77908)|||D|3|||||,G|missense_variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|RS1057519786&SER214CYS|ENST00000377045\x2E4\x3Ac\x2E641C\x3EG&NP\x5F001645\x2E1\x3Ap\x2ESer214Cys&NM\x5F001654\x2E4\x3Ac\x2E641C\x3EG&NC\x5F000023\x2E10\x3Ag\x2E47426121C\x3EG|CA16602595|376137|11.0|evidence|40|https://civicdb.org/links/evidence/40|24569458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sorafenib_(NCIt_ID_C61948)|||D|3|||||,G|missense_variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|RS1057519786&SER214CYS|ENST00000377045\x2E4\x3Ac\x2E641C\x3EG&NP\x5F001645\x2E1\x3Ap\x2ESer214Cys&NM\x5F001654\x2E4\x3Ac\x2E641C\x3EG&NC\x5F000023\x2E10\x3Ag\x2E47426121C\x3EG|CA16602595|376137|11.0|evidence|17|https://civicdb.org/links/evidence/17|24569458_(PubMed)|Somatic|accepted|Sensitivity/Response|Supports|Lung_Non-small_Cell_Carcinoma_(DOID_3908)|Sorafenib_(NCIt_ID_C61948)|||C|2|||||
X	47429340	825	T	A	.	.	GN=ARAF;VT=S490T;CSQ=A|missense_variant|ARAF|369|transcript|ENST00000377045.4|||S490T|825|SER490THR||CA412818377|NONE_FOUND|2.5|evidence|1905|https://civicdb.org/links/evidence/1905|27729313_(PubMed)|Somatic|accepted|Resistance|Supports|Colorectal_Cancer_(DOID_9256)|Irinotecan_(NCIt_ID_C62040)&Cetuximab_(NCIt_ID_C1723)&Vemurafenib_(NCIt_ID_C64768)|Combination||C|1|||||
X	66943549	175	T	C	.	.	GN=AR;VT=F877L;CSQ=C|missense_variant|AR|367|transcript|ENST00000374690.3|ENST00000374690.3:c.2629T>C||F877L|175|PHE877LEU|NP\x5F000035\x2E2\x3Ap\x2EPhe877Leu&NM\x5F000044\x2E4\x3Ac\x2E2629T\x3EC&NC\x5F000023\x2E10\x3Ag\x2E66943549T\x3EC&ENST00000374690\x2E3\x3Ac\x2E2629T\x3EC|CA16602789|376347|4.0|evidence|447|https://civicdb.org/links/evidence/447|23779130_(PubMed)|Somatic|accepted|Resistance|Supports|Prostate_Cancer_(DOID_10283)|Apalutamide_(NCIt_ID_C92574)&Enzalutamide_(NCIt_ID_C71744)|Substitutes||D|4|||||
X	100611165	168	A	T	.	.	GN=BTK;VT=C481S;CSQ=T|missense_variant|BTK|695|transcript|ENST00000308731.7|ENST00000308731.7:c.1441T>A||C481S|168|RS1057519826&CYS481SER|NP\x5F000052\x2E1\x3Ap\x2ECys481Ser&NM\x5F000061\x2E2\x3Ac\x2E1441T\x3EA&ENST00000308731\x2E7\x3Ac\x2E1441T\x3EA&NC\x5F000023\x2E10\x3Ag\x2E100611165A\x3ET|CA16602659|376204|40.0|evidence|1770|https://civicdb.org/links/evidence/1770|26182309_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Ibrutinib_(NCIt_ID_C81934)|||B|4|||||,T|missense_variant|BTK|695|transcript|ENST00000308731.7|ENST00000308731.7:c.1441T>A||C481S|168|RS1057519826&CYS481SER|NP\x5F000052\x2E1\x3Ap\x2ECys481Ser&NM\x5F000061\x2E2\x3Ac\x2E1441T\x3EA&ENST00000308731\x2E7\x3Ac\x2E1441T\x3EA&NC\x5F000023\x2E10\x3Ag\x2E100611165A\x3ET|CA16602659|376204|40.0|evidence|436|https://civicdb.org/links/evidence/436|24869598_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Ibrutinib_(NCIt_ID_C81934)|||B|4|||||
X	100613633	870	T	C	.	.	GN=BTK;VT=T316A;CSQ=C|missense_variant|BTK|695|transcript|ENST00000308731.7|ENST00000308731.7:c.946T>C||T316A|870|THR316ALA|NC\x5F000023\x2E10\x3Ag\x2E100613633T\x3EC&NM\x5F000061\x2E2\x3Ac\x2E946T\x3EC&ENST00000308731\x2E7\x3Ac\x2E946T\x3EC|CA413928923|NONE_FOUND|10.0|evidence|1985|https://civicdb.org/links/evidence/1985|27626698_(PubMed)|Somatic|accepted|Resistance|Supports|Chronic_Lymphocytic_Leukemia_(DOID_1040)|Ibrutinib_(NCIt_ID_C81934)|||C|4|||||
